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Abstract 
Temperature, water, and light are three stress factors that have major influences on 
plant growth, development, and reproduction. Plants can be primed to an acclimated state 
by a prior mild stress to enhance their resistance to future stress. ‘Priming’ is related to 
plant stress ‘memory’ during recovery. Plants may need to balance between keeping the 
memory for enhanced stress defense and resetting for maximum growth and development 
during recovery. In the field, plants are more often to encounter a combination of different 
abiotic stresses rather than a specific single stress condition. Plant responses to a 
combination of stresses may exhibit quite unique defense and acclimation responses as 
compared to the response elicited by each individual stress, which should not be simply 
considered as the sum of the two different stresses. However, the simultaneous occurrence 
of multiple stress events is rarely studied experimentally, especially by metabolomics 
methods. Metabolomics, the comprehensive, quantitative and qualitative analysis of small 
molecules, is an emerging 'omics' platform that is an important next-generation systems 
biology approach. By providing an instantaneous “snapshot” of metabolic processes that 
occur in an organism, metabolomics can potentially provide insightful molecular 
mechanism information to questions about physiological function in complex biological 
systems.  
The objective of this thesis research was to use both untargeted and targeted 
metabolomics approaches to investigate plant shared and unique metabolic features in 
responses to single as well as multiple abiotic stresses, the priming effect of temperature 
stresses, plant memory during recovery phase, and the relationships between combined 
stress with each of individual stresses. An ultra-high pressure liquid chromatography-high 
resolution mass spectrometry (UHPLC-HR-MS)-based metabolomics approach was 
utilized. In chapter two, a metabolomics study on Arabidopsis thaliana 11-day-old 
seedling’s abiotic stress responses including heat (basal and acquired), cold (basal and 
acquired), drought and high light with 2-day-recovery was performed using a standardized 
reference system. In chapter three, Arabidopsis thaliana 11-day-old seedlings that were 
induced by the combination of different abiotic stresses including heat, cold, drought, 
salinity, and high light, that mimics field environment was studied. 
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From this thesis research, a number of potential stress signatures determined from 
the untargeted analysis were identified, quantified and clustered by stress response patterns. 
Central metabolism were found to undergo a complex regulatory process in response to 
stress. Shared and unique metabolic signatures were identified across different abiotic 
single and combined stresses. The majority of stress signatures clustered together and 
exhibited shared response patterns. However, cysteine, glutathione, and maltose showed 
unique and dramatic patterns, demonstrating large changes in glutathione biosynthesis, 
glutathione oxidation, and starch degradation. The results showed that only two combined 
stresses, including high light x cold and cold x salinity, had metabolic effects that reflected  
both of their constituent single stresses. Most combined stresses had one dominant stress 
that had a defining impact on the plant metabolic profile. Drought stress is the dominant 
stress for all of its stress combinations. Two combined stresses, including high light x heat 
and high light x salinity, showed unique metabolic stress response patterns that are not 
similar to any of their individual stresses.  Most of these metabolic features were 
specifically changed only in the combined stress, which should thus be considered as novel 
stress conditions. In summary, this work utilized metabolomics to study plant priming 
effects, recovery processes, and combined stress responses. It led to an improved 
understanding of how plants respond to abiotic stresses and may support subsequent studies 
on plant abiotic stress metabolic flux analyses. 
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Chapter 1. Introduction: plant abiotic stress and metabolomics 
The importance of studying plant responses to abiotic stress, priming, recovery, and 
a combination of stress events 
Stress in plants can be described as anything that can cause a change from ideal 
growth and optimal developmental conditions (Shulaev et al., 2008). Stresses can be 
classified as abiotic or biotic (Wardlaw, 1972) where abiotic stresses are caused by 
nonliving factors in the surrounding environment such as extremes in temperature and light 
intensity, draught, high salinity, and deﬁciency or toxic levels of nutrients (Dietz and 
Sunkar, 2010). Biotic stresses are caused by other competing or pathogenic organisms such 
as bacteria, viruses, fungi, herbivores, and nearby cultivated or native plants (Wardlaw, 
1972). Plant are especially dependent on their environment due to their inability to move 
to optimize conditions. Therefore, abiotic stress is essentially unavoidable and harmful to 
plants (Rizhsky, 2004). The yield reduction of food crops that has been caused by abiotic 
stress worldwide (Ahmad and Prasad, 2012) is considered the major factor in reduced 
agricultural productivity. Many abiotic stress factors have been predicted to increase in the 
future due to global climate change, as reported by the Intergovernmental Panel on Climate 
Change (http://www.ipcc.ch/). Thus, understanding abiotic stress and plant responses to 
various stress events is an important topic in plant research. 
Plants can be primed to an acclimated state for enhanced future stress resistance by 
a pretreatment with a mild stress; this process is also known as ‘hardening off’. Because of 
this priming effect, it is widely accepted that plants may have a type of environmental 
‘memory’. However, plants may also need to seek a balance between keeping that  memory 
or forgetting the hardening events, because constantly staying in the acclimated state may 
sacrifice a plant’s optimal growth and orderly development (Crisp et al., 2016). In addition 
to a specific stress effect, the pretreatment with one abiotic stress may lead to a plant 
priming for enhanced resistance to another stressor, a phenomenon called plant ‘cross 
hardening’. ‘Cross hardening’ suggests  that different abiotic stresses may  share common 
stress responses or that synergistic effects mediated by co-activation of stress signaling 
pathways may be result in observed plant ‘cross memory’ effects (Firtzlaff et al., 2016). 
Several previous metabolomics studies have reported that specific plant abiotic stress 
responses, such as heat (Kaplan et al., 2004), cold (Kaplan et al., 2004, 2007), freezing 
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(Hannah, 2006; Korn et al., 2010), drought (Urano et al., 2009), high light (Wulff-Zottele 
et al., 2010; Caldana et al., 2011), and heat and drought combination (Rizhsky, 2004) result 
in significant metabolic responses. Still, less has been done to integrate these stresses 
together into some uniform understanding of shared and specific stress targets, recovery, 
and crosstalk between different stresses.  
Rather than a particular single stress, plants under typical field conditions most 
often  encounter a combination of stress conditions  simultaneously and the metabolic costs 
of responding to multiple stresses has been shown to  severely affect crop production  
worldwide (Smith and Matthews, 2015). Some combinations of  stresses cause more severe 
damage than each  individual stress (Craufurd and Peacock, 1993; Savin and Nicolas, 
1996). The National Centers for Environmental Information (NCEI) reported that the 
combination of heat waves and the accompanying drought has become one of the most 
common weather disasters resulting in damage worth more than $210 billion annually 
(Smith and Matthews, 2015). In recognition of these issues, a well-researched goal for 
maize breeding is to generate resistant lines against stress combinations. However, studies 
on combination stress response mechanisms is an extremely neglected area as compared to 
single stress studies. Transgenic plants tested under laboratory conditions that are resistant 
to one specific stress had only limited success when evaluated for  enhanced resistance in 
the field (Gao et al., 2000; McKersie et al., 1999; Mohamed et al., 2001). These results 
indicate that the effect of a combined stress event should not be assumed to be simply the 
sum of any two individual stresses. Two different stresses may have an antagonistic effect 
with each other and, alternatively, may cause a novel and unique plant response to their 
combination (Pandey et al., 2017). A massive and complex challenge exists to fully 
describe and understand the key mechanisms for plant responses to stress combinations as 
found under typical conditions in the natural environment.  
 
Complex mechanisms for plant abiotic stress responses  
Stress leads to complex regulatory responses including changes in global gene 
expression, protein modifications, and the changes in metabolite composition (Wardlaw, 
1972; Gilmour et al., 2000). Abiotic stress can induce physiological, biochemical, and 
morphological changes in membrane structure and function, tissue water content, protein, 
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lipid, and primary and secondary metabolite composition (Hallberg et al., 1985; Hirayama 
and Shinozaki, 2010). Abiotic stress may disrupt cellular osmotic homeostasis and cause 
osmotic or oxidative secondary stresses (Vinocur and Altman, 2005). Second messengers 
such as Ca2+, phosphatidic acid (PtdOH), reactive oxygen species (ROS), or osmosensors 
like Arabidopsis thaliana histidine kinase-1 (AtHK1) can trigger downstream signaling 
cascades including mitogen-activated protein kinases (MAPK), overly sensitive (SOS) 
kinases, and calcium dependent protein kinases (CDPKs) (Mittler, 2002; Qiu et al., 2002; 
Shou et al., 2004; Schachtman and Schroeder, 1994; Shi et al., 2002). Those signaling 
cascades can induce important stress responsive transcription factors including heat shock 
factor (HSF), C-repeat-binding factor/dehydration-responsive element binding protein 
(CBF/DREB), inducer of CBF expression 1 (ICE1), ABA-responsive element binding 
factor/ABA-responsive element (ABF/ABRE) families, basic leucine zipper transcription 
factor (Bzip), and MYC/MYB (Zhang et al., 2004; Jaglo-Ottosen et al., 1998; Chinnusamy 
et al., 2003; Shen and Ho, 1995). Once induced the stress-inducible transcription factors 
can regulate genes encoding both functional and regulatory proteins that are directly or 
indirectly involved in implementing plant abiotic stress defenses (Hirayama and Shinozaki, 
2010). For example, heat shock protein (Hsp) and late embryogenesis abundant (LEA) 
proteins function as chaperones (Wang et al., 2003, 2004) and protect protein structures 
from denaturation events during stress exposure. Superoxide dismutase (SOD) and 
peroxidase (PX) function in detoxification (Yoshimura et al., 2004) of oxygen radicals that 
increase under stress and would otherwise damage the cell. Proteins involved in ion and 
water transport like aquaporin and ion transporter (Vera-Estrella, 2004) similarly protect 
the osmotic integrity of the cell. Finally, proteins important for generation of stress-
associated metabolites will be synthesized to function in abiotic stress defenses (Vinocur 
and Altman, 2005). These include metabolites that function as osmoprotectants or 
compatible solutes for protein and membrane stabilization and turgor pressure maintenance 
such as amino acids and derivatives, sugars and derivatives, phosphodiesters, quaternary 
ammonium compounds, and polyols (Yancey et al., 1982; Shahjee et al., 2002; Kang et al., 
2002). Metabolites also have antioxidant roles complementary to SOD and PX function for 
ROS detoxification, protein redox regulation, and cellular component protection and these 
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include  sugars and sugar alcohols as well as glutathione (Alscher, 1989; Chiang et al., 
2005; Nishizawa et al., 2008). 
 
Using metabolomics as a tool to study plant abiotic stress 
Metabolomics is a powerful tool for the post-genomic era that is a rapidly 
expanding area of research that enables scientists to better understand an organism’s 
physiological state and response to stimuli. Metabolomics is the comprehensive, 
quantitative and qualitative analysis of the metabolome, the complete set of small 
molecules in a biological  system (Dettmer et al., 2007). Because metabolites are the final 
product of cellular regulatory processes, and unlike gene and protein whose functions that 
are affected by epigenetic regulation and posttranslational modifications, metabolomics 
studies are potentially a more direct indicator of chemical phenotype (Shulaev et al., 2008). 
Metabolomic analyses can be classified as either untargeted and targeted where untargeted 
analysis focuses on pattern-based classification of as many metabolites as possible in the 
system with unbiased and global screening.  Untargeted metabolomics is more commonly 
used for discovery-based questions such as characterization of  the metabolic changes 
following treatment, genetic perturbation, or disease (Patti et al., 2012). In contrast, 
targeted metabolomic analysis focuses on identification and quantification of metabolites 
in a selected biochemical pathway or a specific class of compounds, and is more often 
employed to address questions in a hypothesis-driven manner (Dudley et al., 2010). 
The plant kingdom is estimated to contain between 200,000 and 1,000,000 
metabolites. Arabidopsis thaliana has  about 8,000 (Pichersky and Lewinsohn, 2011; Obata 
and Fernie, 2012). Due to this huge chemical diversity, as well as  the wide range in 
concentrations, there is no single instrumental platform currently for the comprehensive 
examination of whole metabolome (Bino et al., 2004). Only 1,000 and 2,000 metabolic 
features (mass-over-charge ratio (m/z) and retention time (rt) pairs) can be detected using 
the most comprehensive methods (Obata and Fernie, 2012). Importantly, a particular 
metabolic feature is not always a unique metabolite, but can also be an isotope, adduct, or  
neutral loss (Schrimpe-Rutledge et al., 2016). To increase the number of features or to 
focus on particular physical properties of the metabolite, metabolomics can be performed 
with a variety of separation methods such as liquid chromatography (LC) and gas 
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chromatography (GC), and utilizing detection platforms such as mass spectrometry (MS) 
and nuclear magnetic resonance (NMR). Among them, LC-high resolution MS has become 
a leading technology for untargeted metabolomics because of the speed of the analyses and 
the structural information it provides (Schrimpe-Rutledge et al., 2016). Untargeted 
metabolomics provides a broader exploration and a global view of the metabolism in the 
system with no or limited preexisting knowledge of the metabolites of interests (Shulaev 
et al., 2008). However, this is accompanied by major challenges in data analysis, 
quantification accuracy, and feature annotation because of the high volume and high 
complexity dataset (Johnson et al., 2015). Therefore, it is important that the hypotheses 
generated from untargeted metabolomics, based on the relative quantification of both 
known and unknown metabolites, can be further studied with the tools provided by targeted 
metabolomics (Shulaev et al., 2008). 
 
Methodologies for untargeted metabolomics 
The workflow of untargeted metabolomics incorporate five steps including 
experimental design and sample collection, data collection, data preprocessing, statistical 
analysis, and feature annotation (Guitton et al., 2017). First, experimental design should 
define the biological questions to be addressed with appropriate quality controls such as 
reagent blanks and sample pools (Guitton et al., 2017). After sample collection and 
extraction, the data is collected from different analytical instruments. The choice of 
instrument should be based on the predicted chemical properties of metabolites of interest. 
For example, LC-MS can analyze a wide variety of metabolites from polar to non-polar, 
from low to high molecular weight using reversed phase, hydrophobic interaction, or  ion 
exchange columns (Schrimpe-Rutledge et al., 2016). Electrospray ionization (ESI) utilized 
in LC-MS has advantages in that it is able to generate multiple charged ions for larger 
molecules and it can generate and be operated in both positive and negative modes 
(Allwood et al., 2008). However, LC-MS generates adducts that can complicate analyses 
and it has less consistent retention indices and spectra libraries compared to GC-MS 
(Dettmer et al., 2007). In comparison, GC-MS has higher reproducibility with larger 
spectral libraries for metabolite annotation. Nevertheless, GC-MS is only suitable for 
volatile compounds that can be ionized typically in the positive ion mode, not for large, 
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polar, and/or heat-labile compounds directly. Chemical derivatization thus is typically 
required as the vast majority of metabolites that are polar non-volatile compounds (amino 
acids, sugars and organic acids etc.) that cannot be analyzed  by GC-MS without 
derivatization (Allwood et al., 2008).  
After data collection, the raw data can be preprocessed for peak detection, retention 
time alignment, noise filtering, and adduct and isotope annotation. The matrix of peak 
relative abundance are generated for further statistical analysis to detect metabolic changes 
between groups of interests. A variety of statistical approaches can then be performed from 
multivariate to univariate, from unsupervised to supervised. Combining both multivariate 
modeling and univariate hypothesis testing has become popular to build prediction models 
and to determine the features of interest (Wang et al., 2012; Thévenot et al., 2015). 
Univariate statistics, like the t-test and ANOVA, perform hypothesis testing on each 
individual variable and measure significance, which is particularly useful for non-normal 
data and outlier intensity measurements (Vinaixa et al., 2012). In comparison, multivariate 
statistics, such as principal component analysis (PCA), partial least squares discriminant 
analysis (PLS-DA), orthogonal projections to latent structures discriminant analysis 
(OPLS-DA), and hierarchical cluster analysis (HCA), generate models for the entire 
dataset. Among them, PCA and HCA are unsupervised, whereas PLS-DA and OPLS-DA 
are supervised. OPLS-DA has a greater discrimination power compared to PLS-DA by 
introducing the OPLS algorithm to improve interpretation between predictive components 
and the systematic variation (Trygg et al., 2001). Unsupervised PCA is a useful clustering 
method particularly useful early in the analysis in order to show groups of observations, 
trends, and outliers. It allows large multivariate data tables to be graphically visualized 
without  overwhelming the analyses  by reducing the dimensionality of original variables 
into two or three principal components (Wold et al., 1987). Once the differences between 
groups of interests are identified by PCA, it is worthwhile to use supervised OPLS-DA to 
discover biomarkers or signatures that contribute to the differences. The S-plot of OPLS-
DA visualizes both the covariance (variable magnitude) and correlation (reliability) of each 
variable. The most positive and negative loadings in the S-plot represent variables as ideal 
biomarkers with both high magnitude and high reliability. The variable importance in 
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projection (VIP) scores for OPLS-DA that reflect the importance of each variable in the 
projection can also be used for feature selection (Guitton et al., 2017). 
After data analysis, a selection of features as potential biomarkers can be identified 
to draw biological conclusions. First, putative identification can be performed by query of 
MS1 compounds and spectral databases such as METLIN (Smith et al., 2005), ChemSpider 
(http://www.chemspider.com),  Human Metabolome DataBase (HMDB) (Wishart et al., 
2013), KEGG (Ogata et al., 1999), MassBank (Horai et al., 2010), mzCloud 
(https://www.mzcloud.org), GNPS (http://gnps. ucsd.edu/), etc. The development of high-
resolution high-mass accuracy mass spectrometry has significantly improved the MS1 
database searching by lowering the mass tolerance window for potential candidates 
(Schrimpe-Rutledge et al., 2016). However, even the high mass accuracy measurement 
with less than 1 ppm error is not sufficient to always fully determine elemental composition 
(Kind and Fiehn, 2006). Further information such as isotope ratio and MS2 fragmentation 
data are need. Nonetheless, the spectra databases for MS2 searching are currently 
considered incomplete because the fragmentation patterns are greatly affected by 
instrument, collision energy, and ionization source. Therefore, the scores for MS2 
searching can often result in  false positive and false negative results (Cajka and Fiehn, 
2016). As a consequence, reference standards are always recommended for confident 
metabolic feature identification by validating MS1, retention time, and MS2 fragmentation 
data. Those confidently identified features may be linked back to metabolic networks to 
give insight as to their biological functions (Guitton et al., 2017). 
 
Metabolome dynamics and metabolic flux analysis 
Measurement of metabolite abundance alone, in most cases, cannot accurately 
describe the situation in vivo. For example, the explanation for metabolite abundance 
changes is typically complicated, and may need to be integrated with metabolic flux 
information to correctly model the observed changes. Metabolic flux is the flow of the 
carbon skeleton of a target metabolite through an organism’s metabolic pathways (Roscher 
et al., 2000). It is affected by the rate of biosynthesis and degradation in a metabolic 
pathway during complex plant behaviors including plant growth, development, and 
responses to multiple environments (Pratt et al., 2002). Even though two metabolites have 
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the same absolute abundance at a particular time, their metabolic fluxes may be very 
different. Some metabolites may be very active metabolically and have high flux rates to 
channel large quantities of metabolites through them, others have metabolic roles as 
enzyme intermediates where low steady-state levels remain part of the  substrate-enzyme 
complex, whereas some metabolites may be the final products and thus have very low flux 
rates (Yang et al., 2010). Therefore, metabolic flux analysis may add additional 
information often necessary for the complete understanding of plant metabolic behaviors.  
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Chapter 2. Metabolic signatures of Arabidopsis thaliana abiotic stress responses 
elucidate patterns in stress priming, acclimation and recovery. 
Introduction 
Stress in plants has been described as any condition that causes a change in optimal 
growth, development, and reproduction (Wardlaw, 1972). Stress can be classified as abiotic 
and biotic (Guy, 1999). Abiotic stress is caused by nonliving factors in the environment 
such as temperature, the supply of water, and light intensity. In comparison, living factors 
such as bacteria, fungi, parasites, and herbivores cause biotic stress. Abiotic stress is 
particularly constraining to plants because, unlike animals, plants are not able to move and 
are thus particularly dependent on environmental factors (Rizhsky, 2004). Temperature, 
the supply of water, and light intensity are three major abiotic stress factors that have 
significant impact on plant growth, development, and reproduction. Increased climatic 
variability and more frequent extreme conditions can lead to plants being exposed to 
multiple stresses simultaneously.  
Despite the fact that abiotic stresses arising at different stages of plant growth 
increases damage risk, earlier mild stress events can prime plants to an acclimated state to 
enhance their resistance against future stress by stronger or more rapid responses (Hallberg 
et al., 1985). Since different stressors often share common response pathways, sometimes 
a specific preceding stress may also prime a plant for an unrelated, different type of 
upcoming future stress, which is called the ‘cross stress tolerance/memory’ (Firtzlaff et al., 
2016). Because of the priming effect, it has been widely accepted that plants have memory, 
which can occur at any developmental stage with various modifications from epigenetics 
to transcription level, and proteome to metabolome levels (Li and Liu, 2016). 
By retaining stress memories, plants benefit by enhanced defense against future 
stress from a stronger or more rapid activation of defense responses. However, keeping the 
stress memory may also impede plant recovery and cause delayed growth and development 
(Crisp et al., 2016). Therefore, as soon as the favorable conditions return, it may be more 
adventitious for plants to reset, or to ‘forget’ in order to obtain the maximum growth. Plants 
need to seek a balance between resetting (growth) and memory maintenance (defense) 
during the recovery processes. Plant stress memory studies have been described in terms 
of epigenetics (Crisp et al., 2016), as changes in transcript levels (Avramova, 2015; 
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Firtzlaff et al., 2016), and protein changes (Li and Liu, 2016). However, plant memory has 
been less frequently defined in metabolomic terms. Metabolomics is a post-genomic 
biology with goals to identify and quantify the metabolome, the small molecules that 
participate in metabolic reactions and represent the most direct phenotype of a biological 
system (Freund and Hegeman, 2017).  
In this study, metabolic changes induced by three abiotic stressors including 
temperature, water, and light in Arabidopsis thaliana 11-day-old seedlings with and 
without priming and a 2-day-recovery treatment were measured using a liquid 
chromatography–mass spectrometry based metabolomics approach. Treatments were 
performed under identical growth conditions to minimize the influence of non-stress 
factors. Our focus was on primary metabolites since they best represent plant growth and 
development conditions and have important roles during plant stress resistant. Primary 
metabolites can function as energy sources, precursors of secondary metabolites, signaling 
molecules, osmoprotectants, and antioxidants. Therefore, hydrophilic interaction liquid 
chromatography (HILIC) was used for best retention and separation of the polar 
metabolites in primary metabolism. Precursors, intermediates, and products in the same 
metabolic pathways were monitored simultaneously. This study provides a unique 
contribution to our understanding of plant priming and memory, as well as shared and 
unique metabolic stress signatures for different abiotic stresses measured using closely 
matched parallel workflows. 
 
Results 
We conducted a comprehensive characterization of priming and recovery effects of 
Arabidopsis thaliana metabolome physiological variations in abiotic stresses including 
cold, heat, drought, and high light. The most statistically significant metabolic differences 
between stressed and control plants were identified using an untargeted metabolomics 
approach. Untargeted metabolomics is a pattern-based classification approach for as many 
metabolites as possible in the system using a global unbiased screening (De Vos et al., 
2007). It is commonly used for discovery-based studies to characterize metabolic changes 
in disease, environmental or genetic perturbations (Patti et al., 2012). In this study, we 
executed a comprehensive analysis using both multivariate and univariate statistics. 
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Multivariate statistics modeling PCA and OPLS-DA were performed for clustering and 
potential stress metabolic signature selection. The top five most contributed metabolic 
features for different treatments were reported in Supplemental Table 2-1. The identified 
potential stress metabolic signatures with loadings of |p[1]|>0.07 from OPLS-DA were 
reported in Supplemental Table 2-2. In order to monitor the changes of precursors, 
intermediates, and products of those stress metabolic signatures in the same metabolic 
pathway, the univariate statistics ANOVA test was performed for metabolites in the same 
class or metabolic pathway. Because of their ability to define differences, both univariate 
and OPLS methods have increased in popularity for metabolic signature studies and been 
suggested to complement each other (Zhang and Watson, 2015). Overall, we 
comprehensively examined the changes of metabolites as stress metabolic signatures and 
their precursors, intermediates, and products in key central metabolic pathways.   
 
Multivariate statistical comparisons using PCA and OPLS-DA 
In this study, principle components analysis (PCA) was performed in a hierarchical 
manner to assess the extent of divergence between metabolites under different conditions 
(Figure 2-1). First, PCA of all the stress and recovery samples was performed (Figure 2-
1A), which resulted in two large clusters consisting of the stress and stress-control group 
well separated from recovery and recovery-control group.  This clustering pattern indicates 
that significant metabolic changes occur during the 2-day growth recovery period.  
Reanalysis of stress and stress-control (Figure 2-1B) and recovery and recovery-control 
(Figure 2-1C) subgroups were performed in an attempt to separate these groups into 
additional sub-clusters. In the stress group, both AH and BH heat stresses cluster together 
and are well separated from the other stresses and control, thus indicating that heat stress 
has the most dramatically different metabolic response within this group (Figure 2-1B). 
Additional reanalysis of subgroup (HL, D, AC, BC & control) in Figure 2-1B1 shows the 
control is well separated from stresses in PC2 (18%), indicating that all of the stress groups 
have metabolic changes compared to control. Drought stress (D) is also well separated from 
the other stresses in this subgroup, while AC, BC and HL have more similar metabolic 
signatures. PCA of the basal and acquired heat subgroup (Figure 2-1B2) showed these two 
sets of samples are not well separated in both PC1 and PC2, indicating priming treatment 
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of heat stress has a relatively minor effect right after the stress treatment. Subsequent PCA 
of the acquired cold, basal cold, and high light subgroup (Figure 2-1B1a) showed that 
acquired and basal cold cluster together but are separated from high light, indicating high 
light stress has a different response than cold stress. While priming treatment for cold, 
similar to what was observed for heat, has little significant difference from the unprimed 
treatment right after the stress treatment.  
In the PCA of the recovery subgroup, drought recovery, basal heat recovery, and 
acquired heat recovery were well separated from another subgroup composed of acquired 
cold, basal cold, high light, together with the control, indicating that drought and heat have 
the most distinct metabolic responses (Figure 2-1C), and that the priming treatment for 
heat has a large and significant impact during 2-day-recovery.  Subgroup PCA (Figure 2-
1C1) showed acquired cold recovery and control recovery are separated from basal cold 
recovery and high light recovery. Additional subgroup PCAs (Figure 2-1C1a and Figure 
2-1C1b) showed minor separation for acquired cold and control, and basal cold and high 
light. These results indicated the priming effect has dramatic influence during 2-day-
recovery. Cold stress with priming treatment is more similar to the control than the 
unprimed cold stress following the 2-day-recovery period. Cold stress without the priming 
treatment is, interestingly, more similar to the high light after 2-day-recovery. It is known 
that Arabidopsis is more resilient to cold stress after priming with cold, and it seems likely, 
given the PCA results, that priming leads to faster recovery from cold stress. Whereas the 
observation of co-clustering of unprimed (basal) cold and high-light stress responses 
indicates that the plant’s metabolic response for these stresses are similar, and may form 
the metabolic basis for cross stress tolerance/memory behavior. 
Using the clustering hierarchy from the above PCA, we then performed Partial 
Least Squares Discriminant Analysis (PLS-DA) Orthogonal Projections to Latent 
Structures Discriminant Analysis (OPLS-DA) to identify which metabolic features were 
the most important drivers of differentiation. Compared to unsupervised PCA modeling, 
Both PLS-DA and OPLS-DA are supervised techniques that request a response value to be 
assigned. However, PLS approaches are often hard to interpret for complex datasets as 
uncorrelated variation is always present in the scores. To solve this problem, Trygg et al., 
2001 introduced the orthogonal projection to latent structures (OPLS) algorithm by 
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incorporating an Orthogonal Signal Correction (OSC) filter into a PLS model to separate 
the correlated (predictive) variation from uncorrelated (orthogonal) variation. In doing so, 
OPLS-DA helps identify correlated components in the presence of systematic variation 
(Thévenot et al., 2015). The clustering results from PCA was used to perform a 
corresponding hierarchical OPLS-DA for all the subgroups (Supplemental Figure 2-1) 
and all the treatment compared with their corresponding control (Supplemental Figure 2-
2). The combination of both PCA and OPLS-DA produced novel information regarding 
general metabolic trends and stress-specific metabolic signatures. 
 
Targeted metabolite analysis and hierarchical clustering 
Metabolites that were identified as having significant abundance changes in one or 
more stress conditions as well as precursors, intermediates, and products in the same 
metabolic pathways were selected for further targeted analysis in order to provide a better 
representation of the central metabolic stress response. To do this, putative identities of the 
selected metabolites were confirmed by: 1) comparison chromatographic retention by co-
injection; and 2) by comparison of MS/MS fragmentation behavior (Supplemental 
Figures 4.1 & 4.2) with standard compounds (Supplemental Table 2-5). After metabolite 
identities were confirmed, their corresponding LC-HRMS peaks were manually integrated 
in both positive and negative ionization modes and the fold change in the average 
intensities across replicates between stress and control samples were calculated. Fold-
changes in intensities for metabolites observed in both ionization modes were averaged if 
they were deemed indistinguishable by ANOVA, otherwise the values derived from the 
most intense signals were used on the assumption that the values derived from lower 
signals were so due to ion-suppression. These confirmed metabolite abundance fold-
change values (Supplemental Table 2-4) and treatments were then clustered by 
hierarchical clustering analysis (HCA) to provide relationships between stressors, priming, 
and recovery using this targeted central metabolism dataset. Figure 2-2 shows a heatmap 
of an HCA analysis performed using the complete linkage with maximum distance 
measurement method. The clustering and distance methods were chosen based on De 
Souza et al., 2006 who tested three of the most popular clustering methods including single 
linkage, complete linkage and centroid methods, and found complete linkage and centroid 
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methods performed better than single linkage. They explained that both complete linkage 
and centroid methods have a tendency to create compact, spherical clusters, whereas single 
linkage has a tendency to make elongated clusters. In addition, Edelbrock, 1979 reported 
that complete linkage was more accurate than single linkage when using Euclidean distance 
as the measure of similarity. We also tested complete linkage using other distance methods 
including Euclidean (Supplemental Figure 2-5A), Manhattan (Supplemental Figure 2-
5B), and Minkowski (Supplemental Figure 2-5C), and other clustering methods including 
Ward’s method (Supplemental Figure 2-5D) and McQuitty's method (Supplemental 
Figure 2-5E), and got comparable clustering results.  
HCA elucidated five distinct clusters of the six stress and six recovery treatments 
(detailed in Table 2-1) that we named A-E as well as seven clusters of metabolites named 
1-7.  Group A contained treatments AC and D. It displayed increased abundance of 
metabolites in clusters 6 & 7 and decreased abundance in clusters 1, 4 & 5. Group B 
consisted of treatments AH and BH.  It displayed a decreased abundance in metabolites in 
cluster 7 and an increased abundance of metabolites clusters 3, 5 & 6. Group C included 
treatments BC and HL. It displayed a decreased abundance of metabolites in clusters 1, 4, 
5, & 7 and an increased abundance in clusters 2 & 6. Group D included treatments ACR, 
BCR, and HLR. It displayed decreased abundance in clusters 5, 6, & 7, and increased 
abundance in clusters 2 & 4. Group E was composed by treatments DR, AHR, and BHR, 
which displayed decreased abundance in clusters 2, 6 & 7 and increased abundance in 
cluster 4. 
 
Discussion 
Shared stress metabolic signatures  
We found many metabolites showed similar responses to different stresses. These 
metabolites may function as shared stress metabolic signatures, indicating their common 
participation and general response patterns in multiple stresses. In Figure 2-2, metabolites 
in clusters 1, 2, 3, and 5 are shared stress metabolic signatures and exhibited similar 
response patterns across different abiotic stresses. Cluster 1 contained three metabolites in 
sugar metabolism (sucrose) and purine metabolism (adenine and adenosine). Their 
abundance increased in ACR, DR, AHR, BHR, BH, but decreased in BCR, HLR, AC, BC, 
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AH. Previous studies showed that sucrose might function as signal molecules and osmotic 
regulators during plant stress responses (Kaplan et al., 2004; Rizhsky, 2004). The increase 
of sucrose may suggest its roles in stress signaling and osmotic stress responses.  
Cluster 2 includes fifteen metabolites in aspartate family amino acids (aspartic acid, 
asparagine), glycolysis (DHAP, fructose 6−phosphate, glucose 6− phosphate), TCA cycle 
(DHAP, α−ketoglutaric acid.), glutathione metabolism (glutamic acid, GSSG), purine 
metabolism (guanosine monophosphate, ribose 5-phosphate), urea cycle (citrulline, 
arginine, ornithine, urea), and serine family amino acids (serine).  They are increased in 
ACR, BCR, HLR, AC, BC, HL, AH, BH, and decreased in DR, BHR. Major nitrogen 
transport amino acids glutamate, asparagine, and aspartic acid are in cluster 2. While 
glutamine, another primary nitrogen assimilation amino acid, is in cluster 3. Most of 
glycolysis intermediates and two TCA cycle intermediates are in cluster 2. The increase of 
GSSG in AC, BC, D, HL may be caused by plant oxidative stress defense. During oxidative 
stress, reduced glutathione GSH can be oxidized to GSSG to detoxify ROS (Foyer et al., 
1997). The decrease of GSSG in BHR and DR may indicate the severe level of oxidative 
stress decreased during recovery. 
Cluster 3 was composed by seventeen metabolites in TCA cycle (oxaloacetic acid, 
succinic acid, malic acid, citric acid, fumaric acid), GABA shunt (-aminobutyric acid, 
shikimate pathway (shikimic acid), glutamate family amino acids (proline, glutamine, 
histidine), pyruvate family amino acids (alanine, pyruvic acid), oxaloacetate family of 
amino acids (threonine), glutathione metabolism (glycine), and sugar metabolism (glucose, 
xylose, fructose). They are increased in D, HL, AH, BH, decreased in DR, BHR. We found 
most of analyzed TCA cycle intermediates, including oxaloacetate, succinate, malate, 
citrate, and fumarate clustered together with the non-proteinogenic amino acid GABA. The 
radial plots for ratio changes of these metabolites were reported in Figure 2-3D. TCA cycle 
generates energy with reducing power, and is responsible for the most part of carbohydrate, 
amino acid, and fatty acid (Fernie et al., 2004). GABA is known to drive TCA cycle via 
GABA shunt (Caldana et al., 2011). During GABA shunt, succinate can be synthesized 
from GABA via succinic semialdehyde. Previous studies showed that GABA synthesis 
increased during temperature stress including heat and cold (Kinnersley and Turano, 2000). 
In addition, GABA shunt was reported to coordinate with general N and C metabolism 
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(Weigelt et al., 2008). The increase of both TCA cycle intermediates and GABA in AH, 
BH, D, HL may indicate that GABA may fuel central metabolism via TCA cycle for 
increased energy demand during stress. 
We also noticed that proline and sugars including glucose, fructose, and xylose in 
cluster 3 are all known osmoprotectants or compatible solutes. Proline is synthesized from 
glutamate by the enzymes P5CS (1-pyrroline-5-carboxylate synthase) that contributes to 
osmotic adjustment, free radical scavenging, and subcellular structure stabilization (Hare 
and Cress, 1997). Previous studies showed that proline concentration increased in drought, 
salinity, and extreme temperatures (Kaplan et al., 2004, 2007; Sanchez et al., 2008). 
Glucose, fructose, and xylose were known to function as both stress signal and 
osmoprotectants molecules (Koch, 1996; Roitsch, 1999; Rizhsky, 2004).  The increase of 
proline and sugars in AH, BH, and D may indicate their roles as osmolytes to help plant 
survive from osmotic stress. 
Cluster 5 was consisted of nine metabolites in aromatic amino acids (phenylalanine, 
tyrosine, and tryptophan), pyruvate family of amino acids (valine, leucine), sugar alcohol 
(mannitol), sugar metabolism (raffinose), oxaloacetate family amino acids (lysine), and 
purine metabolism (guanine). Figure 2-3A showed similar pattern of metabolites in cluster 
5 that increased in BHR, AH, BH, but decreased in ACR, BCR, HLR, AC, BC. Aromatic 
amino acids (tryptophan, tyrosine, and phenylalanine) are known to be precursors of 
pigments, alkaloids, hormones, and cell wall components (Dixon, 2001). While branched-
chain amino acids (isoleucine, leucine and valine) are precursors of cyanogenic glycosides 
(Vetter, 2000). Both aromatic amino acids (tryptophan, tyrosine, and phenylalanine) and 
branched-chain amino acids (leucine and valine) are grouped in cluster 5, indicating they 
may act as precursors of secondary metabolites during stress responses. In addition, 
osmotic stress can induce the accumulation of branched-chain amino acids by abscisic 
acid-regulated protein degradation in Arabidopsis thaliana (Huang and Jander, 2017). 
 
Primary metabolites have important roles during stress response 
Primary metabolites are directly involved in plant normal growth, development, 
and reproduction. They act as building blocks and primary source of energy, carbon, and 
nitrogen. For example, sugar is an important energy source. To be able to fuel energy, sugar 
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will move to glycolysis and thereby into the TCA cycle. Plant cell needs incoming solutes 
to cover the growing demand energy for both anabolism and catabolism. TCA cycle 
generates energy with reducing power, and is responsible for the most part of carbohydrate, 
amino acid, and fatty acid (Fernie et al., 2004). Amino acids are essential for protein 
synthesis and nitrogen balance. Inorganic nitrogen is incorporated into glutamine and 
glutamate, and function as nitrogen source to be converted into other amino acids or 
nitrogenous compounds.  
Primary metabolites are known to be precursors of many secondary metabolites 
that function as defense compounds against biotic stresses elicited by pest, bacteria, and 
fungi (Kaplan et al., 2004). For example, aromatic amino acids are precursors of indole 
glucosinolates, phytoalexins, alkaloids, lignins, flavonoids, isoflavonoids, and 
hydroxycinnamic acids (Dixon, 2001). Branched-chain amino acids are precursors of 
cyanogenic glycosides, glucosinolates, and acyl-sugars (Vetter, 2000). In our study, both 
aromatic amino acids (tryptophan, tyrosine, and phenylalanine) and branched-chain amino 
acids (leucine and valine) are increased in BHR, AH, BH in cluster 5. They may act as 
precursors of secondary metabolites to accumulate in response against the opportunistic 
attack by pathogens on heat stress weakened host.   
Previous studies show that primary metabolites could also function as signal 
molecules during stress responses. Many soluble sugars such as glucose, fructose, and 
sucrose have roles in plant stress signaling (Chiou and Bush, 1998; Koch, 1996; Roitsch, 
1999). In our study, sucrose in cluster 1, glucose, xylose, and fructose in cluster 3 may be 
participated in stress signaling in plant. 
Besides, primary metabolites act as osmolytes or compatible solutes to stabilize 
proteins and membranes and to maintain cellular turgor pressure. Major compatible solutes 
include amino acids and derivatives, sugars and derivatives, phosphodiesters, quaternary 
ammonium compounds, and polyols (Yancey et al., 1982; Shahjee et al., 2002). In this 
study, sucrose in cluster 1, asparagine, ornithine, and serine in cluster 2, GABA, alanine, 
proline, glycine, glucose, succinate, fructose, and malate in cluster 3, mannitol and 
raffinose in cluster 5, maltose in cluster 6 have both known compatible solutes properties 
and compatible solute-like properties. The accumulation of these metabolites indicated that 
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multiple compatible solutes may act synergistically in response to osmotic stress induced 
by abiotic stresses. 
Moreover, primary metabolites can function as antioxidant to detoxify ROS and 
prevent oxidative damage during oxidative stress. Carbohydrates like raffinose (Nishizawa 
et al., 2008) and sugar alcohols such as mannitol (Chiang et al., 2005) have been reported 
to improve plant abiotic stress tolerance by acting as antioxidants. Glutathione (GSH) is 
also known to be an important plant antioxidant to regulate protein redox and to prevent 
cellular component damage caused by reactive oxygen species (ROS) (Alscher, 1989).  In 
our study, raffinose and mannitol in cluster 5 and GSH in cluster 6 may be connected to 
plant defense against oxidative stress. 
 
Unique stress metabolic signatures 
Three clusters each containing one single metabolite in HCA (Figure 2-2) attracted 
our attention: cluster 4 with GSH only, cluster 6 with cysteine only, and cluster 7 with 
maltose only. The separation of these three metabolites from all the other clusters was 
consistent using different clustering and distance methods including Euclidean 
(Supplemental Figure 2-5A), Manhattan (Supplemental Figure 2-5B), and Minkowski 
(Supplemental Figure 2-5C), and other clustering methods including Ward’s method 
(Supplemental Figure 2-5D) and McQuitty's method (Supplemental Figure 2-5E). 
Cysteine, GSH, and maltose were always isolated in separate clusters. The unique 
clustering pattern for these three metabolites may be caused by their unique changing trend 
and ratio changes as shown in Figure 2-3B and 3C. We found cysteine increased 
dramatically in stress groups up to 339 fold but had minor changes in the recovery groups. 
In contrast, GSH decreased tremendously in stress groups up to 66 fold but had little 
changes in the recovery groups. Both cysteine and GSH are critical compounds in 
glutathione metabolism. In addition, cysteine is one of the precursors for GSH. The big 
increase of cysteine may also lead to the increase of the GSH pool. However, GSH may be 
quickly consumed by oxidation to GSSG in order to detoxify the reactive oxygen species 
(ROS) produced from oxidative stress, which serves as a secondary stress of different 
abiotic stresses. This may be the account for the measured large decrease of GSH in the 
stress groups. On the other hand, maltose, the direct product of starch degradation, showed 
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different responses from other sugars such as glucose, fructose, and sucrose and formed its 
own single cluster, indicating the potential differences between catabolism and anabolism 
during plant stress responses. In summary, cysteine, GSH, and maltose may function as 
unique stress metabolic signatures that has special role in stress responses. 
 
Cysteine, GSH, and GSSG in glutathione metabolism 
Glutathione (GSH) is a main low molecular mass plant non-protein thiol compound 
that is important for regulation of the redox state of the cells (Alscher, 1989).  It also 
functions as an antioxidant in plant defense systems. The biosynthesis of glutathione 
consists of two enzymatic reactions (Strohm et al., 1995). First, glutamic acid and cysteine 
form γ-glutamylcysteine. Second, γ-glutamylcysteine and glycine form GSH. Under stress 
conditions, GSH functions as an antioxidant for reactive oxygen species (ROS) via the 
ascorbate-glutathione cycle to form the glutathione disulfide (GSSG), resulting in the 
increase for GSSG and GSSG/GSH ratio (Foyer et al., 1997). Along with its function as an 
antioxidant, GSH also performs other roles such as thiol disulfide exchange, detoxification, 
and cell signaling. Thus, alteration of GSH concentration may function together with the 
changes in amino acids such as glutamate and glutamine, which are GSH-dependent 
through the γ-glutamyl cycle. Glutathione S-transferases (GSTs) can function in processes 
to detoxify xenobiotics (Marrs, 1996) through forming phytochelatins that are important 
for heavy metal detoxification (Chen and Goldsbrough, 1994), and can also activate genes 
for acclimation, stress tolerance, and pathogen defense response (Wingate et al., 1988). 
Glutathione has previously been reported to play important roles for plant abiotic 
stress defense responses including chilling and cold (Foster and Hess, 1980), heat (Nieto-
Sotelo et al., 1999), drought (Gamble and Burke, 1984), salt (Roxas et al., 1997), high light 
(Cakmak and Marschner, 1992), and UV irradiation (Strid et al., 1994). In this study, the 
radial plots for ratio changes of cysteine, reduced glutathione (GSH), and oxidized 
glutathione (GSSG) were reported in Figure 2-3C. Cysteine, as one of the precursors of 
GSH, increased in all the stress groups, especially with a dramatic increase in the AH and 
BH with fold changes of 339 and 297. GSH decreased in all the stress groups, especially 
in AC, BC, and HL, with ratio changes of 66, 66 and 20, respectively. In contrast, GSSG 
had minor changes compared to GSH and cysteine. The increase of cysteine in stress 
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groups may be related to GSH biosynthesis. The decreased GSH in all the stress groups 
may result from the oxidation of GSH through its function as an antioxidant. However, it 
is also possible that the biosynthesis pathway from cysteine to GSH is blocked during AH 
and BH, which leads to the accumulation of cysteine and decrease of GSH. Cysteine, GSH, 
and GSSG all showed minor changes during recovery, indicating resetting is the 
predominant strategy for glutathione metabolism during recovery.  
 
Maltose from starch degradation 
Maltose is the direct product from starch breakdown by -amylase. The radial 
plots for ratio changes of maltose and other sugars including glucose, fructose, xylose, 
mannitol, and raffinose were reported in Figure 2-3B. In our study, maltose elevated in 
AC and D up to 33 and 36 fold, but decreased in BH, HL, BHR, and BHL. The increase of 
maltose may be caused by starch degradation. Previous work showed that the activity and 
transcription of -amylase can be induced during temperature stress (Dreier et al., 1995). 
Kaplan and Guy, 2005 reported maltose was accumulated in Arabidopsis by starch 
degradation in cold shock in order to protect photosynthetic electron transport chain and 
proteins in chloroplast stroma. Rizhsky, 2004 reported that both maltose abundance and 
the expression of starch degradation transcripts were elevated in response to drought and 
heat combination stress. Maltose is also reported to function as compatible solutes and 
contributed to the protection of plant from freezing stress (Kaplan et al., 2004). It was 
suggested that moderate level of drought stress is occurred with elevated proline and 
Glycine-betaine, whereas severe level of drought stress is together with sugar accumulation 
(Hoekstra et al., 2001). In our study, maltose increased in AC and D of 33 and 36 fold, 
whereas proline increased in AH and BH. This result indicated that AC and D may induce 
more severe drought stress compared to AH and BH. Maltose is also involved in the 
production of glucose and sucrose from starch (Lu and Sharkey, 2004). However, in our 
study, the increase of maltose did not result in the increase of glucose and sucrose, 
indicating the accumulation of maltose may be occurred only in the plastids, spatially 
isolated from cytosolic primary sugar metabolism. 
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Overcompensation/overcorrection for recovery of basal heat and drought, may be 
caused by a slow recovery process or an adjusted metabolic baseline 
Stress recovery is the process involved after a plant is returned to the favorable 
conditions until it has achieved a new state of homeostasis (Crisp et al., 2016). This period 
determines whether plants will keep the stress memory or reset. The group D, including 
ACR, BCR, and HLR, had lower metabolic fold changes compared to group E, indicating 
group D during a 2-day-recovery tends to reset to a pre-stress state. If memory dominates, 
the recovery groups should be more similar to its corresponding stress group. However, 
none of the recovery groups clustered together with stress group, indicating memory is an 
exception rather than the rule for most metabolites during plant stress recovery. Group E 
including DR, AHR, and BHR, showed higher metabolic changes compared to group D. 
Interestingly, BHR and DR showed opposite metabolic changes with their corresponding 
stress groups especially in metabolite cluster 2 and 3. The general trend for cluster 2 and 3 
increased in BH and D, but decreased in BHR and DR. We call this phenomenon as 
overcompensation or overcorrection. It is possible that the resetting processes for BH and 
D during recovery are slow. In order to return to the pre-stress metabolic state faster, plant 
overcorrected their metabolic changes at beginning to decrease the increased metabolites 
induced by stress responses. However, it is also possible that a new distinct post-stress 
homeostasis was achieved during recovery process. Plant may keep the balance between 
memory and forgetfulness to adjust the metabolic baseline of some key signaling 
metabolites (cluster 2 and 3) in order to better adapt and survive from future recurring stress 
with minor cost of growth and development. 
  
Common stress responses between AC and D, BC and HL, AH and BH  
For cold stress, priming effect has bigger impact than stressors. AC and D, BC and 
HL showed common stress responses and clustered together in groups A and C. Crosstalk 
has been found between cold and drought stress responses at transcription level (Seki et 
al., 2002). Both cold and drought can activate the expression of genes containing the 
drought responsive and abscisic-acid-responsive promoter elements (DRE and ABRE) cis-
acting element and drought-responsive-element-binding (DRE-binding) transcription 
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factors DREB/CBF (Knight and Knight, 2001). Compared to cross talk between cold and 
drought stress, the relationship between cold and light stress is less studied. 
 
In addition, no previous work showed that the priming treatment of cold stress will 
lead to different shared responses from high light stress to drought stress. The biggest 
different between group A and C is cluster 7 that composed by maltose only, which 
increased 33 fold in AC and 36 fold in D, but has minor change in BC and decreased in 
HL. This difference may suggest that the priming treatment of cold stress imposed on plant 
a different type of internal stress similar to drought stress, indicating AC and D may require 
increased maltose as osmoprotectant and elevated catabolism through starch degradation. 
 
Cross memory/resistance may happen between heat and drought, cold and high light 
In recovery groups, DR clustered together with AH and BH, whereas HL clustered 
together with AC and BC. The priming treatment for heat and cold has no effect on the 
metabolic cross talk between different stresses. This may indicate the potential of plant 
cross memory between drought and heat, high light and cold. Plants exposed to different 
stresses may keep similar memories after 2-day-recovery. In that way, the prior exposure 
of one stress may enhance plant future resistance to the other. For example,  Rajashekar 
and Panda, 2014 reported that drought stress can trigger cold tolerance in Arabidopsis, 
wheat, oats, rye, and strawberry. This potential cross memory is important for plants to 
better survive in nature since the reoccur stress may not be identical and predictable. Thus, 
the appearance of one stress may serves as an indicator that prepares for the other types of 
stress. In addition, the memory formation or depletion may be similar between heat and 
drought, and cold and high light. For CR and HLR, metabolites had smaller fold changes 
compared to HR and DR, indicating they may tend to forget/reset in order to maximum 
their growth and development. For HR and DR, plant may prefer to keep the memory or 
adjust the metabolic baseline to a new state of homeostasis in order to prepare for stronger 
and quicker defense for reoccurring future stress. This balance mechanism may indicate 
plant have the ability to acknowledge different stresses to different severe level. Heat and 
drought may considered being more severe, easier reoccurring stress compared to cold and 
high light.  
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Measurements of precursors, intermediates, and products of important metabolic 
pathways in central metabolism  
In this study, we monitored entire metabolic pathways from precursors and 
intermediates to products simultaneously in order to reveal the subtle interplay of 
functionally related metabolites. A clear example of substrate and product relationship of 
identified metabolites that play critical roles in metabolism, stress tolerance, priming, and 
memory during recovery processes can be observed in Figure 2-4.  (Larger versions of the 
radial plots used in Figure 2-4 are provided in Supplemental Figure 5). It also shows the 
important transitions that regulate stress and recovery processes. The biosynthesis rate of 
product is largely depended on the availability of precursors and intermediates. However, 
the possible explanations for the metabolite abundance changes is complicated, and may 
need to be integrated with metabolic flux information in future studies to give a better 
picture of the processes measured. Metabolic flux is the flow of the carbon of a metabolite 
through an organism’s metabolic pathways (Roscher et al., 2000) as determined by the rate 
of biosynthesis and degradation (Pratt et al., 2002). Some metabolites may be very active 
and have a high flux rate to channel large quantities of metabolites through them or play 
roles as intermediates that are never released by the enzyme complex, whereas some 
metabolites may be the end products that accumulate to high levels yet have very low fluxes 
(Yang et al., 2010). 
We showed that in some cases, in the same metabolic pathway, the substrate 
increased, however the products synthesized from it decreased. One good example is 
cysteine increased dramatically in all the stress treatments, but GSH synthesized from it 
decreased notably in AC, BC, and HL. The low abundance of the GSH pool may be caused 
by the high demand and high flux rate of GSH because of its function as an antioxidant to 
detoxify the ROS during oxidative stress defense and repair responses. In contrast, we also 
saw that the substrate decreased, while the products synthesized from it increased. For 
instance, glutamate decreased in basal heat stress treatments, however amino acids 
synthesized from it (arginine, glutamine, and proline) increased. Similarly, aspartate 
decreased in basal heat, drought, and high light stress treatments, whereas amino acids 
derived from it (asparagine, lysine, and threonine) increased in those treatments. Similarly, 
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serine decreased in BH and HL, however amino acids synthesized from serine (cysteine 
and glycine) increased in these treatments. Moreover, pyruvate decreased in BH, but amino 
acids synthesized from it (alanine, leucine, and valine) increased. These results are 
consistent with the hypothesis that the low abundance of substrate may be caused by a high 
flux rate to more stable product pools, whereas the high abundance of product may be 
caused by the low flux rate in utilization pathways (Bateman et al., 2007). These results 
again suggest that it will be important to incorporate full metabolic flux analysis into future 
studies to better explain the increase or decrease of those metabolites’ abundance. 
 
Materials and Methods 
Plant materials, growth conditions, and treatments 
Arabidopsis thaliana wild-type (Col-0) seeds were obtained from Lehle Seeds and 
were sterilized with 30% (v/v) bleach containing 0.1% (v/v) Triton X-100 and vernalized 
at 4 °C for 2 days. Seedlings were germinated on 1/2 x MS media made from MS Salts 
(PhytoTechnology Laboratories, M524 Murashige & Skoog (MS) Basal Salt Mixture, 4.33 
g/L for 1 x MS) with 1.5% agar. Plants were grown prior to stress, during recovery, and as 
unstressed controls, vertically, at 22°C under a 16-h-light/8-h-dark photoperiod, with ∼80 
μmol m-2 s-1 illumination from cool-white fluorescent tube lights (control conditions). 
Eleven-day-old seedlings were treated with abiotic stress conditions described in Table 2-
1. After the stress treatments, plants were removed back to the ‘control conditions’ for two 
days. Whole seedlings were harvested for stress and recovery groups, frozen in liquid 
nitrogen, and stored at -80°C. Experiments were performed using three biological 
replicates, and each replicate consisted of 25 seedlings grown together on a single plate 
and pooled. The recovery group for drought stress was obtained by moving the desiccated 
seedlings back to the agar medium under ‘control conditions’ for 2 days prior to harvest.  
 
Sample extraction and LC-HRMS analysis 
About 100 mg (fresh weight) of frozen seedlings were ground in 1 mL of 70% 
isopropanol alcohol with one 2.5 mm tungsten carbide ball in a Geno/Grinder™ (OPS 
Diagnostics) for 7 minutes at an intensity of 10,956 x g on -20°C chilled blocks. After 
centrifugation for 5 minutes at 100,956 x g, 1 μL of supernatant was injected onto a UHPLC 
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(Ultimate 3000, Dionex) with ZIC-cHILIC column (100 mm ×2.1 mm, 3 μm particle size, 
EMD Millipore Corporation, Billerica, MA). Solvents A (0.1% (v/v) formic acid in water) 
and B (0.1% (v/v) formic acid in acetonitrile) were used as mobile phases for gradient 
separation. Extract corresponding to 100 µg of plant material (fresh weight) was loaded 
onto the column with at a flow rate of 0.4 mL/min, followed by the following gradient 
separation: 2 min from 98% B, 30 min to 55% B, 2 min to 95% B and maintained for 3 
min. The column was equilibrated for 2 min with 98% B prior to the next run. The samples 
were analyzed using a hybrid quadrupole Orbitrap mass spectrometer (Q Exactive, Thermo 
Fisher Scientific, San Jose CA). Full scan MS (range 50−750 m/z) were acquired with 35 
k resolution for both positive and negative mode in polarity switching. The target value 
based on predictive automatic gain control was 1.0 × 106 with 200 ms of maximum 
injection time. The flow rate for sheath gas, aux gas, and sweep gas was 50, 20, and 1 
separately. The capillary temperature was 350 °C. The S-lens RF was set to 55. The Aux 
gas heater temperature was 300 °C. Targeted MS/MS acquisition was used during 
metabolite identification with similar settings to (Fan et al., 2016) with minor 
modifications. Briefly, the precursor ions were sequentially fragmented in the HCD 
collision cell with normalized collision energy of 10%, 20%, 40%. MS/MS scans were 
acquired with 17.5 k resolution and the target value was 2.0 × 105 with 100 ms of maximum 
injection time. An isolation width of 2.0 m/z was used for precursor ion selection in MS/MS 
mode.  
 
Data analysis 
Thermo RAW files were converted to mzXML format using MSConvert (Chambers 
et al., 2012).  Peak detection, grouping, and retention time correction were performed in 
XCMS in R. Statistics analysis including multivariate modeling PCA, OPLSDA and 
hierarchical clustering were performed in Workflow4Metabolomics.org online resource 
for computational metabolomics (Giacomoni et al., 2015). Annotation was first performed 
by databases including BMRB (Markley et al., 2008), METLIN (Smith et al., 2005), and 
HMDB (Wishart et al., 2013) public databases, and identities were confirmed with 
authentic standards for m/z, retention time, and fragmentation data listed in Supplemental 
Table 2-5. Univariate testing ANOVA was performed using both 
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Workflow4Metabolomics.org online resource (Giacomoni et al., 2015) and Excel 2016 
(Microsoft). The peak area for each targeted metabolites was exported from the Quan 
Browser module of the Xcalibur software (Thermo Fisher Scientific) after visual 
confirmation of mass and retention times to validate the XCMS feature extraction. 
Metabolic pathways were generated by reference to the KEGG pathway Database 
(Kanehisa et al., 2017). Radial plots were generated using KaleidaGraph. S-plots of OPLS-
DA were generated to select variables with both high correlation and high covariance as 
metabolic signature candidates (Wiklund et al., 2008). To generate these plots the 
covariance p[1] was plotted on the x-axis whereas the correlation profile p(corr)[1] is 
plotted on the y-axis; the most positive and negative loadings in p[1] and p(corr)[1] of the 
S-plot represent variables with both high magnitude and high reliability. The S-plots for all 
the subgroups (Supplemental Figure 2-3) and all the treatments with their corresponding 
controls (Supplemental Figure 2-4) are included in the Supplemental Materials. The top 
5 most contributed variables to OPLS-DA S-plot with both high correlation and high 
covariance in different groups were reported in Supplemental Table 2-1. The potential 
stress metabolic signatures whose |p[1]|>0.07  identified with reference standards were 
reported by Supplemental Table 2-2. Metabolites as potential stress metabolic signatures 
and their corresponding precursors, intermediates, or products in the same metabolic 
pathway that were identified by authentic standards with m/z, retention time, and 
fragmentation (Supplemental Figure 2-6, Supplemental Figure 2-7, Supplemental 
Table 2-3).  
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Tables 
Table 2-1. Abiotic stress conditions 
Stress treatment Conditions Time Reference1 
Drought (D) 
remove seedling grown on nylon membrane from medium  
and desiccate in air for 2h 
9:00 AM Li et al., 2008 
Basal heat (BH) 45°C  for 5h 9:00 AM Kaplan et al., 2004; 
Acquired heat (AH) 38°C  for 1.5h, 22°C for 2h, 45°C  for 5h 9:00 AM 
Kaplan et al., 2004; Larkindale, 
2005 
Basal cold (BC) 4°C  for 3h 9:00 AM Kaplan et al., 2004 
Acquired cold (AC) 4°C for 3 h, 22°C for 1h, -15°C for 1 h 9:00 AM Kaplan et al., 2004 
High light (HL) 902 μmol m-2 s-1 metal halide light for 1h 9:00 AM Rossel et al., 2002 
Recovery treatment Recovery Conditions2     
Drought (DR) 
seedlings transferred back to agar medium in control chamber for 
48h 
11:00 AM 
  
Basal heat (BHR) plates of seedlings moved from stress to control chamber for 48h 2:00 PM   
Acquired heat (AHR) plates of seedlings moved from stress to control chamber for 48h 5:30 PM   
Basal cold (BCR) plates of seedlings moved from stress to control chamber for 48h 11:00 AM   
Acquired cold (ACR) plates of seedlings moved from stress to control chamber for 48h 2:00 PM   
High light (HLR) plates of seedlings moved from stress to control chamber for 48h 10:00 AM   
1Source from which stress conditions, with minor modifications, were derived. 
2All recovery treatments were identical to the above stress treatments, but were sampled after a 48 hr recovery period at ‘control 
conditions’ (22°C, 16-h-light/8-h-dark photoperiod with lights on at 8:00 AM., and ~80 μmol m-2 s-1 from cool-white fluorescent 
lights) 
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Figures 
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Figure 2-1. PCA score plots of treatments in subgroups with hierarchical manner for clustering identification. 
In the score plot, the symbols and colors corresponded to treatments in stress and recovery groups. (A) All groups. (B) Stress groups. 
(C) Recovery groups. (B1) Control, acquired cold, basal cold, drought, high light groups. (B2) Basal heat and acquired heat groups. 
(C1) Control recovery, acquired cold recovery, basal cold recovery, and high light recovery groups. (B1a) Acquired cold, basal cold, 
and high light groups. (C1a) Control recovery and acquired cold recovery groups. (C1b) Basal cold recovery and high light recovery 
groups. 
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Figure 2-2. Hierarchical clustering analysis (HCA) for potential stress metabolic signatures and their precursors, 
intermediates, or products in the same pathway. 
The top horizontal side bar reflects the log2-transformed fold changes of average for both positive and negative observations as 
reported in Supplemental Table 2-4. Clusters were generated using the complete linkage and maximum distance measurement. Five 
clusters of treatments were labeled by A-E. Seven clusters of metabolites were labeled by 1-7.  
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Figure 2-3. Radial plots for ratio changes of tryptophan, phenylalanine, tyrosine, leucine, valine, lysine, mannitol, raffinose, 
and guanine. 
(A) maltose, glucose, fructose, xylose, mannitol, and raffinose (B) cysteine, GSH, and GSSG (C), GABA, succinate, fumarate, malate, 
citrate, and -ketoglutaric acid (D) in different treatment compared to control. The ratio change 1 as no change with control was 
shown as blue circle. 
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Figure 2-4. Metabolic pathways and radial plots for identified potential stress metabolic signatures with their precursors, 
intermediates, or products in the same metabolic pathway. 
Radial plots were generated using the ratio change of each metabolite compared to control. The ratio change 1 has no change with 
control, as shown as a blue circle.  
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Supplemental materials 
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Supplemental Figure 2-1. OPLS-DA score plots of treatments in subgroups with hierarchical manner for clustering 
identification corresponded to Figure 2-1. 
In the score plot, the colors corresponded to different supervised subgroups based on clustering results from PCA. (A) Stress groups 
and recovery groups. (B) Control, acquired cold, basal cold, drought, high light groups and basal heat and acquired heat groups. (C) 
Control recovery, acquired cold recovery, basal cold recovery, and high light recovery groups and drought recovery, basal heat 
recovery, and acquired heat recovery groups. (B1) Acquired cold, basal cold, and high light groups and control and drought groups. 
(B2) Basal heat group and acquired heat group. (C1) Control recovery and acquired cold recovery groups and basal cold recovery and, 
high light recovery groups. (B1a) Acquired cold and basal cold groups and high light group. (C1a) control recovery group and 
acquired cold recovery group. (C1b) Basal cold recovery group and high light recovery group. 
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Supplemental Figure 2-1. OPLS-DA score plots of treatment compared to 
corresponding control.  
(A) Acquired cold and control. (B) Acquired heat and control. (C) Basal cold and control. 
(D) Basal heat and control. (E) Drought and control. (F) High light and control. (G) 
Acquired cold recovery and control recovery. (H) Acquired heat recovery and control 
recovery. (I) Basal cold recovery and control recovery. (J) Basal heat recovery and 
control recovery. (K) Drought recovery and control recovery. (L) High light recovery and 
control recovery.  
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Supplemental Figure 2-2. OPLS-DA S-plot of treatments in subgroups with hierarchical manner for clustering identification 
corresponded to Figure 2-1. 
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The representative OPLS-DA loadings S-pot showing relative contribution of metabolic features to the corresponding supervised 
clusters. (A) Stress groups and recovery groups. (B) Control, acquired cold, basal cold, drought, high light groups and basal heat and 
acquired heat groups. (C) Control recovery, acquired cold recovery, basal cold recovery, and high light recovery groups and drought 
recovery, basal heat recovery, and acquired heat recovery groups. (B1) Acquired cold, basal cold, and high light groups and control 
and drought groups. (B2) Basal heat group and acquired heat group. (C1) Control recovery & acquired cold recovery groups and basal 
cold recovery and, high light recovery groups. (B1a) Acquired cold and basal cold groups and high light group. (C1a) control recovery 
group and acquired cold recovery group. (C1b) Basal cold recovery group and high light recovery group. The p[1] and p(corr)[1] 
axises represents the covariance and the correlation of features towards the predictive variation shown in the corresponding OPLS-DA 
loading score.  
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Supplemental Figure 2-3. OPLS-DA S-plot of treatment compared to corresponding control. 
The representative OPLS-DA loadings S-pot showing relative contribution of metabolic features to the corresponding supervised 
clusters. (A) Acquired cold and control. (B) Acquired heat and control. (C) Basal cold and control. (D) Basal heat and control. (E) 
Drought and control. (F) High light and control. (G) Acquired cold recovery and control recovery. (H) Acquired heat recovery and 
control recovery. (I) Basal cold recovery and control recovery. (J) Basal heat recovery and control recovery. (K) Drought recovery and 
control recovery. (L) High light recovery and control recovery. The p[1] and p(corr)[1] axises represents the covariance and 
correlation of features towards the predictive variation shown in the corresponding OPLS-DA loading score.  
43 
 
 
44 
 
 
45 
 
 
46 
 
 
47 
 
 
Supplemental Figure 2-4. Hierarchical clustering analysis (HCA) for potential stress 
metabolic signatures and their precursors, intermediates, or products in the same 
pathway. 
The top horizontal side bar reflects the log2-transformed fold changes of average for both 
positive and negative observations as reported in Supplemental Table 2-4. Clusters were 
generated using the complete linkage and Euclidean distance measurement (A), complete 
linkage and Manhattan distance measurement (B), complete linkage and Minkowski 
distance measurement (C), Wards’s method and maximum distance measurement (D), 
and McQuitty's method with maximum distance measurement (E). Clusters of treatments 
were labeled by A-E. Clusters of metabolites were labeled by 1-7.  
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Supplemental Figure 2-5. Metabolites that were identified by authentic standards with m/z, retention time, and fragmentation 
in positive mode. 
The top scheme represents metabolite in sample. The bottom scheme represents metabolite in standard.  Standard compounds include: 
adenine (A), adenosine (B), -aminobutyric acid (C), GSH (D), GSSG (E), guanine (F), guanosine monophosphate (G), L-alanine (H), 
L-arginine (I), L-asparagine (J), L-aspartic acid (K), L-citrulline (L), L-cysteine (M), L-glutamic acid (N), L-glutamine (O), L-glycine 
(P), L-histidine (Q), L-leucine (R), L-lysine (S), L-ornithine (T), L-phenylalanine (U), L-proline (V), L-serine (W), L-threonine (X), 
L-tryptophan (Y), L-tyrosine (Z), L-valine (AA), mannitol (AB), urea (AC).  It should be noted that while standard compounds of the 
specified stereochemistry were used, analytical procedures that would resolve enantiomers were not employed.  Because of this 
absolute stereo-assignments for each of these compounds were not included as part of the assignment, though it is likely that the vast 
majority of amino acids identified are of the L-configuration as D-amino acids are unusual in plants and typically occur in specialized 
metabolic contexts. 
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Supplemental Figure 2-6. Metabolites that were identified by authentic standards with m/z, retention time, and fragmentation 
in negative mode. 
The top scheme represents metabolite in sample. The bottom scheme represents metabolite in standard.  Standard compounds include: 
adenosine (A), -ketoglutaric acid (B), citric acid (C), dihydroxyacetone phosphate (D), fructose (E), fructose 6-phosphate (F), 
fumaric acid (G), glucose (H), glucose 6-phosphate (I), GSH (J), GSSG (K), L-arginine (L), L-asparagine (M), L-aspartic acid (N), L-
citrulline (O), L-glutamic acid (P), L-glutamine (Q), L-glycine (R), L-histidine (S), L-leucine (T), L-lysine (U), L-ornithine (V), L-
phenylalanine (W), L-serine (X), L-threonine (Y), L-tryptophan (Z), L-tyrosine (AA), L-valine (AB), malic acid (AC), maltose (AD), 
mannitol (AE), oxoloacetate (AF), pyruvic acid (AG), raffinose (AH), ribose 5-phosphate (AI), shikimic acid (AJ), succinic acid 
(AK), sucrose (AL), xylose (AM). As noted above, while standard compounds of the specified stereochemistry were used, analytical 
procedures that would resolve enantiomers were not employed. 
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Supplemental Table 2-1. Top five most contributed variables to OPLS-DA S-plot with both high correlation and high 
covariance in different groups 
M/z 
Retenti
on time 
(min) 
Polarity 
Groups or stress that 
contributed the most 
P[1] P(corr)[1] 
Identified with 
reference 
standard 
Potential 
mass (5 
ppm) 
Potential 
Heuristical 
Formula (5 
ppm) 
Potential identification by 
KEGG or PubChem (5 
ppm) 
226.9806 8.45 negative (a) all groups -0.11 -0.77  227.9851 C6H5ClN2O3S 
m-Benzenesulfonium 
diazonium chloride 
248.9613 9.20 negative (a) all groups -0.11 -0.92  
249.966276
997 
C5H11NS5 
7-N,N-Dimethylamino-
1,2,3,4,5-
pentathiocyclooctane 
293.0525 8.00 negative (a) all groups -0.11 -0.87  294.0617 C9H15N2O7P Pyrimidine 5'-nucleotide 
316.2819 5.22 positive (a) all groups 0.11 0.73     
318.2974 5.25 positive (a) all groups 0.11 0.82  317.293 C18H39NO3 Phytosphingosine 
94.5733 14.37 positive (b) stress groups only -0.11 -0.76 Lysine (M+ACN+2H)  
118.0862 6.97 positive (b) stress groups only -0.11 -0.64 Valine    
189.1514 10.89 positive (b) stress groups only 0.12 0.84  188.1442 C10H14N2O (R)-6-Hydroxynicotine 
276.1136 12.19 positive (b) stress groups only -0.14 -0.76  275.1044 C13H11NO5 Oxolinic acid 
294.9360 3.08 positive (b) stress groups only 0.10 0.61     
126.9055 6.04 negative (c) recovery groups only 0.08 0.86     
273.0404 8.84 negative (c) recovery groups only 0.08 0.93  274.0477 C14H10O6 Isoathyriol 
380.8439 5.53 negative (c) recovery groups only 0.09 0.95     
404.8459 5.77 negative (c) recovery groups only -0.09 -0.96     
360.8383 5.80 positive (c) recovery groups only -0.08 -0.95     
57.9757 8.70 negative 
(d) control, acquired cold, 
basal cold, drought, high 
light groups 
0.13 0.89  58.98297 CHNS Thiocyanate 
306.0774 11.62 negative 
(d) control, acquired cold, 
basal cold, drought, high 
light groups 
-0.09 -0.54 GSH    
178.1261 4.52 positive 
(d) control, acquired cold, 
basal cold, drought, high 
light groups 
0.14 0.69     
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447.1921 14.23 positive 
(d) control, acquired cold, 
basal cold, drought, high 
light groups 
-0.12 -0.89  446.1812 C21H36INO Tridihexethyl iodide 
454.2921 7.82 positive 
(d) control, acquired cold, 
basal cold, drought, high 
light groups 
-0.12 -0.91  453.2875 C23H30N2O6 Cinegalline 
505.1671 14.89 negative 
(e) basal heat and acquired 
heat groups 
-0.14 -0.77  506.175 C16H23N6O10P L-2-Aminoadipate adenylate 
539.1376 14.89 negative 
(e) basal heat and acquired 
heat groups 
-0.12 -0.75 Raffinose (M+Cl)   
551.1711 14.90 negative 
(e) basal heat and acquired 
heat groups 
-0.11 -0.74 Raffinose (M+FA-H) [M+2]  
137.0532 5.46 positive 
(e) basal heat and acquired 
heat groups 
0.09 0.78     
205.0963 7.35 positive 
(e) basal heat and acquired 
heat groups 
0.14 0.71 Tryptophan   
255.0192 7.33 negative 
(f) control recovery, 
acquired cold recovery, 
basal cold recovery, and 
high light recovery groups 
0.13 0.70     
551.7563 6.13 negative 
(f) control recovery, 
acquired cold recovery, 
basal cold recovery, and 
high light recovery groups 
-0.17 -0.68     
107.9674 6.41 positive 
(f) control recovery, 
acquired cold recovery, 
basal cold recovery, and 
high light recovery groups 
0.14 0.77     
123.9393 6.40 positive 
(f) control recovery, 
acquired cold recovery, 
basal cold recovery, and 
high light recovery groups 
0.13 0.72     
629.6773 6.12 positive 
(f) control recovery, 
acquired cold recovery, 
basal cold recovery, and 
high light recovery groups 
-0.17 -0.67     
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221.0692 12.42 negative 
(g) acquired cold, basal 
cold, and high light groups 
0.14 0.95  
222.077249
175 
C8H9N3O4 
302.1022 12.83 negative 
(g) acquired cold, basal 
cold, and high light groups 
-0.12 -0.97     
455.1034 12.97 negative 
(g) acquired cold, basal 
cold, and high light groups 
0.14 0.95  
456.113926
926 
C23H22N2O6S Carfecillin 
216.0619 14.17 positive 
(g) acquired cold, basal 
cold, and high light groups 
-0.11 -0.97  215.0559 C5H14NO6P 
sn-glycero-3-
Phosphoethanolamine 
365.1027 12.97 positive 
(g) acquired cold, basal 
cold, and high light groups 
0.13 0.95 Sucrose (M+Na)   
163.0220 7.98 negative 
(h) control recovery & 
acquired cold recovery 
groups 
-0.13 -0.81  164.0273 C5H9NO3S Acetylcysteine 
66.0682 12.54 positive 
(h) control recovery & 
acquired cold recovery 
groups 
-0.15 -0.79     
82.5371 22.55 positive 
(h) control recovery & 
acquired cold recovery 
groups 
0.12 0.75     
90.0549 8.66 positive 
(h) control recovery & 
acquired cold recovery 
groups 
-0.10 -0.50 Alanine    
94.0450 22.54 positive 
(h) control recovery & 
acquired cold recovery 
groups 
0.12 0.75     
227.8576 6.12 negative 
(i) basal cold recovery and, 
high light recovery groups 
-0.25 -0.89     
333.9394 6.31 negative 
(i) basal cold recovery and, 
high light recovery groups 
0.25 0.92   C8H2N2O11P0S1 
401.9273 6.38 negative 
(i) basal cold recovery and, 
high light recovery groups 
-0.21 -0.83   C8H18N0O4P0S7 
117.0738 7.56 positive 
(i) basal cold recovery and, 
high light recovery groups 
0.11 0.97 Proline [M+1]   
122.5831 23.45 positive 
(i) basal cold recovery and, 
high light recovery groups 
0.17 0.80     
221.0692 12.42 negative acquired cold -0.11 -0.93  222.0772 C8H9N3O4 Nicorandil 
306.0774 11.62 negative acquired cold 0.12 0.97 GSH    
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341.1117 13.00 negative acquired cold -0.10 -0.97 Maltose    
379.9210 4.66 negative acquired cold 0.12 0.90     
193.1440 4.42 positive acquired cold -0.11 -0.90     
162.9404 6.10 negative acquired cold recovery -0.13 -0.81     
66.0682 12.54 positive acquired cold recovery -0.15 -0.79     
82.5371 22.55 positive acquired cold recovery 0.12 0.75     
90.0549 8.66 positive acquired cold recovery -0.10 -0.50 Alanine    
94.0450 22.54 positive acquired cold recovery 0.12 0.75     
503.1613 14.88 negative acquired heat 0.08 0.88 Raffinose   
539.1376 14.89 negative acquired heat 0.09 0.87 Raffinose (M+Cl)   
550.1691 14.89 negative acquired heat 0.09 0.86 Raffinose (M+FA-H) [M+1]  
551.1711 14.90 negative acquired heat 0.09 0.86 Raffinose (M+FA-H) [M+2]  
442.7732 6.15 positive acquired heat -0.08 -0.88     
126.9055 6.04 negative acquired heat recovery -0.09 -0.99     
315.8734 6.19 negative acquired heat recovery 0.08 0.98     
394.8930 9.26 negative acquired heat recovery -0.08 -0.97     
359.8495 6.38 positive acquired heat recovery 0.09 0.98     
402.8205 5.41 positive acquired heat recovery 0.08 0.98     
161.0469 12.44 negative basal cold -0.11 -0.98  162.052 C6H6N2O3 Imidazol-5-yl-pyruvate 
306.0774 11.62 negative basal cold 0.13 0.97 GSH    
379.9210 4.66 negative basal cold 0.11 0.95     
455.1034 12.97 negative basal cold -0.11 -0.99  456.1139 C23H22N2O6S Carfecillin 
136.0791 5.33 positive basal cold -0.15 -0.95     
330.8636 6.16 negative basal cold recovery 0.13 0.98     
401.9273 6.38 negative basal cold recovery -0.11 -0.89     
450.8088 6.16 negative basal cold recovery 0.12 1.00     
324.8255 6.15 positive basal cold recovery 0.12 0.99     
359.8495 6.38 positive basal cold recovery -0.11 -0.85     
248.0549 9.15 negative basal heat -0.09 -0.91  249.0596 C13H10Cl2 Bis(4'-chlorophenyl)methane 
468.8975 5.45 negative basal heat 0.07 0.98     
188.0708 7.36 positive basal heat -0.09 -0.95  187.0625 C6H10ClN5 Deethylatrazine 
276.1136 12.19 positive basal heat -0.10 -0.93  
275.104370
253 
C13H11NO5 Oxolinic acid 
526.7586 4.82 positive basal heat 0.07 0.80     
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448.8060 6.15 negative basal heat recovery -0.07 -0.99     
136.0621 6.02 positive basal heat recovery 0.07 1.00 Adenine    
359.8495 6.38 positive basal heat recovery 0.07 1.00     
402.8205 5.41 positive basal heat recovery 0.07 1.00     
494.7613 6.18 positive basal heat recovery -0.07 -1.00     
402.1015 11.91 negative drought -0.12 -0.97  403.1067 C17H12F4N2O2S SC-58125 
422.0435 12.71 negative drought -0.13 -1.00  423.0465 C13H12N5NaO5S2 Ceftizoxime sodium 
94.0573 22.72 positive drought 0.10 0.84     
324.0928 12.70 positive drought -0.11 -0.98  
323.084374
874 
C13H12N2O5S Nimesulide 
398.1643 11.13 positive drought 0.12 0.99  397.1547 C14H17N5O8 Succinoadenosine 
246.9367 10.91 negative drought recovery -0.06 -1.00     
380.8439 5.53 negative drought recovery -0.07 -1.00     
402.8205 5.41 positive drought recovery 0.07 1.00     
442.7732 6.15 positive drought recovery -0.06 -0.99     
478.8338 6.40 positive drought recovery 0.06 1.00     
232.0221 5.84 negative high light -0.09 -0.97     
306.0774 11.62 negative high light 0.12 0.98 GSH    
379.9210 4.66 negative high light 0.10 0.81     
118.0862 6.97 positive high light -0.10 -0.72 Valine    
280.0903 12.85 positive high light -0.09 -0.99  279.0814 C13H12Cl2N2 
4,4'-Methylene-bis-(2-
chloroaniline) 
246.9018 6.16 negative high light recovery 0.12 0.86     
315.8734 6.19 negative high light recovery 0.13 0.92     
366.8774 6.30 negative high light recovery -0.11 -0.97     
275.8880 6.41 positive high light recovery 0.12 0.93     
324.8255 6.15 positive high light recovery -0.13 -0.97     
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Supplemental Table 2-2. Potential stress metabolic signatures whose |p[1]|>0.07  identified with reference standards 
M/z 
Retention 
time (min) 
Polarity Groups or stress that contributed the most P[1] P(corr)[1] 
Identified with reference 
standard 
76.0393 10.04 positive (i) basal cold recovery and, high light recovery groups 0.08 0.88 Glycine 
87.0090 4.31 negative (d) control, acquired cold, basal cold, drought, high light groups 0.09 0.84 Pyruvate 
90.0548 8.89 positive 
(f) control recovery, acquired cold recovery, basal cold recovery, and high 
light recovery groups_regroup 
-0.10 -0.44 Alanine 
90.0548 8.89 positive (g) acquired cold, basal cold, and high light groups 0.10 0.62 Alanine 
90.0548 8.89 positive (h) control recovery & acquired cold recovery groups -0.10 -0.50 Alanine 
90.0548 8.89 positive (i) basal cold recovery and, high light recovery groups 0.07 0.31 Alanine 
90.0548 8.89 positive acquired cold recovery -0.10 -0.50 Alanine 
94.5733 14.37 positive (b) stress groups only -0.11 -0.76 Lysine (M+ACN+2H) 
94.5733 14.37 positive basal heat -0.08 -0.96 Lysine (M+ACN+2H) 
104.072 7.42 positive (d) control, acquired cold, basal cold, drought, high light groups -0.08 -0.75 gamma-Aminobutyric acid 
116.0705 7.54 positive (d) control, acquired cold, basal cold, drought, high light groups 0.09 0.63 Proline 
116.0705 7.54 positive (i) basal cold recovery and, high light recovery groups 0.10 0.97 Proline 
116.072 7.01 negative (b) stress groups only -0.11 -0.64 Valine 
116.072 7.01 negative acquired cold -0.08 -0.65 Valine 
116.072 7.01 negative basal cold -0.09 -0.68 Valine 
116.072 7.01 negative basal heat -0.08 -0.80 Valine 
116.072 7.01 negative high light -0.10 -0.72 Valine 
117.0738 7.56 positive (i) basal cold recovery and, high light recovery groups 0.11 0.97 Proline [M+1] 
118.0862 6.97 positive (b) stress groups only -0.11 -0.64 Valine 
118.0862 6.97 positive acquired cold -0.08 -0.65 Valine 
118.0862 6.97 positive basal cold -0.09 -0.68 Valine 
118.0862 6.97 positive basal heat -0.08 -0.80 Valine 
118.0862 6.97 positive high light -0.10 -0.72 Valine 
120.0654 9.87 positive 
(f) control recovery, acquired cold recovery, basal cold recovery, and high 
light recovery groups_regroup 
-0.13 -0.59 Threonine 
132.1018 6.44 negative (b) stress groups only -0.11 -0.72 Leucine 
132.1018 6.44 negative (g) acquired cold, basal cold, and high light groups -0.07 -0.88 Leucine 
132.1018 6.44 negative acquired heat 0.08 0.92 Leucine 
132.1018 6.44 negative basal heat -0.08 -0.98 Leucine 
132.1018 6.44 negative high light -0.08 -0.95 Leucine 
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133.0152 7.44 negative (d) control, acquired cold, basal cold, drought, high light groups 0.07 0.85 Malic acid 
133.1050 6.47 positive (b) stress groups only -0.11 -0.72 Leucine [M+1] 
133.1050 6.47 positive (g) acquired cold, basal cold, and high light groups -0.07 -0.88 Leucine [M+1] 
133.1050 6.47 positive acquired heat 0.08 0.92 Leucine [M+1] 
133.1050 6.47 positive basal heat -0.08 -0.98 Leucine [M+1] 
133.1050 6.47 positive high light -0.08 -0.95 Leucine [M+1] 
136.0621 5.90 positive (c) recovery groups only -0.07 -0.87 Adenine 
136.0621 5.90 positive basal heat recovery 0.07 1.00 Adenine 
145.0629 10.81 negative (h) control recovery & acquired cold recovery groups -0.07 -0.86 Glutamine 
145.0629 10.81 negative acquired cold recovery -0.07 -0.86 Glutamine 
147.076 10.80 positive (h) control recovery & acquired cold recovery groups -0.09 -0.93 Glutamine 
147.076 10.80 positive acquired cold recovery -0.09 -0.93 Glutamine 
152.0568 8.29 positive (b) stress groups only -0.11 -0.72 Guanine 
166.0862 6.74 positive acquired cold -0.07 -0.99 Phenylalanine 
166.0862 6.74 positive acquired heat 0.08 0.91 Phenylalanine 
166.0862 6.74 positive basal cold -0.08 -0.97 Phenylalanine 
180.068 9.13 negative (b) stress groups only -0.07 -0.85 Tyrosine 
182.0812 9.11 positive (b) stress groups only -0.11 -0.75 Tyrosine 
182.0812 9.11 positive acquired heat 0.07 0.88 Tyrosine 
182.0812 9.11 positive basal heat -0.08 -0.97 Tyrosine 
183.085 8.81 positive (b) stress groups only -0.10 -0.77 Mannitol 
205.0963 7.35 positive (e) basal heat and acquired heat groups 0.14 0.71 Tryptophan 
205.0963 7.35 positive basal heat -0.08 -0.97 Tryptophan 
205.0963 7.35 positive high light -0.07 -0.90 Tryptophan 
206.1003 7.32 positive (b) stress groups only -0.11 -0.76 Tryptophan [M+1] 
206.1003 7.32 positive acquired heat 0.07 0.89 Tryptophan [M+1] 
206.1003 7.32 positive basal heat -0.08 -0.97 Tryptophan [M+1] 
206.1003 7.32 positive high light -0.07 -0.89 Tryptophan [M+1] 
259.0227 20.13 negative (d) control, acquired cold, basal cold, drought, high light groups 0.07 0.75 Glucose 6-phosphate 
259.0227 20.13 negative (g) acquired cold, basal cold, and high light groups 0.07 0.90 Glucose 6-phosphate 
259.0227 20.13 negative (g) acquired cold, basal cold, and high light groups 0.08 0.89 Glucose 6-phosphate 
259.023 20.69 negative (d) control, acquired cold, basal cold, drought, high light groups 0.08 0.76 Fructose 6-P 
306.0774 11.60 negative (d) control, acquired cold, basal cold, drought, high light groups -0.09 -0.54 GSH 
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306.0774 11.60 negative acquired cold 0.12 0.97 GSH 
306.0774 11.60 negative basal cold 0.13 0.97 GSH 
306.0774 11.60 negative high light 0.12 0.98 GSH 
341.1116 12.94 negative (d) control, acquired cold, basal cold, drought, high light groups 0.08 0.55 Maltose 
341.1116 12.94 negative (g) acquired cold, basal cold, and high light groups 0.12 0.95 Maltose 
341.1116 12.94 negative acquired cold -0.10 -0.97 Maltose 
341.1116 12.94 negative basal cold -0.10 -0.99 Maltose 
365.1027 12.97 positive (g) acquired cold, basal cold, and high light groups 0.13 0.95 Sucrose (M+Na) 
365.1027 12.97 positive basal cold -0.11 -0.99 Sucrose (M+Na) 
377.0880 12.96 negative (g) acquired cold, basal cold, and high light groups 0.12 0.95 Sucrose (M+Cl) 
377.0880 12.96 negative acquired cold -0.09 -0.99 Sucrose (M+Cl) 
377.0880 12.96 negative basal cold -0.10 -0.99 Sucrose (M+Cl) 
503.1614 14.89 negative (b) stress groups only -0.08 -0.50 Raffinose 
503.1614 14.89 negative (e) basal heat and acquired heat groups -0.11 -0.75 Raffinose 
503.1614 14.89 negative acquired heat 0.08 0.88 Raffinose 
539.1376 14.89 negative (e) basal heat and acquired heat groups -0.12 -0.75 Raffinose (M+Cl) 
539.1376 14.89 negative acquired heat 0.09 0.87 Raffinose (M+Cl) 
549.1656 14.89 negative (b) stress groups only -0.08 -0.52 Raffinose (M+FA-H) 
549.1656 14.89 negative (e) basal heat and acquired heat groups -0.11 -0.74 Raffinose (M+FA-H) 
549.1656 14.89 negative (g) acquired cold, basal cold, and high light groups -0.08 -0.95 Raffinose (M+FA-H) 
549.1656 14.89 negative acquired heat 0.08 0.90 Raffinose (M+FA-H) 
550.1691 14.90 negative (e) basal heat and acquired heat groups -0.11 -0.75 Raffinose (M+FA-H) [M+1] 
550.1691 14.90 negative acquired heat 0.09 0.86 Raffinose (M+FA-H) [M+1] 
551.1711 14.90 negative (b) stress groups only -0.11 -0.58 Raffinose (M+FA-H) [M+2] 
551.1711 14.90 negative (e) basal heat and acquired heat groups -0.11 -0.74 Raffinose (M+FA-H) [M+2] 
551.1711 14.90 negative acquired heat 0.09 0.86 Raffinose (M+FA-H) [M+2] 
613.163 18.10 positive (a) all groups 0.07 0.90 GSSG 
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Supplemental Table 2-3. Metabolites as potential stress metabolic signatures that are identified with reference standard 
Identity M/z 
retenti
on 
time 
(min) 
polarity 
Molecular 
formula 
Monoisot
opic Mass 
Adduct 
Theoretic
al exact 
mass (Da) 
Mass 
accuracy 
(ppm) 
Fragment ions 
Adenine 136.062 7.08 positive C5H5N5 135.055 M+H 136.062 4 119.04, 94.04, 92.03 
Adenosine 266.09 5.66 negative C10H13N5O4 267.097 M-H 266.09 2 134.05 
Adenosine 268.103 5.62 positive C10H13N5O4 267.097 M+H 268.104 4 136.06 
Alanine 90.0548 8.89 positive C3H7NO2 89.0477 M+H 90.055 2 74.10, 72.08, 72.04, 60.08, 54.00 
alpha-Ketoglutaric acid 145.015 7.36 negative C5H6O5 146.022 M-H 145.014 5 118.04, 101.06, 77.01, 64.02 
Arginine 173.105 14.25 negative C6H14N4O2 174.112 M-H 173.104 3 156.08, 131.08, 114.06, 58.04 
Arginine 175.119 14.22 positive C6H14N4O2 174.112 M+H 175.119 1 
158.09, 141.07, 130.10, 116.07, 112.09, 97.08, 
72.08, 70.07, 60.06 
Asparagine 131.047 11.36 negative C4H8N2O3 132.054 M-H 131.046 4 
131.05, 114.02, 113.04, 111.02, 96.01, 95.03, 
72.01, 70.03, 58.03 
Asparagine 133.061 11.09 positive C4H8N2O3 132.054 M+H 133.061 1 116.03, 88.04, 87.06, 74.02, 70.03, 60.04 
Aspartic acid 132.031 12.87 negative C4H7NO4 133.038 M-H 132.03 4 115.00, 113.04, 88.04, 71.01 
Aspartic acid 134.045 12.25 positive C4H7NO4 133.038 M+H 134.045 0 116.03, 88.04, 74.02, 70.03 
Citric acid 191.02 12.44 negative C6H8O7 192.027 M-H 191.02 3 129.02, 111.01, 102.95, 87.01, 57.03 
Citrulline 174.089 11.81 negative C6H13N3O3 175.096 M-H 174.088 4 131.08 
Citrulline 176.103 11.81 positive C6H13N3O3 175.096 M+H 176.103 0 141.07, 130.10, 115.09, 113.07, 97.08, 70.07 
Cysteine 122.027 16.09 positive C3H7NO2S 121.02 M+H 122.027 3 122.03, 120.01, 104.11 
Dihydroxyacetone 
phosphate 
168.992 17.35 negative C3H7O6P 169.998 M-H 168.991 4 96.97, 78.96 
Fructose 179.057 7.97 negative C6H12O6 180.063 M-H 179.056 4 168.89, 122.89, 89.02, 69.00 
Fructose 6-phosphate 259.023 19.74 negative C6H13O9P 260.03 M-H 259.022 1 223, 199, 168.99, 138.98, 96.97, 78.96 
Fumaric acid 115.004 5.84 negative C4H4O4 116.011 M-H 115.004 3 72.02, 71.01, 69.00 
Glucose 179.057 9.28 negative C6H12O6 180.063 M-H 179.056 4 
163.04, 119.04, 113.02, 101.02, 89.02, 85.03, 
71.01, 59.01 
Glucose 179.057 9.98 negative C6H12O6 180.063 M-H 179.056 5 
163.04, 119.04, 113.02, 101.02, 89.02, 85.03, 
71.01, 59.01 
Glucose 6-phosphate 259.023 20.13 negative C6H13O9P 260.03 M-H 259.022 1 199.00, 168.99, 138.98, 101.02, 96.97, 78.96 
Glutamic acid 146.046 11.17 negative C5H9NO4 147.053 M-H 146.046 4 128.04, 102.06 
Glutamic acid 148.06 11.77 positive C5H9NO4 147.053 M+H 148.06 0 130.05, 102.06, 84.04 
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Glutamine 145.063 10.81 negative C5H10N2O3 146.069 M-H 145.062 7 
128.04, 127.05, 125.04, 109.04, 101.07, 99.06, 
86.02, 84.05, 74.02, 72.01, 58.03 
Glutamine 147.076 10.80 positive C5H10N2O3 146.069 M+H 147.076 1 130.09, 123.96, 102,05, 84.08, 64.93 
Glycine 74.0249 9.98 negative C2H5NO2 75.032 M-H 74.0248 2 72.99 
Glycine 76.0393 10.04 positive C2H5NO2 75.032 M+H 76.0393 0 57.05, 58.04, 75.06 
GSH  306.077 11.60 negative C10H17N3O6S 307.084 M-H 306.077 3 
288.07, 272.09, 254.08, 242.08, 210.09, 179.05, 
160.01, 143.05, 74.02 
GSH  308.09 12.47 positive C10H17N3O6S 307.084 M+H 308.091 2 
291.06, 245.06, 233.06, 179.05, 162.02, 130.05, 
84.04, 76.02 
GSSG 611.152 18.11 negative 
C20H32N6O12S
2 
612.152 M-H 611.145 # 
593.14, 482.10, 338.05, 306.08, 272.09, 254.08, 
210.09, 143.05 
GSSG 613.163 18.1 positive 
C20H32N6O12S
2 
612.152 M+H 613.159 6 
538.13, 484.12, 466.11, 409.09, 355.08, 288.07, 
324.04, 177.03, 130.05 
Guanine 152.057 8.29 positive C5H5N5O 151.049 M+H 152.057 1 108.52, 99.51, 97.01, 88.00, 87.00 
Guanosine 
monophosphate 
364.068 19.19 positive C10H14N5O8P 363.058 M+H 364.065 6 152.06, 97.03 
Histidine 154.063 14.47 negative C6H9N3O2 155.07 M-H 154.062 5 137.04, 110.07, 96.96, 93.05, 81.05, 72.01 
Histidine 156.077 14.47 positive C6H9N3O2 155.07 M+H 156.077 0 110.07, 95.06, 83.06 
Leucine 130.088 6.46 negative C6H13NO2 131.095 M-H 130.087 5 89.01, 85.03, 65.01 
Leucine 132.102 6.39 positive C6H13NO2 131.095 M+H 132.102 0 86.10, 69.07 
Leucine [M+1] 133.105 6.47 positive           86.10, 69.07 
Lysine 145.099 14.38 negative C6H14N2O2 146.106 M-H 145.098 7 128.04, 127.05, 102.06, 100.95, 85.93 
Lysine 147.113 14.37 positive C6H14N2O2 146.106 M+H 147.113 1 130.09, 123.96, 102.05, 84.08 
Lysine (M+ACN+2H) 94.5733 14.37 positive C6H14N2O2 146.106 
M+ACN+
2H 
94.5733 0 130.09, 123.96, 102.05, 84.08 
Malic acid 133.015 7.41 negative C4H6O5 134.022 M-H 133.014 3 115.00, 89.02, 72.99, 71.01 
Maltose 341.111 12.9 negative C12H22O11 342.116 M-H 341.109 6 221.07, 119.04, 161.05, 119.04, 101.02, 89.02 
Mannitol 181.073 8.81 negative C6H14O6 182.079 M-H 181.072 6 
163.06, 149.05, 131.04, 119.04, 113.02, 101.02, 
89.02, 85.03, 73.03, 71.01, 59.01 
Mannitol 183.085 8.81 positive C6H14O6 182.079 M+H 183.086 9 
165.05, 147.04, 136.08, 123.04, 119.05, 113.96, 
91.05 
Ornithine 131.083 14.86 negative C5H12N2O2 132.09 M-H 131.083 4 
115.00, 114.02, 113.04, 111.02, 95.03, 88.04, 
72.03, 70.03, 58.03 
Ornithine 133.097 14.96 positive C5H12N2O2 132.09 M+H 133.097 0 116.07, 115.09, 70.07 
Oxoloacetate 130.997 11.32 negative C4H4O5 132.006 M-H 130.999 # 104.03, 89.01, 65.01 
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Phenylalanine 164.072 6.89 negative C9H11NO2 165.079 M-H 164.072 4 136.05, 121.05, 96.96, 82.04, 65.01 
Phenylalanine 166.086 6.88 positive C9H11NO2 165.079 M+H 166.086 0 149.06, 131.05, 120.08, 103.05 
Proline 116.071 7.55 positive C5H9NO2 115.063 M+H 116.071 0 70.07 
Proline [M+1] 117.074 7.56 positive           70.07 
Pyruvic acid 87.009 4.31 negative C3H4O3 88.016 M-H 87.0088 3 62.63, 59.01 
Raffinose 503.161 14.89 negative C18H32O16 504.169 M-H 503.162 1 
289.07, 272.09, 254.08, 228.10, 210.09, 179.05, 
160.01, 143.05, 128.04, 74.02 
Raffinose (M+Cl) 539.138 14.89 negative C18H32O16 504.169 M+Cl 539.138 2 
289.07, 272.09, 254.08, 228.10, 210.09, 179.05, 
160.01, 143.05, 128.04, 74.03 
Raffinose (M+FA-H) 549.166 14.89 negative C18H32O16 504.169 M+FA-H 549.167 2 
289.07, 272.09, 254.08, 228.10, 210.09, 179.05, 
160.01, 143.05, 128.04, 74.04 
Raffinose (M+FA-H) 
[M+1] 
550.169 14.90 negative           
289.07, 272.09, 254.08, 228.10, 210.09, 179.05, 
160.01, 143.05, 128.04, 74.05 
Raffinose (M+FA-H) 
[M+2] 
551.171 14.90 negative           
289.07, 272.09, 254.08, 228.10, 210.09, 179.05, 
160.01, 143.05, 128.04, 74.06 
Ribose 5-phosphate 229.013 18.73 negative C5H11O8P 230.019 M-H 229.012 3 138.98, 96.97, 78.96 
Serine 104.036 11.42 negative C3H7NO3 105.043 M-H 104.035 5 74.02, 72.01, 61.99 
Serine 106.05 11.37 positive C3H7NO3 105.043 M+H 106.05 1 88.04, 70.03, 60.04 
Shikimic acid 173.045 6.52 negative C7H10O5 174.053 M-H 173.046 1 
137.02, 129.02, 111.05, 99.05, 93.03, 83.05, 73.03, 
71.01 
Succinic acid 117.02 5.42 negative C4H6O4 118.027 M-H 117.019 4 99.01, 73.03 
Sucrose 341.111 12.20 negative C12H22O11 342.116 M-H 341.109 5 221.07, 119.04, 101.02, 89.02, 71.01, 59.01 
Sucrose (M+Cl) 377.088 12.96 negative C12H22O11 342.116 M+Cl 377.086 6 221.07, 119.04, 101.02, 89.02, 71.01, 59.01 
Sucrose (M+Na) 365.103 12.97 positive C12H22O11 342.116 M+Na 365.105 7 221.07, 119.04, 101.02, 89.02, 71.01, 59.01 
Threonine 118.052 10.08 negative C4H9NO3 119.058 M-H 118.051 5 74.02, 72.01, 59.01 
Threonine 120.066 10.09 positive C4H9NO3 119.058 M+H 120.066 0 102.05, 84.04, 74.06, 56.05 
Tryptophan 203.083 7.31 negative C11H12N2O2 204.09 M-H 203.083 3 106.04, 96.96, 82.04, 65.01 
Tryptophan 205.097 7.33 positive C11H12N2O2 204.09 M+H 205.097 0 
188.07, 170.06, 159.09, 146.06, 144.08, 132.08, 
91.05, 74.02 
Tryptophan [M+1] 206.1 7.32 positive           
188.07, 170.06, 159.09, 146.06, 144.08, 132.08, 
91.05, 74.02 
Tyrosine 180.068 9.13 negative C9H11NO3 181.074 M-H 180.067 5 
163.04, 119.05, 101.02, 93.03, 89.02, 85.03, 72.01, 
59.01 
Tyrosine 182.081 9.12 positive C9H11NO3 181.074 M+H 182.081 1 
165.05, 147.04, 136.08, 123.04, 119.05, 113.96, 
91.05 
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Urea 61.0398 2.79 positive CH4N2O 60.0324 M+H 61.0396 3 60.04 
Valine 116.072 7.01 negative C5H11NO2 117.079 M-H 116.072 6 99.93, 89.01, 74.02, 73.03, 69.00 
Valine 118.086 7.09 positive C5H11NO2 117.079 M+H 118.086 0 72.08 
Xylose 149.046 6.98 negative C5H10O5 150.053 M-H 149.046 4 89.02, 71.01, 59.01 
γ-Aminobutyric acid 104.072 7.42 positive C4H9NO2 103.063 M+H 104.071 # 87.04, 86.06, 69.03 
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Supplemental Table 2-4. Average fold change of metabolites identified with reference standards observed between positive and 
negative mode compared to control 
Metabolites 
Acquired 
cold 
stress 
Acquired 
heat 
stress 
Basal 
cold 
stress 
Basal 
heat 
stress 
Drought 
stress 
High 
light 
stress 
Acquired 
cold 
recovery 
Acquired 
heat 
recovery 
Basal cold 
recovery 
Basal heat 
recovery 
Drought 
recovery 
High light 
recovery 
Adenine 1.16 1.20 1.17 2.60 1.38 0.99 0.92 0.79 0.91 3.29 0.70 0.87 
Adenosine 1.01 0.98 1.11 3.03 1.17 1.29 1.46 1.17 0.96 6.61 1.95 1.01 
Alanine 2.56 3.77 1.54 4.20 1.99 1.26 1.25 1.46 0.95 1.01 0.58 0.74 
alpha-Ketoglutaric acid 0.84 0.32 0.69 0.32 0.46 0.91 1.19 0.48 0.94 0.15 0.35 0.99 
Arginine 0.84 0.90 0.91 1.16 1.36 1.00 1.08 0.67 0.69 0.55 0.10 0.76 
Asparagine 0.71 2.17 0.95 1.87 1.09 1.22 1.24 0.77 0.81 0.32 0.19 0.61 
Aspartic acid 0.52 0.50 0.89 0.55 0.90 0.85 1.15 0.60 0.92 0.27 0.20 0.74 
Citric acid 2.88 0.93 1.46 1.16 2.17 1.47 1.17 0.75 1.13 0.50 0.68 0.91 
Citrulline 0.64 0.14 0.75 0.30 1.25 0.62 1.16 0.27 0.77 0.12 0.11 0.57 
Cysteine 2.33 339.19 1.73 297.28 39.84 15.84 1.12 0.92 0.45 2.34 0.36 0.51 
Dihydroxyacetone phosphate 1.97 1.36 0.80 1.17 0.18 0.63 0.84 1.07 0.46 1.12 0.09 0.51 
Fructose 1.00 1.11 1.02 1.46 1.17 1.43 1.00 1.25 0.92 1.43 0.82 0.81 
Fructose 6-phosphate 1.15 1.00 1.06 0.98 0.43 0.65 1.48 0.59 0.79 0.44 0.17 0.87 
Fumaric acid 1.05 1.56 1.00 1.15 0.68 2.20 0.74 0.63 0.81 0.14 1.64 0.75 
gamma-Aminobutyric acid 1.58 2.71 1.04 5.43 5.30 1.14 0.99 1.06 1.04 2.21 0.62 1.01 
Glucose 0.99 1.34 0.91 1.62 0.61 1.20 0.89 1.40 1.00 1.18 1.08 0.84 
Glucose 6-phosphate 1.12 0.52 0.91 0.54 0.36 0.50 1.05 0.47 0.65 0.33 0.15 0.62 
Glutamic acid 0.50 0.47 0.63 0.58 0.72 0.92 1.02 0.59 0.84 0.21 0.07 0.74 
Glutamine 0.80 1.40 0.95 1.38 1.19 1.07 1.34 1.35 1.07 1.22 0.57 1.01 
Glycine 1.26 2.38 2.03 1.85 1.51 2.64 0.98 0.76 0.93 0.77 0.86 0.52 
GSH  0.02 0.16 0.02 0.18 0.44 0.05 1.37 2.37 0.75 5.59 0.28 0.62 
GSSG 1.21 0.60 1.38 0.49 1.86 1.43 1.44 0.37 0.73 0.07 0.07 0.64 
Guanine 0.80 7.66 0.85 17.65 1.06 0.90 4.31 3.43 0.83 27.39 7.87 0.79 
Guanosine monophosphate 0.54 0.06 0.69 0.41 0.30 0.96 0.89 0.51 0.61 0.26 0.15 0.62 
Histidine 0.73 2.47 1.12 2.50 1.58 1.43 1.30 1.23 0.89 1.47 0.21 0.69 
Leucine 1.42 28.30 1.35 31.08 7.32 4.27 0.96 7.60 0.74 31.30 5.94 0.59 
Lysine 0.63 7.36 0.78 8.77 2.30 1.28 1.25 1.21 0.71 5.70 0.44 0.71 
Malic acid 0.97 1.33 1.11 0.59 0.57 1.80 1.03 0.66 0.94 0.16 0.46 0.82 
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Maltose 33.58 1.49 1.36 0.42 36.11 0.97 3.04 2.60 1.31 0.56 1.27 0.66 
Mannitol 0.58 11.67 0.98 15.80 2.65 1.29 0.62 1.63 0.29 9.23 0.85 0.27 
Ornithine 0.79 0.49 1.07 0.67 1.65 1.02 1.22 0.68 0.68 0.33 0.09 0.61 
Oxaloacetic acid 2.66 13.49 1.82 7.88 2.44 1.09 1.80 0.99 1.14 0.48 0.11 0.77 
Phenylalanine 2.51 19.84 3.17 14.86 4.05 4.56 1.80 3.38 0.81 11.08 1.73 0.73 
Proline 0.79 2.98 0.85 3.25 1.85 1.34 0.99 0.84 2.46 1.50 1.23 0.99 
Pyruvic acid 2.63 0.73 2.63 0.78 0.42 1.16 1.20 0.54 1.20 0.25 0.36 0.82 
Raffinose 0.62 27.55 0.63 3.14 1.67 2.00 1.15 23.70 2.39 8.71 1.17 2.06 
Ribose 5-phosphate 0.50 1.48 0.88 1.45 0.48 0.63 1.16 0.65 0.65 0.55 0.12 0.61 
Serine 0.47 0.51 0.54 0.55 0.74 0.75 0.99 0.28 0.80 0.10 0.22 0.80 
Shikimic acid 0.79 1.00 0.83 1.00 0.97 0.76 1.01 0.76 1.03 0.50 0.84 0.97 
Succinic acid 0.86 1.44 0.81 3.14 0.95 1.83 0.71 0.76 0.69 0.56 0.70 0.64 
Sucrose 0.44 0.47 0.48 0.48 0.50 0.64 1.08 1.21 0.93 1.91 1.04 0.71 
Threonine 0.95 2.68 0.91 2.68 1.44 1.34 1.00 1.52 0.95 1.51 0.85 0.74 
Tryptophan 2.40 51.88 2.91 58.43 5.71 5.17 1.52 9.41 1.35 41.28 15.79 1.69 
Tyrosine 1.23 27.99 1.49 32.75 5.30 3.54 1.02 2.36 0.63 15.94 0.85 0.56 
Urea 0.33 0.34 0.35 0.71 0.41 0.44 1.01 0.40 0.40 0.25 0.50 0.58 
Valine 0.96 15.32 1.24 16.59 3.19 2.39 1.30 4.04 1.27 8.12 0.72 0.93 
Xylose 0.71 1.43 0.80 1.16 1.39 1.09 1.15 2.31 1.16 1.34 0.68 1.35 
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Supplemental Table 2-5. Standard compounds used for feature identification by retention time and MS/MS fragmentation 
pattern matching 
Adenine 
Adenosine 
α-Ketoglutaric acid 
Citric acid 
Dihydroxyacetone phosphate dilithium salt 
D-(−)-Fructose 
D-Fructose 6-phosphate disodium salt hydrate 
Fumaric acid 
γ-Aminobutyric acid 
D-(+)-Glucose 
D-Glucose 6-phosphate sodium salt 
L-Glutathione reduced 
L-Glutathione oxidized 
Guanine 
Guanosine 3′-monophosphate disodium salt 
L-Alanine 
L-Arginine 
L-Asparagine 
L-Aspartic acid 
L-Citrulline 
L-Cysteine 
L-Glutamic acid 
L-Glutamine 
Glycine 
L-Histidine 
L-Leucine 
L-Lysine 
L-Ornithine monohydrochloride 
L-Phenylalanine 
L-Proline 
L-Serine 
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L-Threonine 
L-Tryptophan 
L-Tyrosine 
L-Valine 
Malic acid 
D-(+)-Maltose monohydrate 
D-Mannitol 
Oxaloacetic acid 
Pyruvic acid 
D-(+)-Raffinose pentahydrate 
D-Ribose 5-phosphate disodium salt hydrate 
Shikimic acid 
Succinic acid 
Sucrose 
Urea 
D-(+)-Xylose 
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Chapter 3. Metabolomics study on the response of Arabidopsis thaliana to 
combinations of abiotic stresses that mimic the field environment including heat, 
cold, drought, salinity, and high light  
Introduction 
Abiotic stress can have significant effects on plant growth, development, and 
reproduction. Although plant responses after exposure to one specific stress has been 
extensively studied, less is known about how a plant responds to a combination of two 
different stresses. In the field, a complex set of abiotic stresses, including extremes of 
temperatures, low water availability, high salinity, and high irradiance can and often occur 
simultaneously. For example, plants in drought-stricken areas may be subjected to drought 
stress in combination with heat, salinity, or high light stress (Mittler et al., 2001). Plants in 
arid and semi-arid regions may encounter a combination of salinity and heat stress (Pandey 
et al., 2017). Vitis vinifera (grapes) growing in continental climate regions, like North 
China, are known to be particularly vulnerable to combined drought and cold stress (Su et 
al., 2015). The productivity of crops growing in the Mediterranean regions and northern 
countries like Canada and Sweden are reduced by cold and high light combined stresses 
(Loreto and Bongi, 1989). In the US, corn and soybean are especially susceptible to drought 
and heat combinations (Mittler, 2006). High light and heat often accompany each other 
(Pandey et al., 2017) and thus, plants face a combination of abiotic stresses more often than 
a specific single stress under natural and crop field conditions.  
Combined stresses also cause extensive losses in crop production worldwide 
(Mittler, 2006). According to the report of National Centers for Environmental Information 
(NCEI) (https://www.ncdc.noaa.gov/billions/), from 1980 to 2017, the U.S. has sustained 
219 weather disasters with a damage cost of more than $1 billion. Among these weather 
conditions the combination of drought and heat waves occurred most often and caused 
greatest amount of damage, worth more than $210 billion (Smith and Matthews, 2015). 
The effect of drought and heat combination stress has been studied on maize, barley, 
sorghum, and grasses. It was found that the extent of damage caused by combined stresses 
was more than that of each of the individual stresses (Craufurd and Peacock, 1993; Savin 
and Nicolas, 1996). Because combined stresses cause significantly more detrimental 
damages on agricultural crops, it is crucial to develop crop plants that are more resistant to 
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combined stress. A well-known breeding target in maize is to generate resistant lines to a 
combination of stresses (Rizhsky, 2004). However, the great majority of research remains 
focused on plant responses to each individual abiotic stress condition. Transgenic plants or 
crops developed from laboratory experimentation with enhanced resistant to only a single 
stress typically fail to show enhanced tolerance when tested in the field (Gao et al., 2000; 
McKersie et al., 1999; Mohamed et al., 2001), likely because such selections are based on 
unrealistic assumptions about field stress conditions. 
Plants can acquire tolerance to one stress after being exposed to another, a 
phenomenon known as cross hardening, which suggests that different abiotic stresses may 
have a synergistic effects and may co-activate stress response signal transduction pathways 
(Mittler, 2006). For example, drought stress enhances plant cold tolerance (Cloutier and 
Andrews, 1984) and toxic mineral stress improves plant heat tolerance (Bonham-Smith et 
al., 1987). The synergistic effects between different abiotic stresses may be controlled via 
calcium and ROS signaling (Bowler and Fluhr, 2000), mitogen-activated protein kinase 
(MAPK) cascades, stress responsive transcription factors and genes (Cardinale et al., 2002; 
Xiong, 2003),  and stress hormones including abscisic acid (ABA), jasmonic acid (JA), and 
ethylene (ET) (Anderson, 2004). Both ethylene and the multiprotein bridging factor 1c 
(MBF1c) transcription factor were found to enhance Arabidopsis heat and osmotic stress 
tolerance (Suzuki, 2005). In addition, Rizhsky (2004) found that the transcripts expressed 
during a combination of drought and heat overlapped largely with individual drought and 
heat stress, suggesting that the combined stress of drought and heat may co-activate the 
same defense pathways for drought or heat stress individually.  
In contrast, abiotic stresses may also have an antagonistic effect with each other 
when they are combined (Mittler, 2006). For instance, plants subjected to heat stress may 
open stomata to enhance transpiration in order to lower the temperature of leaves. 
However, when a plant is faced with a combination of heat and drought stress, the stomata 
would be closed and the leaves thus cannot be cooled (Rizhsky et al., 2002). Similarly, 
during heat and salinity stress combination, the effect of salinity stress may be aggravated 
because enhanced transpiration may result in enhanced uptake of salts (Keleş and Öncel, 
2002; Wen et al., 2005). High light combined with cold or drought stress may limit CO2 
availability and increase O2 production, which may in turn lead to ROS production (Mittler, 
77 
 
2002). In such cases, a plant’s response to a combined stress may need to be adjusted or 
compensated account for the synergistic and antagonistic effects of the two individual 
stresses in order to seek an appropriately balanced response (Mittler, 2006). 
Plant responses to a combination of stresses may exhibit quite unique defense and 
acclimation responses as compared to the response elicited by each individual stress. The 
effect of combined stress in such cases would not be just the sum or either of the two 
different stresses, but in contrast may be determined by a set of complex interactions 
between the two applied stresses (Pandey et al., 2017). A combination of heat and drought 
stress were found to have a distinct effect on both tobacco and Arabidopsis apart from their 
individual stress responses (Rizhsky et al., 2002; Rizhsky, 2004). The response to heat and 
drought combined stress has a large number of unique altered transcripts and features 
(Rizhsky, 2004). It is evident from such studies that it is quite important to explore the 
interactions that occur when combined stresses are applied. The need for such 
investigations was envisioned when a ‘stress matrix’ was developed by to demonstrate the 
potential interactions among different agriculturally important abiotic and biotic stresses 
on plant growth and production (Mittler, 2006; Suzuki et al., 2014). The matrix 
demonstrated that stress combinations could have both negative (enhanced damage) and 
positive (cross-protection) effects on plants. In comparison to abiotic and biotic stress 
interactions, unfortunately most of abiotic stress combinations in the ‘stress matrix’ were 
not well-studied (Mittler, 2006).  It is thus important to determine if a combination of 
abiotic stresses represents a new state of stress, in some cases notably distinct from the two 
individual stresses that are compounded.   It was therefore essential to further investigate, 
using untargeted metabolomics, preferential metabolic response pathways, and stress 
interactions in Arabidopsis thaliana in order to gain a greater mechanistic understanding 
of the adverse effects following a combination of stress challenges. 
 
Results 
Multivariate statistical comparisons using unsupervised principle components 
analysis (PCA) for clustering and supervised orthogonal projections to latent 
structures discriminant analysis (OPLS-DA) for potential stress signatures 
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We report on a comprehensive characterization of multiple stressor effects on the 
Arabidopsis thaliana metabolome that define the physiological variations under abiotic 
stresses including cold, heat, drought, salinity, and high light. The most statistically 
significant metabolic differences between stressed and control plants were identified using 
an untargeted metabolomics approach. Untargeted metabolomics is a pattern-based 
classification approach for as many metabolites as possible in the system using a global 
unbiased screening (De Vos et al., 2007). It is commonly used for discovery-based studies 
to characterize metabolic changes in disease, environmental or genetic perturbations (Patti 
et al., 2012). In this study, we executed a comprehensive analysis using both multivariate 
and univariate statistics. Multivariate statistics modeling PCA and OPLS-DA were 
performed for clustering and potential stress metabolic signature selection. The top ten 
metabolic features with highest and lowest OPLS-DA S-plot covariance value in different 
treatments compared to control and subgroups based on the clustering results of PCA were 
reported in Supplemental Table 3-1. Metabolic features increased or decreased more than 
2 fold in different treatments compared to control were reported in Supplemental Table 
3-2. The changes of precursors, intermediates, and products of those stress metabolic 
signatures in the same metabolic pathway were also monitored by both hierarchical 
clustering analysis (HCA) and ANOVA. Overall, we comprehensively examined the 
relationships between combined stress with its individual stresses, and identified stress 
metabolic signatures exhibiting shared or unique patterns across different single or 
combined stresses.   
In this study, PCA was performed in a hierarchical manner to assess the extent of 
divergence between metabolites under different conditions (Figure 3-1). First, PCA of all 
the samples were performed (Figure 3-1A), which resulted in two large clusters A1 and 
A2. Combined stresses including heat x drought, high light x drought, and high light x heat 
cluster together in A2 and are separated from the other groups in A1 in PC2 (15%), thus 
indicating that these three combined stresses had the most dramatically different metabolic 
responses within these groups. Additional re-analysis of subgroup A2 in Figure 3-1C 
shows high light x heat in C2 is well separated from heat x drought and high light x drought 
in C1 in PC1 (50%). In addition, heat x drought is well separated from high light x drought 
in PC2 (20%). This indicated that all these three combined stresses result in distinctly 
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different metabolic patterns. PCA of cluster A1 was re-analyzed for additional sub-cluster 
separation (Figure 3-1B). Three treatments including heat, heat x salinity, and high light x 
salinity in B2 were separated from all the other stresses in B1 in PC2 (15%). Additional re-
analysis of B2 in Figure 3-1E shows high light x salinity in E2 is well separated from two 
other stresses in E1 in PC1 (48%), indicating that high light x salinity has dramatically 
different metabolic responses within this sub-cluster. PCA for sub-cluster B1 performed in 
Figure 3-1D shows that three stresses in D2 including drought, salinity, and cold x drought 
clustered together and were separated from all the other stresses in D1 in PC2 (15%). 
Further separation of sub-cluster D2 (Figure 3-1G) shows that drought is separated from 
the other two stresses in PC2 (21%); cold x drought is separated from salinity in PC1 
(38%), indicating the different metabolic responses between these three treatments. 
Similarly, to better separate treatments in D1, we performed sub-cluster PCA in Figure 3-
1F. High light and high light x cold cluster together in F2 and are separated from F1 in 
PC1 (23%), indicating the similar metabolic responses between these two stresses. 
Whereas control, cold, and cold x salinity cluster in F1, indicating cold and cold x salinity 
are less severe stresses that have a minor separation from control. Final re-analysis of sub-
cluster F1 in Figure 3-1H shows that control is separated from stresses including cold and 
cold x salinity in PC2 (18%), indicating that all of the stress groups have metabolic changes 
compared to control. However, cold and cold x salinity are not well separated in both PC1 
and PC2, indicating these two treatments cause similar metabolic responses in the plant.  
Using the clustering hierarchy from the aforementioned PCA analyses, we then 
performed orthogonal projections to latent structures discriminant analysis (OPLS-DA) to 
identify which metabolic features were the most important drivers of differentiation. 
Compared to unsupervised PCA modeling, OPLS-DA are supervised techniques that 
request a response value to be assigned. In order to better interpret for complex datasets, 
Trygg et al., 2001 introduced the orthogonal projection to latent structures (OPLS) 
algorithm by incorporating an Orthogonal Signal Correction (OSC) filter into a Partial 
Least Squares Discriminant Analysis (PLS) model to separate the correlated (predictive) 
variation from uncorrelated (orthogonal) variation. In doing so, OPLS-DA helps identify 
correlated components in the presence of systematic variation (Thévenot et al., 2015). The 
clustering results from PCA was used to perform a corresponding hierarchical OPLS-DA 
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for both score plot and s-plot of all the subgroups (Supplemental Figure 3-1, 
Supplemental Figure 3-3) and all the treatment compared with their corresponding control 
(Supplemental Figure 3-2, Supplemental Figure 3-4). The combination of both PCA and 
OPLS-DA produced novel information regarding general metabolic trends and stress 
metabolic signatures. 
 
Hierarchical clustering analysis (HCA) for all the metabolic features revealed both 
dominant and unique metabolic changes for combined stresses with the 
corresponding individual stresses 
All the metabolic features detected were used to represent the entire measured 
metabolome. The ratio changes for all the features in treatments compared to control 
(Supplemental Table 3-4) were used to perform HCA in order to elucidate the relationship 
between single and combined stresses. Figure 3-2 shows a HCA heat map using the 
complete linkage with the Euclidean distance function. The clustering and distance 
functions were chosen based on De Souza et al. (2006) who tested three of the most popular 
clustering methods including single linkage, complete linkage and centroid methods in 
their metabolomics data, and found complete linkage and the centroid methods performed 
better than single linkage. They explained that both complete linkage and centroid methods 
have a tendency to create compact, spherical clusters, whereas single linkage has a 
tendency to make elongated clusters. In addition, Edelbrock (1979) reported that complete 
linkage was more accurate than single linkage when using Euclidean distance function.  
In Figure 3-2, HCA elucidated five distinct clusters of the five single stress and 
eight combined stress treatments that we named A-E.  Group A consisted of the single 
treatment, high light x heat. Group B consisted of treatments cold x drought, drought, heat 
x drought, and high light x drought. Group C also consisted of a single treatment, high light 
x salinity. Group D included treatments heat and heat x salinity. Group E contained 
treatments salinity, high light, high light x cold, cold, and cold x salinity. Other HCA 
clustering methods and distance functions were also tested including complete linkage 
using distance functions including Manhattan (Supplemental Figure 3-5A), Minkowski 
(Supplemental Figure 3-5B), Ward’s methods using distance functions including 
Euclidean (Supplemental Figure 3-5C), Manhattan (Supplemental Figure 3-5D), 
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Minkowski (Supplemental Figure 3-5E), McQuitty’s methods using distance functions 
including Euclidean (Supplemental Figure 3-5F), Minkowski (Supplemental Figure 3-
5G), and average linkage using distance functions including Euclidean (Supplemental 
Figure 3-5H), Manhattan (Supplemental Figure 3-5I), and Minkowski (Supplemental 
Figure 3-5J). All these HCA methods provided comparable clustering results, 
demonstrating the consistency of the techniques.  
Table 3-2 summarizes which combined stresses are the result of both dominant and 
unique metabolomic changes when compared with each pair of single component stress 
conditions. We found only two combined stresses, including high light combined with cold 
and cold combined with salinity, cluster together with both of their corresponding single 
stresses. This suggested that for these two combined stresses, both corresponding single 
stresses are important aspects of the response. Each single stress may have synergistic 
effect and may co-activate the same stress responses pathway. In that case, the metabolic 
changes of these two combined stresses are the results of a combined response to the two 
corresponding single stresses. Figure 3-3 illustrates Venn diagrams scaled to the numbers 
of features that are increased or decreased more than 2 fold for each combined and set of 
corresponding single stresses. Interestingly, cold stress always separate and has no overlap 
between both its combined stresses and other stresses. This result indicated that cold stress 
may be the subordinate stress for its combined stresses and may has smaller and distinct 
impact on plant combined stress responses. When plant is subjected to cold stress combined 
with other stresses like drought, salinity, and high light, plant may take priority to other 
stresses and make corresponding metabolic changes.  
Most combined stresses cluster together with only one of its individual stresses 
components but not to the other, indicating that the metabolic profile of combined stress is 
more similar to one of its individual stresses. This suggested that the single stress is the 
dominant stress of the combined stresses, and in those cases may have a bigger impact on 
plant stress responses. This result indicates that when subjected to the combined stresses, 
the plant’s major metabolic responses are to the dominant stress, and that plants may only 
make minor adjustments to accommodate the non-dominant stress. Interestingly, drought 
stress is the dominant stress for all of its combined stresses including cold x drought, heat 
x drought, and high light x drought. This result indicated that water deficit is a more 
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dominant stressor than temperature extremes and high light intensity. When a plant 
encounters drought coupled with other abiotic stresses, the plant may need to take drought 
stress as its priority response to defend first, and then it may make adjustment or 
compensation to other stresses based on its response to drought stress. It has previously 
been shown that drought stress was accompanied by closed stomata, heat stress was 
accompanied by opened stomata, whereas drought and heat combined stress accompanied 
by closed stroma, which is the same as drought stress (Rizhsky, 2004). This physiological 
characterization may provide one of the possible explanations that why drought stress is 
always the dominant stress for its combined stress. 
One possibility for the noted dominant role of drought stress is that the severity of 
drought stress may be higher than that of the other stresses tested in our experiments. To 
test this idea, we determined the numbers of metabolic features decreased or increased 
more than 2 fold in all treatments compared to control to use as a gauge of over-all 
metabolic impact of each stress condition/combination (reported in Table 3-3 and 
Supplemental Table 3-2). Using this metric drought stress, despite its dominance, actually 
induced the smallest number of changes compared to other stresses. A total of 54 metabolic 
features were increased or decreased more than 2 fold in drought stress treatment. In 
comparison, the number of metabolic features increased or decreased more than 2 fold in 
cold, heat, salinity, and high light are 98, 101, 57, and 63, respectively. The Van Krevelen 
diagrams for scatter plot and heat map showed chemical composition changes for all 
metabolic features in all groups (Supplemental Figure 3-9, Supplemental Figure 3-10), 
and the features changed more than 2 fold in all treatments compared to control 
(Supplemental Figure 3-11, Supplemental Figure 3-12). However, no obvious 
differences were found for chemical composition of both all the features and features that 
changed more than 2 fold between drought and other single stresses. Therefore, the 
dominant role of drought stress is not mainly caused by its higher severity compared to 
other stresses.  
In addition to those combined stresses with both or dominant effects from two 
single stress responses, we also noticed that two combined stresses, high light x heat and 
high light x salinity, showed unique metabolic responses. The metabolic profiles of these 
two combined stresses are not similar to any of their corresponding single stresses, 
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suggesting that the combined stresses may influence plant metabolism in a new response 
pattern that is distinct from changes caused by each of single stress applied individually. 
In addition, these two combined stresses are in the two most positive loadings of the top 2 
principal components in PCA score plots. In Figure 3-1A, high light x heat is in the most 
positive loading of PC1. Whereas high light x salinity is in the most positive loading of 
PC2. This result confirmed that these two treatments have unique metabolic profiles 
compared to other treatments. It is likely that the two single stresses have antagonistic 
effects with each other so that the plant may need a new defense or acclimation strategy to 
adjust or compensate for the antagonistic effect. Therefore, high light x heat and high light 
x salinity should be considered as two novel abiotic stress combinations.  
Moreover, high light x heat and high light x salinity induced top 2 maximum 
number of metabolic features that either increased or decreased more than 2 fold (Table 3-
3) compared to control as 244 and 179 respectively. The metabolic composition changes 
for those features reported by the Van Krevelen diagrams for scatter plot and heat map 
(Supplemental Figure 3-11, Supplemental Figure 3-12) also showed most obvious 
difference compared to all the other treatments. Figure 3-3 shows Venn diagrams scaled 
to the numbers of features increased or decreased more than 2 fold for each combined and 
set of corresponding single stresses. Very limited similarity was found between these two 
unique combined stresses with their individual stresses and most of changed features are 
combined stress specific. For high light x heat-combined stress, a total of 103 metabolic 
features increased and 141 decreased more than 2 fold. However, 47 features specifically 
increased and 118 specifically decreased in high light x heat. A similar situation was 
observed with high light and salinity combined stress. Out of 60 metabolic features 
increased and 119 decreased more than 2 fold, 35 of the increasing and 97 of the decreasing 
metabolites are high light x salinity-specific. Therefore, plants subjected to these two 
combined stresses have specific and more severe metabolic changes that are different from 
that of plant subjected to individual stresses. Some of those combined stress specific 
changed metabolites were identified using reference standard. For high light x salinity-
combined stress, fructose 6-phosphate, sucrose, tyrosine, and urea are identified 
metabolites that uniquely increased in the combined stress. While adenine, alpha-
ketoglutaric acid, arginine, GABA, glucose 6-phosphate, guanosine monophosphate, 
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lysine, maltose, ornithine, proline, ribose 5-phosphate, and xylose are identified 
metabolites that specifically decreased in the combined stress. For high light x heat-
combined stress, adenine, adenosine, GABA, guanine, pyruvic acid, and sucrose are 
identified metabolites specifically increased in the combined stress. Whereas alpha-
ketoglutaric acid, citric acid, glucose 6-phosphate, GSH, GSSG, and ribose 5-phosphate 
are identified metabolites particularly decreased in the combined stress. It is noteworthy to 
mention that GSH decreased more than 1076 fold in high light x heat, which may 
tremendously contributed to the uniqueness of this combined stress.  
 
Targeted metabolite analysis and hierarchical clustering revealed similar stress 
clustering patterns with untargeted analysis  
Metabolites that were identified as having significant abundance changes in one or 
more stress conditions as well as precursors, intermediates, and products in the same 
metabolic pathways were selected for further targeted analysis in order to provide a better 
representation of the central metabolic stress response. To do this, putative identities of the 
selected metabolites were confirmed by: 1) comparison of chromatographic retention by 
co-injection; and 2) by comparison of MS/MS fragmentation patterns (Supplemental 
Figures 5.1, Supplemental Figure 3-7, Supplemental Figure 3-8) with standard 
compounds (Supplemental Table 3-6). After metabolite identities were confirmed, their 
corresponding LC-HRMS peak areas from the polarity with highest intensity were 
integrated and the average fold change of relative abundances across replicates between 
stress and control samples were calculated (Supplemental Table 3-5). These confirmed 
metabolite abundance fold-change values and treatments were then clustered by HCA to 
determine metabolites with shared response across multiple stresses and metabolites with 
unique and dramatic responses.  
Figure 3-4 shows a HCA heat map using complete linkage with Euclidean distance 
function. The treatment clustering results of Figure 3-4 are compared with Figure 3-2. 
Three groups in Figure 3-4 are identical with group A, C, D in Figure 3-2, so we named 
them as group A’, C’, D’. Group D’ included heat and heat x salinity. Group A’ and group 
C’ both consisted by one single treatment; high light x heat for Group A’, and high light x 
salinity for group C’. This consistent clustering results indicated that the targeted identified 
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stress signatures may contribute to the unique metabolic patterns of high light x heat and 
high light x salinity. However, one treatment cold x drought that was in group B in Figure 
3-2 split from group B’ and merge into group E’(B’’) in Figure 3-4. Group B’ consisted 
of treatments drought, heat x drought, and high light x drought. Group E’ (B’’) contained 
treatments cold x drought, salinity, high light, high light x cold, cold, and cold x salinity. 
The similar treatment clustering results between Figure 3-2 and Figure 3-4 confirmed that 
these identified targeted compounds are important stress signatures that may determine the 
metabolic stress responses patterns between different treatments. We also tested complete 
linkage using distance functions including Manhattan (Supplemental Figure 3-6A), 
Maximum (Supplemental Figure 3-6B), Ward’s methods using distance functions 
including Euclidean (Supplemental Figure 3-6C), Manhattan (Supplemental Figure 3-
6D), Maximum (Supplemental Figure 3-6E), McQuitty's methods using distance 
functions including Euclidean (Supplemental Figure 3-6F), Manhattan (Supplemental 
Figure 3-6G), and average linkage using distance functions including Euclidean 
(Supplemental Figure 3-6H) and Manhattan (Supplemental Figure 3-6I), and got 
comparable clustering results.  
 
Discussion 
Primary metabolites play important roles during stress response 
Primary metabolites have important functions, in addition to core metabolism, as 
signal molecules, osmolytes, antioxidant, and precursors of secondary metabolites during 
plant stress responses. Previous studies showed that many soluble sugars such as glucose, 
fructose, and sucrose have roles in plant stress signaling (Chiou and Bush, 1998; Koch, 
1996; Roitsch, 1999). Osmolytes or compatible solutes can stabilize proteins and 
membranes and function to maintain cellular turgor pressure. Major osmolytes include 
amino acids and derivatives, sugars and derivatives, phosphodiesters, quaternary 
ammonium compounds, and polyols (Yancey et al., 1982; Shahjee et al., 2002). 
Antioxidants play important roles to regulate protein redox and to prevent cellular 
component damage caused by reactive oxygen species (ROS) (Alscher, 1989). Glutathione 
(GSH), carbohydrates like raffinose (Nishizawa et al., 2008), and sugar alcohols such as 
mannitol (Chiang et al., 2005) have been reported to act as plant antioxidants. Moreover, 
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primary metabolites are known to be precursors for many secondary metabolites that 
function as defense compounds against biotic stresses (Kaplan et al., 2004). For example, 
aromatic amino acids are precursors of indole glucosinolates, phytoalexins, alkaloids, 
lignins, flavonoids, isoflavonoids, and hydroxycinnamic acids (Dixon, 2001) and 
branched-chain amino acids are precursors of cyanogenic glycosides, glucosinolates, and 
acyl-sugars (Vetter, 2000).  
 
Shared stress metabolic signatures  
We found many metabolites had similar responses to different stresses. These 
metabolites may function as shared stress metabolic signatures with common participation 
and general response patterns in different stresses. Figure 3-4 and Figure 3-5 showed 
metabolites in cluster 1, 2, 3, 4 and 5 are shared stress metabolites that exhibited similar 
response patterns across different single and combined stresses. Cluster 1 contained four 
metabolites in purine metabolism (adenine, adenosine, guanine, and GMP). The significant 
increase of these purine metabolites in high light x heat may be related to high light induced 
DNA oxidative damage, which is consistent with the significant decrease of GSH in high 
light x heat. 
Cluster 2 was consisted of seven metabolites including aromatic amino acids 
(phenylalanine, tryptophan, and tyrosine), sugar alcohol (mannitol), sugar metabolism 
(raffinose), pyruvate family of amino acids (alanine, leucine). Aromatic amino acids 
(tryptophan, tyrosine, and phenylalanine) are known to be precursors of pigments, 
alkaloids, hormones, and cell wall components (Dixon, 2001). While branched-chain 
amino acids (isoleucine, leucine, and valine) are precursors of the cyanogenic glycosides 
(Vetter, 2000). All three aromatic amino acids and leucine were increased in all treatments 
except salinity stress, possibly because they serve as precursors for secondary metabolites 
that may accumulate during stress responses. Both raffinose (Nishizawa et al., 2008) and 
mannitol (Chiang et al., 2005) have been reported to have compatible solutes properties 
and function as antioxidants.  
Cluster 3 enclosed fifteen metabolites in the aspartate family of amino acids 
(aspartic acid and asparagine), the glutamate family of amino acids (glutamate, glutamine), 
glycolysis (glucose 6− phosphate), TCA cycle (citric acid and α−ketoglutaric acid.), 
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glutathione metabolism (GSSG), purine metabolism (ribose 5-phosphate), urea cycle 
(arginine, citrulline, and ornithine), and serine family of amino acids (serine).  Inorganic 
nitrogen can be incorporated into glutamine and glutamate as a nitrogen source to be 
converted into other amino acids or nitrogenous compounds. Primary nitrogen assimilation 
and transport amino acids glutamate, glutamine, asparagine, and aspartic acid are all in 
cluster 3. They may play important roles in nitrogen balance during plant abiotic stress 
responses. The increase of GSSG in heat x drought, high light x drought, cold x drought, 
drought, heat x salinity, heat, cold, high light x cold, and cold x salinity may relate to plant 
oxidative stress defenses. During oxidative stress, reduced glutathione GSH can be 
oxidized to GSSG to detoxify ROS (Foyer et al., 1997).  
Cluster 4 was composed by six metabolites in sugar metabolism (glucose, fructose), 
glycolysis (DHAP and pyruvate), TCA cycle (malic acid), and urea cycle (urea). Sugars, 
including glucose and fructose, are known as both stress signal molecules and 
osmoprotectants (Koch, 1996; Roitsch, 1999; Rizhsky, 2004). Sugar is, most centrally, an 
important energy source. To provide energy, sugars will, of course, be consumed by 
glycolysis and through the TCA cycle yielding ATP and reducing power. Plant cells may 
need incoming sugars to cover the growing demand for energy for both anabolism and 
catabolism during certain stress events.  
Cluster 5 contained eleven metabolites in the TCA cycle (succinic acid and fumaric 
acid), GABA shunt (γ−aminobutyric acid), glutamate family of amino acids (proline and 
histidine), sugar metabolism (sucrose), glycolysis (fructose 6-phosphate), pyruvate family 
of amino acids (valine), oxaloacetate family of amino acids (lysine, threonine), and 
glutathione metabolism (glycine). We found the non-proteinogenic amino acid GABA 
clustered together with TCA cycle intermediates succinate and fumarate. The TCA cycle 
generates energy with reducing power, and is responsible for the most part of carbohydrate, 
amino acid, and fatty acid precursors (Fernie et al., 2004). GABA is known to drive the 
TCA cycle via GABA shunt (Caldana et al., 2011). During GABA shunt, succinate can be 
synthesized from GABA via succinic semialdehyde. Previous studies showed that GABA 
increased during heat and cold stresses (Kinnersley and Turano, 2000). The GABA shunt 
was also reported to coordinate with general nitrogen and carbon metabolism (Weigelt et 
al., 2008). The increase of both TCA cycle intermediates and GABA in high light x heat, 
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heat, heat x salinity, heat x drought, drought, and high light x drought, indicates that GABA 
may fuel central metabolism via the TCA cycle for increased energy demand during stress. 
Proline in cluster 5 increased in heat, drought, high light, heat x drought, high light x 
drought, heat x salinity, high light x heat, high light x cold. Proline is synthesized from 
glutamate by the enzyme P5CS (1-pyrroline-5-carboxylate synthase) that contributes to 
osmotic adjustment, free radical scavenging, and subcellular structure stabilization (Hare 
and Cress, 1997). Previous studies showed that proline concentrations increased in drought, 
salinity, and extreme temperatures (Kaplan et al., 2004, 2007; Sanchez et al., 2008). 
Sucrose functions as both a plant stress signal molecule and an osmotic regulator (Kaplan 
et al., 2004; Rizhsky, 2004). The increase of sucrose may suggest its involvement in stress 
signaling or as an osmotic stress defense response.  
 
Unique stress metabolic signatures GSH and maltose 
Two clusters each containing one single metabolite in HCA (Figure 3-2) attracted 
our attention: cluster 6 with GSH only and cluster 7 with maltose only. The separation of 
these two metabolites from all the other clusters was consistent using different clustering 
and distance functions including complete linkage using distance functions including 
Manhattan (Supplemental Figure 3-6A), Maximum (Supplemental Figure 3-6B), 
Ward’s methods using distance functions including Euclidean (Supplemental Figure 3-
6C), Manhattan (Supplemental Figure 3-6D), Maximum (Supplemental Figure 3-6E), 
Mcquitty’s methods using distance functions including Euclidean (Supplemental Figure 
3-6F), Manhattan (Supplemental Figure 3-6G), and average linkage using distance 
functions including Euclidean (Supplemental Figure 3-6H) and Manhattan 
(Supplemental Figure 3-6I). GSH and maltose were always isolated in separate clusters. 
The unique clustering pattern for these two metabolites may be caused by their unique and 
dramatic changing trend shown in Figure 3-5. We found GSH decreased in drought, 
salinity, heat x drought, and dramatically decreased in high light x heat up to 1076 fold, 
which may contribute to the unique stress response patter of high light x heat.. GSH, of 
course, is a critical compound in all aspects of glutathione metabolism. During oxidative 
stress, GSH may be quickly consumed by oxidation to GSSG in order to detoxify the 
reactive oxygen species (ROS). This may account for the measured large decrease of GSH 
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in the stress groups. On the other hand, maltose increased dramatically in heat x drought, 
high light x cold, cold x drought and dramatically increased in cold x salinity up to 37 fold. 
Maltose is the direct product of starch degradation and it showed different responses from 
other sugars, indicating the potential differences between catabolism and anabolism during 
plant stress responses. In summary, GSH and maltose may function as unique stress 
metabolic signatures that highlight special roles in both single and combined stress 
responses. 
 
GSH and GSSG in glutathione metabolism  
Glutathione (GSH) is a main low molecular mass plant non-protein thiol compound 
that is important for regulation of the redox state of the cells (Alscher, 1989).  It also 
functions as an antioxidant in plant defense systems. The biosynthesis of glutathione 
consists of two enzymatic reactions (Strohm et al., 1995). First, glutamic acid and cysteine 
form γ-glutamylcysteine. Second, γ-glutamylcysteine and glycine form GSH. Under stress 
conditions, GSH functions as an antioxidant for reactive oxygen species (ROS) via the 
ascorbate-glutathione cycle to form the glutathione disulfide (GSSG), resulting in the 
increase for the GSSG and GSSG/GSH ratio (Foyer et al., 1997). Along with its function 
as an antioxidant, GSH also performs other roles such as thiol disulfide exchange, 
detoxification, and cell signaling. Thus, alteration of GSH concentration may function 
together with the changes in amino acids such as glutamate and glutamine, which are GSH-
dependent through the γ-glutamyl cycle. Glutathione S-transferases (GSTs) can function 
in processes to detoxify xenobiotics (Marrs, 1996) through forming phytochelatins that are 
important for heavy metal detoxification (Chen and Goldsbrough, 1994), and can also 
activate genes for acclimation, stress tolerance, and pathogen defense response (Wingate 
et al., 1988). 
Glutathione has previously been reported to play important roles for plant abiotic 
stress defense responses including chilling and cold (Foster and Hess, 1980), heat (Nieto-
Sotelo et al., 1999), drought (Gamble and Burke, 1984), salt (Roxas et al., 1997), high light 
(Cakmak and Marschner, 1992), and UV irradiation (Strid et al., 1994). In this study, the 
ratio changes of metabolites in glutathione metabolism including glycine, glutamate, 
reduced glutathione (GSH), and oxidized glutathione (GSSG) were reported in Figure 3-
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5, Figure 3-6, and Supplemental Table 3-5. Among them, GSH showed unique response 
pattern that decreased in cold x drought, cold x salinity, drought, salinity, heat, drought, 
high light x salinity, especially in high light x heat, with ratio change of 9.29 x 10-4, more 
than a 1076 fold decrease compared to control. The decrease of GSH may be caused by the 
high demand of GSH for its function as an antioxidant to detoxify ROS during oxidative 
stress defense and repair responses. 
 
Maltose from starch degradation 
Maltose is the direct product from starch breakdown by α-amylase. The ratio 
changes of maltose and other sugars including glucose, fructose, xylose, mannitol, and 
raffinose were shown in Figure 3-5, Figure 6, and Supplemental Table 3-5. In our study, 
maltose showed unique stress response pattern that was elevated in cold x drought, heat x 
drought, high light x cold, and especially in cold x salinity up to 37 fold, but decreased in 
high light x drought and high light x salinity. The increase of maltose may be caused by 
starch degradation or as a potential osmoregulator. Previous work showed that the activity 
and transcription of α-amylase can be induced during temperature stress (Dreier et al., 
1995). Kaplan and Guy (2005) reported maltose accumulated in Arabidopsis by starch 
degradation under cold shock potentially to protect the photosynthetic electron transport 
chain and proteins in the chloroplast stroma. Rizhsky (2004) reported that both maltose 
abundance and the expression of starch degradation transcripts were elevated in response 
to drought and heat combination stress. Maltose is also reported to function as compatible 
solute and contributed to the protection of plants from freezing stress (Kaplan et al., 2004). 
It was suggested that with moderate levels of drought stress plant’s respond with elevated 
proline and glycine-betaine, whereas with more severe levels of drought stress these 
changes occur together with sugar accumulation (Hoekstra et al., 2001). In our study, 
proline increased in heat, drought, high light, heat x drought, high light x drought, heat x 
salinity, high light x heat, high light x cold up to 2.6 fold. Whereas maltose increased in 
cold, heat, salinity, cold x drought, heat x drought, cold x salinity, high light x heat, high 
light x cold up to 37 fold. Maltose is also involved in the production of glucose and sucrose 
from starch (Lu and Sharkey, 2004). However, in our study, the increase in maltose did not 
result in a measured increase for glucose and sucrose, indicating the accumulation of 
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maltose may occur in the plastids, spatially isolated from cytosolic primary sugar 
metabolism. 
 
Measurements of precursors, intermediates, and products of important metabolic 
pathways in central metabolism  
We monitored metabolic pathways from precursors and intermediates to products 
simultaneously in order to reveal the subtle interplay of functionally related metabolites. A 
clear example of substrate and product relationship and important transitions in primary 
metabolism that regulate single and combined stresses can be observed in Figure 6. The 
relationships between combined stresses with their individual stresses were also illustrated. 
The biosynthesis rate of products is, of course, largely dependent on the availability of 
primary precursors and intermediates. However, the possible explanations for the 
metabolite abundance changes is often complicated, and may need to be integrated with 
metabolic flux information in future studies to give a better picture of the processes 
measured. Metabolic flux is the flow of the carbon of a metabolite through an organism’s 
metabolic pathways (Roscher et al., 2000) as determined by the rate of biosynthesis and 
degradation (Pratt et al., 2002). Some metabolites may be very active and have a high flux 
rate to channel large quantities of metabolites through them or play roles as intermediates 
that are never released by the enzyme complex, whereas some metabolites may be the end 
products that accumulate to high levels yet have very low flux rates (Yang et al., 2010).In 
our study, we saw the phenomenon that fit for the hypothesis that intermediate abundances 
decreased or had no change caused by the high flux rate, but product abundance increase 
caused by the low flux rate. For instance, shikimic acid decreased or no change in heat, 
salinity, and high light x heat, however the three aromatic amino acids derived from it 
increased dramatically in these three treatments. Similar situation was found in pyruvate 
with its products pyruvate family amino acids leucine, valine, and alanine. Therefore, it 
will be important to incorporate full metabolic flux analysis into future studies to better 
explain the increase or decrease of those metabolites’ abundance. 
Plants are more often to encounter in nature a combination of different abiotic 
stresses rather than a specific single stress condition. However, the simultaneous 
occurrence of multiple stress events is rarely studied experimentally, especially by 
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metabolomics methods, where the results provide a direct indication of the biochemical 
adaptations of a stress-responding plant. Our results showed that only two combined 
stresses including high light x cold and cold x salinity had metabolic effects from both of 
their individual stresses. Most of the combined stresses exhibited one dominant stress 
response. Among them, drought stress is the dominant stress for all combined stresses. The 
dominant effect is not caused by the more severe experimental conditions tested in our 
study, indicating that water deficiency may either be a more important stress responded to 
by plant or, alternatively, the one stress that metabolic intervention can partially alleviate. 
The metabolic response of plants to combined stresses of high light and heat, and high light 
and salinity are unique and result in more severe metabolic changes that cannot be simply 
explained by linear combinations of the corresponding single stress responses. Most of 
metabolic features are specifically changed in these two combined stresses which should 
be considered as novel stress conditions. Many identified stress signatures contributed to 
the differences between stress and control showed shared patterns across different abiotic 
treatments. However, maltose and GSH showed unique stress response patterns. Our study 
indicated that it is imperative to study plant combination stress tolerance that mimics the 
field environment that may potentially contribute to future research designed to enhance 
crop plant tolerance to field abiotic stress conditions. 
 
Materials and Methods 
Plant materials, growth conditions, and treatments 
Arabidopsis thaliana wild-type (Col-0) seeds were obtained from Lehle Seeds and 
were sterilized with 30% (v/v) bleach containing 0.1% (v/v) Triton X-100 and vernalized 
at 4 °C for 2 days. Seedlings were germinated on 1/2 x MS media made from MS Salts 
(PhytoTechnology Laboratories, M524 Murashige & Skoog (MS) Basal Salt Mixture, 4.33 
g/L for 1 x MS) with 1.5% agar. Plants were grown prior to stress, during recovery, and as 
unstressed controls, vertically, at 22°C under a 16-h-light/8-h-dark photoperiod, with ∼80 
μmol m-2 s-1 illumination from cool-white fluorescent tube lights (control conditions). 
Eleven-day-old seedlings were treated with single and combination stress conditions 
described in Table 3-1. Whole seedlings were harvested, frozen in liquid nitrogen, and 
stored at -80°C. Experiments were performed using three biological replicates.  
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Sample extraction and LC-HRMS analysis 
Seedlings were lyophilized, weighed, and extracted in 70% isopropanol alcohol 
with one 2.5 mm tungsten carbide ball in a Geno/Grinder™ (OPS Diagnostics) for 7 
minutes at an intensity of 10,956 x g on -20°C chilled blocks to make a final concentration 
of 10 mg/ml (dry weight). After centrifugation for 10 minutes at 100,956 x g, 1 μL of 
supernatant was injected onto a UHPLC (Ultimate 3000, Dionex) with a ZIC-cHILIC 
column (100 mm ×2.1 mm, 3 μm particle size, EMD Millipore Corporation, Billerica, 
MA). Solvents A (0.1% (v/v) formic acid in water) and B (0.1% (v/v) formic acid in 
acetonitrile) were used as mobile phases for gradient separation. Extract corresponding to 
100 µg of plant material (fresh weight) was loaded onto the column with at a flow rate of 
0.4 mL/min, followed by the following gradient separation: 1 min from 98% B, 17 min to 
65% B and maintained for 2 min, then 95% B and maintained for 1.5 min. The column was 
equilibrated for 1 min with 98% B prior to the next run. The samples were analyzed using 
a hybrid quadrupole Orbitrap mass spectrometer (Q Exactive, Thermo Fisher Scientific, 
San Jose CA). Full scan MS (range 50−750 m/z) were acquired with 35 k resolution for 
both positive and negative mode in polarity switching. The target value based on predictive 
automatic gain control was 1.0 × 106 with 200 ms of maximum injection time. The flow 
rate for sheath gas, aux gas, and sweep gas was 50, 20, and 1 separately. The capillary 
temperature was 350 °C. The S-lens RF was set to 55. The Aux gas heater temperature was 
300 °C. Targeted MS/MS acquisition was used during metabolite identification with an 
inclusion list of ions of interest. Briefly, the precursor ions were sequentially fragmented 
in the HCD collision cell with normalized collision energy of 10%, 20%, 40%. MS/MS 
scans were acquired with 17.5 k resolution and the target value was 2.0 × 105 with 100 ms 
of maximum injection time. An isolation width of 2.0 m/z was used for precursor ion 
selection in MS/MS mode.  
 
Data analysis 
Thermo RAW files were converted to mzXML format using MSConvert (Chambers 
et al., 2012).  Preprocessing including peak detection, grouping, and retention time 
correction and statistics analysis including multivariate modeling PCA, OPLS-DA and 
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hierarchical clustering analysis were performed in Workflow4Metabolomics.org online 
resource for computational metabolomics (Giacomoni et al., 2015). Annotation was first 
performed from databases including BMRB (Markley et al., 2008), METLIN (Smith et al., 
2005), and HMDB (Wishart et al., 2013) public databases, and identities were confirmed 
with authentic standards for accurate mass measurement, retention time, and fragmentation 
data listed in Supplemental Table 3-6. Univariate testing ANOVA was performed using 
both Workflow4Metabolomics.org online resource (Giacomoni et al., 2015) and Excel 
2016 (Microsoft). Metabolic pathways were generated by reference to the KEGG pathway 
Database (Kanehisa et al., 2017). S-plots of OPLS-DA were generated to select variables 
with both high covariance and correlation values as metabolic signature candidates 
(Wiklund et al., 2008). To generate these S-plots the covariance was plotted on the x-axis 
whereas the correlation profile is plotted on the y-axis; the most positive and negative 
loadings in covariance and correlation represent variables with both high magnitude and 
high reliability. The S-plots for all the subgroups (Supplemental Figure 3-3) and all the 
treatments with their corresponding controls (Supplemental Figure 3-4) are included in 
the Supplemental Materials. The top 10 most positive and negative loadings in S-plot in 
different groups were reported in Supplemental Table 3-1. Metabolic features that 
increased or decreased more than 2 fold in each treatment compared to control were 
reported in Supplemental Table 3-2. Metabolites as potential stress signatures and their 
corresponding precursors, intermediates, or products in the same metabolic pathway that 
were identified by authentic standards with m/z, retention time, and fragmentation were 
reported in Figure 6, Supplemental Table 3-3, Supplemental Table 3-5.  
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Tables 
Table 3-1. Single and combined stress conditions 
 
Stress treatment Conditions Time Period Reference1 
cold 4 °C 9:00 AM 2 h Kaplan et al., 2004 
heat 45 °C 9:00 AM 2 h Larkindale, 2005 
drought 
move seedlings grown on nylon membrane from medium to desiccate 
in air 
9:00 AM 2 h Li et al., 2008 
high light 562 μmol m-2 s-1 cool white fluorescent light 9:00 AM 2 h Rossel et al., 2002 
salinity remove seedlings grown on nylon membrane to 200 mM NaCl plate 9:00 AM 2 h Seki et al., 2002 
heat x high light 45 °C + 565 μmol m-2 s-1 cool white fluorescent light 9:00 AM 2 h  
heat x salinity 45 °C + move seedlings to 200 mM NaCl plate 9:00 AM 2 h  
heat x drought 45 °C + move seedlings to desiccate 9:00 AM 2 h  
cold x high light 4 °C + 338 μmol m-2 s-1 9:00 AM 2 h  
cold x salinity 4 °C + move seedlings to 200 mM NaCl plate 9:00 AM 2 h  
cold x drought 4 °C + move seedlings to desiccate 9:00 AM 2 h  
high light x salinity 562 μmol m-2 s-1 + move seedlings to 200 mM NaCl plate 9:00 AM 2 h  
high light x drought 562 μmol m-2 s-1 + move seedlings to desiccate 9:00 AM 2 h  
1Source from which stress conditions, with minor modifications, were derived.  Plants were grown on a 16 hr light/8 hr dark 
photoperiod with lights on at 8:00 AM. 
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Table 3-2. Relationships between combined stress and each single stresses 
Combined stresses Relationship to Single Stress Responses 
cold x salinity both contribute  
high light x cold both contribute  
heat x salinity heat dominant 
drought x heat drought dominant 
drought x cold drought dominant 
drought x high light drought dominant 
high light x heat Unique 
high light x salinity Unique 
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Table 3-3. Numbers of metabolic features increased or decreased more than 2 fold 
compared to control 
Treatment Increase Decrease Total 
Cold 20 78 98 
Drought 34 20 54 
Heat 79 22 101 
High light 41 16 57 
Salinity 24 39 63 
Cold x Drought 24 8 32 
Cold x Salinity 26 5 31 
Heat x Drought 77 29 106 
Heat x Salinity 91 17 108 
High light x Cold 33 15 48 
High light x Drought 56 36 92 
High light x Heat 103 141 244 
High light x Salinity 60 119 179 
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Figures 
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Figure 3-1. PCA score plots of treatments in subgroups with hierarchical manner 
for clustering identification.  
In the score plot, the names and colors corresponded to different treatments. Letters and 
circles indicated subgroups (A) All groups. (B) control, cold, heat, drought, salinity, high 
light, cold x drought, cold x salinity, heat x salinity, high light x cold, high light x 
salinity. (C) heat x drought, high light x drought, high light x heat. (D) control, cold, 
drought, salinity, high light, cold x drought, cold x salinity, high light x cold, high light x 
salinity. (E) heat, heat x salinity, high light x salinity. (F) control, cold, high light, cold x 
salinity, high light x cold, high light x salinity. (G) drought, salinity, cold x drought. (H) 
control, cold, cold x salinity.   
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Figure 3-2. Hierarchical clustering analysis (HCA) for all the metabolic features. 
The top horizontal side bar reflects the log2-transformed fold changes of metabolic 
features in different treatments compared to control as reported in Supplemental Table 
3-4. Clusters were generated using the complete linkage and Euclidean distance function. 
Five clusters of treatments were labeled A-E.  
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Figure 3-3. Venn diagrams showing the numbers and overlap of metabolic features 
increased (top) or decreased (bottom) more than 2 fold in plants in responses to 
stresses/combined stress conditions.  
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Figure 3-4. Hierarchical clustering analysis (HCA) for potential stress metabolic signatures and their precursors, 
intermediates, or products in the same pathway. 
The top horizontal side bar reflects the log2-transformed average fold changes of identified metabolites in different treatments 
compared to control as reported in Supplemental Table 3-5. Clusters were generated using the complete linkage and Euclidean 
distance function. Five clusters of treatments were labeled A’-E’. Seven clusters of metabolites were labeled 1-7.  
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Figure 3-5. Plots for metabolites in cluster 1-7 from Figure 3-4 using the ratio 
change (Supplemental Table 3-5) in metabolite abundance represented by the 
colored area for each stress/combined stress condition with the control area shown 
by the black circles.  
Lines are used to connect the stresses to show how they are combined.   
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Figure 3-6. Metabolic pathways and plots for identified potential stress metabolic signatures with their precursors, 
intermediates, or products.  
The fold changes (Supplemental Table 3-5) in metabolite abundance are represented by the colored area for each stress/combined 
stress condition, with the control area outlined by the black circles. Lines are used to connect the stresses to show how they are 
combined.   
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Supplemental Figure 3-1. OPLS-DA score plots of treatments in subgroups with 
hierarchical clustering identification that corresponds to Figure 3-1. 
In the score plot, the names and colors corresponded to different supervised subgroups 
based on clustering results from PCA. (A) All groups. (B) control, cold, heat, drought, 
salinity, high light, cold x drought, cold x salinity, heat x salinity, high light x cold, high 
light x salinity. (C) heat x drought, high light x drought, high light x heat. (D) control, 
cold, drought, salinity, high light, cold x drought, cold x salinity, high light x cold, high 
light x salinity. (E) heat, heat x salinity, high light x salinity. (F) control, cold, high light, 
cold x salinity, high light x cold, high light x salinity. (G) drought, salinity, cold x 
drought. (H) control, cold, coldxsalinity.  
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Supplemental Figure 3-2. OPLS-DA score plots of treatments compared to control. 
(A) cold and control. (B) drought and control. (C) heat and control. (D) high light and control. (E) salinity and control. (F) cold x 
drought and control. (G) cold x salinity and control. (H) heat x drought and control. (I) heat x salinity and control. (J) high light x cold 
and control. (K) high light x drought and control. (L) high light x heat and control. (M) high light x salinity and control. 
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Supplemental Figure 3-3. OPLS-DA S-plot of treatments in subgroups with 
hierarchical clustering identification that corresponds to Figure 3-1. 
The representative OPLS-DA loadings S-pot showing relative contribution of metabolic 
features to the corresponding supervised clusters. (A) All groups. (B) control, cold, heat, 
drought, salinity, high light, cold x drought, cold x salinity, heat x salinity, high light x 
cold, high light x salinity. (C) heat x drought, high light x drought, high light x heat. (D) 
control, cold, drought, salinity, high light, cold x drought, cold x salinity, high light x 
cold, high light x salinity. (E) heat, heat x salinity, high light x salinity. (F) control, cold, 
high light, cold x salinity, high light x cold, high light x salinity. (G) drought, salinity, 
cold x drought. (H) control, cold, cold x salinity.  
The x and y axis represents the covariance and the correlation of features towards the 
predictive variation shown in the corresponding OPLS-DA loading score.  
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Supplemental Figure 3-4. OPLS-DA S-plot of treatment compared to control. 
The representative OPLS-DA loadings S-plot showing relative contribution of metabolic features to the corresponding supervised 
clusters. (A) cold and control. (B) drought and control. (C) heat and control. (D) high light and control. (E) salinity and control. (F) 
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cold x drought and control. (G) cold x salinity and control. (H) heat x drought and control. (I) heat x salinity and control. (J) high light 
x cold and control. (K) high light x drought and control. (L) high light x heat and control. (M) high light x salinity and control. The x 
and y axis represents the covariance and the correlation of features towards the predictive variation shown in the corresponding OPLS-
DA loading score.  
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Supplemental Figure 3-5. Hierarchical clustering analysis (HCA) for all the 
metabolic features.  
The top horizontal side bar reflects the log2-transformed fold changes of metabolic 
features in different treatments compared to control reported in Supplemental Table 3-4. 
Clusters were generated using the complete linkage and Manhattan distance function 
(Supplemental Figure 3-5A), complete linkage and Minkowski distance function 
(Supplemental Figure 3-5B), Ward’s methods using and Euclidean distance function 
(Supplemental Figure 3-5C), Ward’s methods and Manhattan distance function 
(Supplemental Figure 3-5D), Ward’s methods and Minkowski distance function 
(Supplemental Figure 3-5E), McQuitty’s methods and Euclidean distance function 
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(Supplemental Figure 3-5F), McQuitty’s methods and Minkowski distance function 
(Supplemental Figure 3-5G), average linkage and Euclidean distance function 
(Supplemental Figure 3-5H), average linkage and Manhattan distance function 
(Supplemental Figure 3-5I), average linkage and Minkowski distance function 
(Supplemental Figure 3-5J). 
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Supplemental Figure 3-6. Hierarchical clustering analysis (HCA) for potential stress metabolic signatures and their 
precursors, intermediates, or products in the same pathway.  
The top horizontal side bar reflects the log2-transformed fold changes of average for both positive and negative observations as 
reported in Supplemental Table 3-5. Clusters were generated using the complete linkage and Manhattan distance function 
(Supplemental Figure 3-6A), complete linkage and Maximum distance function (Supplemental Figure 3-6B), ward methods using and 
Euclidean distance function (Supplemental Figure 3-6C), Ward’s methods and Manhattan distance function (Supplemental Figure 3-
6D), Ward’s methods and Maximum distance function (Supplemental Figure 3-6E), McQuitty’s methods and Euclidean distance 
function (Supplemental Figure 3-6F), McQuitty’s methods and Manhattan distance function (Supplemental Figure 3-6G), average 
linkage and Euclidean distance function (Supplemental Figure 3-6H), average linkage and Manhattan distance function (Supplemental 
Figure 3-6I). 
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Supplemental Figure 3-7. Metabolites that were identified by authentic standards with m/z, retention time, and fragmentation 
in positive mode. 
The top scheme represents metabolite in sample. The bottom scheme represents metabolite in standard.  Standard compounds include: 
adenine (A), adenosine (B), γ-aminobutyric acid (C), GSH (D), GSSG (E), guanine (F), guanosine monophosphate (G), L-alanine (H), 
L-arginine (I), L-asparagine (J), L-aspartic acid (K), L-glutamic acid (L), L-glutamine (M), L-glycine (N), L-leucine (O), L-lysine (P), 
L-ornithine (Q), L-phenylalanine (R), L-proline (S), L-serine (T), L-threonine (U), L-tryptophan (V), L-tyrosine (W), L-valine (X), 
138 
 
mannitol (Y), urea (Z). It should be noted that while standard compounds of the specified stereochemistry were used, analytical 
procedures that would resolve enantiomers were not employed.  Because of this, absolute stereo-assignments for each of these 
compounds were not included as part of the assignment, though it is likely that the vast majority of amino acids identified are of the L-
configuration as D-amino acids are unusual in plants and typically occur in specialized metabolic contexts. 
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Supplemental Figure 3-8. Metabolites that were identified by authentic standards with m/z, retention time, and fragmentation 
in negative mode. 
The top scheme represents metabolite in sample. The bottom scheme represents metabolite in standard.  Standard compounds include: 
α-ketoglutaric acid (A), citric acid (B), dihydroxyacetone phosphate (C), fructose (D), fructose 6-phosphate (E), fumaric acid (F), 
glucose (G), glucose 6-phosphate (H), L-citrulline (I), L-histidine (J), malic acid (K), maltose (L), pyruvic acid (M), raffinose (N), 
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ribose 5-phosphate (O), shikimic acid (P), succinic acid (Q), sucrose (R), xylose (S). As noted above, while standard compounds of 
the specified stereochemistry were used, analytical procedures that would resolve enantiomers were not employed. 
142 
 
 
143 
 
 
 
Supplemental Figure 3-9. The Van Krevelen diagrams of scatter plot for metabolic 
composition changes of all metabolic features. 
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Supplemental Figure 3-10. The Van Krevelen diagrams of heatmap for metabolic 
composition changes of all metabolic features. 
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 Supplemental Figure 3-11. The Van Krevelen diagrams of scatter plot for metabolic 
composition changes of metabolic features increased or decreased more than 2 fold 
in all treatments. 
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Supplemental Figure 3-12. The Van Krevelen diagrams of heatmap for metabolic 
composition changes of metabolic features increased or decreased more than 2 fold 
in all treatments. 
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Supplemental Table 3-1. Metabolic features with top 10 most positive and negative covariance loadings to OPLS-DA S-plot in 
different groups 
M/z 
Retention 
time 
Polarity Covariance Correlation Vip_prediction Treatment 
Potential 
heuristical 
formula 
Identified with reference standard 
132.1018 6.47 positive 3078 0.5 2.0 all treatments C6H13NO2 Leucine 
116.0704 7.43 positive 2842 0.5 1.8 all treatments C5H9NO2 Proline 
90.0548 8.59 positive 2663 0.6 2.3 all treatments C3H7NO2 Alanine 
104.0704 6.65 positive 2557 0.4 1.5 all treatments C4H9NO2 gamma-Aminobutyric acid 
86.0600 6.60 positive 2402 0.6 2.2 all treatments C4H7NO   
118.0861 6.96 positive 2016 0.6 2.1 all treatments C5H11NO2 Valine 
147.0762 10.56 positive 1848 0.2 0.8 all treatments C5H10N2O3 Glutamine 
72.0808 6.93 positive 1682 0.6 2.1 all treatments C4H9N   
87.0440 6.65 positive 1454 0.4 1.5 all treatments C4H6O2   
166.0860 6.75 positive 1366 0.5 1.9 all treatments C9H11NO2 Phenylalanine 
259.0226 19.06 negative -535 -0.4 1.6 all treatments C6H13O9P Glucose 6-phosphate 
148.0603 11.01 positive -573 -0.2 0.6 all treatments C5H9NO4 Glutamic acid 
176.1028 11.61 positive -576 -0.6 2.1 all treatments C6H13N3O3 Citrulline 
234.0194 7.40 positive -613 -0.3 1.3 all treatments   
134.0446 12.03 positive -766 -0.5 2.0 all treatments C4H7NO4 Aspartic acid 
391.1194 7.38 positive -826 -0.4 1.4 all treatments   
194.0501 7.42 negative -1056 -0.3 1.3 all treatments   
88.0756 5.12 positive -1373 -0.6 2.2 all treatments C4H9NO   
196.0635 7.40 positive -1399 -0.3 1.2 all treatments   
61.9882 10.57 negative -2579 -0.4 1.3 all treatments   
175.1186 14.01 positive 804 0.5 1.0 cold C6H14N4O2 Arginine 
114.1025 12.22 positive 720 0.7 1.5 cold     
196.0635 7.40 positive 681 0.3 0.6 cold     
130.0497 10.55 positive 652 0.4 0.8 cold C5H7NO3   
98.9840 14.99 positive 569 0.5 1.1 cold C2H3KO2   
66.0683 12.22 positive 507 0.8 1.6 cold     
106.0498 11.45 positive 503 0.7 1.3 cold C3H7NO3 Serine 
194.0501 7.42 negative 466 0.3 0.6 cold     
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104.0704 6.65 positive 446 0.3 0.6 cold C4H9NO2 gamma-Aminobutyric acid 
81.0447 1.94 positive 425 0.8 1.6 cold C4H4N2   
341.1104 12.04 negative -514 -0.8 1.7 cold C12H22O11 Sucrose 
259.0226 19.06 negative -549 -1.0 1.9 cold C6H13O9P Glucose 6-phosphate 
133.0151 7.34 negative -556 -0.6 1.3 cold C4H6O5 Malic acid 
72.0808 6.93 positive -567 -0.8 1.6 cold C4H9N   
118.0861 6.96 positive -659 -0.8 1.6 cold C5H11NO2 Valine 
120.0807 6.75 positive -707 -0.9 1.9 cold     
439.0775 12.05 negative -722 -0.9 1.9 cold     
89.0248 2.53 negative -779 -0.5 1.0 cold C3H6O3   
166.0860 6.75 positive -787 -0.9 1.9 cold C9H11NO2 Phenylalanine 
90.0548 8.59 positive -1200 -1.0 1.9 cold C3H7NO2 Alanine 
175.1186 14.01 positive 1070 0.9 1.5 coldxdrought C6H14N4O2 Arginine 
196.0635 7.40 positive 979 0.7 1.1 coldxdrought   
147.0762 10.56 positive 970 0.8 1.3 coldxdrought C5H10N2O3 Glutamine 
114.1025 12.22 positive 619 0.8 1.3 coldxdrought   
194.0501 7.42 negative 567 0.5 0.9 coldxdrought   
130.0497 10.55 positive 551 0.5 0.9 coldxdrought C5H7NO3   
391.1194 7.38 positive 514 0.7 1.2 coldxdrought   
66.0683 12.22 positive 423 0.8 1.4 coldxdrought   
311.1265 7.41 positive 366 0.6 1.0 coldxdrought C20H14N4   
65.0605 14.01 positive 357 0.9 1.5 coldxdrought   
339.0736 5.91 negative -644 -0.8 1.4 coldxdrought C15H16O9   
132.1018 6.47 positive -658 -1.0 1.7 coldxdrought C6H13NO2 Leucine 
120.0807 6.75 positive -714 -1.0 1.7 coldxdrought   
118.0861 6.96 positive -750 -1.0 1.7 coldxdrought C5H11NO2 Valine 
166.0860 6.75 positive -795 -1.0 1.7 coldxdrought C9H11NO2 Phenylalanine 
86.0600 6.60 positive -838 -0.9 1.6 coldxdrought C4H7NO   
87.0440 6.65 positive -923 -0.9 1.6 coldxdrought C4H6O2   
112.9862 7.82 negative -928 -0.5 0.8 coldxdrought   
90.0548 8.59 positive -1084 -1.0 1.7 coldxdrought C3H7NO2 Alanine 
104.0704 6.65 positive -1611 -0.9 1.6 coldxdrought C4H9NO2 gamma-Aminobutyric acid 
196.0635 7.40 positive 1073 0.7 1.3 coldxsalinity   
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116.0704 7.43 positive 904 0.6 1.2 coldxsalinity C5H9NO2 Proline 
112.9862 7.82 negative 898 0.3 0.7 coldxsalinity   
147.0762 10.56 positive 820 0.4 0.8 coldxsalinity C5H10N2O3 Glutamine 
133.0606 11.13 positive 782 0.6 1.2 coldxsalinity C4H8N2O3 Asparagine 
98.9840 14.99 positive 744 0.7 1.3 coldxsalinity C2H3KO2   
194.0501 7.42 negative 744 0.6 1.3 coldxsalinity   
148.0603 11.01 positive 717 0.5 1.0 coldxsalinity C5H9NO4 Glutamic acid 
311.1265 7.41 positive 602 0.7 1.5 coldxsalinity C20H14N4   
88.0756 5.12 positive 577 0.6 1.3 coldxsalinity C4H9NO   
130.0862 6.83 positive -483 -1.0 2.0 coldxsalinity C6H11NO2   
89.0248 2.53 negative -498 -0.8 1.5 coldxsalinity C3H6O3   
139.0079 9.13 negative -505 -0.4 0.8 coldxsalinity   
387.1156 12.04 negative -547 -0.7 1.5 coldxsalinity   
341.1104 12.04 negative -547 -0.7 1.4 coldxsalinity C12H22O11 Sucrose 
120.0807 6.75 positive -604 -1.0 1.9 coldxsalinity   
166.0860 6.75 positive -679 -1.0 1.9 coldxsalinity C9H11NO2 Phenylalanine 
68.9958 7.55 negative -688 -0.5 1.1 coldxsalinity   
439.0775 12.05 negative -744 -0.8 1.6 coldxsalinity   
90.0548 8.59 positive -1135 -0.9 1.9 coldxsalinity C3H7NO2 Alanine 
104.0704 6.65 positive 2131 0.9 1.6 drought C4H9NO2 gamma-Aminobutyric acid 
116.0704 7.43 positive 1642 0.7 1.3 drought C5H9NO2 Proline 
87.0440 6.65 positive 1200 0.9 1.6 drought C4H6O2   
132.1018 6.47 positive 1115 0.9 1.7 drought C6H13NO2 Leucine 
86.0600 6.60 positive 1094 0.9 1.6 drought C4H7NO   
118.0861 6.96 positive 917 0.9 1.6 drought C5H11NO2 Valine 
139.0079 9.13 negative 893 0.7 1.3 drought     
112.9862 9.14 negative 838 0.5 1.0 drought     
72.0808 6.93 positive 766 0.9 1.6 drought C4H9N   
420.0473 12.65 negative 622 1.0 1.8 drought     
234.0194 7.40 positive -634 -0.8 1.5 drought     
175.1186 14.01 positive -751 -0.5 0.9 drought C6H14N4O2 Arginine 
104.1068 0.99 positive -757 -0.5 0.9 drought     
391.1194 7.38 positive -831 -0.9 1.7 drought     
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98.9840 14.99 positive -851 -0.7 1.3 drought C2H3KO2   
194.0501 7.42 negative -1114 -0.9 1.6 drought     
130.0497 10.55 positive -1234 -0.8 1.4 drought C5H7NO3   
61.9882 10.57 negative -1406 -0.5 0.9 drought     
147.0762 10.56 positive -1557 -0.8 1.4 drought C5H10N2O3 Glutamine 
196.0635 7.40 positive -1642 -0.9 1.7 drought     
147.0762 10.56 positive 3242 1.0 1.5 heat C5H10N2O3 Glutamine 
132.1018 6.47 positive 2466 1.0 1.6 heat C6H13NO2 Leucine 
116.0704 7.43 positive 2161 1.0 1.5 heat C5H9NO2 Proline 
90.0548 8.59 positive 1896 1.0 1.6 heat C3H7NO2 Alanine 
86.0600 6.60 positive 1704 1.0 1.6 heat C4H7NO   
118.0861 6.96 positive 1626 1.0 1.6 heat C5H11NO2 Valine 
130.0497 10.55 positive 1455 0.5 0.8 heat C5H7NO3   
72.0808 6.93 positive 1348 1.0 1.6 heat C4H9N   
166.0860 6.75 positive 1166 1.0 1.6 heat C9H11NO2 Phenylalanine 
120.0807 6.75 positive 1034 1.0 1.6 heat     
159.0762 11.61 positive -369 -1.0 1.6 heat C6H10N2O3 
196.0635 7.40 positive -384 -0.2 0.4 heat     
114.1025 12.22 positive -402 -0.6 1.0 heat     
176.1028 11.61 positive -407 -1.0 1.6 heat C6H13N3O3 Citrulline 
134.0446 12.03 positive -431 -0.9 1.4 heat C4H7NO4 Aspartic acid 
148.0603 11.01 positive -472 -0.5 0.7 heat C5H9NO4 Glutamic acid 
110.9763 10.75 negative -497 -0.5 0.9 heat CH4O4S   
104.1068 0.99 positive -664 -0.6 1.0 heat     
88.0756 5.12 positive -831 -0.9 1.5 heat C4H9NO   
61.9882 10.57 negative -1305 -0.5 0.7 heat     
104.0704 6.65 positive 2559 1.0 1.4 heatxdrought C4H9NO2 gamma-Aminobutyric acid 
130.0497 10.55 positive 1802 0.9 1.3 heatxdrought C5H7NO3   
116.0704 7.43 positive 1722 0.9 1.3 heatxdrought C5H9NO2 Proline 
147.0762 10.56 positive 1619 0.8 1.1 heatxdrought C5H10N2O3 Glutamine 
90.0548 8.59 positive 1466 1.0 1.4 heatxdrought C3H7NO2 Alanine 
87.0440 6.65 positive 1456 1.0 1.4 heatxdrought C4H6O2   
86.0600 6.60 positive 1327 1.0 1.4 heatxdrought C4H7NO   
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132.1018 6.47 positive 1245 1.0 1.4 heatxdrought C6H13NO2 Leucine 
436.0427 15.70 negative 942 1.0 1.4 heatxdrought   
420.0473 12.65 negative 862 1.0 1.4 heatxdrought   
218.0454 7.41 positive -459 -1.0 1.4 heatxdrought   
234.0194 7.40 positive -462 -0.8 1.2 heatxdrought   
112.9862 7.82 negative -488 -0.3 0.4 heatxdrought   
88.0756 5.12 positive -585 -0.8 1.2 heatxdrought C4H9NO   
110.9763 10.75 negative -594 -0.7 1.0 heatxdrought CH4O4S   
391.1194 7.38 positive -665 -0.9 1.4 heatxdrought   
175.1186 14.01 positive -668 -0.7 1.0 heatxdrought C6H14N4O2 Arginine 
61.9882 10.57 negative -847 -0.3 0.5 heatxdrought   
194.0501 7.42 negative -908 -0.9 1.3 heatxdrought   
196.0635 7.40 positive -1301 -0.9 1.3 heatxdrought   
132.1018 6.47 positive 2284 1.0 1.5 heatxsalinity C6H13NO2 Leucine 
116.0704 7.43 positive 2128 1.0 1.4 heatxsalinity C5H9NO2 Proline 
90.0548 8.59 positive 1837 1.0 1.5 heatxsalinity C3H7NO2 Alanine 
86.0600 6.60 positive 1597 1.0 1.5 heatxsalinity C4H7NO   
118.0861 6.96 positive 1437 1.0 1.4 heatxsalinity C5H11NO2 Valine 
175.1186 14.01 positive 1224 0.8 1.1 heatxsalinity C6H14N4O2 Arginine 
72.0808 6.93 positive 1200 1.0 1.4 heatxsalinity C4H9N   
166.0860 6.75 positive 1060 1.0 1.5 heatxsalinity C9H11NO2 Phenylalanine 
133.0606 11.13 positive 1008 0.8 1.2 heatxsalinity C4H8N2O3 Asparagine 
120.0807 6.75 positive 947 1.0 1.5 heatxsalinity   
62.0602 6.00 positive -299 -0.8 1.2 heatxsalinity C2H7NO   
68.9958 7.55 negative -311 -0.3 0.5 heatxsalinity   
136.0617 6.00 positive -329 -0.8 1.2 heatxsalinity C5H5N5 Adenine 
134.0446 12.03 positive -377 -0.9 1.3 heatxsalinity C4H7NO4 Aspartic acid 
112.9862 9.14 negative -522 -0.6 0.9 heatxsalinity   
148.0603 11.01 positive -587 -0.6 0.9 heatxsalinity C5H9NO4 Glutamic acid 
110.9763 10.75 negative -745 -0.7 1.1 heatxsalinity CH4O4S   
88.0756 5.12 positive -833 -0.9 1.4 heatxsalinity C4H9NO   
112.9862 7.82 negative -1327 -0.7 1.0 heatxsalinity   
61.9882 10.57 negative -1803 -0.7 1.0 heatxsalinity   
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130.0497 10.55 positive 1257 0.5 0.8 high light C5H7NO3   
147.0762 10.56 positive 1175 0.5 0.7 high light C5H10N2O3 Glutamine 
112.9862 9.14 negative 1132 0.9 1.4 high light     
133.0151 7.34 negative 910 0.9 1.4 high light C4H6O5 Malic acid 
90.0548 8.59 positive 889 1.0 1.5 high light C3H7NO2 Alanine 
132.1018 6.47 positive 873 1.0 1.5 high light C6H13NO2 Leucine 
104.0704 6.65 positive 823 0.7 1.0 high light C4H9NO2 gamma-Aminobutyric acid 
118.0861 6.96 positive 809 1.0 1.5 high light C5H11NO2 Valine 
115.0043 5.74 negative 731 1.0 1.5 high light C4H4O4 Fumaric acid 
139.0079 9.13 negative 730 0.7 1.1 high light     
391.1194 7.38 positive -545 -0.8 1.2 high light     
114.1025 12.22 positive -549 -0.8 1.2 high light     
98.9840 14.99 positive -583 -0.7 1.0 high light C2H3KO2   
61.9882 10.57 negative -614 -0.3 0.4 high light     
88.0756 5.12 positive -695 -0.9 1.4 high light C4H9NO   
133.0606 11.13 positive -778 -0.8 1.2 high light C4H8N2O3 Asparagine 
104.1068 0.99 positive -855 -0.8 1.2 high light     
194.0501 7.42 negative -862 -0.8 1.3 high light     
175.1186 14.01 positive -934 -0.8 1.2 high light C6H14N4O2 Arginine 
196.0635 7.40 positive -1043 -0.7 1.1 high light     
147.0762 10.56 positive 1636 0.6 1.0 high lightxcold C5H10N2O3 Glutamine 
130.0497 10.55 positive 1604 0.7 1.1 high lightxcold C5H7NO3   
112.9862 9.14 negative 1041 0.8 1.4 high lightxcold   
133.0151 7.34 negative 904 0.9 1.5 high lightxcold C4H6O5 Malic acid 
90.0548 8.59 positive 787 0.9 1.5 high lightxcold C3H7NO2 Alanine 
112.9862 7.82 negative 783 0.4 0.7 high lightxcold   
166.0860 6.75 positive 761 1.0 1.6 high lightxcold C9H11NO2 Phenylalanine 
84.0443 10.68 positive 756 0.9 1.5 high lightxcold   
339.0736 5.91 negative 713 0.9 1.5 high lightxcold C15H16O9   
118.0861 6.96 positive 710 1.0 1.6 high lightxcold C5H11NO2 Valine 
234.0194 7.40 positive -470 -0.7 1.2 high lightxcold   
66.0683 12.22 positive -487 -0.9 1.5 high lightxcold   
106.0498 11.45 positive -505 -0.8 1.3 high lightxcold C3H7NO3 Serine 
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148.0603 11.01 positive -665 -0.6 1.0 high lightxcold C5H9NO4 Glutamic acid 
133.0606 11.13 positive -719 -0.7 1.2 high lightxcold C4H8N2O3 Asparagine 
104.1068 0.99 positive -720 -0.7 1.1 high lightxcold   
114.1025 12.22 positive -736 -0.9 1.4 high lightxcold   
194.0501 7.42 negative -771 -0.7 1.2 high lightxcold   
196.0635 7.40 positive -891 -0.6 1.0 high lightxcold   
175.1186 14.01 positive -1187 -0.9 1.5 high lightxcold C6H14N4O2 Arginine 
116.0704 7.43 positive 1579 0.9 1.4 high lightxdrought C5H9NO2 Proline 
104.0704 6.65 positive 1562 0.9 1.4 high lightxdrought C4H9NO2 gamma-Aminobutyric acid 
132.1018 6.47 positive 1163 1.0 1.5 high lightxdrought C6H13NO2 Leucine 
90.0548 8.59 positive 1085 1.0 1.5 high lightxdrought C3H7NO2 Alanine 
118.0861 6.96 positive 931 1.0 1.5 high lightxdrought C5H11NO2 Valine 
87.0440 6.65 positive 878 0.9 1.4 high lightxdrought C4H6O2   
420.0473 12.65 negative 828 1.0 1.5 high lightxdrought   
86.0600 6.60 positive 798 0.9 1.4 high lightxdrought C4H7NO   
112.9862 7.82 negative 787 0.5 0.7 high lightxdrought   
439.0775 12.05 negative 784 1.0 1.5 high lightxdrought   
62.0602 6.00 positive -420 -0.8 1.2 high lightxdrought C2H7NO   
194.0501 7.42 negative -432 -0.5 0.8 high lightxdrought   
391.1194 7.38 positive -434 -0.6 1.0 high lightxdrought   
136.0617 6.00 positive -448 -0.9 1.4 high lightxdrought C5H5N5 Adenine 
114.1025 12.22 positive -551 -0.7 1.1 high lightxdrought   
175.1186 14.01 positive -556 -0.5 0.8 high lightxdrought C6H14N4O2 Arginine 
98.9840 14.99 positive -593 -0.7 1.0 high lightxdrought C2H3KO2   
196.0635 7.40 positive -751 -0.6 0.9 high lightxdrought   
104.1068 0.99 positive -972 -0.9 1.3 high lightxdrought   
147.0762 10.56 positive -1032 -0.8 1.3 high lightxdrought C5H10N2O3 Glutamine 
104.0704 6.65 positive 1966 1.0 1.2 high lightxheat C4H9NO2 gamma-Aminobutyric acid 
132.1018 6.47 positive 1860 1.0 1.2 high lightxheat C6H13NO2 Leucine 
90.0548 8.59 positive 1373 1.0 1.2 high lightxheat C3H7NO2 Alanine 
86.0600 6.60 positive 1272 1.0 1.2 high lightxheat C4H7NO   
268.1038 5.50 positive 1198 1.0 1.2 high lightxheat C10H13N5O4 Adenosine 
87.0440 6.65 positive 1119 1.0 1.2 high lightxheat C4H6O2   
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118.0861 6.96 positive 998 1.0 1.2 high lightxheat C5H11NO2 Valine 
166.0860 6.75 positive 993 1.0 1.2 high lightxheat C9H11NO2 Phenylalanine 
136.0617 6.00 positive 957 1.0 1.2 high lightxheat C5H5N5 Adenine 
112.9862 9.14 negative 956 0.9 1.1 high lightxheat   
114.1025 12.22 positive -681 -0.9 1.1 high lightxheat   
196.0635 7.40 positive -690 -0.7 0.9 high lightxheat   
88.0756 5.12 positive -727 -0.9 1.1 high lightxheat C4H9NO   
175.1186 14.01 positive -817 -1.0 1.2 high lightxheat C6H14N4O2 Arginine 
133.0606 11.13 positive -852 -0.9 1.1 high lightxheat C4H8N2O3 Asparagine 
104.1068 0.99 positive -1013 -0.9 1.1 high lightxheat   
148.0603 11.01 positive -1220 -1.0 1.2 high lightxheat C5H9NO4 Glutamic acid 
61.9882 10.57 negative -1614 -0.7 0.9 high lightxheat   
130.0497 10.55 positive -1694 -1.0 1.2 high lightxheat C5H7NO3   
147.0762 10.56 positive -2056 -1.0 1.2 high lightxheat C5H10N2O3 Glutamine 
439.0775 12.05 negative 1136 1.0 1.3 high lightxsalinity   
341.1104 12.04 negative 1121 1.0 1.3 high lightxsalinity C12H22O11 Sucrose 
387.1156 12.04 negative 1077 1.0 1.3 high lightxsalinity   
130.0497 10.55 positive 996 0.7 0.9 high lightxsalinity C5H7NO3   
147.0762 10.56 positive 837 0.5 0.7 high lightxsalinity C5H10N2O3 Glutamine 
365.1042 12.03 positive 709 1.0 1.3 high lightxsalinity Sucrose 
(M+Na) 
112.9862 9.14 negative 655 0.8 1.1 high lightxsalinity   
248.9608 5.41 negative 435 0.9 1.3 high lightxsalinity   
440.0809 12.05 negative 429 1.0 1.3 high lightxsalinity   
388.1191 12.04 negative 413 1.0 1.3 high lightxsalinity C23H19NO5 
104.0704 6.65 positive -930 -0.7 1.0 high lightxsalinity C4H9NO2 gamma-Aminobutyric acid 
194.0501 7.42 negative -938 -1.0 1.3 high lightxsalinity   
133.0606 11.13 positive -957 -0.9 1.2 high lightxsalinity C4H8N2O3 Asparagine 
98.9840 14.99 positive -959 -0.9 1.2 high lightxsalinity C2H3KO2   
104.1068 0.99 positive -1053 -0.9 1.2 high lightxsalinity   
116.0704 7.43 positive -1070 -0.8 1.1 high lightxsalinity C5H9NO2 Proline 
112.9862 7.82 negative -1180 -0.7 0.9 high lightxsalinity   
175.1186 14.01 positive -1248 -1.0 1.3 high lightxsalinity C6H14N4O2 Arginine 
196.0635 7.40 positive -1421 -0.9 1.3 high lightxsalinity   
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61.9882 10.57 negative -1578 -0.6 0.8 high lightxsalinity   
112.9862 9.14 negative 1008 0.9 1.3 salinity     
104.0704 6.65 positive 862 0.7 1.0 salinity C4H9NO2 gamma-Aminobutyric acid 
139.0079 9.13 negative 799 0.8 1.1 salinity     
112.9862 7.82 negative 662 0.4 0.6 salinity     
68.9958 9.12 negative 599 0.9 1.3 salinity     
339.0736 5.91 negative 583 0.9 1.3 salinity C15H16O9   
110.9763 10.75 negative 541 0.6 0.9 salinity CH4O4S   
87.0440 6.65 positive 496 0.7 1.0 salinity C4H6O2   
223.0618 5.90 negative 487 0.9 1.3 salinity C11H12O5   
86.0600 6.60 positive 453 0.7 1.0 salinity C4H7NO   
98.9840 14.99 positive -716 -0.7 1.1 salinity C2H3KO2   
88.0756 5.12 positive -718 -0.9 1.3 salinity C4H9NO   
391.1194 7.38 positive -737 -1.0 1.4 salinity     
148.0603 11.01 positive -937 -0.8 1.2 salinity C5H9NO4 Glutamic acid 
133.0606 11.13 positive -1007 -0.9 1.3 salinity C4H8N2O3 Asparagine 
194.0501 7.42 negative -1115 -1.0 1.4 salinity     
130.0497 10.55 positive -1140 -0.8 1.2 salinity C5H7NO3   
175.1186 14.01 positive -1149 -0.9 1.4 salinity C6H14N4O2 Arginine 
147.0762 10.56 positive -1497 -0.8 1.2 salinity C5H10N2O3 Glutamine 
196.0635 7.40 positive -1548 -1.0 1.5 salinity     
104.0704 6.65 positive 3705 0.9 2.6 subgroupA C4H9NO2 
 
87.0440 6.65 positive 2109 0.9 2.6 subgroupA C4H6O2   
132.1018 6.47 positive 1670 0.4 1.3 subgroupA C6H13NO2 Leucine 
116.0704 7.43 positive 1590 0.4 1.2 subgroupA C5H9NO2 Proline 
86.0600 6.60 positive 1589 0.6 1.7 subgroupA C4H7NO   
90.0548 8.59 positive 1446 0.5 1.4 subgroupA C3H7NO2 Alanine 
268.1038 5.50 positive 1168 0.6 1.7 subgroupA C10H13N5O4 Adenosine 
436.0427 15.70 negative 1078 0.8 2.2 subgroupA   
420.0473 12.65 negative 922 0.7 2.0 subgroupA   
136.0617 6.00 positive 890 0.5 1.5 subgroupA C5H5N5 Adenine 
134.0446 12.03 positive -425 -0.4 1.3 subgroupA C4H7NO4 Aspartic acid 
112.9862 7.82 negative -458 -0.1 0.4 subgroupA   
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259.0226 19.06 negative -471 -0.6 1.6 subgroupA C6H13O9P Glucose 6-phosphate 
133.0151 7.34 negative -494 -0.3 0.8 subgroupA C4H6O5 Malic acid 
223.0618 5.90 negative -523 -0.5 1.3 subgroupA C11H12O5   
130.0497 10.55 positive -621 -0.1 0.4 subgroupA C5H7NO3   
339.0736 5.91 negative -650 -0.5 1.3 subgroupA C15H16O9   
68.9958 7.55 negative -714 -0.4 1.1 subgroupA   
61.9882 10.57 negative -1037 -0.2 0.6 subgroupA   
147.0762 10.56 positive -1227 -0.2 0.7 subgroupA C5H10N2O3 Glutamine 
132.1018 6.47 positive 2227 0.7 1.7 subgroupB C6H13NO2 Leucine 
147.0762 10.56 positive 2131 0.5 1.2 subgroupB C5H10N2O3 Glutamine 
90.0548 8.59 positive 1553 0.6 1.6 subgroupB C3H7NO2 Alanine 
130.0497 10.55 positive 1552 0.4 1.0 subgroupB C5H7NO3   
439.0775 12.05 negative 1410 0.8 2.1 subgroupB     
116.0704 7.43 positive 1397 0.4 1.0 subgroupB C5H9NO2 Proline 
341.1104 12.04 negative 1381 0.8 2.1 subgroupB C12H22O11 Sucrose 
387.1156 12.04 negative 1340 0.8 2.1 subgroupB     
86.0600 6.60 positive 1271 0.5 1.4 subgroupB C4H7NO   
118.0861 6.96 positive 1242 0.6 1.5 subgroupB C5H11NO2 Valine 
134.0446 12.03 positive -535 -0.6 1.6 subgroupB C4H7NO4 Aspartic acid 
87.0440 6.65 positive -563 -0.4 0.9 subgroupB C4H6O2   
136.0617 6.00 positive -595 -0.7 1.7 subgroupB C5H5N5 Adenine 
104.1068 0.99 positive -647 -0.4 0.9 subgroupB     
148.0603 11.01 positive -681 -0.4 1.0 subgroupB C5H9NO4 Glutamic acid 
62.0602 6.00 positive -735 -0.7 1.7 subgroupB C2H7NO   
104.0704 6.65 positive -987 -0.4 0.9 subgroupB C4H9NO2 gamma-Aminobutyric acid 
88.0756 5.12 positive -1114 -0.8 2.0 subgroupB C4H9NO   
112.9862 7.82 negative -1724 -0.5 1.4 subgroupB     
61.9882 10.57 negative -2534 -0.6 1.5 subgroupB     
132.1018 6.47 positive 1731 1.0 1.4 subgroupC C6H13NO2 Leucine 
268.1038 5.50 positive 1329 1.0 1.4 subgroupC C10H13N5O4 Adenosine 
136.0617 6.00 positive 1085 1.0 1.4 subgroupC C5H5N5 Adenine 
110.9763 10.75 negative 1050 0.9 1.2 subgroupC CH4O4S   
166.0860 6.75 positive 944 1.0 1.4 subgroupC C9H11NO2 Phenylalanine 
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112.9862 9.14 negative 893 0.8 1.1 subgroupC     
86.0600 6.60 positive 853 0.7 1.0 subgroupC C4H7NO   
120.0807 6.75 positive 838 1.0 1.4 subgroupC     
90.0548 8.59 positive 814 0.7 1.0 subgroupC C3H7NO2 Alanine 
118.0861 6.96 positive 756 0.9 1.3 subgroupC C5H11NO2 Valine 
145.0627 10.50 negative -654 -0.9 1.2 subgroupC C5H10N2O3 Glutamine 
420.0473 12.65 negative -742 -1.0 1.4 subgroupC     
68.9958 7.55 negative -823 -0.8 1.1 subgroupC     
104.1068 0.99 positive -931 -0.7 1.0 subgroupC     
133.0606 11.13 positive -947 -0.9 1.3 subgroupC C4H8N2O3 Asparagine 
116.0704 7.43 positive -968 -0.7 0.9 subgroupC C5H9NO2 Proline 
148.0603 11.01 positive -1449 -1.0 1.4 subgroupC C5H9NO4 Glutamic acid 
61.9882 10.57 negative -1637 -0.7 0.9 subgroupC     
130.0497 10.55 positive -2037 -0.8 1.1 subgroupC C5H7NO3   
147.0762 10.56 positive -2298 -0.8 1.2 subgroupC C5H10N2O3 Glutamine 
104.0704 6.65 positive 2318 0.8 2.1 subgroupD C4H9NO2 gamma-Aminobutyric acid 
87.0440 6.65 positive 1325 0.8 2.2 subgroupD C4H6O2   
116.0704 7.43 positive 1213 0.4 1.2 subgroupD C5H9NO2 Proline 
86.0600 6.60 positive 1207 0.8 2.2 subgroupD C4H7NO   
420.0473 12.65 negative 626 0.8 2.1 subgroupD     
477.0651 11.95 negative 618 0.7 2.0 subgroupD     
110.9763 10.75 negative 568 0.3 0.9 subgroupD CH4O4S   
436.0427 15.70 negative 561 0.7 2.1 subgroupD     
132.1018 6.47 positive 510 0.3 0.9 subgroupD C6H13NO2 Leucine 
105.0738 6.65 positive 488 0.8 2.1 subgroupD     
90.0548 8.59 positive -635 -0.4 1.1 subgroupD C3H7NO2 Alanine 
145.0627 10.50 negative -639 -0.5 1.4 subgroupD C5H10N2O3 Glutamine 
439.0775 12.05 negative -703 -0.5 1.4 subgroupD     
194.0501 7.42 negative -717 -0.4 1.0 subgroupD     
61.9882 10.57 negative -740 -0.2 0.5 subgroupD     
76.0393 9.69 positive -828 -0.7 2.0 subgroupD C2H5NO2 Glycine 
133.0151 7.34 negative -1002 -0.6 1.7 subgroupD C4H6O5 Malic acid 
196.0635 7.40 positive -1283 -0.5 1.3 subgroupD     
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130.0497 10.55 positive -2159 -0.5 1.5 subgroupD C5H7NO3   
147.0762 10.56 positive -2595 -0.6 1.6 subgroupD C5H10N2O3 Glutamine 
341.1104 12.04 negative 821 0.9 1.2 subgroupE C12H22O11 Sucrose 
387.1156 12.04 negative 777 0.9 1.2 subgroupE     
439.0775 12.05 negative 765 0.9 1.2 subgroupE     
110.9763 10.75 negative 611 0.6 0.9 subgroupE CH4O4S   
112.9862 9.14 negative 600 0.6 0.9 subgroupE     
365.1042 12.03 positive 543 0.9 1.2 subgroupE   Sucrose (M+Na) 
248.9608 5.41 negative 435 1.0 1.3 subgroupE     
89.0248 2.53 negative 423 0.8 1.1 subgroupE C3H6O3   
68.9958 7.55 negative 370 0.5 0.7 subgroupE     
68.9958 9.12 negative 358 0.7 0.9 subgroupE     
104.0704 6.65 positive -1136 -0.8 1.1 subgroupE C4H9NO2 gamma-Aminobutyric acid 
147.0762 10.56 positive -1166 -0.4 0.6 subgroupE C5H10N2O3 Glutamine 
196.0635 7.40 positive -1214 -0.7 1.0 subgroupE     
133.0606 11.13 positive -1230 -0.9 1.3 subgroupE C4H8N2O3 Asparagine 
175.1186 14.01 positive -1277 -0.8 1.0 subgroupE C6H14N4O2 Arginine 
118.0861 6.96 positive -1298 -1.0 1.3 subgroupE C5H11NO2 Valine 
86.0600 6.60 positive -1487 -1.0 1.4 subgroupE C4H7NO   
90.0548 8.59 positive -1539 -1.0 1.3 subgroupE C3H7NO2 Alanine 
132.1018 6.47 positive -2003 -1.0 1.4 subgroupE C6H13NO2 Leucine 
116.0704 7.43 positive -2156 -1.0 1.3 subgroupE C5H9NO2 Proline 
130.0497 10.55 positive 2090 0.7 1.4 subgroupF C5H7NO3   
147.0762 10.56 positive 1921 0.6 1.2 subgroupF C5H10N2O3 Glutamine 
112.9862 7.82 negative 1189 0.5 1.0 subgroupF     
133.0151 7.34 negative 1110 0.9 2.0 subgroupF C4H6O5 Malic acid 
112.9862 9.14 negative 1099 0.7 1.4 subgroupF     
104.0704 6.65 positive 1058 0.6 1.3 subgroupF C4H9NO2 gamma-Aminobutyric acid 
116.0704 7.43 positive 1021 0.7 1.5 subgroupF C5H9NO2 Proline 
339.0736 5.91 negative 952 0.9 2.0 subgroupF C15H16O9   
132.1018 6.47 positive 850 0.8 1.7 subgroupF C6H13NO2 Leucine 
115.0043 5.74 negative 846 0.9 2.0 subgroupF C4H4O4 Fumaric acid 
89.0248 2.53 negative -398 -0.3 0.7 subgroupF C3H6O3   
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114.1025 12.22 positive -434 -0.4 0.9 subgroupF     
134.0446 12.03 positive -513 -0.7 1.5 subgroupF C4H7NO4 Aspartic acid 
61.9882 10.57 negative -576 -0.2 0.4 subgroupF     
88.0756 5.12 positive -582 -0.6 1.3 subgroupF C4H9NO   
133.0606 11.13 positive -586 -0.5 1.0 subgroupF C4H8N2O3 Asparagine 
196.0635 7.40 positive -635 -0.3 0.7 subgroupF     
194.0501 7.42 negative -641 -0.4 0.9 subgroupF     
104.1068 0.99 positive -831 -0.6 1.3 subgroupF     
175.1186 14.01 positive -869 -0.5 1.1 subgroupF C6H14N4O2 Arginine 
116.0704 7.43 positive 1857 0.7 1.6 subgroupG C5H9NO2 Proline 
104.0704 6.65 positive 1516 0.6 1.4 subgroupG C4H9NO2 gamma-Aminobutyric acid 
132.1018 6.47 positive 1087 0.8 1.9 subgroupG C6H13NO2 Leucine 
87.0440 6.65 positive 828 0.6 1.4 subgroupG C4H6O2   
118.0861 6.96 positive 766 0.6 1.5 subgroupG C5H11NO2 Valine 
86.0600 6.60 positive 756 0.6 1.4 subgroupG C4H7NO   
175.1186 14.01 positive 644 0.4 0.8 subgroupG C6H14N4O2 Arginine 
72.0808 6.93 positive 622 0.6 1.4 subgroupG C4H9N   
439.0775 12.05 negative 612 0.5 1.2 subgroupG     
387.1156 12.04 negative 605 0.6 1.4 subgroupG     
259.0226 19.06 negative -446 -0.7 1.7 subgroupG C6H13O9P Glucose 6-phosphate 
90.0548 8.59 positive -508 -0.4 0.9 subgroupG C3H7NO2 Alanine 
223.0618 5.90 negative -548 -0.8 1.8 subgroupG C11H12O5   
133.0151 7.34 negative -561 -0.5 1.1 subgroupG C4H6O5 Malic acid 
136.0617 6.00 positive -595 -0.7 1.7 subgroupG C5H5N5 Adenine 
339.0736 5.91 negative -660 -0.8 1.8 subgroupG C15H16O9   
104.1068 0.99 positive -877 -0.5 1.1 subgroupG     
68.9958 7.55 negative -1156 -0.7 1.8 subgroupG     
112.9862 7.82 negative -1314 -0.5 1.3 subgroupG     
61.9882 10.57 negative -1785 -0.5 1.2 subgroupG     
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Supplemental Table 3-2. Metabolic features increased or decreased more than 2 fold in different treatments compared to 
control 
M/z 
Retention time 
(min) 
Polarity Ratio change Treatment Increase or decrease 
Potential 
heuristical 
formula 
Identified with reference standard 
341.1109 12.90 negative 33.58 cold increase C12H22O11 
365.1027 12.97 positive 32.01 cold increase C21H16O6 
221.0675 12.91 negative 22.26 cold increase C8H14O7   
196.0238 4.73 negative 10.06 cold increase C8H7NO5 
115.0403 3.86 negative 3.09 cold increase C5H8O3 Fumaric acid 
191.0203 12.44 negative 2.88 cold increase C6H8O7   
166.0863 6.80 positive 2.76 cold increase C9H11NO2 
231.1001 5.07 positive 2.68 cold increase C14H14O3 
87.0089 4.33 negative 2.68 cold increase C3H4O3   
166.0862 6.88 positive 2.66 cold increase C9H11NO2 
87.0090 4.31 negative 2.63 cold increase C3H4O3   
91.0582 8.73 positive 2.62 cold increase C4H10S   
90.0549 8.74 positive 2.57 cold increase C3H7NO2 Alanine 
90.0548 8.89 positive 2.56 cold increase C3H7NO2 
90.0549 8.66 positive 2.56 cold increase C3H7NO2 Alanine 
96.0444 3.91 positive 2.46 cold increase C5H5NO   
164.0723 6.89 negative 2.36 cold increase C9H11NO2 
241.0308 16.09 positive 2.33 cold increase C6H12N2O4S2 
191.0204 12.15 negative 2.27 cold increase C6H8O7   
131.0816 8.73 positive 2.26 cold increase C5H10N2O2 
218.1171 1.06 positive 0.50 cold decrease C13H15NO2 
307.0773 7.06 positive 0.50 cold decrease C14H14N2O4S 
228.9940 7.33 negative 0.50 cold decrease C9H8Cl2N2O 
133.0338 12.25 negative 0.49 cold decrease C5H10O2S 
141.0660 8.86 positive 0.49 cold decrease C6H8N2O2 
110.9764 10.98 negative 0.49 cold decrease CH4O4S   
146.0465 11.17 negative 0.48 cold decrease C5H9NO4 
171.0069 16.97 negative 0.48 cold decrease C3H9O6P   
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379.0841 13.91 negative 0.47 cold decrease C21H17ClN2O3 
132.0501 11.19 negative 0.47 cold decrease C5H11NOS 
379.0843 12.21 negative 0.47 cold decrease C21H17ClN2O3 
187.0731 8.69 negative 0.47 cold decrease C7H12N2O4 
145.0496 12.20 positive 0.46 cold decrease C6H8O4   
132.0308 12.87 negative 0.46 cold decrease C4H7NO4 
89.0246 3.05 negative 0.46 cold decrease C3H6O3   
132.0308 12.26 negative 0.46 cold decrease C4H7NO4 
124.9560 8.24 negative 0.46 cold decrease C2H6S3   
382.0810 12.18 positive 0.46 cold decrease C14H15N5O6S 
341.1116 12.99 negative 0.44 cold decrease C12H22O11 
113.0358 11.15 negative 0.44 cold decrease C4H6N2O2 
104.0357 11.63 negative 0.43 cold decrease C3H7NO3 
104.0358 11.42 negative 0.43 cold decrease C3H7NO3 
73.0649 5.37 positive 0.43 cold decrease C4H8O   
341.1104 12.20 negative 0.43 cold decrease C12H22O11 
343.1156 12.20 negative 0.43 cold decrease C8H21N6O7P2 
254.0157 7.33 negative 0.43 cold decrease C12H11Cl2NO 
182.9711 7.34 negative 0.42 cold decrease C3H5O7P   
389.1206 12.20 negative 0.41 cold decrease C20H22O8 
131.0471 11.30 negative 0.41 cold decrease C4H8N2O3 Asparagine 
85.0284 12.21 positive 0.41 cold decrease C4H4O2   
388.1192 12.20 negative 0.41 cold decrease C23H19NO5 
300.0823 11.25 negative 0.41 cold decrease C7H18N4O7P 
187.0236 5.36 negative 0.41 cold decrease C7H8O6   
305.1441 9.98 positive 0.40 cold decrease C11H20N4O6 
315.0818 11.19 negative 0.39 cold decrease C16H16N2O3S 
157.0608 11.22 positive 0.39 cold decrease C6H8N2O3 
265.0763 7.95 negative 0.39 cold decrease C16H12NO3 
285.0824 11.32 negative 0.38 cold decrease C12H16NO7 
285.1100 7.44 positive 0.38 cold decrease C17H16O4 
361.1515 12.19 positive 0.38 cold decrease C16H24O9 
325.1110 12.20 positive 0.37 cold decrease C19H17ClN2O 
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223.9852 11.64 negative 0.37 cold decrease C6H11NO3Se 
453.0930 12.21 negative 0.36 cold decrease C22H18N2O9 
97.0284 12.23 positive 0.36 cold decrease C5H4O2   
103.0866 5.47 positive 0.35 cold decrease C4H10N2O 
124.0081 11.07 negative 0.35 cold decrease C2H7NO3S 
117.0198 5.42 negative 0.35 cold decrease C4H6O4   
74.0248 11.64 negative 0.33 cold decrease C2H5NO2 
61.0398 2.79 positive 0.33 cold decrease CH4N2O Urea 
185.0079 5.44 negative 0.32 cold decrease C7H6O6   
61.0398 2.76 positive 0.32 cold decrease CH4N2O   
109.0285 12.22 positive 0.32 cold decrease C6H4O2   
189.0887 11.18 negative 0.32 cold decrease C7H14N2O4 
339.0454 7.27 positive 0.31 cold decrease C9H13N3O9P 
127.0391 12.21 positive 0.31 cold decrease C6H6O3   
180.0327 11.33 positive 0.30 cold decrease C5H9NO4S 
275.1340 11.25 positive 0.29 cold decrease C10H18N4O5 
178.0552 9.41 negative 0.29 cold decrease C6H13NO3S 
204.0866 12.20 positive 0.25 cold decrease C8H13NO5 
156.0422 5.68 positive 0.21 cold decrease C3H10NO4P 
139.0503 6.89 positive 0.20 cold decrease C6H6N2O2 
211.9973 4.66 negative 0.20 cold decrease C4H8NO7P 
299.0485 11.63 negative 0.19 cold decrease C10H12N4O5S 
150.1125 1.20 positive 0.18 cold decrease C6H15NO3 
437.0455 15.86 negative 0.12 cold decrease C15H20NO10S2- 
130.1591 1.14 positive 0.11 cold decrease C8H19N   
551.1711 14.90 negative 0.09 cold decrease C23H32N6O6S2 
181.0153 7.35 negative 0.08 cold decrease C8H6O5   
166.0514 6.14 negative 0.05 cold decrease C8H9NO3 
247.0342 11.63 negative 0.04 cold decrease C11H8N2O5 
129.1023 5.11 positive 0.04 cold decrease C6H12N2O 
160.0758 4.52 positive 0.02 cold decrease C10H9NO 
308.0894 11.55 positive 0.02 cold decrease C10H17N3O6S 
306.0774 11.61 negative 0.01 cold decrease C18H13NO4 
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306.0774 11.60 negative 0.01 cold decrease C18H13NO4 
144.1384 11.48 positive 0.01 cold decrease C8H17NO 
145.0146 5.62 negative 0.01 cold decrease C5H6O5   
113.0245 7.98 negative 0.00 cold decrease C5H6O3   
236.1135 11.06 positive 329.94 coldxdrought increase C9H17NO6 
281.0884 12.72 negative 135.38 coldxdrought increase C10H18O9 
222.0978 11.36 positive 88.27 coldxdrought increase C8H15NO6 
254.0843 11.66 positive 62.23 coldxdrought increase C12H15NO3S 
221.0674 12.74 negative 37.61 coldxdrought increase C8H14O7   
162.0404 12.66 positive 35.69 coldxdrought increase C5H7NO5 
252.1084 13.36 positive 35.66 coldxdrought increase C9H17NO7 
130.0650 11.96 positive 26.98 coldxdrought increase C9H7N   
341.1103 12.66 negative 25.47 coldxdrought increase C12H22O11 Maltose 
161.0465 12.72 negative 23.87 coldxdrought increase C6H10O5   
447.0548 13.82 negative 13.02 coldxdrought increase C16H20N2O9S2 
207.0584 13.80 positive 12.88 coldxdrought increase C10H10N2OS 
160.0755 11.94 positive 6.83 coldxdrought increase C10H9NO 
303.0037 10.78 negative 3.66 coldxdrought increase C15H9ClO5 
293.2107 0.90 positive 3.43 coldxdrought increase C18H28O3 
596.1678 8.43 positive 3.28 coldxdrought increase C27H31O15 
503.1611 14.65 negative 3.16 coldxdrought increase C18H32O16 Raffinose 
301.1057 8.67 positive 3.16 coldxdrought increase C17H16O5 
166.0860 6.75 positive 2.93 coldxdrought increase C9H11NO2 Phenylalanine 
203.0835 7.20 negative 2.52 coldxdrought increase C11H12N2O2 
91.0582 8.59 positive 2.34 coldxdrought increase C4H10S   
90.0548 8.59 positive 2.29 coldxdrought increase C3H7NO2 Alanine 
163.0752 5.90 positive 2.27 coldxdrought increase C10H10O2 
595.2917 12.05 negative 2.07 coldxdrought increase C34H44O9 
122.0811 9.07 positive 0.45 coldxdrought decrease C4H11NO3 
175.1074 8.25 positive 0.43 coldxdrought decrease C7H14N2O3 
93.0463 1.99 negative 0.43 coldxdrought decrease C5H6N2   
150.0430 8.17 negative 0.40 coldxdrought decrease C5H5N5O 
209.0819 13.99 negative 0.40 coldxdrought decrease C11H14O4 
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139.0501 2.00 positive 0.34 coldxdrought decrease C6H6N2O2 
139.0501 6.84 positive 0.31 coldxdrought decrease C6H6N2O2 
308.0905 11.42 positive 0.28 coldxdrought decrease C10H17N3O6S GSH  
281.0884 12.72 negative 206.92 coldxsalinity increase C10H18O9 
221.0674 12.74 negative 54.50 coldxsalinity increase C8H14O7   
341.1103 12.66 negative 37.85 coldxsalinity increase C12H22O11 Maltose 
161.0465 12.72 negative 34.45 coldxsalinity increase C6H10O5   
236.1135 11.06 positive 9.24 coldxsalinity increase C9H17NO6 
93.0463 1.99 negative 6.82 coldxsalinity increase C5H6N2   
252.1084 13.36 positive 5.71 coldxsalinity increase C9H17NO7 
130.0862 6.83 positive 5.32 coldxsalinity increase C6H11NO2 
293.2107 0.90 positive 5.05 coldxsalinity increase C18H28O3 
139.0501 2.00 positive 4.68 coldxsalinity increase C6H6N2O2 
351.1035 6.16 positive 4.57 coldxsalinity increase C16H18N2O5S 
125.0363 10.83 negative 4.29 coldxsalinity increase C5H6N2O2 
254.0843 11.66 positive 3.42 coldxsalinity increase C12H15NO3S 
222.0978 11.36 positive 3.16 coldxsalinity increase C8H15NO6 
168.9915 16.50 negative 3.11 coldxsalinity increase C3H7O6P Dihydroxyacetone phosphate 
301.1057 8.67 positive 2.71 coldxsalinity increase C17H16O5 
122.0811 9.07 positive 2.70 coldxsalinity increase C4H11NO3 
139.0501 6.84 positive 2.63 coldxsalinity increase C6H6N2O2 
379.0991 6.02 positive 2.53 coldxsalinity increase C17H18N2O6S 
203.0835 7.20 negative 2.37 coldxsalinity increase C11H12N2O2 
345.1145 5.85 positive 2.35 coldxsalinity increase C22H17ClN2 
89.0248 2.53 negative 2.30 coldxsalinity increase C3H6O3   
91.0582 8.59 positive 2.12 coldxsalinity increase C4H10S   
90.0548 8.59 positive 2.10 coldxsalinity increase C3H7NO2 Alanine 
325.1121 12.05 positive 2.09 coldxsalinity increase C12H20O10 
166.0860 6.75 positive 2.07 coldxsalinity increase C9H11NO2 Phenylalanine 
265.0718 5.60 negative 0.47 coldxsalinity decrease C16H12NO3 
207.0584 13.80 positive 0.45 coldxsalinity decrease C10H10N2OS 
229.1443 5.58 positive 0.41 coldxsalinity decrease C12H20O4 
447.0548 13.82 negative 0.41 coldxsalinity decrease C16H20N2O9S2 
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308.0905 11.42 positive 0.32 coldxsalinity decrease C10H17N3O6S GSH  
236.1135 11.06 positive 326.28 drought increase C9H17NO6 
254.0843 11.66 positive 114.05 drought increase C12H15NO3S 
222.0978 11.36 positive 112.75 drought increase C8H15NO6 
252.1084 13.36 positive 45.95 drought increase C9H17NO7 
162.0404 12.66 positive 44.61 drought increase C5H7NO5 
130.0650 11.96 positive 31.44 drought increase C9H7N   
207.0584 13.80 positive 17.77 drought increase C10H10N2OS 
447.0548 13.82 negative 17.74 drought increase C16H20N2O9S2 
293.2107 0.90 positive 16.72 drought increase C18H28O3 
160.0755 11.94 positive 7.71 drought increase C10H9NO 
111.0206 1.94 negative 4.93 drought increase C4H4N2O2 
303.0037 10.78 negative 4.81 drought increase C15H9ClO5 
258.1098 12.64 positive 3.93 drought increase C10H15N3O5 
503.1611 14.65 negative 3.79 drought increase C18H32O16 Raffinose 
214.0494 13.95 negative 3.13 drought increase C5H14NO6P 
93.0463 1.99 negative 3.11 drought increase C5H6N2   
132.1018 6.47 positive 2.70 drought increase C6H13NO2 Leucine 
182.0810 8.96 positive 2.51 drought increase C9H11NO3 Tyrosine 
309.2079 0.99 negative 2.50 drought increase C18H30O4 
165.0544 8.96 positive 2.47 drought increase C9H8O3   
136.0756 8.94 positive 2.45 drought increase C8H9NO   
431.2220 8.51 negative 2.34 drought increase C29H28N4 
139.0501 2.00 positive 2.31 drought increase C6H6N2O2 
203.0835 7.20 negative 2.30 drought increase C11H12N2O2 
104.0704 6.65 positive 2.29 drought increase C4H9NO2 gamma-Aminobutyric acid 
72.0808 6.93 positive 2.27 drought increase C4H9N   
87.0440 6.65 positive 2.27 drought increase C4H6O2   
86.0600 6.60 positive 2.26 drought increase C4H7NO   
121.0303 5.56 negative 2.24 drought increase C7H6O2   
69.0335 6.65 positive 2.18 drought increase C4H4O   
166.0860 6.75 positive 2.11 drought increase C9H11NO2 Phenylalanine 
128.0705 6.63 positive 2.05 drought increase C6H9NO2 
169 
 
123.0440 8.94 positive 2.02 drought increase C7H6O2   
118.0861 6.96 positive 2.01 drought increase C5H11NO2 Valine 
279.0274 10.85 negative 0.50 drought decrease C14H13ClO2S 
275.0756 3.23 negative 0.50 drought decrease C11H16O8 
175.1073 9.56 positive 0.49 drought decrease C7H14N2O3 
134.0481 6.05 negative 0.48 drought decrease C5H5N5   
131.0471 11.19 negative 0.47 drought decrease C4H8N2O3 Asparagine 
182.9920 5.75 negative 0.46 drought decrease C7H4O6   
285.1022 9.04 positive 0.46 drought decrease C12H17N2O4P 
187.0986 3.08 negative 0.45 drought decrease C9H16O4   
255.1080 9.64 positive 0.44 drought decrease C9H18O8   
229.0867 1.15 positive 0.44 drought decrease C14H12O3 
154.0156 6.20 negative 0.42 drought decrease C6H5NO4 
259.0226 19.06 negative 0.38 drought decrease C6H13O9P Glucose 6-phosphate 
101.0249 9.86 negative 0.35 drought decrease C4H6O3   
229.1443 5.58 positive 0.35 drought decrease C12H20O4 
277.1671 5.82 positive 0.34 drought decrease C14H20N4O2 
364.0647 18.38 positive 0.32 drought decrease C10H14N5O8P Guanosine monophosphate 
76.0757 5.16 positive 0.31 drought decrease C3H9NO   
308.0905 11.42 positive 0.17 drought decrease C10H17N3O6S GSH  
175.1074 8.25 positive 0.12 drought decrease C7H14N2O3 
150.0430 8.17 negative 0.08 drought decrease C5H5N5O 
236.1135 11.06 positive 64.27 heat increase C9H17NO6 
254.0843 11.66 positive 31.90 heat increase C12H15NO3S 
222.0978 11.36 positive 26.24 heat increase C8H15NO6 
102.0549 10.49 positive 17.63 heat increase C4H7NO2 
252.1084 13.36 positive 17.28 heat increase C9H17NO7 
125.0363 10.83 negative 17.09 heat increase C5H6N2O2 
203.0835 7.20 negative 14.21 heat increase C11H12N2O2 
301.1057 8.67 positive 14.06 heat increase C17H16O5 
503.1611 14.65 negative 13.55 heat increase C18H32O16 Raffinose 
136.0756 8.94 positive 11.81 heat increase C8H9NO   
231.0154 5.74 negative 11.59 heat increase C9H4N4O4 
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182.0810 8.96 positive 11.48 heat increase C9H11NO3 Tyrosine 
132.1018 6.47 positive 11.42 heat increase C6H13NO2 Leucine 
188.0705 7.20 positive 11.39 heat increase C6H10ClN5 
165.0544 8.96 positive 11.39 heat increase C9H8O3   
205.0969 7.21 positive 11.23 heat increase C11H12N2O2 Tryptophan 
123.0461 6.39 negative 10.31 heat increase C7H8O2   
162.0404 12.66 positive 9.84 heat increase C5H7NO5 
123.0440 8.94 positive 8.97 heat increase C7H6O2   
167.0359 6.40 negative 7.93 heat increase C3H10N3O3S 
130.0650 11.96 positive 7.93 heat increase C9H7N   
207.0584 13.80 positive 7.13 heat increase C10H10N2OS 
217.0837 10.98 negative 7.07 heat increase C8H14N2O5 
447.0548 13.82 negative 6.94 heat increase C16H20N2O9S2 
298.0955 14.04 positive 6.18 heat increase C11H15N5O3S 
166.0860 6.75 positive 5.96 heat increase C9H11NO2 Phenylalanine 
91.0582 8.59 positive 5.87 heat increase C4H10S   
90.0548 8.59 positive 5.69 heat increase C3H7NO2 Alanine 
72.0808 6.93 positive 5.61 heat increase C4H9N   
258.1098 12.64 positive 5.58 heat increase C10H15N3O5 
144.0807 7.28 positive 5.52 heat increase C10H9N   
180.0666 8.95 negative 5.40 heat increase C9H11NO3 Tyrosine 
293.2107 0.90 positive 5.17 heat increase C18H28O3 
214.0494 13.95 negative 5.16 heat increase C5H14NO6P 
145.0991 14.13 negative 5.14 heat increase C6H14N2O2 Lysine 
86.0600 6.60 positive 4.82 heat increase C4H7NO   
118.0861 6.96 positive 4.72 heat increase C5H11NO2 Valine 
147.1126 14.14 positive 4.43 heat increase C6H14N2O2 Lysine 
281.0884 12.72 negative 3.41 heat increase C10H18O9 
115.0043 5.74 negative 3.35 heat increase C4H4O4 Fumaric acid 
84.0807 14.14 positive 3.13 heat increase C5H9N   
595.2917 12.05 negative 2.97 heat increase C34H44O9 
162.0759 9.98 positive 2.97 heat increase C6H11NO4 
275.0215 7.34 negative 2.92 heat increase C14H12O2S2 
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158.0832 5.75 negative 2.80 heat increase C7H13NO3 
71.0139 5.78 negative 2.61 heat increase C3H4O2   
168.0654 12.05 positive 2.55 heat increase C8H9NO3 
76.0757 5.16 positive 2.51 heat increase C3H9NO   
70.0651 7.43 positive 2.51 heat increase C4H7N   
116.0704 7.43 positive 2.48 heat increase C5H9NO2 Proline 
119.0347 12.03 negative 2.46 heat increase C4H8O4   
325.1121 12.05 positive 2.45 heat increase C12H20O10 
221.0674 12.74 negative 2.41 heat increase C8H14O7   
219.0972 10.97 positive 2.35 heat increase C8H14N2O5 
204.0865 12.03 positive 2.34 heat increase C8H13NO5 
311.1144 6.02 negative 2.28 heat increase C15H20O7 
163.0599 12.04 positive 2.25 heat increase C6H10O5   
109.0283 12.09 positive 2.23 heat increase C6H4O2   
211.9975 4.44 negative 2.22 heat increase C4H8NO7P 
161.0916 9.05 positive 2.20 heat increase C6H12N2O3 
128.0361 4.44 negative 2.20 heat increase C5H7NO3 
154.0631 14.24 negative 2.19 heat increase C6H9N3O2 Histidine 
97.0284 12.06 positive 2.17 heat increase C5H4O2   
127.0389 12.07 positive 2.12 heat increase C6H6O3   
308.0905 11.42 positive 2.12 heat increase C10H17N3O6S GSH  
259.0131 12.03 negative 2.11 heat increase C6H12O9S Fructose 6-phosphate 
85.0283 12.05 positive 2.10 heat increase C4H4O2   
233.1131 8.87 positive 2.10 heat increase C9H16N2O5 
339.0736 5.91 negative 2.07 heat increase C15H16O9 
147.0308 6.40 negative 2.06 heat increase C5H8O5   
161.0465 12.72 negative 2.05 heat increase C6H10O5   
160.0755 11.94 positive 2.04 heat increase C10H9NO 
145.0494 12.05 positive 2.03 heat increase C6H8O4   
159.0309 6.54 negative 2.03 heat increase C6H8O5   
207.0650 5.88 positive 2.03 heat increase C11H10O4 
110.0712 14.25 positive 2.01 heat increase C5H7N3   
156.0766 14.25 positive 2.01 heat increase C6H9N3O2 Histidine 
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213.0501 10.91 negative 2.00 heat increase C8H10N2O5 
117.0201 5.31 negative 2.00 heat increase C4H6O4 Succinic acid 
303.0037 10.78 negative 0.50 heat decrease C15H9ClO5 
285.1022 9.04 positive 0.48 heat decrease C12H17N2O4P 
365.1193 5.90 positive 0.48 heat decrease C17H20N2O5S 
115.0865 14.72 positive 0.46 heat decrease C5H10N2O 
133.0970 14.72 positive 0.45 heat decrease C5H12N2O2 Ornithine 
169.0152 7.89 negative 0.45 heat decrease C7H6O5   
364.0647 18.38 positive 0.44 heat decrease C10H14N5O8P Guanosine monophosphate 
277.1671 5.82 positive 0.43 heat decrease C14H20N4O2 
114.0550 11.60 positive 0.42 heat decrease C5H7NO2 
229.0867 1.15 positive 0.41 heat decrease C14H12O3 
134.0481 6.05 negative 0.38 heat decrease C5H5N5   
187.0986 3.08 negative 0.37 heat decrease C9H16O4   
170.0469 6.41 negative 0.36 heat decrease C7H9NO4 
159.0762 11.61 positive 0.36 heat decrease C6H10N2O3 
176.1028 11.61 positive 0.36 heat decrease C6H13N3O3 Citrulline 
93.0463 1.99 negative 0.32 heat decrease C5H6N2   
174.0893 11.61 negative 0.32 heat decrease C6H13N3O3 Citrulline 
139.0501 2.00 positive 0.29 heat decrease C6H6N2O2 
139.0501 6.84 positive 0.25 heat decrease C6H6N2O2 
115.0865 6.90 positive 0.24 heat decrease C5H10N2O 
188.0575 6.42 negative 0.18 heat decrease C7H11NO5 
175.1074 8.25 positive 0.07 heat decrease C7H14N2O3 
236.1135 11.06 positive 593.92 heatxdrought increase C9H17NO6 
254.0843 11.66 positive 287.25 heatxdrought increase C12H15NO3S 
222.0978 11.36 positive 230.47 heatxdrought increase C8H15NO6 
293.2107 0.90 positive 157.88 heatxdrought increase C18H28O3 
162.0404 12.66 positive 108.97 heatxdrought increase C5H7NO5 
252.1084 13.36 positive 100.96 heatxdrought increase C9H17NO7 
303.0037 10.78 negative 82.12 heatxdrought increase C15H9ClO5 
130.0650 11.96 positive 60.49 heatxdrought increase C9H7N   
207.0584 13.80 positive 57.98 heatxdrought increase C10H10N2OS 
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447.0548 13.82 negative 57.93 heatxdrought increase C16H20N2O9S2 
102.0549 10.49 positive 19.65 heatxdrought increase C4H7NO2 
311.2237 0.99 negative 19.30 heatxdrought increase C18H32O4 
281.0884 12.72 negative 16.74 heatxdrought increase C10H18O9 
160.0755 11.94 positive 13.84 heatxdrought increase C10H9NO 
279.1182 11.50 positive 12.13 heatxdrought increase C22H14   
217.0837 10.98 negative 12.13 heatxdrought increase C8H14N2O5 
111.0206 1.94 negative 12.12 heatxdrought increase C4H4N2O2 
180.0868 12.10 positive 10.81 heatxdrought increase C6H13NO5 
309.2079 0.99 negative 10.71 heatxdrought increase C18H30O4 
503.1611 14.65 negative 9.27 heatxdrought increase C18H32O16 Raffinose 
595.2917 12.05 negative 9.23 heatxdrought increase C34H44O9 
221.0674 12.74 negative 8.77 heatxdrought increase C8H14O7   
203.0835 7.20 negative 8.62 heatxdrought increase C11H12N2O2 
301.1057 8.67 positive 6.91 heatxdrought increase C17H16O5 
161.0465 12.72 negative 6.14 heatxdrought increase C6H10O5   
214.0494 13.95 negative 6.08 heatxdrought increase C5H14NO6P 
125.0363 10.83 negative 5.15 heatxdrought increase C5H6N2O2 
341.1103 12.66 negative 5.11 heatxdrought increase C12H22O11 Maltose 
258.1098 12.64 positive 5.08 heatxdrought increase C10H15N3O5 
75.0089 3.66 negative 4.66 heatxdrought increase C2H4O3   
91.0582 8.59 positive 4.57 heatxdrought increase C4H10S   
293.1762 1.01 negative 4.50 heatxdrought increase C17H26O4 
90.0548 8.59 positive 4.47 heatxdrought increase C3H7NO2 Alanine 
103.0407 2.08 negative 4.34 heatxdrought increase C4H8O3   
132.1018 6.47 positive 4.30 heatxdrought increase C6H13NO2 Leucine 
219.0972 10.97 positive 4.26 heatxdrought increase C8H14N2O5 
136.0756 8.94 positive 4.01 heatxdrought increase C8H9NO   
188.0705 7.20 positive 4.00 heatxdrought increase C6H10ClN5 
205.0969 7.21 positive 3.95 heatxdrought increase C11H12N2O2 Tryptophan 
182.0810 8.96 positive 3.94 heatxdrought increase C9H11NO3 Tyrosine 
165.0544 8.96 positive 3.88 heatxdrought increase C9H8O3   
104.0704 6.65 positive 3.86 heatxdrought increase C4H9NO2 gamma-Aminobutyric acid 
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87.0440 6.65 positive 3.86 heatxdrought increase C4H6O2   
86.0600 6.60 positive 3.84 heatxdrought increase C4H7NO   
69.0335 6.65 positive 3.72 heatxdrought increase C4H4O   
431.2220 8.51 negative 3.57 heatxdrought increase C29H28N4 
275.1348 11.15 positive 3.41 heatxdrought increase C10H18N4O5 
128.0361 4.44 negative 3.37 heatxdrought increase C5H7NO3 
358.1843 13.98 positive 3.35 heatxdrought increase C17H27NO7 
211.9975 4.44 negative 3.29 heatxdrought increase C4H8NO7P 
123.0440 8.94 positive 3.20 heatxdrought increase C7H6O2   
137.0253 2.13 negative 3.20 heatxdrought increase C7H6O3   
128.0705 6.63 positive 3.17 heatxdrought increase C6H9NO2 
159.0309 6.54 negative 2.86 heatxdrought increase C6H8O5   
147.0308 6.40 negative 2.75 heatxdrought increase C5H8O5   
177.0414 6.47 negative 2.74 heatxdrought increase C6H10O6   
166.0860 6.75 positive 2.71 heatxdrought increase C9H11NO2 Phenylalanine 
145.0991 14.13 negative 2.66 heatxdrought increase C6H14N2O2 Lysine 
117.0201 5.31 negative 2.58 heatxdrought increase C4H6O4 Succinic acid 
298.0955 14.04 positive 2.54 heatxdrought increase C11H15N5O3S 
72.0808 6.93 positive 2.52 heatxdrought increase C4H9N   
130.0650 5.13 positive 2.48 heatxdrought increase C9H7N   
231.0154 5.74 negative 2.34 heatxdrought increase C9H4N4O4 
596.1678 8.43 positive 2.33 heatxdrought increase C27H31O15 
70.0651 7.43 positive 2.32 heatxdrought increase C4H7N   
215.1386 5.77 positive 2.25 heatxdrought increase C10H18N2O3 
116.0704 7.43 positive 2.23 heatxdrought increase C5H9NO2 Proline 
76.0757 5.16 positive 2.23 heatxdrought increase C3H9NO   
123.0461 6.39 negative 2.21 heatxdrought increase C7H8O2   
118.0861 6.96 positive 2.19 heatxdrought increase C5H11NO2 Valine 
147.1126 14.14 positive 2.19 heatxdrought increase C6H14N2O2 Lysine 
291.1297 15.85 positive 2.17 heatxdrought increase C10H18N4O6 
275.0215 7.34 negative 2.14 heatxdrought increase C14H12O2S2 
167.0359 6.40 negative 2.07 heatxdrought increase C3H10N3O3S 
124.0392 8.53 positive 2.03 heatxdrought increase C6H5NO2 
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144.0807 7.28 positive 2.02 heatxdrought increase C10H9N   
131.0722 1.23 negative 2.02 heatxdrought increase C6H12O3   
179.0359 6.04 negative 0.49 heatxdrought decrease C9H8O4   
364.0647 18.38 positive 0.48 heatxdrought decrease C10H14N5O8P Guanosine monophosphate 
259.0226 19.06 negative 0.48 heatxdrought decrease C6H13O9P Glucose 6-phosphate 
85.0298 7.26 negative 0.48 heatxdrought decrease C4H6O2   
145.0151 7.32 negative 0.47 heatxdrought decrease C6H10S2 alpha-Ketoglutaric acid 
129.0202 7.25 negative 0.45 heatxdrought decrease C5H6O4   
111.0094 7.27 negative 0.43 heatxdrought decrease C5H4O3   
122.0811 9.07 positive 0.38 heatxdrought decrease C4H11NO3 
219.0154 7.28 negative 0.38 heatxdrought decrease C7H8O8   
140.0115 8.39 negative 0.35 heatxdrought decrease C2H8NO4P 
139.0501 6.84 positive 0.34 heatxdrought decrease C6H6N2O2 
83.0141 7.27 negative 0.33 heatxdrought decrease C4H4O2   
228.9940 7.23 negative 0.30 heatxdrought decrease C9H8Cl2N2O 
93.0463 1.99 negative 0.30 heatxdrought decrease C5H6N2   
173.0101 7.27 negative 0.29 heatxdrought decrease C6H6O6   
254.9172 5.49 negative 0.24 heatxdrought decrease C4H8Cl3O4P 
132.0653 10.44 positive 0.24 heatxdrought decrease C5H9NO3 
229.0122 18.08 negative 0.23 heatxdrought decrease C5H11O8P Ribose 5-phosphate 
316.9492 5.43 negative 0.21 heatxdrought decrease C14H10Cl4 
116.0512 5.07 negative 0.19 heatxdrought decrease C8H7N   
175.1074 8.25 positive 0.14 heatxdrought decrease C7H14N2O3 
185.0077 5.32 negative 0.13 heatxdrought decrease C7H6O6   
308.0905 11.42 positive 0.12 heatxdrought decrease C10H17N3O6S GSH  
275.0756 3.23 negative 0.11 heatxdrought decrease C11H16O8 
124.9558 6.49 negative 0.08 heatxdrought decrease C2H6S3   
150.0430 8.17 negative 0.05 heatxdrought decrease C5H5N5O 
157.0152 5.05 negative 0.05 heatxdrought decrease C6H6O5   
244.0620 5.05 negative 0.02 heatxdrought decrease C13H11NO4 
168.0451 0.91 positive 0.01 heatxdrought decrease C3H9N3O3S 
311.1144 6.02 negative 98.16 heatxsalinity increase C15H20O7 
503.1611 14.65 negative 19.59 heatxsalinity increase C18H32O16 Raffinose 
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254.0843 11.66 positive 17.73 heatxsalinity increase C12H15NO3S 
125.0363 10.83 negative 17.13 heatxsalinity increase C5H6N2O2 
203.0835 7.20 negative 16.58 heatxsalinity increase C11H12N2O2 
301.1057 8.67 positive 15.53 heatxsalinity increase C17H16O5 
252.1084 13.36 positive 14.98 heatxsalinity increase C9H17NO7 
188.0705 7.20 positive 12.40 heatxsalinity increase C6H10ClN5 
205.0969 7.21 positive 12.17 heatxsalinity increase C11H12N2O2 Tryptophan 
236.1135 11.06 positive 11.96 heatxsalinity increase C9H17NO6 
136.0756 8.94 positive 11.87 heatxsalinity increase C8H9NO   
182.0810 8.96 positive 11.53 heatxsalinity increase C9H11NO3 Tyrosine 
132.1018 6.47 positive 11.45 heatxsalinity increase C6H13NO2 Leucine 
165.0544 8.96 positive 11.37 heatxsalinity increase C9H8O3   
123.0440 8.94 positive 8.91 heatxsalinity increase C7H6O2   
258.1098 12.64 positive 8.72 heatxsalinity increase C10H15N3O5 
222.0978 11.36 positive 7.72 heatxsalinity increase C8H15NO6 
231.0154 5.74 negative 7.60 heatxsalinity increase C9H4N4O4 
298.0955 14.04 positive 7.46 heatxsalinity increase C11H15N5O3S 
351.1035 6.16 positive 7.34 heatxsalinity increase C16H18N2O5S 
123.0461 6.39 negative 7.32 heatxsalinity increase C7H8O2   
217.0837 10.98 negative 6.93 heatxsalinity increase C8H14N2O5 
214.0494 13.95 negative 6.76 heatxsalinity increase C5H14NO6P 
130.0862 6.83 positive 6.52 heatxsalinity increase C6H11NO2 
293.2107 0.90 positive 6.46 heatxsalinity increase C18H28O3 
91.0582 8.59 positive 6.35 heatxsalinity increase C4H10S   
102.0549 10.49 positive 6.30 heatxsalinity increase C4H7NO2 
90.0548 8.59 positive 6.15 heatxsalinity increase C3H7NO2 Alanine 
144.0807 7.28 positive 6.04 heatxsalinity increase C10H9N   
167.0359 6.40 negative 5.98 heatxsalinity increase C3H10N3O3S 
166.0860 6.75 positive 5.82 heatxsalinity increase C9H11NO2 Phenylalanine 
145.0991 14.13 negative 5.60 heatxsalinity increase C6H14N2O2 Lysine 
72.0808 6.93 positive 5.33 heatxsalinity increase C4H9N   
180.0666 8.95 negative 5.15 heatxsalinity increase C9H11NO3 Tyrosine 
86.0600 6.60 positive 4.93 heatxsalinity increase C4H7NO   
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147.1126 14.14 positive 4.78 heatxsalinity increase C6H14N2O2 Lysine 
118.0861 6.96 positive 4.45 heatxsalinity increase C5H11NO2 Valine 
162.0759 9.98 positive 4.35 heatxsalinity increase C6H11NO4 
281.0884 12.72 negative 4.32 heatxsalinity increase C10H18O9 
275.0215 7.34 negative 3.74 heatxsalinity increase C14H12O2S2 
162.0404 12.66 positive 3.45 heatxsalinity increase C5H7NO5 
84.0807 14.14 positive 3.41 heatxsalinity increase C5H9N   
168.0654 12.05 positive 3.29 heatxsalinity increase C8H9NO3 
221.0674 12.74 negative 3.08 heatxsalinity increase C8H14O7   
595.2917 12.05 negative 3.03 heatxsalinity increase C34H44O9 
115.0043 5.74 negative 2.99 heatxsalinity increase C4H4O4 Fumaric acid 
325.1121 12.05 positive 2.92 heatxsalinity increase C12H20O10 
119.0347 12.03 negative 2.91 heatxsalinity increase C4H8O4   
204.0865 12.03 positive 2.88 heatxsalinity increase C8H13NO5 
109.0283 12.09 positive 2.83 heatxsalinity increase C6H4O2   
76.0757 5.16 positive 2.78 heatxsalinity increase C3H9NO   
97.0284 12.06 positive 2.71 heatxsalinity increase C5H4O2   
127.0389 12.07 positive 2.67 heatxsalinity increase C6H6O3   
70.0651 7.43 positive 2.66 heatxsalinity increase C4H7N   
116.0704 7.43 positive 2.64 heatxsalinity increase C5H9NO2 Proline 
163.0599 12.04 positive 2.64 heatxsalinity increase C6H10O5   
85.0283 12.05 positive 2.64 heatxsalinity increase C4H4O2   
154.0631 14.24 negative 2.63 heatxsalinity increase C6H9N3O2 Histidine 
379.0991 6.02 positive 2.58 heatxsalinity increase C17H18N2O6S 
453.0928 12.08 negative 2.54 heatxsalinity increase C22H18N2O9 
259.0131 12.03 negative 2.54 heatxsalinity increase C6H12O9S Fructose 6-phosphate 
130.0650 11.96 positive 2.51 heatxsalinity increase C9H7N   
145.0494 12.05 positive 2.42 heatxsalinity increase C6H8O4   
341.1104 12.04 negative 2.40 heatxsalinity increase C12H22O11 Sucrose 
71.0139 5.78 negative 2.39 heatxsalinity increase C3H4O2   
343.1153 12.04 negative 2.39 heatxsalinity increase C8H21N6O7P2 
219.0972 10.97 positive 2.39 heatxsalinity increase C8H14N2O5 
211.9975 4.44 negative 2.39 heatxsalinity increase C4H8NO7P 
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128.0361 4.44 negative 2.39 heatxsalinity increase C5H7NO3 
141.0202 3.90 negative 2.38 heatxsalinity increase C6H6O4   
156.0766 14.25 positive 2.37 heatxsalinity increase C6H9N3O2 Histidine 
389.1206 12.04 negative 2.37 heatxsalinity increase C20H22O8 
110.0712 14.25 positive 2.37 heatxsalinity increase C5H7N3   
388.1191 12.04 negative 2.36 heatxsalinity increase C23H19NO5 
180.0868 12.10 positive 2.35 heatxsalinity increase C6H13NO5 
322.1124 8.19 positive 2.28 heatxsalinity increase C13H23NO4S2 
76.0393 9.69 positive 2.26 heatxsalinity increase C2H5NO2 Glycine 
233.1131 8.87 positive 2.26 heatxsalinity increase C9H16N2O5 
161.0465 12.72 negative 2.26 heatxsalinity increase C6H10O5   
87.0091 4.09 negative 2.25 heatxsalinity increase C3H4O3 Pyruvic acid 
239.1486 0.95 positive 2.22 heatxsalinity increase C11H18N4O2 
120.0654 9.76 positive 2.18 heatxsalinity increase C4H9NO3 Threonine 
161.0916 9.05 positive 2.11 heatxsalinity increase C6H12N2O3 
187.0734 8.61 negative 2.11 heatxsalinity increase C7H12N2O4 
345.1145 5.85 positive 2.11 heatxsalinity increase C22H17ClN2 
191.0207 13.99 negative 2.09 heatxsalinity increase C6H8O7 Citric acid 
118.0517 9.77 negative 2.09 heatxsalinity increase C4H9NO3 Threonine 
164.0738 12.52 positive 2.08 heatxsalinity increase C6H13NO2S 
102.0549 12.57 positive 2.07 heatxsalinity increase C4H7NO2 
327.0678 8.19 positive 2.07 heatxsalinity increase C14H14O9 
207.0584 13.80 positive 2.05 heatxsalinity increase C10H10N2OS 
381.0936 5.90 positive 0.49 heatxsalinity decrease C21H16O7 
283.2647 1.84 negative 0.49 heatxsalinity decrease C18H36O2 
365.1193 5.90 positive 0.48 heatxsalinity decrease C17H20N2O5S 
105.0199 5.82 negative 0.48 heatxsalinity decrease C3H6O4   
387.1310 5.91 negative 0.47 heatxsalinity decrease C18H20N4O6 
187.0986 3.08 negative 0.47 heatxsalinity decrease C9H16O4   
285.1022 9.04 positive 0.46 heatxsalinity decrease C12H17N2O4P 
88.0756 5.12 positive 0.46 heatxsalinity decrease C4H9NO   
150.0430 8.17 negative 0.38 heatxsalinity decrease C5H5N5O 
253.0933 4.42 negative 0.37 heatxsalinity decrease C9H18O8   
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175.1074 8.25 positive 0.31 heatxsalinity decrease C7H14N2O3 
140.0115 8.39 negative 0.29 heatxsalinity decrease C2H8NO4P 
170.0469 6.41 negative 0.28 heatxsalinity decrease C7H9NO4 
188.0575 6.42 negative 0.24 heatxsalinity decrease C7H11NO5 
115.0865 6.90 positive 0.22 heatxsalinity decrease C5H10N2O 
124.9558 6.49 negative 0.16 heatxsalinity decrease C2H6S3   
185.0077 5.32 negative 0.08 heatxsalinity decrease C7H6O6   
231.0154 5.74 negative 29.55 high light increase C9H4N4O4 
102.0549 10.49 positive 13.80 high light increase C4H7NO2 
258.1098 12.64 positive 9.64 high light increase C10H15N3O5 
125.0363 10.83 negative 9.17 high light increase C5H6N2O2 
503.1611 14.65 negative 7.73 high light increase C18H32O16 Raffinose 
115.0043 5.74 negative 6.02 high light increase C4H4O4 Fumaric acid 
214.0494 13.95 negative 5.79 high light increase C5H14NO6P 
293.2107 0.90 positive 5.67 high light increase C18H28O3 
158.0832 5.75 negative 5.37 high light increase C7H13NO3 
301.1057 8.67 positive 4.94 high light increase C17H16O5 
254.0843 11.66 positive 4.84 high light increase C12H15NO3S 
217.0837 10.98 negative 4.47 high light increase C8H14N2O5 
71.0139 5.78 negative 3.97 high light increase C3H4O2   
252.1084 13.36 positive 3.75 high light increase C9H17NO7 
275.0215 7.34 negative 3.31 high light increase C14H12O2S2 
76.0393 9.69 positive 3.01 high light increase C2H5NO2 Glycine 
161.0465 5.61 negative 2.81 high light increase C6H10O5   
203.0835 7.20 negative 2.79 high light increase C11H12N2O2 
596.1678 8.43 positive 2.78 high light increase C27H31O15 
188.0705 7.20 positive 2.68 high light increase C6H10ClN5 
205.0969 7.21 positive 2.66 high light increase C11H12N2O2 Tryptophan 
207.0650 5.88 positive 2.45 high light increase C11H10O4 
132.1018 6.47 positive 2.40 high light increase C6H13NO2 Leucine 
339.0736 5.91 negative 2.33 high light increase C15H16O9 
171.0308 5.81 negative 2.32 high light increase C7H8O5   
119.0347 12.03 negative 2.31 high light increase C4H8O4   
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325.1121 12.05 positive 2.26 high light increase C12H20O10 
168.0654 12.05 positive 2.23 high light increase C8H9NO3 
72.0808 6.93 positive 2.22 high light increase C4H9N   
163.0752 5.90 positive 2.21 high light increase C10H10O2 
185.0077 5.32 negative 2.21 high light increase C7H6O6   
124.9558 6.49 negative 2.21 high light increase C2H6S3   
167.0359 6.40 negative 2.20 high light increase C3H10N3O3S 
91.0582 8.59 positive 2.19 high light increase C4H10S   
166.0860 6.75 positive 2.19 high light increase C9H11NO2 Phenylalanine 
90.0548 8.59 positive 2.15 high light increase C3H7NO2 Alanine 
223.0618 5.90 negative 2.11 high light increase C11H12O5 
123.0461 6.39 negative 2.09 high light increase C7H8O2   
242.0786 12.06 positive 2.06 high light increase C9H12ClN5O 
163.0599 12.04 positive 2.05 high light increase C6H10O5   
204.0865 12.03 positive 2.04 high light increase C8H13NO5 
134.0446 12.03 positive 0.50 high light decrease C4H7NO4 Aspartic acid 
385.1154 5.66 negative 0.49 high light decrease C17H22O10 
207.0584 13.80 positive 0.48 high light decrease C10H10N2OS 
345.1145 5.85 positive 0.48 high light decrease C22H17ClN2 
132.0311 12.05 negative 0.48 high light decrease C4H7NO4 Aspartic acid 
409.1094 5.63 positive 0.48 high light decrease C19H20O10 
169.0152 7.89 negative 0.46 high light decrease C7H6O5   
365.1193 5.90 positive 0.43 high light decrease C17H20N2O5S 
193.0366 7.18 negative 0.43 high light decrease C6H10O7   
205.0500 5.62 negative 0.41 high light decrease C11H10O4 
351.1035 6.16 positive 0.41 high light decrease C16H18N2O5S 
160.0755 11.94 positive 0.38 high light decrease C10H9NO 
134.0481 6.05 negative 0.37 high light decrease C5H5N5   
209.0819 13.99 negative 0.35 high light decrease C11H14O4 
175.1074 8.25 positive 0.16 high light decrease C7H14N2O3 
231.1004 5.12 positive 0.15 high light decrease C14H14O3 
231.0154 5.74 negative 15.78 high lightxcold increase C9H4N4O4 
281.0884 12.72 negative 13.01 high lightxcold increase C10H18O9 
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102.0549 10.49 positive 10.97 high lightxcold increase C4H7NO2 
125.0363 10.83 negative 8.94 high lightxcold increase C5H6N2O2 
221.0674 12.74 negative 6.86 high lightxcold increase C8H14O7   
161.0465 12.72 negative 4.95 high lightxcold increase C6H10O5   
158.0832 5.75 negative 4.73 high lightxcold increase C7H13NO3 
341.1103 12.66 negative 3.99 high lightxcold increase C12H22O11 Maltose 
115.0043 5.74 negative 3.84 high lightxcold increase C4H4O4 Fumaric acid 
168.9915 16.50 negative 3.62 high lightxcold increase C3H7O6P Dihydroxyacetone phosphate 
301.1057 8.67 positive 3.34 high lightxcold increase C17H16O5 
175.1073 9.56 positive 3.27 high lightxcold increase C7H14N2O3 
275.0215 7.34 negative 3.21 high lightxcold increase C14H12O2S2 
166.0860 6.75 positive 3.01 high lightxcold increase C9H11NO2 Phenylalanine 
596.1678 8.43 positive 2.94 high lightxcold increase C27H31O15 
71.0139 5.78 negative 2.89 high lightxcold increase C3H4O2   
252.1084 13.36 positive 2.75 high lightxcold increase C9H17NO7 
130.0862 6.83 positive 2.60 high lightxcold increase C6H11NO2 
217.0837 10.98 negative 2.53 high lightxcold increase C8H14N2O5 
76.0393 9.69 positive 2.39 high lightxcold increase C2H5NO2 Glycine 
203.0835 7.20 negative 2.36 high lightxcold increase C11H12N2O2 
205.0969 7.21 positive 2.35 high lightxcold increase C11H12N2O2 Tryptophan 
188.0705 7.20 positive 2.35 high lightxcold increase C6H10ClN5 
207.0650 5.88 positive 2.33 high lightxcold increase C11H10O4 
161.0465 5.61 negative 2.31 high lightxcold increase C6H10O5   
339.0736 5.91 negative 2.25 high lightxcold increase C15H16O9 
122.0811 9.07 positive 2.25 high lightxcold increase C4H11NO3 
171.0308 5.81 negative 2.20 high lightxcold increase C7H8O5   
124.9558 6.49 negative 2.19 high lightxcold increase C2H6S3   
223.0618 5.90 negative 2.12 high lightxcold increase C11H12O5 
225.0755 5.70 positive 2.09 high lightxcold increase C11H12O5 
105.0199 5.82 negative 2.08 high lightxcold increase C3H6O4   
163.0752 5.90 positive 2.01 high lightxcold increase C10H10O2 
297.0585 5.99 positive 0.49 high lightxcold decrease C10H20N2S4 
205.0500 5.62 negative 0.49 high lightxcold decrease C11H10O4 
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115.0865 14.72 positive 0.48 high lightxcold decrease C5H10N2O 
133.0970 14.72 positive 0.48 high lightxcold decrease C5H12N2O2 Ornithine 
293.1762 1.01 negative 0.47 high lightxcold decrease C17H26O4 
345.1145 5.85 positive 0.45 high lightxcold decrease C22H17ClN2 
203.1499 10.54 positive 0.43 high lightxcold decrease C8H18N4O2 
132.0653 10.44 positive 0.43 high lightxcold decrease C5H9NO3 
169.0152 7.89 negative 0.41 high lightxcold decrease C7H6O5   
134.0481 6.05 negative 0.39 high lightxcold decrease C5H5N5   
365.1193 5.90 positive 0.38 high lightxcold decrease C17H20N2O5S 
303.0037 10.78 negative 0.37 high lightxcold decrease C15H9ClO5 
182.9920 5.75 negative 0.35 high lightxcold decrease C7H4O6   
409.1094 5.63 positive 0.33 high lightxcold decrease C19H20O10 
209.0819 13.99 negative 0.25 high lightxcold decrease C11H14O4 
236.1135 11.06 positive 487.02 high lightxdrought increase C9H17NO6 
254.0843 11.66 positive 188.28 high lightxdrought increase C12H15NO3S 
222.0978 11.36 positive 170.94 high lightxdrought increase C8H15NO6 
162.0404 12.66 positive 96.66 high lightxdrought increase C5H7NO5 
293.2107 0.90 positive 61.23 high lightxdrought increase C18H28O3 
252.1084 13.36 positive 49.72 high lightxdrought increase C9H17NO7 
207.0584 13.80 positive 35.58 high lightxdrought increase C10H10N2OS 
447.0548 13.82 negative 34.80 high lightxdrought increase C16H20N2O9S2 
130.0650 11.96 positive 32.11 high lightxdrought increase C9H7N   
303.0037 10.78 negative 11.26 high lightxdrought increase C15H9ClO5 
160.0755 11.94 positive 7.82 high lightxdrought increase C10H9NO 
111.0206 1.94 negative 7.43 high lightxdrought increase C4H4N2O2 
503.1611 14.65 negative 7.36 high lightxdrought increase C18H32O16 Raffinose 
102.0549 10.49 positive 6.99 high lightxdrought increase C4H7NO2 
258.1098 12.64 positive 6.23 high lightxdrought increase C10H15N3O5 
217.0837 10.98 negative 5.58 high lightxdrought increase C8H14N2O5 
301.1057 8.67 positive 5.36 high lightxdrought increase C17H16O5 
203.0835 7.20 negative 5.31 high lightxdrought increase C11H12N2O2 
214.0494 13.95 negative 5.16 high lightxdrought increase C5H14NO6P 
311.2237 0.99 negative 4.55 high lightxdrought increase C18H32O4 
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309.2079 0.99 negative 4.39 high lightxdrought increase C18H30O4 
144.0464 0.93 negative 4.10 high lightxdrought increase C9H7NO   
275.1348 11.15 positive 3.60 high lightxdrought increase C10H18N4O5 
281.0884 12.72 negative 3.55 high lightxdrought increase C10H18O9 
182.0810 8.96 positive 3.52 high lightxdrought increase C9H11NO3 Tyrosine 
132.1018 6.47 positive 3.47 high lightxdrought increase C6H13NO2 Leucine 
136.0756 8.94 positive 3.47 high lightxdrought increase C8H9NO   
165.0544 8.96 positive 3.47 high lightxdrought increase C9H8O3   
231.0154 5.74 negative 2.94 high lightxdrought increase C9H4N4O4 
123.0440 8.94 positive 2.87 high lightxdrought increase C7H6O2   
205.0969 7.21 positive 2.85 high lightxdrought increase C11H12N2O2 Tryptophan 
188.0705 7.20 positive 2.80 high lightxdrought increase C6H10ClN5 
431.2220 8.51 negative 2.79 high lightxdrought increase C29H28N4 
91.0582 8.59 positive 2.72 high lightxdrought increase C4H10S   
90.0548 8.59 positive 2.66 high lightxdrought increase C3H7NO2 Alanine 
72.0808 6.93 positive 2.59 high lightxdrought increase C4H9N   
168.0654 12.05 positive 2.53 high lightxdrought increase C8H9NO3 
166.0860 6.75 positive 2.43 high lightxdrought increase C9H11NO2 Phenylalanine 
185.0077 5.32 negative 2.34 high lightxdrought increase C7H6O6   
325.1121 12.05 positive 2.34 high lightxdrought increase C12H20O10 
118.0861 6.96 positive 2.30 high lightxdrought increase C5H11NO2 Valine 
219.0972 10.97 positive 2.24 high lightxdrought increase C8H14N2O5 
163.0599 12.04 positive 2.24 high lightxdrought increase C6H10O5   
204.0865 12.03 positive 2.23 high lightxdrought increase C8H13NO5 
119.0347 12.03 negative 2.21 high lightxdrought increase C4H8O4   
97.0284 12.06 positive 2.12 high lightxdrought increase C5H4O2   
221.0674 12.74 negative 2.12 high lightxdrought increase C8H14O7   
181.0152 6.57 negative 2.11 high lightxdrought increase C8H6O5   
85.0283 12.05 positive 2.09 high lightxdrought increase C4H4O2   
279.1182 11.50 positive 2.08 high lightxdrought increase C22H14   
259.0131 12.03 negative 2.08 high lightxdrought increase C6H12O9S Fructose 6-phosphate 
145.0991 14.13 negative 2.07 high lightxdrought increase C6H14N2O2 Lysine 
254.9172 5.49 negative 2.07 high lightxdrought increase C4H8Cl3O4P 
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316.9492 5.43 negative 2.07 high lightxdrought increase C14H10Cl4 
109.0283 12.09 positive 2.05 high lightxdrought increase C6H4O2   
127.0389 12.07 positive 2.03 high lightxdrought increase C6H6O3   
87.0091 4.09 negative 0.50 high lightxdrought decrease C3H4O3 Pyruvic acid 
135.0461 6.05 negative 0.49 high lightxdrought decrease C8H8O2   
268.1038 5.50 positive 0.49 high lightxdrought decrease C10H13N5O4 Adenosine 
139.0501 2.00 positive 0.48 high lightxdrought decrease C6H6N2O2 
265.0718 5.60 negative 0.47 high lightxdrought decrease C16H12NO3 
179.0359 6.04 negative 0.46 high lightxdrought decrease C9H8O4   
161.0918 7.24 positive 0.45 high lightxdrought decrease C6H12N2O3 
139.0501 6.84 positive 0.44 high lightxdrought decrease C6H6N2O2 
187.0986 3.08 negative 0.42 high lightxdrought decrease C9H16O4   
136.0617 6.00 positive 0.41 high lightxdrought decrease C5H5N5 Adenine 
119.0357 9.81 negative 0.37 high lightxdrought decrease C5H4N4   
189.1231 6.38 positive 0.37 high lightxdrought decrease C8H16N2O3 
179.0570 9.82 negative 0.37 high lightxdrought decrease C7H8N4O2 Glucose 
233.1493 6.64 positive 0.37 high lightxdrought decrease C10H20N2O4 
229.0122 18.08 negative 0.37 high lightxdrought decrease C5H11O8P Ribose 5-phosphate 
122.0811 9.07 positive 0.36 high lightxdrought decrease C4H11NO3 
259.0226 19.06 negative 0.35 high lightxdrought decrease C6H13O9P Glucose 6-phosphate 
89.0248 9.82 negative 0.34 high lightxdrought decrease C3H6O3   
134.0481 6.05 negative 0.34 high lightxdrought decrease C5H5N5   
112.0505 9.17 positive 0.34 high lightxdrought decrease C4H5N3O 
71.0139 9.83 negative 0.33 high lightxdrought decrease C3H4O2   
143.0358 9.80 negative 0.32 high lightxdrought decrease C6H8O4   
59.0137 9.82 negative 0.31 high lightxdrought decrease C2H4O2   
175.1074 8.25 positive 0.30 high lightxdrought decrease C7H14N2O3 
152.0566 9.00 positive 0.30 high lightxdrought decrease C5H5N5O Guanine 
284.0985 9.05 positive 0.30 high lightxdrought decrease C10H13N5O5 
275.0756 3.23 negative 0.28 high lightxdrought decrease C11H16O8 
157.0152 5.05 negative 0.28 high lightxdrought decrease C6H6O5   
125.0363 10.83 negative 0.25 high lightxdrought decrease C5H6N2O2 
229.0867 1.15 positive 0.24 high lightxdrought decrease C14H12O3 
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364.0647 18.38 positive 0.22 high lightxdrought decrease C10H14N5O8P Guanosine monophosphate 
93.0463 1.99 negative 0.20 high lightxdrought decrease C5H6N2   
244.0620 5.05 negative 0.16 high lightxdrought decrease C13H11NO4 
101.0249 9.86 negative 0.16 high lightxdrought decrease C4H6O3   
285.1022 9.04 positive 0.08 high lightxdrought decrease C12H17N2O4P 
168.0451 0.91 positive 0.06 high lightxdrought decrease C3H9N3O3S 
293.2107 0.90 positive 136.76 high lightxheat increase C18H28O3 
303.0037 10.78 negative 66.47 high lightxheat increase C15H9ClO5 
254.0843 11.66 positive 38.43 high lightxheat increase C12H15NO3S 
285.1022 9.04 positive 30.59 high lightxheat increase C12H17N2O4P 
152.0566 9.00 positive 24.16 high lightxheat increase C5H5N5O Guanine 
268.1038 5.50 positive 24.08 high lightxheat increase C10H13N5O4 Adenosine 
284.0985 9.05 positive 23.23 high lightxheat increase C10H13N5O5 
595.2917 12.05 negative 22.77 high lightxheat increase C34H44O9 
148.0974 9.05 positive 21.09 high lightxheat increase C6H13NO3 
203.0835 7.20 negative 16.33 high lightxheat increase C11H12N2O2 
252.1084 13.36 positive 15.95 high lightxheat increase C9H17NO7 
136.0756 8.94 positive 14.66 high lightxheat increase C8H9NO   
112.0505 9.17 positive 14.34 high lightxheat increase C4H5N3O 
165.0544 8.96 positive 14.18 high lightxheat increase C9H8O3   
182.0810 8.96 positive 13.84 high lightxheat increase C9H11NO3 Tyrosine 
217.0837 10.98 negative 13.08 high lightxheat increase C8H14N2O5 
236.1135 11.06 positive 12.82 high lightxheat increase C9H17NO6 
222.0978 11.36 positive 11.60 high lightxheat increase C8H15NO6 
231.0154 5.74 negative 11.39 high lightxheat increase C9H4N4O4 
132.1018 6.47 positive 11.37 high lightxheat increase C6H13NO2 Leucine 
123.0440 8.94 positive 11.30 high lightxheat increase C7H6O2   
130.0650 11.96 positive 10.53 high lightxheat increase C9H7N   
231.1004 5.12 positive 10.29 high lightxheat increase C14H14O3 
301.1057 8.67 positive 9.59 high lightxheat increase C17H16O5 
243.0628 5.51 negative 9.14 high lightxheat increase C9H12N2O6 
166.0860 6.75 positive 7.27 high lightxheat increase C9H11NO2 Phenylalanine 
144.0464 0.93 negative 7.04 high lightxheat increase C9H7NO   
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447.0548 13.82 negative 6.66 high lightxheat increase C16H20N2O9S2 
171.0308 5.81 negative 6.60 high lightxheat increase C7H8O5   
233.1493 6.64 positive 6.58 high lightxheat increase C10H20N2O4 
111.0206 1.94 negative 6.46 high lightxheat increase C4H4N2O2 
124.0392 8.53 positive 6.38 high lightxheat increase C6H5NO2 
207.0584 13.80 positive 6.26 high lightxheat increase C10H10N2OS 
311.2237 0.99 negative 5.98 high lightxheat increase C18H32O4 
188.0705 7.20 positive 5.79 high lightxheat increase C6H10ClN5 
149.0252 5.93 negative 5.73 high lightxheat increase C8H6O3   
205.0969 7.21 positive 5.70 high lightxheat increase C11H12N2O2 Tryptophan 
91.0582 8.59 positive 5.47 high lightxheat increase C4H10S   
162.0404 12.66 positive 5.46 high lightxheat increase C5H7NO5 
180.0666 8.95 negative 5.42 high lightxheat increase C9H11NO3 Tyrosine 
117.0201 5.31 negative 5.35 high lightxheat increase C4H6O4 Succinic acid 
145.0991 14.13 negative 5.34 high lightxheat increase C6H14N2O2 Lysine 
90.0548 8.59 positive 5.31 high lightxheat increase C3H7NO2 Alanine 
215.1386 5.77 positive 5.19 high lightxheat increase C10H18N2O3 
136.0617 6.00 positive 4.89 high lightxheat increase C5H5N5 Adenine 
86.0600 6.60 positive 4.76 high lightxheat increase C4H7NO   
110.0255 6.56 negative 4.46 high lightxheat increase C5H5NO2 
147.1126 14.14 positive 4.32 high lightxheat increase C6H14N2O2 Lysine 
72.0808 6.93 positive 4.14 high lightxheat increase C4H9N   
261.1441 7.39 positive 3.77 high lightxheat increase C15H20N2S 
75.0089 3.66 negative 3.72 high lightxheat increase C2H4O3   
73.0296 5.34 negative 3.70 high lightxheat increase C3H6O2   
298.0955 14.04 positive 3.57 high lightxheat increase C11H15N5O3S 
118.0861 6.96 positive 3.47 high lightxheat increase C5H11NO2 Valine 
219.0972 10.97 positive 3.46 high lightxheat increase C8H14N2O5 
87.0440 6.65 positive 3.42 high lightxheat increase C4H6O2   
104.0704 6.65 positive 3.42 high lightxheat increase C4H9NO2 gamma-Aminobutyric acid 
150.0430 8.17 negative 3.41 high lightxheat increase C5H5N5O 
221.0674 12.74 negative 3.41 high lightxheat increase C8H14O7   
189.1231 6.38 positive 3.30 high lightxheat increase C8H16N2O3 
187 
 
69.0335 6.65 positive 3.29 high lightxheat increase C4H4O   
168.0654 12.05 positive 3.27 high lightxheat increase C8H9NO3 
144.0807 7.28 positive 3.25 high lightxheat increase C10H9N   
87.0091 4.09 negative 3.14 high lightxheat increase C3H4O3 Pyruvic acid 
84.0807 14.14 positive 3.14 high lightxheat increase C5H9N   
325.1121 12.05 positive 3.09 high lightxheat increase C12H20O10 
309.2079 0.99 negative 3.08 high lightxheat increase C18H30O4 
281.0884 12.72 negative 3.06 high lightxheat increase C10H18O9 
116.0512 5.07 negative 3.03 high lightxheat increase C8H7N   
109.0283 12.09 positive 2.99 high lightxheat increase C6H4O2   
119.0347 12.03 negative 2.96 high lightxheat increase C4H8O4   
158.0832 5.75 negative 2.95 high lightxheat increase C7H13NO3 
115.0043 5.74 negative 2.94 high lightxheat increase C4H4O4 Fumaric acid 
128.0361 4.44 negative 2.89 high lightxheat increase C5H7NO3 
127.0389 12.07 positive 2.75 high lightxheat increase C6H6O3   
244.0620 5.05 negative 2.73 high lightxheat increase C13H11NO4 
494.2581 6.70 positive 2.64 high lightxheat increase C26H39NO6S 
97.0284 12.06 positive 2.63 high lightxheat increase C5H4O2   
163.0599 12.04 positive 2.63 high lightxheat increase C6H10O5   
204.0865 12.03 positive 2.57 high lightxheat increase C8H13NO5 
85.0283 12.05 positive 2.51 high lightxheat increase C4H4O2   
161.0465 12.72 negative 2.49 high lightxheat increase C6H10O5   
76.0757 5.16 positive 2.48 high lightxheat increase C3H9NO   
128.0705 6.63 positive 2.45 high lightxheat increase C6H9NO2 
145.0494 12.05 positive 2.43 high lightxheat increase C6H8O4   
293.1762 1.01 negative 2.43 high lightxheat increase C17H26O4 
139.0501 6.84 positive 2.43 high lightxheat increase C6H6N2O2 
431.2220 8.51 negative 2.41 high lightxheat increase C29H28N4 
185.0077 5.32 negative 2.28 high lightxheat increase C7H6O6   
134.0481 6.05 negative 2.27 high lightxheat increase C5H5N5   
503.1611 14.65 negative 2.27 high lightxheat increase C18H32O16 Raffinose 
130.0650 5.13 positive 2.26 high lightxheat increase C9H7N   
131.0722 1.23 negative 2.26 high lightxheat increase C6H12O3   
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130.0518 6.37 negative 2.25 high lightxheat increase C5H9NO3 
160.0755 11.94 positive 2.21 high lightxheat increase C10H9NO 
177.0414 6.47 negative 2.17 high lightxheat increase C6H10O6   
343.1153 12.04 negative 2.13 high lightxheat increase C8H21N6O7P2 
341.1104 12.04 negative 2.12 high lightxheat increase C12H22O11 Sucrose 
337.1098 11.88 positive 2.10 high lightxheat increase C20H16O5 
259.0131 12.03 negative 2.10 high lightxheat increase C6H12O9S Fructose 6-phosphate 
129.0657 6.88 positive 2.09 high lightxheat increase C5H8N2O2 
389.1206 12.04 negative 2.05 high lightxheat increase C20H22O8 
388.1191 12.04 negative 2.02 high lightxheat increase C23H19NO5 
151.0623 7.23 positive 0.50 high lightxheat decrease C6H14S2   
359.1480 0.95 positive 0.49 high lightxheat decrease C20H22O6 
101.0709 10.54 positive 0.49 high lightxheat decrease C4H8N2O 
145.0627 10.50 negative 0.49 high lightxheat decrease C5H10N2O3 Glutamine 
101.0249 7.31 negative 0.48 high lightxheat decrease C4H6O3   
127.0521 10.50 negative 0.48 high lightxheat decrease C5H8N2O2 
109.0413 10.49 negative 0.48 high lightxheat decrease C5H6N2O 
130.0497 10.55 positive 0.48 high lightxheat decrease C5H7NO3 
72.0808 12.22 positive 0.48 high lightxheat decrease C4H9N   
133.0606 11.13 positive 0.47 high lightxheat decrease C4H8N2O3 Asparagine 
150.0582 7.25 positive 0.47 high lightxheat decrease C5H11NO2S 
116.0341 11.13 positive 0.47 high lightxheat decrease C4H5NO3 
134.0639 11.12 positive 0.47 high lightxheat decrease C5H11NOS 
305.0992 3.55 positive 0.46 high lightxheat decrease C11H16N2O8 
132.0653 10.44 positive 0.45 high lightxheat decrease C5H9NO3 
147.0762 10.56 positive 0.45 high lightxheat decrease C5H10N2O3 Glutamine 
131.0471 11.19 negative 0.45 high lightxheat decrease C4H8N2O3 Asparagine 
133.0317 7.24 positive 0.45 high lightxheat decrease C5H8O2S   
102.0549 10.49 positive 0.43 high lightxheat decrease C4H7NO2 
357.1204 6.02 negative 0.43 high lightxheat decrease C17H18N4O5 
135.0647 11.13 positive 0.43 high lightxheat decrease C5H10O4   
174.0418 6.78 negative 0.42 high lightxheat decrease C6H9NO5 
254.9172 5.49 negative 0.42 high lightxheat decrease C4H8Cl3O4P 
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210.0759 9.20 positive 0.42 high lightxheat decrease C10H11NO4 
141.0202 6.67 negative 0.41 high lightxheat decrease C6H6O4   
208.0623 9.19 negative 0.41 high lightxheat decrease C10H11NO4 
275.1348 11.15 positive 0.40 high lightxheat decrease C10H18N4O5 
133.0515 3.54 negative 0.40 high lightxheat decrease C6H6N4   
175.1073 9.56 positive 0.40 high lightxheat decrease C7H14N2O3 
172.0625 4.45 negative 0.40 high lightxheat decrease C7H11NO4 
283.2647 1.84 negative 0.39 high lightxheat decrease C18H36O2 
128.0361 11.02 negative 0.39 high lightxheat decrease C5H7NO3 
188.0575 6.42 negative 0.39 high lightxheat decrease C7H11NO5 
88.0756 5.12 positive 0.38 high lightxheat decrease C4H9NO   
187.0986 3.08 negative 0.38 high lightxheat decrease C9H16O4   
258.1098 12.64 positive 0.38 high lightxheat decrease C10H15N3O5 
163.0622 6.53 negative 0.37 high lightxheat decrease C6H12O5   
114.0550 11.60 positive 0.37 high lightxheat decrease C5H7NO2 
144.1018 5.50 positive 0.37 high lightxheat decrease C7H13NO2 
130.0862 6.83 positive 0.37 high lightxheat decrease C6H11NO2 
213.0413 8.29 negative 0.37 high lightxheat decrease C9H10O6   
253.0933 4.42 negative 0.36 high lightxheat decrease C9H18O8   
129.0656 10.55 positive 0.35 high lightxheat decrease C5H8N2O2 
229.0867 1.15 positive 0.35 high lightxheat decrease C14H12O3 
113.0339 5.95 positive 0.35 high lightxheat decrease C4H4N2O2 
115.0865 0.95 positive 0.35 high lightxheat decrease C5H10N2O 
85.0298 7.26 negative 0.34 high lightxheat decrease C4H6O2   
289.0686 4.63 positive 0.32 high lightxheat decrease C15H12O6 
595.1644 8.44 positive 0.32 high lightxheat decrease C27H30O15 
163.0422 9.22 positive 0.32 high lightxheat decrease C6H10O3S 
145.0151 7.32 negative 0.31 high lightxheat decrease C6H10S2 alpha-Ketoglutaric acid 
365.1835 5.51 negative 0.31 high lightxheat decrease C22H26N2O3 
191.0207 13.99 negative 0.31 high lightxheat decrease C6H8O7 Citric acid 
177.0414 7.83 negative 0.30 high lightxheat decrease C6H10O6   
219.0154 7.28 negative 0.30 high lightxheat decrease C7H8O8   
189.0891 11.01 negative 0.28 high lightxheat decrease C7H14N2O4 
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138.0569 6.47 negative 0.28 high lightxheat decrease C7H9NO2 
431.3182 1.06 negative 0.28 high lightxheat decrease C27H44O4 
178.0519 5.17 negative 0.28 high lightxheat decrease C9H9NO3 
176.1028 11.61 positive 0.28 high lightxheat decrease C6H13N3O3 Citrulline 
159.0762 11.61 positive 0.28 high lightxheat decrease C6H10N2O3 
338.1227 8.18 positive 0.27 high lightxheat decrease C16H19NO7 
327.0678 8.19 positive 0.27 high lightxheat decrease C14H14O9 
322.1124 8.19 positive 0.27 high lightxheat decrease C13H23NO4S2 
457.1099 3.47 positive 0.26 high lightxheat decrease C17H21N4O9P 
191.1024 11.02 positive 0.26 high lightxheat decrease C7H14N2O4 
371.1360 5.87 negative 0.26 high lightxheat decrease C17H24O9 
174.0893 11.61 negative 0.25 high lightxheat decrease C6H13N3O3 Citrulline 
162.0781 11.66 negative 0.25 high lightxheat decrease C7H9N5   
379.0991 6.02 positive 0.24 high lightxheat decrease C17H18N2O6S 
417.1510 5.41 positive 0.24 high lightxheat decrease C22H24O8 
147.0475 6.76 positive 0.24 high lightxheat decrease C6H10O2S 
122.0811 9.07 positive 0.24 high lightxheat decrease C4H11NO3 
174.0758 11.01 positive 0.24 high lightxheat decrease C7H11NO4 
145.1082 5.89 positive 0.23 high lightxheat decrease C5H12N4O 
134.0446 12.03 positive 0.23 high lightxheat decrease C4H7NO4 Aspartic acid 
613.1557 17.01 positive 0.23 high lightxheat decrease C20H32N6O12S2 GSSG 
141.0202 3.90 negative 0.22 high lightxheat decrease C6H6O4   
139.0749 10.48 positive 0.22 high lightxheat decrease C8H10O2   
135.0480 12.03 positive 0.21 high lightxheat decrease C5H10O2S 
124.0392 9.96 positive 0.21 high lightxheat decrease C6H5NO2 
314.1079 11.99 positive 0.21 high lightxheat decrease C17H16ClN3O 
132.0311 12.05 negative 0.21 high lightxheat decrease C4H7NO4 Aspartic acid 
297.0585 5.99 positive 0.21 high lightxheat decrease C10H20N2S4 
129.0202 7.25 negative 0.21 high lightxheat decrease C5H6O4   
115.0865 14.72 positive 0.19 high lightxheat decrease C5H10N2O 
187.0734 8.61 negative 0.19 high lightxheat decrease C7H12N2O4 
193.0366 7.18 negative 0.19 high lightxheat decrease C6H10O7   
173.0919 11.02 positive 0.19 high lightxheat decrease C7H12N2O3 
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146.0468 10.97 negative 0.19 high lightxheat decrease C5H9NO4 Glutamic acid 
133.0970 14.72 positive 0.18 high lightxheat decrease C5H12N2O2 Ornithine 
139.0501 2.00 positive 0.18 high lightxheat decrease C6H6N2O2 
163.0752 5.90 positive 0.18 high lightxheat decrease C10H10O2 
277.1671 5.82 positive 0.18 high lightxheat decrease C14H20N4O2 
177.0616 9.80 positive 0.17 high lightxheat decrease C4H8N4O4 
299.0522 4.40 positive 0.17 high lightxheat decrease C16H10O6 
345.1145 5.85 positive 0.17 high lightxheat decrease C22H17ClN2 
299.0783 7.26 negative 0.16 high lightxheat decrease C13H16O8 
179.0359 6.04 negative 0.16 high lightxheat decrease C9H8O4   
175.1074 8.25 positive 0.16 high lightxheat decrease C7H14N2O3 
148.0603 11.01 positive 0.15 high lightxheat decrease C5H9NO4 Glutamic acid 
141.0656 8.70 positive 0.15 high lightxheat decrease C6H8N2O2 
259.0226 19.06 negative 0.14 high lightxheat decrease C6H13O9P Glucose 6-phosphate 
140.0115 8.39 negative 0.13 high lightxheat decrease C2H8NO4P 
115.0865 6.90 positive 0.12 high lightxheat decrease C5H10N2O 
229.0122 18.08 negative 0.12 high lightxheat decrease C5H11O8P Ribose 5-phosphate 
209.0819 13.99 negative 0.12 high lightxheat decrease C11H14O4 
111.0094 7.27 negative 0.11 high lightxheat decrease C5H4O3   
203.1499 10.54 positive 0.11 high lightxheat decrease C8H18N4O2 
335.1355 6.52 negative 0.11 high lightxheat decrease C18H24O4S 
93.0463 1.99 negative 0.11 high lightxheat decrease C5H6N2   
286.0917 11.77 positive 0.10 high lightxheat decrease C12H15NO7 
132.0423 9.82 negative 0.10 high lightxheat decrease C3H7N3O3 
251.0777 8.28 negative 0.10 high lightxheat decrease C10H12N4O4 
228.9940 7.23 negative 0.10 high lightxheat decrease C9H8Cl2N2O 
387.1310 5.91 negative 0.08 high lightxheat decrease C18H20N4O6 
175.0482 9.82 negative 0.08 high lightxheat decrease C4H8N4O4 
177.0545 7.07 positive 0.08 high lightxheat decrease C10H8O3   
215.0176 9.80 positive 0.07 high lightxheat decrease C4H9NO7P- 
275.0756 3.23 negative 0.07 high lightxheat decrease C11H16O8 
409.1094 5.63 positive 0.06 high lightxheat decrease C19H20O10 
283.0829 4.71 negative 0.05 high lightxheat decrease C12H17N2O4P 
192 
 
385.1154 5.66 negative 0.05 high lightxheat decrease C17H22O10 
168.0451 0.91 positive 0.05 high lightxheat decrease C3H9N3O3S 
351.1035 6.16 positive 0.04 high lightxheat decrease C16H18N2O5S 
207.0519 4.71 negative 0.04 high lightxheat decrease C8H16O2S2 
173.0101 7.27 negative 0.04 high lightxheat decrease C6H6O6   
279.0274 10.85 negative 0.04 high lightxheat decrease C14H13ClO2S 
145.1446 9.29 positive 0.03 high lightxheat decrease C8H18NO 
303.0489 9.66 positive 0.03 high lightxheat decrease C15H10O7 
83.0141 7.27 negative 0.03 high lightxheat decrease C4H4O2   
381.0936 5.90 positive 0.02 high lightxheat decrease C21H16O7 
223.0618 5.90 negative 0.02 high lightxheat decrease C11H12O5 
365.1193 5.90 positive 0.02 high lightxheat decrease C17H20N2O5S 
339.0736 5.91 negative 0.01 high lightxheat decrease C15H16O9 
207.0650 5.88 positive 0.01 high lightxheat decrease C11H10O4 
162.0241 6.47 negative 0.01 high lightxheat decrease C5H9NO3S 
141.0657 5.66 positive 0.00 high lightxheat decrease C6H8N2O2 
225.0755 5.70 positive 0.00 high lightxheat decrease C11H12O5 
308.0905 11.42 positive 0.00 high lightxheat decrease C10H17N3O6S GSH  
167.0220 9.37 negative 0.00 high lightxheat decrease C5H4N4O3 
311.1144 6.02 negative 211.51 high lightxsalinity increase C15H20O7 
125.0363 10.83 negative 26.51 high lightxsalinity increase C5H6N2O2 
155.0360 6.72 negative 23.63 high lightxsalinity increase C7H8O4   
130.0518 6.37 negative 16.90 high lightxsalinity increase C5H9NO3 
147.0308 6.40 negative 13.88 high lightxsalinity increase C5H8O5   
181.0152 6.57 negative 13.18 high lightxsalinity increase C8H6O5   
93.0463 1.99 negative 12.53 high lightxsalinity increase C5H6N2   
254.0843 11.66 positive 11.48 high lightxsalinity increase C12H15NO3S 
209.0819 13.99 negative 10.54 high lightxsalinity increase C11H14O4 
102.0549 10.49 positive 9.74 high lightxsalinity increase C4H7NO2 
258.1098 12.64 positive 9.32 high lightxsalinity increase C10H15N3O5 
236.1135 11.06 positive 9.08 high lightxsalinity increase C9H17NO6 
123.0440 8.94 positive 8.69 high lightxsalinity increase C7H6O2   
285.1022 9.04 positive 8.61 high lightxsalinity increase C12H17N2O4P 
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503.1611 14.65 negative 8.04 high lightxsalinity increase C18H32O16 Raffinose 
139.0501 2.00 positive 7.92 high lightxsalinity increase C6H6N2O2 
203.0835 7.20 negative 7.80 high lightxsalinity increase C11H12N2O2 
168.0654 12.05 positive 6.93 high lightxsalinity increase C8H9NO3 
325.1121 12.05 positive 6.87 high lightxsalinity increase C12H20O10 
293.2107 0.90 positive 6.71 high lightxsalinity increase C18H28O3 
97.0284 12.06 positive 5.66 high lightxsalinity increase C5H4O2   
109.0283 12.09 positive 5.54 high lightxsalinity increase C6H4O2   
204.0865 12.03 positive 5.51 high lightxsalinity increase C8H13NO5 
163.0599 12.04 positive 5.50 high lightxsalinity increase C6H10O5   
214.0494 13.95 negative 5.36 high lightxsalinity increase C5H14NO6P 
127.0389 12.07 positive 5.30 high lightxsalinity increase C6H6O3   
217.0837 10.98 negative 5.09 high lightxsalinity increase C8H14N2O5 
145.0494 12.05 positive 4.86 high lightxsalinity increase C6H8O4   
119.0347 12.03 negative 4.67 high lightxsalinity increase C4H8O4   
252.1084 13.36 positive 4.45 high lightxsalinity increase C9H17NO7 
254.9172 5.49 negative 4.41 high lightxsalinity increase C4H8Cl3O4P 
453.0928 12.08 negative 4.38 high lightxsalinity increase C22H18N2O9 
222.0978 11.36 positive 4.26 high lightxsalinity increase C8H15NO6 
343.1153 12.04 negative 4.01 high lightxsalinity increase C8H21N6O7P2 
341.1104 12.04 negative 3.97 high lightxsalinity increase C12H22O11 Sucrose 
389.1206 12.04 negative 3.83 high lightxsalinity increase C20H22O8 
388.1191 12.04 negative 3.77 high lightxsalinity increase C23H19NO5 
231.0154 5.74 negative 3.76 high lightxsalinity increase C9H4N4O4 
180.0868 12.10 positive 3.69 high lightxsalinity increase C6H13NO5 
182.0810 8.96 positive 3.69 high lightxsalinity increase C9H11NO3 Tyrosine 
165.0544 8.96 positive 3.64 high lightxsalinity increase C9H8O3   
259.0131 12.03 negative 3.48 high lightxsalinity increase C6H12O9S Fructose 6-phosphate 
316.9492 5.43 negative 3.32 high lightxsalinity increase C14H10Cl4 
136.0756 8.94 positive 3.25 high lightxsalinity increase C8H9NO   
213.0501 10.91 negative 3.03 high lightxsalinity increase C8H10N2O5 
89.0248 2.53 negative 2.80 high lightxsalinity increase C3H6O3   
275.0215 7.34 negative 2.74 high lightxsalinity increase C14H12O2S2 
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367.1093 12.03 positive 2.72 high lightxsalinity increase C22H19ClO3 
365.1042 12.03 positive 2.71 high lightxsalinity increase C21H16O6 Sucrose (M+Na) 
61.0398 2.38 positive 2.68 high lightxsalinity increase CH4N2O Urea 
182.9920 5.75 negative 2.54 high lightxsalinity increase C7H4O6   
279.0274 10.85 negative 2.49 high lightxsalinity increase C14H13ClO2S 
111.0206 1.94 negative 2.48 high lightxsalinity increase C4H4N2O2 
162.0404 12.66 positive 2.46 high lightxsalinity increase C5H7NO5 
309.2079 0.99 negative 2.38 high lightxsalinity increase C18H30O4 
379.0991 6.02 positive 2.26 high lightxsalinity increase C17H18N2O6S 
85.0283 12.05 positive 2.18 high lightxsalinity increase C4H4O2   
115.0043 5.74 negative 2.11 high lightxsalinity increase C4H4O4 Fumaric acid 
345.1145 5.85 positive 2.08 high lightxsalinity increase C22H17ClN2 
188.0705 7.20 positive 2.01 high lightxsalinity increase C6H10ClN5 
141.0656 8.70 positive 0.50 high lightxsalinity decrease C6H8N2O2 
457.1099 3.47 positive 0.49 high lightxsalinity decrease C17H21N4O9P 
138.0915 5.64 positive 0.49 high lightxsalinity decrease C8H11NO 
208.0623 9.19 negative 0.49 high lightxsalinity decrease C10H11NO4 
205.0500 5.62 negative 0.49 high lightxsalinity decrease C11H10O4 
145.0151 7.32 negative 0.48 high lightxsalinity decrease C6H10S2 alpha-Ketoglutaric acid 
275.0756 3.23 negative 0.48 high lightxsalinity decrease C11H16O8 
133.0606 11.13 positive 0.48 high lightxsalinity decrease C4H8N2O3 Asparagine 
113.0339 5.95 positive 0.48 high lightxsalinity decrease C4H4N2O2 
289.0686 4.63 positive 0.47 high lightxsalinity decrease C15H12O6 
447.0548 13.82 negative 0.47 high lightxsalinity decrease C16H20N2O9S2 
135.0647 11.13 positive 0.47 high lightxsalinity decrease C5H10O4   
116.0341 11.13 positive 0.47 high lightxsalinity decrease C4H5NO3 
176.1028 11.61 positive 0.45 high lightxsalinity decrease C6H13N3O3 Citrulline 
115.0865 0.95 positive 0.45 high lightxsalinity decrease C5H10N2O 
191.1024 11.02 positive 0.45 high lightxsalinity decrease C7H14N2O4 
159.0762 11.61 positive 0.45 high lightxsalinity decrease C6H10N2O3 
98.9840 14.99 positive 0.44 high lightxsalinity decrease C2H3KO2 
174.0758 11.01 positive 0.43 high lightxsalinity decrease C7H11NO4 
381.0936 5.90 positive 0.43 high lightxsalinity decrease C21H16O7 
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207.0584 13.80 positive 0.43 high lightxsalinity decrease C10H10N2OS 
69.0335 6.65 positive 0.43 high lightxsalinity decrease C4H4O   
172.0625 4.45 negative 0.43 high lightxsalinity decrease C7H11NO4 
146.0599 8.62 positive 0.42 high lightxsalinity decrease C9H7NO   
145.1446 9.29 positive 0.42 high lightxsalinity decrease C8H18NO 
96.9696 14.99 negative 0.42 high lightxsalinity decrease C2H3KO2 
87.0440 6.65 positive 0.42 high lightxsalinity decrease C4H6O2   
104.0704 6.65 positive 0.41 high lightxsalinity decrease C4H9NO2 gamma-Aminobutyric acid 
135.0480 12.03 positive 0.41 high lightxsalinity decrease C5H10O2S 
134.0446 12.03 positive 0.41 high lightxsalinity decrease C4H7NO4 Aspartic acid 
184.0731 13.88 positive 0.41 high lightxsalinity decrease C5H14NO4P 
187.0986 3.08 negative 0.41 high lightxsalinity decrease C9H16O4   
105.0199 5.82 negative 0.40 high lightxsalinity decrease C3H6O4   
174.0893 11.61 negative 0.40 high lightxsalinity decrease C6H13N3O3 Citrulline 
215.0176 9.80 positive 0.40 high lightxsalinity decrease C4H9NO7P- 
140.0115 8.39 negative 0.39 high lightxsalinity decrease C2H8NO4P 
132.0423 9.82 negative 0.39 high lightxsalinity decrease C3H7N3O3 
124.0392 9.96 positive 0.39 high lightxsalinity decrease C6H5NO2 
132.0311 12.05 negative 0.39 high lightxsalinity decrease C4H7NO4 Aspartic acid 
417.1510 5.41 positive 0.39 high lightxsalinity decrease C22H24O8 
364.0647 18.38 positive 0.38 high lightxsalinity decrease C10H14N5O8P Guanosine monophosphate 
189.0415 6.34 negative 0.38 high lightxsalinity decrease C7H10O6   
135.0461 6.05 negative 0.38 high lightxsalinity decrease C8H8O2   
175.0482 9.82 negative 0.38 high lightxsalinity decrease C4H8N4O4 
116.0704 7.43 positive 0.38 high lightxsalinity decrease C5H9NO2 Proline 
173.0919 11.02 positive 0.38 high lightxsalinity decrease C7H12N2O3 
279.1182 11.50 positive 0.37 high lightxsalinity decrease C22H14   
141.0657 5.66 positive 0.36 high lightxsalinity decrease C6H8N2O2 
141.0202 6.67 negative 0.35 high lightxsalinity decrease C6H6O4   
175.1186 14.01 positive 0.35 high lightxsalinity decrease C6H14N4O2 Arginine 
140.0341 8.37 positive 0.34 high lightxsalinity decrease C6H5NO3 
308.0905 11.42 positive 0.34 high lightxsalinity decrease C10H17N3O6S GSH  
160.0755 11.94 positive 0.33 high lightxsalinity decrease C10H9NO 
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144.1018 5.50 positive 0.33 high lightxsalinity decrease C7H13NO2 
197.0673 7.40 positive 0.33 high lightxsalinity decrease C6H12O7   
150.0582 7.25 positive 0.32 high lightxsalinity decrease C5H11NO2S 
253.0933 4.42 negative 0.32 high lightxsalinity decrease C9H18O8   
259.0226 19.06 negative 0.32 high lightxsalinity decrease C6H13O9P Glucose 6-phosphate 
175.1073 9.56 positive 0.32 high lightxsalinity decrease C7H14N2O3 
115.0865 14.72 positive 0.30 high lightxsalinity decrease C5H10N2O 
88.0756 5.12 positive 0.30 high lightxsalinity decrease C4H9NO   
133.0970 14.72 positive 0.30 high lightxsalinity decrease C5H12N2O2 Ornithine 
229.1443 5.58 positive 0.29 high lightxsalinity decrease C12H20O4 
207.0308 6.05 negative 0.29 high lightxsalinity decrease C10H8O5   
163.0752 5.90 positive 0.29 high lightxsalinity decrease C10H10O2 
162.0781 11.66 negative 0.29 high lightxsalinity decrease C7H9N5   
151.0623 7.23 positive 0.28 high lightxsalinity decrease C6H14S2   
437.2046 6.62 negative 0.28 high lightxsalinity decrease C25H30N2O5 
229.0867 1.15 positive 0.28 high lightxsalinity decrease C14H12O3 
179.0359 6.04 negative 0.26 high lightxsalinity decrease C9H8O4   
228.9940 7.23 negative 0.26 high lightxsalinity decrease C9H8Cl2N2O 
161.0918 7.24 positive 0.26 high lightxsalinity decrease C6H12N2O3 
233.1493 6.64 positive 0.25 high lightxsalinity decrease C10H20N2O4 
133.0317 7.24 positive 0.25 high lightxsalinity decrease C5H8O2S   
341.1103 12.66 negative 0.25 high lightxsalinity decrease C12H22O11 Maltose 
70.0652 14.01 positive 0.24 high lightxsalinity decrease C4H7N   
124.9922 12.86 negative 0.24 high lightxsalinity decrease C2H6O4S   
311.1265 7.41 positive 0.23 high lightxsalinity decrease C20H14N4 
76.0757 5.16 positive 0.23 high lightxsalinity decrease C3H9NO   
112.0868 14.01 positive 0.22 high lightxsalinity decrease C5H9N3   
228.0650 13.85 negative 0.21 high lightxsalinity decrease C13H11NO3 
116.0361 7.06 negative 0.21 high lightxsalinity decrease C4H7NO3 
289.0847 6.57 negative 0.21 high lightxsalinity decrease C14H14N2O5 
251.0777 8.28 negative 0.21 high lightxsalinity decrease C10H12N4O4 
182.0469 6.45 negative 0.20 high lightxsalinity decrease C8H9NO4 
95.0599 14.01 positive 0.20 high lightxsalinity decrease C5H6N2   
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265.0718 5.60 negative 0.19 high lightxsalinity decrease C16H12NO3 
138.0569 6.47 negative 0.19 high lightxsalinity decrease C7H9NO2 
149.0465 7.25 negative 0.18 high lightxsalinity decrease C6H14S2 Xylose 
229.0122 18.08 negative 0.17 high lightxsalinity decrease C5H11O8P Ribose 5-phosphate 
163.0622 6.53 negative 0.16 high lightxsalinity decrease C6H12O5   
191.0571 6.49 negative 0.15 high lightxsalinity decrease C7H12O6   
189.1231 6.38 positive 0.15 high lightxsalinity decrease C8H16N2O3 
122.0257 6.21 negative 0.14 high lightxsalinity decrease C6H5NO2 
136.0617 6.00 positive 0.13 high lightxsalinity decrease C5H5N5 Adenine 
140.0361 6.47 negative 0.13 high lightxsalinity decrease C6H7NO3 
164.0738 12.52 positive 0.13 high lightxsalinity decrease C6H13NO2S 
191.0207 13.99 negative 0.13 high lightxsalinity decrease C6H8O7 Citric acid 
154.0156 6.20 negative 0.12 high lightxsalinity decrease C6H5NO4 
177.0545 7.07 positive 0.11 high lightxsalinity decrease C10H8O3   
231.1004 5.12 positive 0.11 high lightxsalinity decrease C14H14O3 
142.0519 6.62 negative 0.10 high lightxsalinity decrease C6H9NO3 
103.0043 6.69 negative 0.10 high lightxsalinity decrease C3H4O4   
196.0294 13.37 negative 0.09 high lightxsalinity decrease C5H11NO5S 
165.0203 6.45 negative 0.09 high lightxsalinity decrease C8H6O4   
145.0991 14.13 negative 0.09 high lightxsalinity decrease C6H14N2O2 Lysine 
193.0366 7.18 negative 0.09 high lightxsalinity decrease C6H10O7   
62.0602 6.00 positive 0.08 high lightxsalinity decrease C2H7NO   
335.1355 6.52 negative 0.06 high lightxsalinity decrease C18H24O4S 
162.0241 6.47 negative 0.05 high lightxsalinity decrease C5H9NO3S 
146.0922 6.20 positive 0.05 high lightxsalinity decrease C5H11N3O2 
100.0410 6.61 negative 0.05 high lightxsalinity decrease C4H7NO2 
293.0541 14.01 negative 0.05 high lightxsalinity decrease C9H15N2O7P 
188.0575 6.42 negative 0.03 high lightxsalinity decrease C7H11NO5 
128.0705 6.63 positive 0.03 high lightxsalinity decrease C6H9NO2 
211.0257 6.82 negative 0.02 high lightxsalinity decrease C9H8O6   
147.0475 6.76 positive 0.02 high lightxsalinity decrease C6H10O2S 
175.1074 8.25 positive 0.02 high lightxsalinity decrease C7H14N2O3 
145.1082 5.89 positive 0.00 high lightxsalinity decrease C5H12N4O 
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236.1135 11.06 positive 17.41 salinity increase C9H17NO6 
254.0843 11.66 positive 13.84 salinity increase C12H15NO3S 
252.1084 13.36 positive 11.94 salinity increase C9H17NO7 
293.2107 0.90 positive 8.64 salinity increase C18H28O3 
222.0978 11.36 positive 7.19 salinity increase C8H15NO6 
130.0862 6.83 positive 6.31 salinity increase C6H11NO2 
93.0463 1.99 negative 5.65 salinity increase C5H6N2   
231.0154 5.74 negative 4.19 salinity increase C9H4N4O4 
162.0241 6.47 negative 3.87 salinity increase C5H9NO3S 
351.1035 6.16 positive 3.43 salinity increase C16H18N2O5S 
139.0501 2.00 positive 3.40 salinity increase C6H6N2O2 
158.0832 5.75 negative 3.22 salinity increase C7H13NO3 
161.0465 5.61 negative 3.12 salinity increase C6H10O5   
595.2917 12.05 negative 2.83 salinity increase C34H44O9 
311.1144 6.02 negative 2.70 salinity increase C15H20O7 
162.0759 9.98 positive 2.52 salinity increase C6H11NO4 
225.0755 5.70 positive 2.46 salinity increase C11H12O5 
139.0501 6.84 positive 2.32 salinity increase C6H6N2O2 
162.0404 12.66 positive 2.29 salinity increase C5H7NO5 
207.0650 5.88 positive 2.26 salinity increase C11H10O4 
121.0303 5.56 negative 2.25 salinity increase C7H6O2   
124.9558 6.49 negative 2.19 salinity increase C2H6S3   
163.0752 5.90 positive 2.09 salinity increase C10H10O2 
339.0736 5.91 negative 2.08 salinity increase C15H16O9 
325.1121 12.05 positive 0.49 salinity decrease C12H20O10 
116.0341 11.13 positive 0.49 salinity decrease C4H5NO3 
168.0654 12.05 positive 0.49 salinity decrease C8H9NO3 
191.1024 11.02 positive 0.48 salinity decrease C7H14N2O4 
134.0639 11.12 positive 0.48 salinity decrease C5H11NOS 
311.1265 7.41 positive 0.48 salinity decrease C20H14N4 
199.0346 11.16 negative 0.47 salinity decrease C11H8N2S 
114.0204 11.13 negative 0.47 salinity decrease C4H5NO3 
134.0481 6.05 negative 0.47 salinity decrease C5H5N5   
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259.0131 12.03 negative 0.46 salinity decrease C6H12O9S Fructose 6-phosphate 
453.0928 12.08 negative 0.45 salinity decrease C22H18N2O9 
193.0366 7.18 negative 0.45 salinity decrease C6H10O7   
154.0156 6.20 negative 0.44 salinity decrease C6H5NO4 
124.9922 12.86 negative 0.44 salinity decrease C2H6O4S   
145.1082 5.89 positive 0.44 salinity decrease C5H12N4O 
131.0471 11.19 negative 0.42 salinity decrease C4H8N2O3 Asparagine 
135.0647 11.13 positive 0.39 salinity decrease C5H10O4   
365.1193 5.90 positive 0.38 salinity decrease C17H20N2O5S 
197.0673 7.40 positive 0.38 salinity decrease C6H12O7   
297.0585 5.99 positive 0.35 salinity decrease C10H20N2S4 
189.0891 11.01 negative 0.35 salinity decrease C7H14N2O4 
173.0919 11.02 positive 0.35 salinity decrease C7H12N2O3 
335.1355 6.52 negative 0.34 salinity decrease C18H24O4S 
409.1094 5.63 positive 0.33 salinity decrease C19H20O10 
275.1348 11.15 positive 0.33 salinity decrease C10H18N4O5 
191.0207 13.99 negative 0.32 salinity decrease C6H8O7 Citric acid 
203.1499 10.54 positive 0.29 salinity decrease C8H18N4O2 
98.0236 11.15 positive 0.29 salinity decrease C4H3NO2 
182.9920 5.75 negative 0.28 salinity decrease C7H4O6   
160.0755 11.94 positive 0.28 salinity decrease C10H9NO 
146.0599 8.62 positive 0.27 salinity decrease C9H7NO   
196.0294 13.37 negative 0.24 salinity decrease C5H11NO5S 
175.1074 8.25 positive 0.21 salinity decrease C7H14N2O3 
277.1671 5.82 positive 0.20 salinity decrease C14H20N4O2 
217.0837 10.98 negative 0.14 salinity decrease C8H14N2O5 
209.0819 13.99 negative 0.14 salinity decrease C11H14O4 
308.0905 11.42 positive 0.12 salinity decrease C10H17N3O6S GSH  
231.1004 5.12 positive 0.08 salinity decrease C14H14O3  
279.0274 10.85 negative 0.01 salinity decrease C14H13ClO2S     
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Supplemental Table 3-3. Metabolites identified with reference standard with m/z, retention time, and fragmentation 
Identity Polarity M/z 
Retenti
on time 
(min) 
Molecular 
formula 
Monoisot
opic Mass 
Adduc
t 
Theoretical 
exact mass 
(Da) 
Mass 
accurac
y (ppm) 
Fragment ions 
Adenine positive 136.0617 6.00 C5H5N5 135.0545 M+H 136.062 0 119.04, 94.04, 92.03 
Adenosine positive 268.1038 5.50 C10H13N5O4 267.0968 M+H 268.104 0 136.06 
Alanine positive 90.0548 8.59 C3H7NO2 89.0477 M+H 90.055 1 74.10, 72.08, 72.04, 60.08, 54.00 
alpha-Ketoglutaric 
acid 
negative 145.0151 7.32 C5H6O5 146.0215 M-H 145.014 6 118.04, 101.06, 77.01, 64.02 
Arginine positive 175.1186 14.01 C6H14N4O2 174.1117 M+H 175.119 1 
158.09, 141.07, 130.10, 116.07, 112.09, 97.08, 
72.08, 70.07, 60.06 
Asparagine positive 133.0606 11.13 C4H8N2O3 132.0535 M+H 133.061 1 116.03, 88.04, 87.06, 74.02, 70.03, 60.04 
Aspartic acid positive 134.0446 12.03 C4H7NO4 133.0375 M+H 134.045 1 116.03, 88.04, 74.02, 70.03 
Citric acid negative 191.0207 13.99 C6H8O7 192.0270 M-H 191.02 5 129.02, 111.01, 102.95, 87.01, 57.03 
Citrulline negative 174.0893 11.61 C6H13N3O3 175.0957 M-H 174.088 5 131.08 
Dihydroxyacetone 
phosphate 
negative 168.9915 16.50 C3H7O6P 169.9980 M-H 168.991 4 96.97, 78.96 
Fructose negative 179.0570 7.84 C6H12O6 180.0634 M-H 179.056 5 168.89, 122.89, 89.02, 69.00 
Fructose 6-phosphate negative 259.0131 12.03 C6H13O9P 260.0297 M-H 259.022 0 223, 199, 168.99, 138.98, 96.97, 78.96 
Fumaric acid negative 115.0043 5.74 C4H4O4 116.0110 M-H 115.004 5 72.02, 71.01, 69.00 
gamma-Aminobutyric 
acid 
positive 104.0704 6.65 C4H9NO2 103.0633 M+H 104.071 1 87.04, 86.06, 69.03 
Glucose negative 179.0570 9.82 C6H12O6 180.0634 M-H 179.056 5 
163.04, 119.04, 113.02, 101.02, 89.02, 85.03, 
71.01, 59.01 
Glucose 6-phosphate negative 259.0226 19.06 C6H13O9P 260.0297 M-H 259.022 0 199.00, 168.99, 138.98, 101.02, 96.97, 78.96 
Glutamic acid positive 148.0603 11.01 C5H9NO4 147.0532 M+H 148.06 0 130.05, 102.06, 84.04 
Glutamine positive 147.0762 10.56 C5H10N2O3 146.0691 M+H 147.076 1 130.09, 123.96, 102,05, 84.08, 64.93 
Glycine positive 76.0393 9.69 C2H5NO2 75.0320 M+H 76.0393 0 57.05, 58.04, 75.06 
GSH positive 308.0905 11.42 
C10H17N3O6
S 
307.0838 M+H 308.091 1 
291.06, 245.06, 233.06, 179.05, 162.02, 130.05, 
84.04, 76.02 
GSSG positive 613.1557 17.01 
C20H32N6O12
S2 
612.1520 M+H 613.159 5 
538.13, 484.12, 466.11, 409.09, 355.08, 288.07, 
324.04, 177.03, 130.05 
Guanine positive 152.0566 9.00 C5H5N5O 151.0494 M+H 152.057 0 108.52, 99.51, 97.01, 88.00, 87.00 
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Guanosine 
monophosphate 
positive 364.0647 18.38 
C10H14N5O8
P 
363.0580 M+H 364.065 2 152.06, 97.03 
Histidine negative 154.0631 14.24 C6H9N3O2 155.0695 M-H 154.062 5 137.04, 110.07, 96.96, 93.05, 81.05, 72.01 
Leucine positive 132.1018 6.47 C6H13NO2 131.0946 M+H 132.102 1 86.10, 69.07 
Lysine positive 147.1126 14.14 C6H14N2O2 146.1055 M+H 147.113 1 130.09, 123.96, 102.05, 84.08 
Malic acid negative 133.0151 7.34 C4H6O5 134.0215 M-H 133.014 6 115.00, 89.02, 72.99, 71.01 
Maltose negative 341.1103 12.66 C12H22O11 342.1162 M-H 341.109 4 221.07, 119.04, 161.05, 119.04, 101.02, 89.02 
Mannitol positive 183.0844 8.95 C6H14O6 182.0790 M+H 183.086 10 
165.05, 147.04, 136.08, 123.04, 119.05, 113.96, 
91.05 
Ornithine positive 133.0970 14.72 C5H12N2O2 132.0899 M+H 133.097 0 116.07, 115.09, 70.07 
Phenylalanine positive 166.0860 6.75 C9H11NO2 165.0790 M+H 166.086 1 149.06, 131.05, 120.08, 103.05 
Proline positive 116.0704 7.43 C5H9NO2 115.0633 M+H 116.071 1 70.07 
Proline [M+1] positive 117.0737        
Pyruvic acid negative 87.0091 4.09 C3H4O3 88.0160 M-H 87.0088 4 62.63, 59.01 
Raffinose negative 503.1611 14.65 C18H32O16 504.1690 M-H 503.162 1 
289.07, 272.09, 254.08, 228.10, 210.09, 179.05, 
160.01, 143.05, 128.04, 74.02 
Ribose 5-phosphate negative 229.0122 18.08 C5H11O8P 230.0192 M-H 229.012 1 138.98, 96.97, 78.96 
Serine positive 106.0498 11.45 C3H7NO3 105.0426 M+H 106.05 0 88.04, 70.03, 60.04 
Shikimic acid negative 173.0471 6.71 C7H10O5 174.0528 M-H 173.046 9 
137.02, 129.02, 111.05, 99.05, 93.03, 83.05, 
73.03, 71.01 
Succinic acid negative 117.0201 5.31 C4H6O4 118.0266 M-H 117.019 6 99.01, 73.03 
Sucrose negative 341.1104 12.04 C12H22O11 342.1162 M-H 341.109 4 221.07, 119.04, 101.02, 89.02, 71.01, 59.01 
Sucrose (M+Na) positive 365.1042 12.03 C12H22O11 342.1162 M+Na 365.105 7 221.07, 119.04, 101.02, 89.02, 71.01, 59.01 
Threonine positive 120.0654 9.76 C4H9NO3 119.0582 M+H 120.066 0 102.05, 84.04, 74.06, 56.05 
Tryptophan positive 205.0969 7.21 C11H12N2O2 204.0899 M+H 205.097 1 
188.07, 170.06, 159.09, 146.06, 144.08, 132.08, 
91.05, 74.02 
Tyrosine positive 182.0810 8.96 C9H11NO3 181.0739 M+H 182.081 1 
165.05, 147.04, 136.08, 123.04, 119.05, 113.96, 
91.05 
Urea positive 61.0398 2.38 CH4N2O 60.0324 M+H 61.0396 2 60.04 
Valine positive 118.0861 6.96 C5H11NO2 117.0790 M+H 118.086 1 72.08 
Xylose negative 149.0465 6.40 C5H10O5 150.0528 M-H 149.046 6 89.02, 71.01, 59.01 
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Supplemental Table 3-4. Average fold change of all metabolic features in all treatments compared to control 
M/z 
Retention 
time 
Polarity Cold Heat Drought Salinity 
High 
light 
Cold x 
drought 
Heat x 
drought 
High light 
x drought 
Cold x 
salinity 
Heat x 
salinity 
High light 
x heat 
High light 
x cold 
High light 
x salinity 
59.0137 7.81 negative 1.29 1.34 0.97 0.84 1.31 1.33 1.03 0.89 1.28 1.58 1.29 1.54 1.16 
59.0137 9.82 negative 1.14 1.44 0.66 1.04 1.24 0.96 0.62 0.31 1.17 1.54 1.14 1.34 1.05 
60.0559 6.01 positive 0.84 0.94 0.73 0.78 0.79 0.89 1.08 0.67 0.90 1.07 0.94 0.78 0.20 
60.0809 1.00 positive 0.91 0.86 0.80 0.86 0.86 1.03 1.10 0.76 0.95 0.91 0.58 0.94 0.68 
61.0398 2.38 positive 5.70 0.95 1.25 1.42 1.20 0.97 1.31 0.92 1.81 1.27 0.79 1.00 2.68 
61.9882 10.57 negative 1.01 0.81 0.84 1.07 0.92 0.98 0.85 1.07 0.98 0.72 0.66 1.00 0.68 
62.0602 6.00 positive 0.91 0.81 0.85 0.95 0.85 1.05 0.93 0.73 0.92 0.86 0.61 0.92 0.08 
63.9925 10.56 negative 1.01 0.94 0.95 0.98 0.87 1.00 0.98 0.94 0.97 1.00 0.79 0.91 0.56 
64.0159 1.09 positive 0.93 0.89 1.00 0.94 0.98 1.00 1.05 0.99 1.00 0.93 0.85 0.92 0.93 
64.0159 5.57 positive 1.21 0.77 0.95 0.69 0.86 0.73 0.81 0.89 1.15 0.78 0.54 0.72 1.08 
65.0145 1.75 negative 0.72 0.95 0.91 0.90 1.04 0.82 0.84 0.61 1.19 0.86 0.81 0.98 0.87 
65.0605 14.01 positive 0.72 0.94 0.79 0.52 0.65 0.68 0.76 0.83 0.89 1.59 0.63 0.59 0.21 
66.0339 1.93 positive 0.76 0.86 0.84 1.06 0.94 0.77 0.79 0.64 0.88 0.91 0.79 0.97 0.97 
66.0683 12.22 positive 0.66 0.79 0.70 0.65 0.69 0.69 0.78 0.68 0.83 1.11 0.36 0.58 0.46 
67.0292 1.93 positive 0.82 0.87 0.83 1.04 0.96 0.83 0.86 0.72 0.86 0.92 0.82 0.99 1.03 
67.0542 14.14 positive 0.90 3.66 1.60 1.04 1.04 1.04 2.04 1.77 0.97 4.00 3.55 0.88 0.76 
68.0495 6.64 positive 0.85 1.21 2.19 1.38 1.35 1.75 3.58 1.89 0.90 1.10 3.13 1.17 0.27 
68.9958 9.12 negative 1.08 1.07 1.21 1.28 1.32 1.01 0.94 1.17 1.06 0.91 1.37 1.26 1.18 
68.9958 7.55 negative 1.40 1.24 0.50 1.43 1.41 1.55 1.22 1.46 1.53 0.65 0.08 1.44 1.40 
69.0335 6.65 positive 0.86 1.25 2.18 1.38 1.33 1.80 3.72 1.91 0.86 1.11 3.29 1.12 0.43 
69.9992 9.12 negative 1.09 1.06 1.21 1.29 1.34 1.02 0.97 1.16 1.07 0.90 1.37 1.25 1.18 
70.0288 11.14 positive 0.88 1.28 0.80 0.40 0.69 0.89 1.13 0.90 0.76 1.53 0.43 0.75 0.52 
70.0651 7.43 positive 0.95 2.51 1.85 1.04 1.26 1.01 2.32 1.92 0.75 2.66 1.50 1.07 0.90 
70.0652 14.01 positive 0.75 0.93 0.80 0.56 0.66 0.70 0.79 0.83 0.88 1.51 0.66 0.61 0.24 
71.0139 5.78 negative 1.25 2.61 0.88 1.59 3.97 1.36 1.44 1.32 1.04 2.39 1.94 2.89 1.70 
71.0139 9.83 negative 1.12 1.38 0.67 1.02 1.27 0.97 0.63 0.33 1.11 1.52 1.11 1.28 0.99 
71.0139 7.84 negative 1.25 1.42 0.97 0.89 1.46 1.28 1.08 0.94 1.24 1.59 1.29 1.57 1.22 
71.0291 4.94 positive 1.10 1.08 1.26 1.38 1.27 1.03 1.22 1.22 1.17 1.19 1.20 1.21 1.30 
71.0491 9.58 positive 0.97 1.08 0.92 0.93 1.10 0.97 1.04 0.86 1.08 1.30 0.74 1.04 0.67 
71.0685 7.43 positive 0.99 2.73 2.03 1.06 1.26 1.06 2.46 2.01 0.76 2.91 1.44 1.08 0.91 
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72.0808 6.93 positive 1.63 5.61 2.27 1.05 2.22 1.88 2.52 2.59 1.19 5.33 4.14 1.82 0.98 
72.0808 12.22 positive 0.72 0.82 0.74 0.70 0.74 0.75 0.84 0.56 0.85 1.12 0.48 0.65 0.56 
72.9932 7.32 negative 1.11 1.63 1.09 1.30 1.71 0.90 1.69 0.80 1.08 1.56 0.94 1.61 0.91 
73.0296 5.34 negative 0.69 1.29 1.37 1.82 1.58 1.39 1.61 1.29 0.72 1.09 3.70 1.85 0.72 
73.0841 6.87 positive 1.59 5.62 2.25 1.01 2.26 1.84 2.47 2.59 1.15 5.34 4.05 1.81 0.94 
73.5317 4.93 positive 1.14 1.00 1.59 1.78 1.65 1.01 1.16 1.41 1.31 1.16 1.50 1.55 1.62 
74.0236 11.20 positive 0.92 1.31 0.82 0.67 0.70 0.91 1.13 0.89 0.76 1.55 0.52 0.74 0.50 
75.0089 3.66 negative 1.63 0.96 0.97 0.63 1.45 1.16 4.66 1.49 0.85 0.88 3.72 1.17 1.74 
76.0393 9.69 positive 1.33 1.63 0.69 0.92 3.01 0.88 1.37 1.24 1.31 2.26 1.05 2.39 1.57 
76.0757 5.16 positive 0.79 2.51 0.31 0.80 1.37 0.93 2.23 0.65 1.00 2.78 2.48 0.81 0.23 
78.9593 14.99 negative 0.84 0.93 0.70 0.67 0.75 0.91 0.99 0.77 0.78 1.00 0.87 0.90 0.42 
79.9569 7.41 negative 0.75 0.80 0.62 0.41 0.57 0.76 0.56 0.79 0.76 1.08 0.75 0.67 0.48 
79.9572 10.58 negative 0.98 1.11 1.05 0.91 1.29 1.02 1.03 1.16 0.95 0.93 1.64 1.20 1.53 
81.0447 1.94 positive 0.73 0.86 0.83 1.14 0.91 0.92 0.73 0.62 0.91 0.89 0.69 1.03 0.87 
82.0525 1.93 positive 0.68 0.88 0.80 0.85 0.89 0.70 0.74 0.62 0.88 0.84 0.72 0.91 0.95 
82.5370 4.94 positive 1.08 1.00 1.40 1.59 1.41 1.00 1.16 1.30 1.19 1.14 1.44 1.33 1.43 
83.0141 7.27 negative 0.99 0.93 1.04 1.01 0.85 1.09 0.33 0.76 0.93 0.94 0.03 0.88 0.72 
83.5358 4.94 positive 1.08 1.00 1.42 1.57 1.43 0.99 1.18 1.33 1.20 1.14 1.42 1.35 1.45 
84.0443 10.68 positive 0.94 1.11 0.86 0.84 1.02 0.96 1.40 1.06 0.94 1.27 0.49 1.71 1.35 
84.0807 0.95 positive 0.73 0.77 0.66 1.00 1.00 0.91 1.11 0.78 0.81 1.04 0.87 1.09 0.66 
84.0807 14.14 positive 0.87 3.13 1.40 0.93 0.95 0.98 1.74 1.55 0.90 3.41 3.14 0.83 0.71 
85.0283 7.81 positive 1.26 1.43 0.96 0.83 1.51 1.32 0.88 0.66 1.33 1.81 1.28 1.76 1.00 
85.0283 12.05 positive 1.48 2.10 1.44 0.63 1.89 1.38 1.57 2.09 1.65 2.64 2.51 1.49 2.18 
85.0298 7.26 negative 1.00 0.95 1.04 1.04 0.88 1.10 0.48 0.87 0.96 0.90 0.34 0.94 0.99 
85.0477 10.55 positive 0.93 1.35 0.87 0.84 1.26 0.96 1.35 1.05 0.93 1.28 0.50 1.68 0.44 
85.0760 1.02 positive 0.78 0.84 0.76 0.84 0.95 1.03 1.04 0.80 0.87 0.97 0.34 0.87 0.57 
86.0600 6.60 positive 0.85 4.82 2.26 1.39 1.36 1.81 3.84 1.96 0.86 4.93 4.76 1.13 0.54 
86.0712 12.22 positive 0.68 0.81 0.71 0.68 0.70 0.71 0.83 0.67 0.82 1.11 0.38 0.60 0.49 
87.0091 4.09 negative 1.49 1.56 0.52 1.03 1.23 0.63 0.78 0.50 1.48 2.25 3.14 1.47 1.04 
87.0440 6.65 positive 0.86 1.28 2.27 1.39 1.36 1.81 3.86 1.97 0.86 1.14 3.42 1.13 0.42 
87.0552 11.13 positive 0.89 1.29 0.82 0.52 0.70 0.91 1.11 0.91 0.76 1.55 0.49 0.75 0.49 
88.0125 4.08 negative 1.68 1.80 0.31 0.98 1.33 0.46 0.67 1.16 2.15 2.77 4.02 1.73 1.12 
88.0392 11.48 positive 1.19 1.21 0.79 0.65 0.73 0.93 1.11 0.97 1.04 1.44 0.50 0.86 1.00 
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88.0473 6.65 positive 0.83 1.29 2.28 1.36 1.34 1.82 3.90 1.99 0.86 1.03 3.46 1.12 0.27 
88.0756 5.12 positive 1.05 0.53 0.91 0.58 0.63 1.07 0.69 0.83 0.80 0.46 0.38 0.84 0.30 
88.1120 0.97 positive 0.89 0.93 0.88 1.03 0.90 1.07 1.16 0.84 0.96 1.04 0.59 0.97 0.76 
89.0248 2.53 negative 5.98 0.69 1.45 0.98 1.01 0.63 1.21 1.39 2.30 0.68 1.12 0.64 2.80 
89.0248 9.82 negative 0.52 1.36 0.57 1.01 1.25 0.95 0.51 0.34 0.51 1.46 1.09 1.31 1.05 
89.0248 7.84 negative 1.23 1.31 0.94 0.81 1.26 1.26 0.97 0.70 1.25 1.51 1.23 1.46 1.12 
89.0483 6.64 positive 0.90 1.19 2.77 1.56 1.65 2.19 4.87 2.40 1.02 0.91 3.94 1.28 0.36 
89.0789 5.12 positive 1.04 0.52 0.90 0.57 0.60 1.06 0.69 0.83 0.79 0.44 0.05 0.84 0.29 
90.0282 2.53 negative 6.02 0.68 1.44 0.96 1.00 0.62 1.20 1.41 2.32 0.67 1.10 0.63 2.84 
90.0548 8.59 positive 2.22 5.69 1.26 1.15 2.15 2.29 4.47 2.66 2.10 6.15 5.31 1.82 1.25 
90.0913 5.60 positive 0.89 0.90 0.86 0.51 0.77 0.89 0.94 0.89 0.60 0.85 0.37 1.08 0.21 
90.9766 1.09 positive 0.92 1.05 1.19 1.14 1.17 1.10 1.23 1.16 1.05 0.92 1.15 0.96 1.37 
90.9766 5.51 positive 1.20 0.76 0.88 0.40 0.90 0.84 0.33 1.09 1.03 0.77 0.75 0.76 1.89 
91.0582 8.59 positive 2.24 5.87 1.30 1.15 2.19 2.34 4.57 2.72 2.12 6.35 5.47 1.83 1.26 
91.5423 4.93 positive 1.04 0.96 1.37 1.44 1.30 0.96 1.16 1.26 1.16 1.11 1.25 1.20 1.38 
93.0463 1.99 negative 109.55 0.32 3.11 5.65 1.29 0.43 0.30 0.20 6.82 1.61 0.11 1.21 12.53 
94.0450 4.94 positive 1.13 0.98 1.68 1.95 1.73 0.98 1.17 1.48 1.34 1.16 1.68 1.53 1.71 
94.9814 12.44 negative 0.99 0.95 0.97 1.03 0.98 0.95 0.99 1.08 0.96 0.87 1.42 0.96 0.66 
95.0257 11.14 negative 0.85 1.36 0.63 0.13 0.71 0.83 1.10 0.76 0.66 1.70 0.25 0.76 0.32 
95.0438 4.94 positive 1.11 1.00 1.73 1.97 1.73 0.99 1.21 1.49 1.35 1.18 1.72 1.60 1.74 
95.0599 14.01 positive 0.73 0.92 0.76 0.56 0.68 0.67 0.77 0.81 0.85 1.47 0.65 0.61 0.20 
95.0603 1.94 positive 0.64 0.83 0.96 0.80 0.90 0.66 0.68 0.57 0.90 0.84 0.61 1.03 0.81 
95.9525 10.75 negative 1.00 0.94 1.09 1.08 1.06 0.98 0.97 1.10 1.09 0.86 1.25 1.04 1.03 
96.0807 6.93 positive 1.28 6.17 2.51 0.71 2.47 1.92 2.51 2.74 1.42 5.59 4.32 1.58 0.04 
96.9696 14.99 negative 0.83 0.93 0.70 0.67 0.76 0.90 0.99 0.78 0.78 1.01 0.88 0.89 0.42 
97.0284 12.06 positive 1.55 2.17 1.44 0.65 1.96 1.41 1.61 2.12 1.64 2.71 2.63 1.53 5.66 
98.0236 11.15 positive 0.93 1.42 0.70 0.29 0.65 0.91 1.18 0.95 0.73 1.80 0.51 0.79 1.81 
98.0474 1.91 positive 0.71 0.85 0.93 0.72 0.91 0.69 0.70 0.58 0.89 0.90 0.68 1.00 0.87 
98.0600 6.93 positive 1.06 0.34 0.78 1.13 0.95 1.15 1.15 1.09 1.39 0.36 0.17 1.29 0.82 
98.9840 14.99 positive 0.84 0.92 0.71 0.66 0.77 0.91 0.96 0.78 0.79 0.99 0.86 0.90 0.44 
99.0093 7.27 negative 0.98 0.92 1.00 0.93 0.80 1.05 0.40 0.82 0.90 0.88 0.07 0.87 0.72 
99.0916 0.95 positive 0.77 0.76 0.68 0.50 0.63 0.98 1.28 0.73 0.70 0.91 0.15 0.66 0.36 
100.0410 6.61 negative 0.83 1.08 1.08 1.02 1.09 1.17 1.09 0.87 0.83 0.73 0.50 1.04 0.05 
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100.1120 4.59 positive 0.94 0.98 1.02 1.01 1.03 0.93 0.94 1.01 0.98 0.93 1.03 1.03 0.92 
100.9342 1.17 negative 0.84 0.91 1.01 0.96 0.98 0.92 1.06 1.00 1.00 0.94 1.00 0.90 1.00 
101.0249 7.31 negative 0.82 0.76 0.85 1.16 0.97 0.63 0.52 0.61 1.43 0.76 0.48 0.91 0.81 
101.0249 9.86 negative 1.13 1.36 0.35 1.04 1.27 0.96 0.65 0.16 1.15 1.49 1.16 1.30 1.10 
101.0709 10.54 positive 0.95 1.42 0.87 0.83 1.26 0.97 1.37 0.92 0.94 1.04 0.49 1.32 1.16 
102.0549 10.49 positive 7.64 17.63 0.86 0.79 13.80 0.95 19.65 6.99 0.91 6.30 0.43 10.97 9.74 
102.0549 12.57 positive 0.99 1.75 1.23 0.66 0.64 0.98 1.09 1.16 1.09 2.07 0.90 0.77 0.88 
102.9574 13.59 negative 0.99 0.95 0.89 0.69 0.84 0.96 0.89 0.92 0.96 1.08 0.63 0.89 1.18 
103.0043 6.69 negative 1.15 1.45 1.34 1.36 1.42 1.31 1.60 1.33 1.02 1.24 1.21 1.20 0.10 
103.0407 2.08 negative 1.71 0.94 1.41 0.79 1.23 1.13 4.34 1.52 1.00 0.91 1.25 1.04 1.14 
103.0542 6.64 positive 2.55 5.92 2.07 1.60 2.22 2.95 2.78 2.39 2.11 5.79 7.16 3.01 1.72 
103.0576 1.05 positive 0.80 0.47 0.67 0.65 0.58 0.84 0.65 0.43 0.64 0.47 0.09 0.81 0.30 
104.0359 11.45 negative 0.78 1.03 0.90 0.88 0.81 1.06 1.04 1.06 0.77 1.19 0.68 0.69 1.31 
104.0704 6.65 positive 0.85 1.30 2.29 1.38 1.36 1.80 3.86 2.00 0.87 1.14 3.42 1.14 0.41 
104.1068 0.99 positive 0.98 0.81 0.76 0.85 0.74 1.05 1.25 0.69 0.94 1.01 0.49 0.81 0.56 
105.0199 5.82 negative 1.30 0.62 0.68 1.71 1.78 1.17 1.72 0.71 1.13 0.48 0.67 2.08 0.40 
105.0393 11.44 negative 0.62 1.10 0.92 0.84 0.77 1.26 1.03 1.19 0.66 1.34 0.57 0.57 1.44 
105.0738 6.65 positive 0.85 1.30 2.28 1.38 1.36 1.81 3.89 2.00 0.86 1.12 3.41 1.13 0.40 
105.1102 0.99 positive 0.97 0.81 0.76 0.84 0.73 1.05 1.24 0.68 0.94 1.00 0.48 0.81 0.55 
105.9611 7.62 negative 1.02 1.05 0.97 1.02 0.99 1.05 0.93 0.97 0.96 0.97 1.07 1.03 0.75 
106.0233 5.81 negative 1.29 0.60 0.70 1.81 1.88 1.16 1.60 1.25 1.51 0.41 0.95 2.19 1.98 
106.0498 11.45 positive 0.74 1.03 0.88 0.86 0.78 1.03 1.04 1.09 0.73 1.24 0.63 0.67 1.29 
107.0531 11.45 positive 0.73 1.04 0.88 0.86 0.77 1.04 1.05 1.09 0.72 1.26 0.62 0.66 1.28 
107.0603 1.93 positive 0.75 0.87 0.85 0.95 0.94 0.77 0.78 0.66 0.90 0.90 0.74 0.95 0.93 
108.0210 5.38 negative 1.19 0.99 1.04 1.20 1.14 1.02 0.87 1.27 1.26 0.75 1.18 1.09 1.32 
108.0681 1.94 positive 0.87 0.98 0.97 0.90 0.89 0.78 0.73 0.56 0.90 1.11 0.76 1.17 0.86 
109.0283 12.09 positive 1.58 2.23 1.45 0.76 1.99 1.49 1.71 2.05 1.52 2.83 2.99 1.67 5.54 
109.0413 10.49 negative 0.99 1.37 0.85 0.79 0.86 0.81 0.93 0.97 0.84 1.18 0.48 1.08 1.37 
110.0086 4.94 positive 1.08 0.96 1.11 1.26 1.03 0.98 1.21 1.16 1.06 1.20 0.75 1.12 1.01 
110.0255 6.56 negative 0.92 1.02 0.77 0.68 0.77 1.08 0.93 1.08 0.92 1.09 4.46 0.82 0.80 
110.0712 14.25 positive 1.20 2.01 1.09 0.73 1.29 1.04 1.24 1.23 0.96 2.37 0.87 1.14 0.84 
110.9763 10.75 negative 0.97 0.94 1.07 1.08 1.00 0.99 0.91 1.04 1.03 0.88 1.23 0.98 1.03 
111.0094 7.27 negative 0.98 0.92 0.99 0.97 0.85 1.04 0.43 0.84 0.88 0.90 0.11 0.90 0.65 
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111.0101 5.76 negative 0.93 2.99 2.14 3.35 3.95 2.24 1.34 1.96 1.07 1.72 6.97 3.83 0.92 
111.0206 1.94 negative 1.16 1.41 4.93 1.22 1.27 1.06 12.12 7.43 0.98 1.66 6.46 0.96 2.48 
111.9798 10.75 negative 0.95 0.93 1.07 1.01 1.00 0.96 0.86 1.05 1.05 0.87 1.16 1.00 0.98 
112.0070 4.96 positive 0.97 0.95 1.13 1.15 1.06 0.93 1.12 1.32 1.08 1.09 1.15 1.07 0.99 
112.0505 9.17 positive 0.84 0.81 0.72 1.33 1.34 0.80 0.87 0.34 1.06 0.85 14.34 1.16 1.17 
112.0868 14.01 positive 0.73 0.93 0.80 0.53 0.66 0.68 0.77 0.83 0.88 1.54 0.64 0.60 0.22 
112.9722 10.75 negative 0.97 0.94 1.07 1.05 1.00 0.98 0.89 1.03 1.03 0.87 1.20 0.97 1.00 
112.9862 9.14 negative 1.08 1.06 1.19 1.25 1.29 1.01 0.94 1.15 1.07 0.90 1.32 1.24 1.15 
112.9862 7.82 negative 1.05 1.01 0.92 1.44 1.42 1.56 0.57 1.48 0.48 0.01 0.48 1.45 0.01 
113.0339 5.95 positive 2.17 1.52 0.98 0.75 1.29 1.24 1.05 1.08 1.41 0.99 0.35 1.19 0.48 
113.0708 11.61 positive 1.07 0.37 0.61 0.68 0.57 0.80 0.66 0.82 0.98 0.61 0.29 1.09 0.45 
113.0906 14.01 positive 0.73 0.93 0.79 0.57 0.65 0.65 0.76 0.80 0.94 1.53 0.61 0.62 0.21 
113.9896 9.12 negative 1.08 1.06 1.20 1.26 1.29 1.01 0.95 1.16 1.07 0.91 1.32 1.26 1.15 
113.9896 7.62 negative 1.08 1.20 0.51 1.46 1.07 1.56 0.69 1.48 1.33 0.58 0.09 1.46 1.03 
114.0204 11.13 negative 0.90 1.28 0.78 0.47 0.75 0.89 1.10 0.86 0.79 1.49 0.57 0.81 0.56 
114.0550 11.60 positive 1.08 0.42 0.72 0.69 0.61 0.88 0.86 1.14 0.94 0.67 0.37 1.05 0.53 
114.1025 12.22 positive 0.71 0.83 0.72 0.68 0.72 0.73 0.84 0.70 0.85 1.13 0.44 0.62 0.57 
114.9369 1.11 negative 0.29 0.51 0.61 0.38 0.86 0.57 0.59 0.78 0.87 0.63 0.39 0.92 0.53 
114.9904 9.12 negative 1.07 1.04 1.17 1.23 1.28 1.02 0.92 1.14 1.06 0.89 1.33 1.24 1.12 
115.0043 5.74 negative 1.37 3.35 0.74 1.69 6.02 1.26 1.62 1.41 1.04 2.99 2.94 3.84 2.11 
115.0044 7.34 negative 1.18 1.41 0.87 1.16 1.57 0.91 1.18 0.89 1.05 1.56 0.86 1.48 0.81 
115.0865 14.72 positive 0.81 0.46 0.55 0.55 0.61 0.68 0.57 0.68 1.06 1.13 0.19 0.48 0.30 
115.0865 6.90 positive 0.95 0.24 0.85 0.99 0.92 1.03 1.21 0.98 1.52 0.22 0.12 1.30 1.36 
115.0865 0.95 positive 0.68 0.70 0.94 0.73 0.54 1.58 1.63 0.79 0.89 0.99 0.35 0.58 0.45 
115.1058 12.22 positive 0.70 0.81 0.72 0.68 0.71 0.72 0.84 0.70 0.84 1.14 0.43 0.62 0.55 
116.0341 11.13 positive 0.89 1.29 0.82 0.49 0.70 0.89 1.11 0.92 0.76 1.53 0.47 0.73 0.47 
116.0361 7.06 negative 1.01 1.04 0.87 0.76 1.47 1.03 0.90 1.17 0.98 1.33 0.59 1.09 0.21 
116.0512 5.07 negative 1.24 1.05 0.70 1.07 1.10 0.87 0.19 0.69 1.21 1.14 3.03 1.23 1.19 
116.0704 7.43 positive 0.93 2.48 1.80 0.98 1.23 0.98 2.23 1.90 0.74 2.64 1.42 1.06 0.38 
116.0818 5.78 positive 1.06 0.98 0.72 0.84 0.90 1.00 1.03 0.84 0.88 0.62 0.02 0.86 0.00 
117.0201 5.31 negative 0.98 2.00 1.51 1.26 1.45 0.92 2.58 1.58 0.69 1.71 5.35 1.10 0.98 
117.0294 9.80 positive 0.77 0.94 0.82 0.80 0.87 0.85 0.69 0.62 0.95 0.98 0.16 0.75 0.54 
117.0375 11.13 positive 0.88 1.32 0.73 0.25 0.65 0.84 1.18 0.87 0.73 1.60 0.38 0.73 0.78 
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117.0737 7.43 positive 0.94 2.49 1.79 0.98 1.23 0.98 2.25 1.89 0.74 2.68 1.42 1.06 0.84 
118.0055 7.26 negative 1.23 1.17 1.62 1.65 1.50 1.11 1.43 1.48 1.15 1.21 1.76 1.36 0.86 
118.0234 5.31 negative 0.98 2.78 1.59 1.34 1.56 0.95 3.00 1.89 0.68 1.80 5.81 1.11 0.98 
118.0517 9.77 negative 1.06 1.83 1.16 1.05 1.81 0.95 1.37 1.24 0.93 2.09 1.93 1.16 1.47 
118.0861 6.96 positive 1.48 4.72 2.01 1.02 1.99 1.67 2.19 2.30 1.17 4.45 3.47 1.69 1.01 
119.0161 8.03 positive 0.54 3.87 1.88 1.32 6.90 0.70 1.08 0.94 0.56 3.81 11.18 1.54 3.47 
119.0347 12.03 negative 1.16 2.46 1.35 0.54 2.31 1.11 1.52 2.21 1.26 2.91 2.96 1.69 4.67 
119.0357 9.81 negative 1.13 1.39 0.67 1.01 1.27 0.98 0.65 0.37 1.12 1.53 1.15 1.32 1.03 
119.0522 5.82 positive 0.76 0.95 0.66 0.33 0.64 0.98 0.93 0.79 0.72 1.21 1.56 0.72 0.00 
119.0894 6.92 positive 1.51 4.88 2.06 1.01 2.04 1.70 2.25 2.37 1.18 4.66 3.53 1.71 1.02 
120.0556 1.96 positive 0.62 0.84 0.83 0.79 0.93 0.66 0.67 0.54 0.92 0.84 0.57 0.91 0.80 
120.0654 9.76 positive 1.00 1.77 1.02 0.94 1.83 0.89 1.28 1.14 0.93 2.18 1.54 1.21 1.37 
120.0807 6.75 positive 2.56 5.99 2.13 1.20 2.21 2.98 2.78 2.42 2.09 5.90 7.34 3.01 1.23 
120.9973 7.88 negative 1.04 1.12 0.94 0.62 0.73 1.17 1.20 0.70 1.10 1.35 0.15 0.64 0.48 
121.0303 5.56 negative 0.94 1.26 2.24 2.25 1.63 1.39 1.44 0.97 1.04 1.22 1.49 1.71 0.84 
121.0396 1.99 positive 85.78 0.22 2.74 4.14 0.96 0.24 0.12 0.28 5.87 0.85 0.19 0.91 21.47 
121.0687 9.76 positive 1.00 1.79 1.03 0.94 1.86 0.86 1.32 1.16 0.93 2.28 1.57 1.21 1.41 
121.0743 6.65 positive 2.64 6.12 2.13 1.20 2.25 3.04 2.80 2.48 2.11 6.09 7.56 3.06 2.88 
122.0257 6.21 negative 0.90 1.50 1.43 1.94 1.45 1.35 1.28 1.10 0.96 1.38 1.43 1.42 0.14 
122.0712 1.94 positive 0.60 0.84 0.98 0.79 0.89 0.65 0.65 0.55 0.92 0.84 0.60 0.97 0.79 
122.0811 9.07 positive 4.48 0.65 0.89 1.76 0.83 0.45 0.38 0.36 2.70 1.20 0.24 2.25 1.95 
123.0403 5.13 positive 1.10 0.99 1.43 1.50 1.35 1.01 1.16 1.34 1.25 1.15 1.45 1.29 1.39 
123.0440 8.94 positive 1.44 8.97 2.02 1.16 1.57 1.35 3.20 2.87 1.13 8.91 11.30 1.13 8.69 
123.0461 6.39 negative 1.17 10.31 0.95 0.95 2.09 1.20 2.21 1.59 0.80 7.32 0.81 1.15 0.79 
124.0392 9.96 positive 0.92 0.92 0.77 0.94 0.77 0.95 0.96 0.67 1.01 1.11 0.21 0.74 0.39 
124.0392 8.53 positive 0.92 1.12 1.22 1.31 1.20 1.59 2.03 0.75 1.14 1.26 6.38 1.19 1.06 
124.0869 1.11 positive 0.66 0.76 0.70 0.90 0.99 0.87 1.01 0.75 0.80 0.90 0.86 1.09 0.75 
124.9558 8.18 negative 1.10 1.14 1.04 1.18 1.14 1.10 1.04 1.05 1.06 1.00 1.18 1.15 0.97 
124.9558 6.49 negative 1.01 1.08 1.37 2.19 2.21 0.78 0.08 1.64 1.09 0.16 1.09 2.19 1.65 
124.9922 12.86 negative 0.88 0.85 0.66 0.44 0.67 0.82 0.61 0.77 0.76 1.00 0.54 0.71 0.24 
125.0363 10.83 negative 1.56 17.09 1.00 0.00 9.17 0.00 5.15 0.25 4.29 17.13 0.00 8.94 26.51 
125.0378 4.93 positive 1.07 0.98 1.41 1.52 1.29 1.02 1.14 1.35 1.23 1.17 1.11 1.25 1.32 
126.0548 5.66 positive 0.69 0.67 0.75 1.06 1.06 0.78 0.75 0.72 0.86 0.87 1.27 0.95 0.89 
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126.9058 8.22 negative 1.24 1.25 0.56 0.54 0.90 1.41 0.99 0.87 0.56 0.61 0.22 1.00 0.53 
127.0389 12.07 positive 1.40 2.12 1.43 0.69 1.96 1.33 1.60 2.03 1.47 2.67 2.75 1.57 5.30 
127.0521 10.50 negative 0.96 1.50 0.87 0.70 1.25 0.91 1.25 0.93 0.79 1.24 0.48 1.31 1.27 
127.0977 5.15 positive 0.93 0.87 0.91 0.68 0.72 1.02 1.36 1.43 0.88 0.94 0.40 0.69 0.35 
128.0191 4.94 positive 1.05 1.02 1.24 1.40 1.22 1.01 1.21 1.22 1.14 1.18 1.17 1.18 1.23 
128.0361 4.44 negative 2.64 2.20 0.94 0.94 0.97 1.11 3.37 1.58 0.94 2.39 2.89 0.81 1.46 
128.0361 11.02 negative 1.23 1.43 0.85 0.75 1.21 1.27 1.32 1.04 0.84 1.48 0.39 1.13 1.25 
128.0422 12.08 positive 1.58 2.56 1.64 0.90 2.37 1.54 1.83 2.47 1.53 3.12 3.44 1.75 6.59 
128.0705 6.63 positive 0.95 1.21 2.05 1.27 1.34 1.66 3.17 1.86 0.77 1.09 2.45 1.17 0.03 
129.0202 7.25 negative 0.99 0.95 0.98 0.98 0.86 1.07 0.45 0.83 0.92 0.90 0.21 0.90 0.71 
129.0395 4.42 negative 2.86 2.34 1.00 0.97 1.01 1.13 3.57 1.66 0.97 2.56 3.06 0.85 1.52 
129.0396 11.02 negative 1.31 1.54 0.77 0.62 1.27 1.28 17.59 1.01 0.72 1.64 13.86 1.14 1.29 
129.0656 10.55 positive 0.94 1.13 0.80 0.77 0.95 0.86 0.71 0.77 0.84 1.05 0.35 0.77 1.00 
129.0657 6.88 positive 1.07 1.29 1.04 0.86 1.03 1.06 1.61 1.20 0.89 1.26 2.09 0.95 0.54 
130.0497 10.55 positive 0.93 1.46 0.86 0.82 1.32 0.96 1.47 0.97 0.93 1.15 0.48 1.37 1.21 
130.0518 6.37 negative 0.86 1.12 1.06 1.07 1.10 1.10 1.11 0.84 0.94 1.23 2.25 0.94 16.90 
130.0650 11.96 positive 0.86 7.93 31.44 1.25 0.84 26.98 60.49 32.11 1.38 2.51 10.53 0.83 1.16 
130.0650 5.13 positive 1.31 0.98 1.45 0.64 1.01 1.20 2.48 1.63 1.36 1.06 2.26 1.32 0.59 
130.0862 6.83 positive 1.01 1.22 1.07 6.31 1.09 1.12 1.50 0.89 5.32 6.52 0.37 2.60 1.93 
130.0890 14.10 positive 0.83 2.69 1.22 0.78 0.84 0.87 1.97 1.35 0.85 3.12 2.63 0.70 0.71 
131.0357 4.65 negative 1.11 1.05 1.00 1.10 0.90 1.07 1.34 0.96 1.37 1.77 0.61 0.84 1.06 
131.0471 11.19 negative 0.70 1.31 0.47 0.42 0.53 0.61 1.09 0.61 0.55 1.51 0.45 0.82 0.57 
131.0530 10.54 positive 0.93 1.46 0.86 0.82 1.31 0.95 1.46 0.96 0.93 1.15 0.48 1.35 1.21 
131.0722 1.23 negative 2.87 1.30 1.19 1.02 1.20 1.09 2.02 1.52 1.28 1.48 2.26 0.89 1.55 
131.0834 14.01 negative 0.79 0.96 0.80 0.60 0.71 0.75 0.80 0.83 0.91 1.41 0.71 0.65 0.64 
131.0895 6.85 positive 0.90 0.93 1.06 9.09 0.86 1.04 1.72 0.61 7.66 9.17 0.18 3.32 1.67 
131.1290 12.21 positive 0.91 0.97 0.83 0.72 0.86 0.88 0.92 0.84 1.07 1.27 0.70 0.74 1.10 
132.0311 12.05 negative 1.24 0.56 0.72 0.76 0.48 0.85 0.67 0.71 1.10 0.64 0.21 0.90 0.39 
132.0423 9.82 negative 0.74 0.79 0.94 0.78 0.59 0.85 0.78 0.72 0.85 0.83 0.10 0.55 0.39 
132.0504 11.13 negative 0.95 1.40 0.79 0.37 0.76 0.93 1.12 0.90 0.79 1.57 0.51 0.85 0.54 
132.0653 10.44 positive 0.90 1.10 0.85 0.80 0.90 0.96 0.24 0.68 0.91 1.11 0.45 0.43 0.55 
132.1018 6.47 positive 1.27 11.42 2.70 1.20 2.40 1.63 4.30 3.47 1.01 11.45 11.37 1.46 1.19 
133.0151 7.34 negative 1.16 1.39 0.85 1.13 1.52 0.90 1.16 0.84 1.04 1.54 0.87 1.46 0.83 
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133.0317 7.24 positive 0.92 0.92 0.65 0.98 1.29 1.13 0.66 0.66 0.89 1.09 0.45 1.13 0.25 
133.0515 3.54 negative 0.95 0.80 0.73 0.77 0.86 0.95 1.06 0.78 0.85 1.01 0.40 0.90 0.50 
133.0606 11.13 positive 0.88 1.28 0.82 0.51 0.69 0.89 1.10 0.91 0.76 1.53 0.47 0.74 0.48 
133.0970 14.72 positive 0.82 0.45 0.53 0.54 0.61 0.66 0.57 0.70 1.04 1.14 0.18 0.48 0.30 
133.1050 6.47 positive 1.25 11.44 2.66 1.19 2.36 1.58 4.26 3.48 1.00 11.54 11.47 1.44 1.19 
134.0446 12.03 positive 1.26 0.59 0.75 0.74 0.50 0.86 0.67 0.75 1.13 0.63 0.23 0.94 0.41 
134.0481 6.05 negative 1.29 0.38 0.48 0.47 0.37 0.67 1.21 0.34 1.30 0.65 2.27 0.39 0.62 
134.0639 11.12 positive 0.87 1.26 0.80 0.48 0.67 0.88 1.07 0.90 0.75 1.51 0.47 0.72 0.54 
134.0810 9.60 positive 0.97 1.10 0.92 0.93 1.17 0.96 1.13 0.79 1.13 1.40 0.69 1.02 0.52 
134.1053 6.46 positive 0.94 6.25 1.58 0.88 1.29 0.94 2.24 2.02 0.94 6.29 6.20 1.06 0.74 
134.1175 5.04 positive 2.18 0.95 1.12 1.75 2.55 1.55 2.76 3.35 2.94 2.05 0.00 1.01 2.40 
135.0280 7.61 negative 1.01 1.24 1.14 1.11 1.61 1.26 2.10 1.40 1.05 1.37 5.96 1.28 1.02 
135.0461 6.05 negative 0.89 0.92 1.05 1.62 0.76 1.36 0.69 0.49 1.00 0.73 1.02 1.07 0.38 
135.0480 12.03 positive 1.35 0.59 0.78 0.77 0.51 0.89 0.68 0.78 1.16 0.66 0.21 0.98 0.41 
135.0647 11.13 positive 0.89 1.28 0.83 0.39 0.66 0.87 1.07 0.89 0.76 1.46 0.43 0.73 0.47 
135.0790 1.94 positive 0.67 0.87 0.82 0.83 0.95 0.72 0.70 0.56 0.92 0.90 0.63 0.97 0.85 
136.0617 6.00 positive 0.84 0.71 0.70 1.50 1.20 1.00 1.09 0.41 0.97 0.64 4.89 1.17 0.13 
136.0756 8.94 positive 1.61 11.81 2.45 1.28 1.70 1.58 4.01 3.47 1.20 11.87 14.66 1.28 3.25 
136.0868 1.94 positive 0.63 0.85 0.99 0.78 0.93 0.67 0.68 0.55 0.91 0.88 0.61 0.95 0.84 
137.0253 2.13 negative 8.60 1.06 0.94 0.85 0.61 1.24 3.20 1.50 1.27 1.16 1.47 1.02 1.12 
137.0477 5.48 negative 0.90 0.75 1.01 0.83 0.82 0.76 0.69 0.89 0.90 0.62 0.78 0.81 1.02 
137.0650 5.99 positive 0.89 0.76 0.62 1.29 1.10 1.05 1.05 0.54 1.00 0.78 4.39 1.03 0.39 
138.0398 1.99 negative 11.41 1.01 0.91 1.10 0.52 1.19 3.91 1.45 1.28 1.14 1.40 0.90 1.23 
138.0569 6.47 negative 0.88 1.09 0.94 0.84 1.09 1.06 1.17 0.98 0.83 1.11 0.28 1.07 0.19 
138.0915 5.64 positive 0.94 1.21 0.95 0.95 0.95 0.96 1.07 1.02 0.90 1.27 0.76 0.96 0.49 
138.1025 1.94 positive 0.76 0.93 0.92 0.91 0.98 0.76 0.78 0.63 0.95 0.99 1.00 0.95 1.08 
139.0079 9.13 negative 1.44 0.81 48.27 48.27 42.42 1.01 0.68 1.36 24.48 0.89 22.97 21.80 0.88 
139.0501 2.00 positive 70.12 0.29 2.31 3.40 1.06 0.34 0.51 0.48 4.68 0.85 0.18 0.85 7.92 
139.0501 6.84 positive 75.33 0.25 1.76 2.32 1.06 0.31 0.34 0.44 2.63 0.95 2.43 0.98 0.62 
139.0749 10.48 positive 0.90 1.00 0.79 0.86 0.53 0.75 0.52 0.74 1.00 0.75 0.22 0.59 0.88 
140.0115 8.39 negative 1.08 0.96 0.62 1.29 1.09 1.27 0.35 1.29 0.81 0.29 0.13 1.20 0.39 
140.0115 9.85 negative 0.95 1.02 1.07 1.00 1.12 0.93 0.92 1.04 1.06 0.98 1.42 1.09 1.00 
140.0341 8.37 positive 0.76 0.82 0.72 0.55 0.79 0.99 0.96 0.87 0.76 0.79 0.00 0.73 0.34 
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140.0361 6.47 negative 0.90 1.12 0.95 0.82 1.06 1.15 1.18 1.02 0.82 1.13 1.94 1.10 0.13 
140.0681 5.79 positive 1.27 0.69 0.76 0.42 0.49 0.57 1.19 0.98 1.15 0.92 0.21 0.50 0.81 
140.0819 1.90 positive 0.66 0.82 0.85 0.81 0.91 0.70 0.72 0.59 0.95 0.90 0.66 0.94 0.84 
141.0037 8.23 negative 1.17 1.13 0.90 1.13 0.98 1.10 0.69 1.11 1.05 0.79 0.22 1.05 0.34 
141.0037 9.85 negative 0.98 1.03 1.06 1.01 1.12 0.93 0.91 1.02 1.07 0.99 1.43 1.09 1.00 
141.0202 3.90 negative 0.83 1.35 0.67 0.81 1.48 1.03 1.15 0.86 1.51 2.38 0.22 0.78 1.24 
141.0202 6.67 negative 0.97 1.05 0.82 0.67 1.17 1.31 1.24 1.11 1.14 1.28 0.41 0.96 0.35 
141.0656 8.70 positive 1.33 1.36 0.96 0.70 1.01 1.40 1.66 1.12 0.78 1.18 0.15 1.15 0.50 
141.0657 5.66 positive 1.19 0.75 0.76 0.55 1.09 1.21 0.85 0.80 0.78 1.03 0.00 0.98 0.36 
142.0519 6.62 negative 0.86 0.98 1.06 0.95 0.97 1.07 1.11 0.84 0.81 0.74 0.65 0.98 0.10 
142.9994 7.28 negative 0.98 0.93 0.97 0.94 0.77 1.13 0.34 0.77 0.87 0.90 0.05 0.84 0.73 
142.9995 3.51 negative 0.99 0.98 0.85 0.90 0.76 1.07 0.34 0.65 0.87 1.14 0.05 0.84 0.51 
143.0358 7.84 negative 1.25 1.35 0.96 0.83 1.28 1.31 0.97 0.68 1.28 1.54 1.26 1.51 1.14 
143.0358 9.80 negative 1.15 1.42 0.67 1.02 1.29 0.97 0.62 0.32 1.20 1.49 1.09 1.30 1.00 
143.0813 6.84 positive 1.05 1.02 1.07 0.64 1.01 1.04 1.06 1.17 1.00 1.38 0.62 0.86 1.10 
144.0029 7.27 negative 0.97 0.88 1.00 0.96 0.77 1.17 0.26 0.75 0.86 0.90 0.01 0.82 0.72 
144.0464 0.93 negative 1.93 0.81 0.94 1.02 0.88 1.01 1.79 4.10 1.43 0.86 7.04 1.11 0.83 
144.0807 7.28 positive 1.61 5.52 0.94 0.61 1.47 1.24 2.02 1.53 1.39 6.04 3.25 1.27 1.16 
144.1018 5.50 positive 0.88 1.04 0.90 1.03 0.78 1.03 1.22 0.76 1.02 0.99 0.37 0.84 0.33 
145.0151 7.32 negative 0.83 0.80 0.67 1.12 0.92 0.66 0.47 0.52 0.96 0.79 0.31 0.88 0.48 
145.0494 12.05 positive 1.49 2.03 1.37 0.62 1.90 1.35 1.49 1.93 1.71 2.42 2.43 1.49 4.86 
145.0627 10.50 negative 0.96 1.28 0.88 0.70 1.26 0.92 1.26 0.97 0.81 1.23 0.49 1.33 1.26 
145.0991 14.13 negative 0.78 5.14 1.97 0.91 0.97 0.94 2.66 2.07 0.81 5.60 5.34 0.62 0.09 
145.1082 5.89 positive 0.94 0.91 0.63 0.44 0.67 0.71 1.08 0.71 0.87 1.13 0.23 0.66 0.00 
145.1335 0.99 positive 0.99 0.69 0.89 0.45 0.59 1.04 1.19 0.84 0.59 0.73 0.01 0.68 0.26 
145.1446 9.29 positive 0.84 0.82 0.60 0.74 0.63 0.86 0.93 0.64 0.87 1.06 0.03 0.54 0.42 
146.0185 7.29 negative 0.72 0.71 0.62 1.28 1.00 0.48 0.37 0.32 1.01 0.65 77.34 0.92 0.48 
146.0468 10.97 negative 1.07 0.90 0.89 0.67 1.06 1.15 1.02 1.14 0.85 0.85 0.19 0.85 0.68 
146.0599 8.62 positive 1.04 1.02 0.59 0.27 0.77 0.86 0.89 1.02 0.80 1.70 1.02 0.75 0.42 
146.0633 0.90 positive 1.03 0.97 0.48 0.78 0.83 0.92 0.57 0.33 0.77 1.02 0.07 1.21 0.71 
146.0922 6.20 positive 0.89 1.35 1.13 1.23 1.06 1.10 1.61 0.88 0.83 1.17 1.12 1.02 0.05 
147.0308 6.40 negative 1.10 2.06 1.34 1.56 1.78 1.31 2.75 1.61 0.87 1.61 1.70 1.37 13.88 
147.0475 6.76 positive 1.11 1.45 0.96 0.97 1.52 1.25 1.35 0.90 0.80 1.59 0.24 1.23 0.02 
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147.0500 11.01 negative 1.07 0.88 0.88 0.64 1.05 1.16 1.03 1.15 0.81 0.85 1.10 0.87 0.66 
147.0672 2.75 negative 0.94 0.97 0.78 0.70 0.83 0.99 1.33 0.91 0.98 1.31 0.59 0.87 0.54 
147.0762 10.56 positive 1.04 1.79 0.84 0.79 1.23 0.93 1.32 0.90 0.92 1.09 0.45 1.29 1.13 
147.1126 14.14 positive 0.87 4.43 1.67 0.94 0.97 1.01 2.19 1.88 0.87 4.78 4.32 0.76 1.01 
148.0511 11.03 negative 1.15 1.04 0.87 0.40 1.23 1.20 1.06 1.27 0.78 0.81 0.04 0.82 0.54 
148.0603 11.01 positive 1.04 0.84 0.87 0.61 1.04 1.16 1.02 1.19 0.81 0.79 0.15 0.78 0.60 
148.0704 2.75 negative 0.91 0.98 0.77 0.67 0.83 1.01 1.34 0.92 0.98 1.30 0.58 0.90 0.52 
148.0868 1.94 positive 0.64 0.83 0.83 0.81 0.92 0.67 0.68 0.55 0.91 0.88 0.62 1.00 0.81 
148.0974 9.05 positive 0.94 1.06 0.84 0.89 1.04 0.95 0.94 0.75 0.99 1.32 21.09 1.07 1.32 
148.9534 7.89 negative 1.03 1.02 1.04 1.06 1.02 1.02 0.99 1.02 1.01 1.01 1.06 1.02 0.92 
149.0252 5.93 negative 1.47 1.07 0.72 1.10 1.16 1.06 0.53 1.25 0.98 0.79 5.73 1.14 1.91 
149.0465 7.25 negative 1.13 1.58 0.93 1.07 1.42 1.30 1.32 1.01 1.00 1.50 0.83 1.10 0.18 
149.0635 11.00 positive 1.03 0.82 0.87 0.60 1.02 1.15 1.01 1.18 0.79 0.77 0.14 0.77 0.58 
150.0430 8.17 negative 0.52 0.52 0.08 1.48 0.76 0.40 0.05 0.00 0.87 0.38 3.41 0.63 0.71 
150.0497 6.40 negative 1.23 1.70 1.00 1.18 1.60 1.05 1.37 0.97 0.86 1.61 0.92 1.19 0.16 
150.0582 7.25 positive 0.95 0.97 0.65 0.97 1.29 1.10 0.66 0.68 0.92 1.12 0.47 1.18 0.32 
150.0947 5.56 positive 0.90 0.94 0.81 0.31 0.54 0.87 1.17 0.72 0.60 1.39 0.46 0.72 0.24 
151.0271 5.41 negative 1.07 1.03 1.01 1.11 1.09 0.92 0.95 1.04 1.10 1.00 1.17 1.00 1.23 
151.0351 4.94 positive 1.04 0.96 1.12 1.15 1.06 0.98 1.18 1.14 1.07 1.16 0.73 1.08 0.95 
151.0620 6.19 negative 1.10 1.15 0.78 0.81 0.92 1.03 1.11 0.79 0.91 1.21 0.57 0.69 0.55 
151.0623 7.23 positive 0.95 1.01 0.66 0.99 1.41 1.16 0.67 0.72 0.94 1.14 0.50 1.23 0.28 
151.0977 1.98 positive 0.69 0.89 0.90 0.85 0.96 0.68 0.71 0.58 0.83 0.96 0.67 0.89 0.97 
152.0162 5.42 negative 0.58 0.83 0.59 1.05 0.98 0.86 0.70 0.62 0.67 0.41 4.14 1.37 0.61 
152.0357 4.94 positive 1.07 0.95 1.12 1.14 1.05 0.97 1.18 1.16 1.06 1.17 0.67 1.07 0.95 
152.0566 9.00 positive 0.94 0.79 0.68 1.26 1.40 0.93 1.08 0.30 1.11 0.85 24.16 1.12 0.96 
152.0817 1.94 positive 0.58 0.80 0.80 0.73 0.90 0.61 0.67 0.53 0.90 0.86 0.55 0.88 0.77 
152.9873 13.63 negative 1.08 1.05 0.97 1.05 1.03 0.96 1.15 1.00 0.97 1.34 0.99 1.00 1.05 
153.0326 4.94 positive 1.06 0.97 1.09 1.12 1.04 0.99 1.17 1.15 1.06 1.15 0.69 1.08 0.92 
154.0156 6.20 negative 0.37 0.91 0.42 0.44 1.18 0.53 0.84 0.80 0.66 0.75 0.79 0.94 0.12 
154.0631 14.24 negative 1.26 2.19 1.13 0.72 1.32 1.06 1.29 1.27 1.02 2.63 0.86 1.18 1.51 
154.0952 5.29 positive 1.07 1.09 0.62 0.59 0.40 1.00 1.21 0.85 0.84 1.19 0.51 0.61 0.45 
154.9196 13.61 negative 0.95 0.93 0.76 0.64 0.77 0.87 0.83 0.86 0.90 1.12 0.50 0.78 1.97 
155.0360 6.72 negative 1.12 1.38 0.95 1.02 1.33 1.19 0.84 0.75 0.97 1.32 0.65 1.02 23.63 
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155.0425 11.19 positive 0.92 0.94 0.95 1.27 0.86 0.85 0.82 0.86 0.97 0.94 1.15 0.88 0.86 
155.0789 14.72 positive 0.79 0.28 0.48 0.53 0.50 0.58 0.42 0.61 1.05 0.71 0.11 0.39 0.25 
156.0766 14.25 positive 1.19 2.01 1.08 0.72 1.28 1.02 1.20 1.23 0.96 2.37 0.84 1.12 0.84 
156.0788 14.01 negative 0.75 0.99 0.80 0.57 0.66 0.72 0.74 0.83 0.89 1.46 0.65 0.60 0.62 
156.9166 13.61 negative 0.94 0.92 0.72 0.61 0.73 0.92 0.79 0.90 0.94 1.16 0.44 0.77 1.72 
156.9540 10.64 positive 1.10 0.60 2.05 2.21 0.74 0.67 0.55 0.87 1.32 0.58 3.03 0.63 1.55 
156.9870 1.42 positive 0.70 0.58 0.87 0.90 0.99 0.92 2.35 1.01 0.81 0.63 0.53 0.69 0.83 
157.0128 2.51 negative 1.81 0.73 1.25 1.00 1.02 0.73 1.04 1.08 1.75 0.70 0.99 0.73 1.88 
157.0152 5.05 negative 1.14 0.94 0.77 1.00 1.96 0.81 0.05 0.28 1.19 1.03 1.15 1.18 1.22 
157.0387 7.10 negative 0.88 1.15 1.03 0.80 0.80 0.94 1.06 0.96 0.81 1.20 0.79 0.74 0.47 
157.0801 14.25 positive 1.22 2.06 1.09 0.68 1.35 1.03 1.26 1.30 0.96 2.46 0.81 1.14 0.84 
158.0416 5.95 positive 1.12 0.75 0.48 1.08 0.65 0.33 1.16 0.08 1.20 1.10 1.56 1.08 1.23 
158.0832 5.75 negative 0.90 2.80 1.43 3.22 5.37 1.71 1.11 1.98 0.77 1.16 2.95 4.73 0.63 
158.0922 14.01 positive 0.75 0.93 0.78 0.52 0.65 0.66 0.78 0.80 0.86 1.75 0.62 0.57 0.32 
158.9639 5.57 positive 1.59 0.58 1.04 0.55 0.86 0.55 1.81 1.78 1.21 0.66 1.90 0.69 9.21 
158.9639 1.10 positive 0.09 0.13 0.15 0.13 0.96 0.11 0.21 0.20 0.09 0.09 0.19 0.09 0.29 
158.9794 4.92 negative 1.00 0.99 0.76 0.71 0.68 1.02 1.16 0.93 0.90 1.12 0.40 0.82 0.52 
159.0309 6.54 negative 1.46 2.03 1.12 1.87 1.45 1.54 2.86 1.07 1.30 1.93 1.75 1.25 0.61 
159.0762 11.61 positive 1.05 0.36 0.61 0.66 0.55 0.81 0.68 0.80 0.95 0.61 0.28 1.07 0.45 
160.0755 11.94 positive 0.88 2.04 7.71 0.28 0.38 6.83 13.84 7.82 1.10 0.61 2.21 1.04 0.33 
160.0966 7.77 positive 1.20 1.18 0.90 0.81 1.03 1.08 1.10 0.94 1.04 1.42 0.70 1.07 0.65 
161.0465 5.61 negative 1.05 1.78 1.80 3.12 2.81 1.45 1.27 1.24 0.90 1.14 0.62 2.31 0.55 
161.0465 12.72 negative 34.63 2.05 0.96 0.91 1.38 23.87 6.14 1.96 34.45 2.26 2.49 4.95 1.66 
161.0821 1.94 positive 0.64 0.83 0.78 0.81 0.93 0.69 0.70 0.55 0.90 0.86 0.62 0.93 0.83 
161.0829 2.29 negative 1.06 1.05 0.87 1.02 0.84 1.11 1.52 1.03 1.25 1.38 0.69 0.96 0.76 
161.0916 9.05 positive 1.12 2.20 1.11 0.91 1.31 1.05 1.31 1.04 0.93 2.11 1.13 1.16 0.72 
161.0918 7.24 positive 0.80 0.72 0.74 0.86 0.83 1.11 0.67 0.45 1.00 0.84 1.81 0.94 0.26 
162.0241 6.47 negative 0.98 1.41 1.02 3.87 1.62 1.10 1.30 1.01 0.74 1.07 0.01 1.44 0.05 
162.0404 12.66 positive 1.51 9.84 44.61 2.29 1.35 35.69 108.97 96.66 0.70 3.45 5.46 0.70 2.46 
162.0759 9.98 positive 0.72 2.97 0.77 2.52 1.25 0.91 0.96 0.59 1.78 4.35 0.87 0.72 1.61 
162.0781 11.66 negative 0.97 0.66 0.64 0.67 0.62 0.70 0.76 0.79 0.91 1.48 0.25 0.53 0.29 
162.9834 8.41 negative 1.06 0.98 1.02 1.10 1.62 1.05 0.90 1.07 1.04 1.77 1.03 1.11 1.64 
163.0422 9.22 positive 0.83 1.11 0.97 0.99 1.10 0.90 0.92 0.71 1.19 1.64 0.32 0.88 0.92 
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163.0599 12.04 positive 1.49 2.25 1.51 0.50 2.05 1.40 1.60 2.24 1.94 2.64 2.63 1.66 5.50 
163.0622 6.53 negative 1.04 1.20 1.01 0.86 0.99 1.23 1.18 1.07 0.83 0.94 0.37 0.93 0.16 
163.0752 5.90 positive 0.84 1.50 1.69 2.09 2.21 2.27 1.26 1.29 0.68 0.54 0.18 2.01 0.29 
163.0977 1.93 positive 0.68 0.85 0.81 0.84 0.92 0.86 0.70 0.59 0.93 0.86 0.65 0.98 0.84 
164.0690 6.61 negative 1.77 3.22 1.47 1.06 1.56 2.14 1.67 1.91 1.37 2.95 3.70 1.98 1.24 
164.0738 12.52 positive 0.94 1.75 1.22 0.64 0.60 0.93 1.05 1.15 1.04 2.08 0.87 0.75 0.13 
164.1102 5.17 positive 0.83 0.79 0.83 0.41 0.62 0.88 0.90 0.82 0.62 0.89 0.30 0.85 0.08 
164.9203 1.11 positive 0.80 1.21 1.44 1.20 1.26 1.50 1.74 1.55 1.08 0.80 1.66 1.00 1.85 
164.9349 4.09 positive 1.55 1.63 0.44 1.02 1.29 0.55 0.75 0.42 1.57 2.45 2.86 1.54 1.06 
165.0203 6.45 negative 1.10 1.45 1.29 1.54 1.51 1.30 0.79 0.74 1.00 0.79 1.87 1.45 0.09 
165.0414 8.55 negative 1.19 1.74 0.95 0.94 1.04 1.29 1.85 1.24 1.06 1.79 0.71 1.00 0.61 
165.0544 8.96 positive 1.64 11.39 2.47 1.26 1.71 1.54 3.88 3.47 1.17 11.37 14.18 1.30 3.64 
166.0236 6.43 negative 1.02 1.93 1.78 2.28 2.22 1.78 0.95 1.62 1.22 1.27 2.97 2.07 0.01 
166.0447 8.59 negative 1.45 2.49 0.99 1.04 1.32 1.65 2.73 1.70 1.15 2.42 0.67 1.02 0.42 
166.0530 11.02 positive 1.02 1.02 0.79 1.01 0.82 0.99 1.77 1.10 1.39 1.89 1.73 0.70 0.94 
166.0860 6.75 positive 2.51 5.96 2.11 1.18 2.19 2.93 2.71 2.43 2.07 5.82 7.27 3.01 1.19 
166.9333 4.93 negative 1.01 1.02 0.75 0.77 0.72 1.00 1.10 0.93 0.85 1.08 0.47 0.90 0.56 
166.9505 2.55 positive 4.22 0.64 1.39 0.92 1.03 0.64 1.03 1.25 2.16 0.62 0.99 0.65 2.46 
166.9971 7.26 negative 0.97 0.84 0.98 1.47 0.94 0.90 0.48 0.72 1.01 0.62 0.18 0.90 4.13 
167.0220 9.37 negative 0.97 1.40 0.87 0.80 0.88 1.01 1.04 0.92 0.93 1.51 0.00 0.89 0.83 
167.0359 6.40 negative 1.04 7.93 0.98 0.97 2.20 1.19 2.07 1.57 0.84 5.98 0.67 1.14 0.75 
167.0894 6.75 positive 2.63 6.30 2.17 1.22 2.27 3.05 2.77 2.53 2.15 6.12 7.72 3.16 1.22 
168.0288 10.98 negative 1.14 0.68 0.87 0.69 1.09 1.11 0.90 1.13 0.93 0.87 0.84 0.88 0.81 
168.0441 13.81 negative 0.99 1.66 0.86 0.66 0.62 0.93 1.00 1.17 0.93 1.89 0.67 0.88 0.68 
168.0451 0.91 positive 1.11 1.06 0.56 0.78 0.98 0.93 0.01 0.06 0.80 0.95 0.05 1.33 0.92 
168.0654 12.05 positive 1.37 2.55 1.65 0.49 2.23 1.30 1.86 2.53 1.60 3.29 3.27 1.76 6.93 
168.0765 14.73 positive 201.30 0.50 1.86 1.34 0.44 2.50 3.32 0.81 0.91 1.65 5.11 1.34 17.41 
168.0920 6.74 positive 3.56 8.71 2.78 3.90 2.97 4.07 3.35 3.13 4.18 8.74 10.65 4.36 1.42 
168.9915 16.50 negative 6.33 0.97 0.74 1.65 1.46 1.06 0.72 0.95 3.11 1.13 1.76 3.62 0.91 
169.0152 7.89 negative 0.59 0.45 0.97 0.58 0.46 0.64 0.70 0.92 0.81 0.59 0.80 0.41 1.26 
169.0355 9.35 positive 1.04 1.51 0.93 0.85 0.96 1.05 1.05 0.96 1.01 1.61 0.00 0.97 0.84 
169.0455 4.94 positive 1.08 0.98 1.54 1.66 1.47 0.98 1.17 1.37 1.28 1.13 1.68 1.36 1.62 
169.0582 10.59 positive 1.00 1.00 0.75 0.63 0.96 0.96 0.88 0.93 0.93 1.02 0.52 0.98 0.70 
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170.0469 6.41 negative 1.45 0.36 0.78 1.02 0.79 1.79 0.67 1.09 1.26 0.28 0.60 1.24 0.00 
170.9710 4.09 negative 1.57 1.67 0.44 1.05 1.28 0.58 0.75 0.42 1.59 2.44 2.68 1.57 1.09 
171.0308 5.81 negative 1.21 1.88 1.25 1.56 2.32 1.76 1.67 1.79 1.07 1.67 6.60 2.20 0.86 
171.0759 10.55 positive 0.95 1.39 0.86 0.77 1.49 0.92 1.43 0.97 0.92 1.15 0.42 0.85 1.22 
172.0625 4.45 negative 0.95 0.83 0.63 0.57 0.78 0.89 0.85 0.83 0.96 1.42 0.40 0.77 0.43 
172.0989 5.59 negative 1.01 1.17 1.08 1.60 1.67 1.11 1.19 1.00 0.97 1.11 1.17 1.53 0.74 
172.9867 2.54 negative 1.42 0.70 1.27 0.99 1.07 0.72 1.04 1.14 1.85 0.66 0.99 0.73 2.08 
173.0101 7.27 negative 0.94 0.87 0.98 0.92 0.70 1.11 0.29 0.76 0.86 0.83 0.04 0.78 0.55 
173.0501 6.71 negative 1.16 1.20 0.94 0.86 1.06 1.21 1.52 0.95 0.79 1.08 0.42 1.05 0.23 
173.0678 4.97 positive 1.09 1.00 1.47 1.39 1.35 0.99 1.10 1.37 1.28 1.12 1.16 1.28 1.41 
173.0781 1.07 positive 1.61 1.10 1.37 1.16 1.12 1.09 1.29 1.12 1.09 1.28 1.30 1.15 1.23 
173.0919 11.02 positive 0.76 1.11 0.83 0.35 0.63 0.84 1.33 1.01 0.84 1.83 0.19 0.52 0.38 
173.1053 14.01 negative 0.77 0.95 0.81 0.60 0.70 0.74 0.80 0.84 0.91 1.40 0.70 0.64 0.65 
174.0418 6.78 negative 1.19 1.17 1.04 0.93 1.06 1.20 1.94 1.23 0.85 1.00 0.42 0.98 1.08 
174.0758 11.01 positive 0.76 1.08 0.88 0.58 0.74 0.82 1.20 1.03 0.81 1.67 0.24 0.62 0.43 
174.0893 11.61 negative 1.04 0.32 0.57 0.68 0.53 0.79 0.61 0.73 0.98 0.55 0.25 1.11 0.40 
174.0899 1.93 positive 0.82 0.96 0.97 0.86 0.92 0.73 0.69 0.54 0.93 1.11 0.70 1.21 0.77 
175.0258 5.07 negative 1.15 0.97 0.61 0.96 1.00 0.79 0.79 1.16 1.14 1.09 1.10 1.16 1.04 
175.0482 9.82 negative 0.73 0.78 0.89 0.73 0.59 0.86 0.80 0.73 0.83 0.86 0.08 0.53 0.38 
175.1073 9.56 positive 1.47 0.90 0.49 0.94 0.86 0.54 0.57 0.55 1.32 1.86 0.40 3.27 0.32 
175.1074 8.25 positive 0.97 0.07 0.12 0.21 0.16 0.43 0.14 0.30 0.89 0.31 0.16 0.63 0.02 
175.1186 14.01 positive 0.74 0.96 0.78 0.53 0.65 0.67 0.77 0.82 0.87 1.68 0.64 0.58 0.35 
175.1439 12.19 positive 1.00 1.03 0.79 0.65 0.78 0.94 1.01 0.90 1.19 1.64 0.57 0.76 1.10 
176.1028 11.61 positive 1.02 0.36 0.60 0.66 0.55 0.80 0.66 0.80 0.95 0.61 0.28 1.07 0.45 
176.1221 14.01 positive 0.75 0.95 0.78 0.53 0.65 0.67 0.78 0.83 0.87 1.69 0.64 0.58 0.35 
176.9369 14.99 negative 0.71 0.86 0.50 0.48 0.58 0.85 0.94 0.60 0.60 0.99 0.76 0.81 0.19 
177.0414 7.83 negative 0.98 1.05 0.94 0.73 0.77 1.12 1.09 0.91 0.96 1.08 0.30 0.81 0.63 
177.0414 6.47 negative 1.82 1.78 1.19 1.46 1.63 1.85 2.74 1.07 1.16 1.74 2.17 1.33 1.52 
177.0545 7.07 positive 1.07 1.09 1.04 0.98 0.96 1.24 1.30 0.93 0.77 0.71 0.08 1.00 0.11 
177.0616 9.80 positive 0.77 0.92 0.81 0.78 0.84 0.82 0.66 0.62 0.92 0.99 0.17 0.73 0.55 
177.1062 11.61 positive 1.05 0.35 0.60 0.66 0.53 0.81 0.87 0.79 0.96 0.60 0.27 1.06 4.11 
177.1238 13.99 positive 0.70 0.90 0.76 0.52 0.61 0.67 0.76 0.78 0.83 1.64 0.61 0.56 0.25 
178.0519 5.17 negative 0.97 1.01 0.69 0.62 0.56 1.14 1.14 0.80 0.83 1.21 0.28 0.67 0.57 
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178.0585 14.26 positive 1.22 1.64 1.06 0.83 1.37 1.08 1.08 1.18 0.96 1.64 0.76 1.24 1.24 
178.1258 5.14 positive 0.81 0.77 0.84 0.42 0.66 0.90 0.90 0.85 0.61 0.81 0.29 0.94 0.27 
179.0029 6.80 negative 1.28 1.47 1.07 1.20 1.54 1.16 1.02 1.11 0.99 1.27 0.36 1.37 0.01 
179.0359 6.04 negative 0.77 0.94 0.99 1.53 1.04 1.29 0.49 0.46 0.70 0.65 0.16 1.12 0.26 
179.0570 9.82 negative 1.14 1.40 0.68 1.02 1.29 0.98 0.65 0.37 1.13 1.52 1.10 1.34 1.02 
179.0570 7.84 negative 1.22 1.29 0.98 0.81 1.18 1.31 1.05 0.72 1.19 1.43 1.06 1.38 0.99 
179.0678 1.09 positive 1.10 1.19 1.31 1.20 1.39 1.28 1.30 1.11 1.33 1.09 1.40 1.34 1.62 
179.1294 5.24 positive 0.90 0.79 0.83 0.52 0.71 0.88 0.93 0.84 0.85 0.88 0.55 0.92 0.19 
180.0666 8.95 negative 1.62 5.40 1.17 0.89 1.37 1.92 1.66 1.74 1.69 5.15 5.42 1.28 1.88 
180.0868 12.10 positive 1.04 1.96 1.08 0.52 1.71 1.77 10.81 1.47 1.23 2.35 1.86 1.36 3.69 
180.0878 8.15 positive 1.01 1.04 0.89 0.80 0.86 1.00 1.06 0.77 0.96 1.16 0.52 0.84 0.51 
180.1216 5.21 positive 0.84 0.63 0.91 0.00 0.00 0.81 0.89 0.84 0.48 0.85 0.00 0.25 0.00 
180.9740 1.12 negative 0.94 1.10 1.24 1.10 0.82 1.13 0.95 1.25 0.95 0.88 1.45 1.01 1.53 
180.9740 5.40 negative 0.91 0.94 1.10 1.15 1.38 1.06 0.26 0.81 0.60 0.34 0.14 1.27 0.10 
181.0152 6.57 negative 0.93 1.00 0.90 0.97 1.39 1.09 0.97 2.11 1.09 0.91 1.74 1.15 13.18 
181.0614 7.87 negative 2.51 1.28 1.04 0.41 0.83 1.23 1.10 0.42 1.23 1.44 6.29 1.06 0.90 
181.9387 1.34 negative 0.50 0.76 1.02 0.52 0.83 0.67 0.80 1.35 0.88 0.58 0.80 0.74 0.80 
182.0469 6.45 negative 0.95 1.32 1.00 0.96 1.16 1.19 1.52 1.05 0.88 1.29 0.60 1.09 0.20 
182.0810 8.96 positive 1.61 11.48 2.51 1.26 1.72 1.56 3.94 3.52 1.18 11.53 13.84 1.32 3.69 
182.9491 5.53 positive 0.91 0.59 0.88 0.42 0.84 0.41 0.98 0.60 1.42 0.72 0.01 0.81 1.61 
182.9920 5.75 negative 1.47 1.11 0.46 0.28 0.51 0.73 1.32 0.69 1.30 1.90 0.50 0.35 2.54 
183.0112 8.13 negative 1.19 1.06 0.89 1.19 0.97 1.12 0.88 1.12 1.05 0.89 1.13 1.12 0.89 
183.0844 8.95 positive 1.69 13.22 2.58 1.26 1.76 1.67 4.47 3.94 1.15 13.15 15.69 1.40 4.07 
184.0731 13.88 positive 0.94 1.78 0.89 0.63 0.61 0.89 1.07 1.24 0.95 2.00 0.71 0.84 0.41 
185.0077 5.32 negative 1.19 1.79 0.83 1.83 2.21 0.96 0.13 2.34 0.73 0.08 2.28 1.81 1.93 
185.0762 13.88 positive 0.92 1.84 0.87 0.58 0.57 0.86 1.06 1.26 0.94 2.07 0.70 0.84 0.36 
186.0761 12.05 positive 1.48 2.68 1.63 0.47 2.20 1.49 2.05 2.49 1.67 3.41 3.19 1.59 7.25 
186.9305 5.94 negative 2.40 1.96 1.88 0.19 0.81 1.39 0.01 6.12 0.04 1.29 1.63 1.34 23.93 
187.0734 8.61 negative 0.96 1.23 1.00 0.99 0.89 1.18 1.77 0.99 1.18 2.11 0.19 0.83 0.66 
187.0986 3.08 negative 1.39 0.37 0.45 0.56 0.81 0.54 0.62 0.42 0.60 0.47 0.38 0.66 0.41 
187.1075 6.82 positive 0.74 0.54 0.58 1.21 0.79 0.86 1.97 0.03 0.74 0.57 2.62 0.82 0.44 
188.0575 6.42 negative 1.16 0.18 0.67 0.81 0.58 1.49 0.57 0.98 1.03 0.24 0.39 1.01 0.03 
188.0705 7.20 positive 2.63 11.39 1.77 1.01 2.68 1.97 4.00 2.80 1.82 12.40 5.79 2.35 2.01 
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189.0415 6.34 negative 1.37 1.50 1.09 1.50 1.24 1.48 1.02 1.06 1.16 0.94 1.38 1.43 0.38 
189.0891 11.01 negative 0.71 1.18 0.84 0.35 0.76 0.78 1.15 0.98 0.85 1.85 0.28 0.62 0.57 
189.1231 6.38 positive 0.78 0.74 0.83 1.19 0.88 1.10 0.73 0.37 0.89 0.74 3.30 0.99 0.15 
189.1345 12.19 positive 0.92 0.96 0.72 0.53 0.67 0.80 0.84 0.78 0.96 1.58 0.54 0.63 1.00 
190.1631 11.26 positive 0.87 1.25 0.71 0.50 0.68 0.98 1.21 0.68 0.74 1.61 0.18 0.71 0.41 
190.9118 5.35 positive 1.32 1.02 0.67 0.85 0.72 1.24 0.75 1.03 1.07 0.89 0.50 0.90 1.42 
191.0207 13.99 negative 0.88 1.26 0.88 0.32 0.59 0.70 0.73 0.82 0.69 2.09 0.31 0.62 0.13 
191.0571 6.49 negative 1.11 1.24 1.05 0.98 1.09 1.32 1.28 1.14 0.89 1.02 0.68 1.06 0.15 
191.1024 11.02 positive 0.72 1.07 0.86 0.48 0.71 0.78 1.16 1.00 0.81 1.65 0.26 0.56 0.45 
192.1059 11.02 positive 0.73 1.08 0.86 0.43 0.66 0.81 1.21 1.06 0.84 1.67 0.20 0.51 0.35 
192.1415 4.99 positive 0.84 0.70 0.87 0.39 0.66 0.91 0.95 0.84 0.59 0.74 0.40 0.99 0.30 
193.0366 7.18 negative 0.87 0.77 0.75 0.45 0.43 1.06 0.60 0.76 0.74 0.77 0.19 0.53 0.09 
193.0549 4.34 negative 0.94 0.93 0.89 0.90 0.71 0.95 1.56 0.72 0.76 1.03 10.77 0.78 0.55 
193.0709 12.23 positive 1.03 0.63 0.72 1.07 1.09 0.87 1.27 1.05 1.10 0.81 0.80 1.07 1.05 
193.1451 4.98 positive 0.82 0.68 0.87 0.35 0.65 0.91 0.96 0.83 0.52 0.75 0.39 0.98 0.26 
193.9298 14.99 positive 0.94 0.95 0.75 0.81 0.80 1.00 1.07 0.80 0.78 1.05 0.99 0.90 0.55 
194.0501 7.42 negative 0.79 0.83 0.58 0.38 0.59 0.80 0.54 0.83 0.77 1.09 0.75 0.66 0.45 
194.1373 4.98 positive 0.80 0.71 0.91 0.37 0.66 0.93 0.96 0.82 0.57 0.77 0.37 1.00 0.29 
194.9374 15.01 negative 0.81 0.91 0.67 0.58 0.71 0.88 0.94 0.74 0.75 1.00 0.75 0.89 0.27 
194.9455 5.30 positive 0.75 1.95 1.17 0.31 0.34 0.91 4.80 0.56 0.64 3.15 0.39 0.34 0.11 
195.0538 7.42 negative 0.79 0.84 0.58 0.38 0.58 0.78 0.53 0.81 0.77 1.09 0.76 0.66 0.44 
195.1225 0.99 positive 1.47 0.90 0.95 0.67 0.71 0.98 0.97 0.80 0.99 1.46 0.79 0.80 0.73 
196.0294 13.37 negative 0.84 0.85 0.54 0.24 0.57 0.81 0.52 0.73 0.65 1.02 0.65 0.64 0.09 
196.0460 7.42 negative 0.79 0.83 0.58 0.38 0.59 0.79 0.53 0.84 0.77 1.09 0.76 0.66 0.50 
196.0635 7.40 positive 0.77 0.86 0.54 0.38 0.66 0.74 0.51 0.78 0.76 1.13 0.74 0.73 0.33 
196.9479 5.37 negative 1.30 1.12 0.72 0.60 0.96 1.25 0.93 0.99 1.29 1.08 1.00 0.84 0.43 
197.0230 3.85 negative 1.07 0.82 0.80 0.72 0.93 1.02 1.15 0.84 0.82 0.78 2.64 0.81 2.16 
197.0493 7.41 negative 0.69 0.74 0.57 0.32 0.57 0.70 0.45 0.81 0.71 1.10 0.73 0.64 0.57 
197.0673 7.40 positive 0.77 0.86 0.54 0.38 0.66 0.74 0.51 0.78 0.76 1.12 0.75 0.73 0.33 
198.0594 7.40 positive 0.77 0.87 0.55 0.38 0.65 0.74 0.51 0.77 0.77 1.12 0.74 0.73 0.33 
198.0758 6.51 negative 2.06 14.20 3.34 1.12 3.16 1.97 4.76 6.68 1.72 14.01 20.49 1.38 50.74 
198.0852 11.64 positive 1.03 0.46 0.63 0.72 0.67 0.80 0.59 0.67 1.31 1.80 0.35 1.10 0.47 
199.0081 9.63 negative 1.32 1.62 1.26 1.50 1.89 1.15 1.02 0.85 1.60 2.03 3.30 1.31 0.61 
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199.0346 11.16 negative 0.95 1.17 0.82 0.47 0.79 0.89 0.99 0.85 0.87 1.30 0.79 0.89 0.77 
199.0436 9.79 positive 0.74 0.82 1.00 0.84 0.76 0.84 0.77 0.83 0.90 0.87 0.16 0.67 0.60 
200.0574 5.50 negative 0.82 0.65 0.82 1.54 1.04 1.14 1.22 0.64 1.07 0.65 9.29 1.01 0.83 
200.9816 5.32 negative 0.57 1.38 1.26 0.18 0.40 0.77 3.59 0.77 0.89 2.62 0.52 0.24 1.55 
200.9872 11.41 negative 0.99 0.84 0.97 1.11 1.05 0.89 1.06 0.85 1.00 0.82 1.12 1.00 1.06 
201.0390 2.49 negative 12.29 0.38 2.01 0.87 0.89 0.35 0.89 1.93 4.01 0.38 1.12 0.40 5.52 
202.1086 1.94 positive 0.66 0.85 0.79 0.82 0.89 0.69 0.70 0.56 0.89 0.87 0.65 0.93 0.86 
202.9974 5.14 negative 0.83 0.98 0.55 0.10 0.13 1.24 1.54 0.80 0.71 1.36 0.04 0.29 0.05 
203.0525 7.86 positive 1.45 1.41 1.08 0.88 1.71 1.41 0.85 0.68 1.32 1.78 1.46 1.97 3.59 
203.0835 7.20 negative 3.52 14.21 2.30 1.15 2.79 2.52 8.62 5.31 2.37 16.58 16.33 2.36 7.80 
203.1041 6.56 positive 1.12 1.01 1.17 1.07 1.08 1.10 1.08 1.06 0.95 0.86 0.96 1.07 0.92 
203.1499 10.54 positive 0.94 0.98 0.56 0.29 0.54 0.85 0.70 0.65 0.87 1.39 0.11 0.43 0.65 
204.0865 7.85 positive 1.19 1.41 0.90 0.82 1.32 1.24 0.93 0.60 1.18 1.73 1.29 1.46 0.99 
204.0865 12.03 positive 1.33 2.34 1.47 0.58 2.04 1.25 1.79 2.23 1.52 2.88 2.57 1.54 5.51 
205.0500 5.62 negative 0.85 0.73 0.71 0.63 0.41 0.82 0.86 0.82 0.89 1.02 0.00 0.49 0.49 
205.0816 12.07 positive 1.25 1.44 1.20 0.41 2.12 0.97 1.10 2.93 0.99 1.75 1.81 1.07 3.12 
205.0969 7.21 positive 2.58 11.23 1.79 0.99 2.66 1.94 3.95 2.85 1.85 12.17 5.70 2.35 1.92 
205.9614 4.42 positive 2.55 2.15 0.90 0.85 0.93 1.03 3.30 1.56 0.91 2.36 1.60 0.76 1.25 
206.0550 13.77 positive 1.02 1.50 0.78 0.71 0.67 0.86 0.69 0.95 0.94 1.61 0.67 0.94 0.47 
207.0308 6.05 negative 0.69 1.14 1.11 1.69 1.00 1.38 0.76 0.60 0.68 0.76 0.71 1.23 0.29 
207.0519 4.71 negative 0.97 0.75 1.17 1.39 0.56 1.20 1.19 0.78 1.51 1.41 0.04 0.88 0.59 
207.0584 13.80 positive 1.01 7.13 17.77 0.84 0.48 12.88 57.98 35.58 0.45 2.05 6.26 0.54 0.43 
207.0650 5.88 positive 0.82 2.03 1.49 2.26 2.45 1.75 0.89 1.33 0.92 1.28 0.01 2.33 0.57 
208.0623 9.19 negative 0.96 1.07 1.16 1.37 1.41 1.17 1.18 0.95 0.98 0.80 0.41 0.84 0.49 
208.9440 10.75 negative 0.94 0.90 1.08 1.11 0.95 0.95 0.81 0.90 1.07 0.91 0.99 0.97 0.89 
209.0675 7.70 negative 0.98 0.99 0.98 0.82 0.78 1.13 1.13 0.83 0.94 1.09 0.55 0.81 0.54 
209.0819 13.99 negative 0.61 0.73 0.53 0.14 0.35 0.40 0.65 0.54 0.65 1.77 0.12 0.25 10.54 
209.1395 4.80 positive 1.38 1.01 1.84 1.92 0.67 1.23 2.66 1.10 1.04 0.95 0.34 0.47 0.53 
209.1397 1.06 positive 1.16 1.01 1.85 1.91 0.72 1.10 2.71 1.16 0.96 0.86 0.53 0.52 0.70 
210.0707 7.85 negative 0.95 0.98 0.95 0.74 0.74 1.11 1.12 0.84 0.93 1.11 0.53 0.76 0.53 
210.0759 9.20 positive 0.95 1.03 1.05 1.17 1.09 1.10 1.19 0.82 0.96 0.82 0.42 0.82 0.52 
211.0021 13.77 negative 0.90 1.13 0.57 0.88 0.68 0.80 0.31 0.18 0.90 1.31 0.56 0.75 0.95 
211.0257 6.82 negative 0.99 0.95 0.99 1.11 1.16 1.06 0.89 0.86 0.77 0.56 0.69 0.95 0.02 
218 
 
211.0486 8.73 negative 0.79 0.68 0.49 0.46 0.63 0.81 0.51 0.76 0.66 0.75 0.33 0.69 0.21 
211.9975 4.44 negative 2.48 2.22 0.94 0.93 0.99 1.10 3.29 1.60 0.97 2.39 1.20 0.81 1.20 
212.0585 8.72 positive 0.83 1.10 0.57 0.41 0.74 0.89 0.72 0.89 0.73 1.22 0.71 0.77 0.27 
213.0413 8.29 negative 1.36 1.27 1.12 1.24 1.47 1.50 1.31 1.21 1.32 0.94 0.37 1.23 0.78 
213.0501 10.91 negative 0.98 2.00 0.90 0.71 1.99 0.87 1.60 1.55 0.77 1.94 0.69 1.94 3.03 
213.0622 8.72 positive 0.81 1.09 0.57 0.39 0.74 0.89 0.72 0.88 0.72 1.22 0.70 0.77 0.25 
214.0341 11.02 negative 1.07 0.70 0.90 0.76 1.11 1.20 0.87 1.17 0.81 0.59 0.10 0.96 0.82 
214.0494 13.95 negative 0.79 5.16 3.13 0.79 5.79 0.94 6.08 5.16 0.64 6.76 0.99 0.94 5.36 
215.0176 9.80 positive 0.75 0.83 0.90 0.71 0.65 0.87 0.77 0.75 0.80 0.96 0.07 0.61 0.40 
215.0336 7.85 negative 1.23 1.10 1.10 0.86 0.94 1.44 0.99 0.82 1.43 1.07 1.56 1.21 0.76 
215.1386 5.77 positive 0.76 1.01 0.64 1.44 1.10 1.19 2.25 0.53 0.83 0.81 5.19 1.08 0.74 
217.0128 2.51 negative 14.53 0.40 2.02 0.88 0.92 0.37 0.91 2.01 4.14 0.38 1.16 0.41 5.85 
217.0295 6.75 negative 0.94 1.08 1.08 0.99 0.92 0.87 1.22 1.14 0.86 1.26 0.65 0.96 0.26 
217.0837 10.98 negative 1.57 7.07 1.10 0.14 4.47 1.42 12.13 5.58 0.70 6.93 13.08 2.53 5.09 
217.1044 0.99 positive 1.58 0.96 1.03 0.70 0.71 1.03 0.91 0.85 0.95 1.47 0.89 0.85 0.84 
217.1282 7.46 positive 0.98 0.47 0.47 0.70 1.64 0.86 0.92 0.64 0.82 0.68 1.35 1.32 1.55 
217.1544 5.37 positive 0.08 0.85 0.37 1.60 0.99 1.56 0.21 0.28 0.40 0.33 8.85 1.31 0.00 
218.0454 7.41 positive 0.85 0.85 0.60 0.45 0.71 0.77 0.53 0.81 0.83 1.06 0.78 0.78 1.38 
218.1079 0.99 positive 1.62 0.97 1.06 0.73 0.77 1.04 0.89 0.86 0.97 1.49 0.88 0.88 0.85 
219.0154 3.41 negative 1.30 0.90 1.50 1.32 0.92 1.62 1.75 1.74 1.11 1.12 0.64 0.85 0.64 
219.0154 7.28 negative 0.95 1.01 0.93 0.94 0.88 1.01 0.38 0.78 0.89 0.90 0.30 0.90 0.72 
219.0492 7.39 positive 0.88 0.88 0.57 0.64 0.71 0.76 0.54 0.83 0.81 1.05 1.66 0.77 1.39 
219.0972 10.97 positive 1.00 2.35 1.05 0.75 1.89 1.16 4.26 2.24 0.84 2.39 3.46 1.22 1.93 
221.0497 6.01 negative 0.74 1.98 1.85 2.61 2.11 2.11 1.18 1.31 1.01 1.72 0.60 2.50 0.45 
221.0674 12.74 negative 55.35 2.41 1.03 0.66 1.45 37.61 8.77 2.12 54.50 3.08 3.41 6.86 1.43 
222.0978 11.36 positive 2.27 26.24 112.75 7.19 1.30 88.27 230.47 170.94 3.16 7.72 11.60 0.86 4.26 
223.0618 5.90 negative 0.93 1.91 1.36 1.99 2.11 1.95 1.02 1.37 1.01 1.43 0.02 2.12 0.65 
223.9854 11.46 negative 0.82 1.01 0.92 1.01 0.90 1.07 0.98 1.08 0.86 1.12 0.81 0.79 1.43 
224.0652 5.90 negative 0.93 1.90 1.36 1.99 2.12 1.97 1.03 1.37 0.99 1.44 0.01 2.14 0.64 
224.9485 2.56 negative 4.00 0.71 1.42 1.07 1.10 0.71 1.10 1.35 2.26 0.82 1.11 0.60 2.68 
225.0623 9.83 negative 1.16 1.41 0.69 1.04 1.31 0.97 0.63 0.35 1.17 1.52 1.11 1.39 1.08 
225.0623 11.47 negative 1.22 1.60 0.77 0.90 0.85 1.20 1.27 0.71 0.90 1.38 0.83 1.08 0.60 
225.0672 5.90 negative 0.94 1.89 1.34 2.01 2.08 1.94 1.03 1.35 1.00 1.37 0.23 2.10 0.63 
219 
 
225.0755 5.70 positive 0.96 1.55 1.48 2.46 1.86 1.45 0.93 1.48 1.03 1.09 0.00 2.09 0.61 
226.0707 10.47 positive 1.03 1.08 1.01 0.98 0.99 1.09 1.28 0.91 0.92 1.01 0.55 0.96 0.74 
226.1799 1.09 positive 2.03 1.27 1.11 1.44 0.91 2.11 0.95 0.97 1.34 1.58 0.88 0.95 0.96 
226.9792 9.12 negative 1.10 1.07 1.41 1.52 1.58 1.01 0.80 1.29 1.12 0.73 1.52 1.42 1.28 
226.9971 7.23 negative 0.91 0.72 1.39 1.09 0.64 1.11 0.36 1.04 0.93 0.57 0.11 0.72 0.30 
227.0205 5.77 negative 0.73 4.21 2.68 4.44 5.82 3.01 1.58 2.32 1.08 1.45 3.65 5.52 0.79 
227.0660 11.80 positive 1.13 1.28 1.31 1.09 1.22 1.18 1.54 1.03 1.04 1.20 0.58 1.10 0.76 
228.0650 13.85 negative 1.05 1.84 0.94 0.81 0.75 0.98 1.07 1.27 1.02 1.82 0.86 1.03 0.21 
228.0993 12.05 positive 1.08 1.44 1.01 0.70 1.52 0.96 1.08 1.23 1.17 1.40 1.08 1.28 1.54 
228.9940 7.23 negative 0.88 0.72 1.39 1.11 0.63 1.08 0.30 1.01 0.87 0.56 0.10 0.73 0.26 
229.0122 18.08 negative 1.39 0.74 0.72 0.62 0.73 1.06 0.23 0.37 1.19 0.86 0.12 1.21 0.17 
229.0867 1.15 positive 0.90 0.41 0.44 0.72 0.71 0.68 0.51 0.24 0.75 1.40 0.35 0.71 0.28 
229.1029 12.02 positive 1.13 1.71 1.07 0.61 1.82 0.98 1.17 1.43 1.28 1.49 1.19 1.43 1.90 
229.1443 5.58 positive 0.49 0.80 0.35 0.93 0.99 0.81 0.81 0.86 0.41 0.77 1.52 0.87 0.29 
230.0973 5.00 positive 0.91 0.70 0.90 0.35 0.60 0.97 1.16 0.75 0.63 0.87 0.29 0.85 0.24 
230.9258 10.73 negative 0.97 1.00 0.97 0.94 0.99 0.98 0.95 0.98 0.99 0.96 0.86 1.00 0.79 
231.0154 5.74 negative 1.74 11.59 0.62 4.19 29.55 1.86 2.34 2.94 0.98 7.60 11.39 15.78 3.76 
231.0605 11.45 negative 0.59 1.01 0.88 0.83 0.66 1.07 1.04 1.12 0.57 1.35 0.48 0.38 1.80 
231.1004 5.12 positive 0.80 0.72 0.82 0.08 0.15 0.96 1.24 0.80 0.57 0.94 10.29 0.87 0.11 
232.9355 9.14 negative 0.97 0.92 1.27 1.22 1.14 1.05 0.91 1.16 0.98 0.79 1.25 1.10 1.24 
233.0673 3.52 negative 1.06 1.00 0.88 0.93 0.80 1.12 0.35 0.69 0.86 1.19 0.01 0.89 0.58 
233.1131 8.87 positive 1.08 2.10 0.93 1.16 1.56 1.01 1.52 0.84 0.92 2.26 1.85 1.78 1.35 
233.1493 6.64 positive 0.86 0.94 0.90 1.40 0.85 1.19 1.27 0.37 1.03 0.91 6.58 0.99 0.25 
234.0194 7.40 positive 0.76 0.81 0.48 0.32 0.52 0.74 0.54 0.63 0.72 1.19 0.36 0.60 0.19 
236.1135 11.06 positive 2.24 64.27 326.28 17.41 1.79 329.94 593.92 487.02 9.24 11.96 12.82 1.92 9.08 
236.9750 9.85 negative 0.80 0.85 0.71 0.77 0.87 0.78 0.60 0.64 0.88 0.90 0.52 0.84 0.64 
237.0411 5.58 negative 1.28 1.65 2.93 3.06 2.04 1.46 2.00 1.23 1.43 1.71 2.10 2.23 1.14 
238.9372 5.30 negative 0.56 1.59 1.24 0.14 0.14 0.84 5.07 0.24 0.69 3.60 0.22 0.15 0.19 
239.0600 7.86 negative 1.09 1.00 0.86 0.70 0.84 1.13 1.21 0.74 0.97 1.16 0.19 0.83 0.61 
239.1486 0.95 positive 2.02 1.27 0.65 1.27 0.83 1.21 1.40 0.77 1.46 2.22 0.94 1.05 1.24 
241.0335 6.70 negative 1.07 1.32 0.51 0.99 1.17 0.92 1.51 1.08 0.99 1.29 0.54 0.97 1.85 
242.0786 12.06 positive 1.02 1.78 0.93 0.67 2.06 0.89 1.01 1.28 1.08 1.27 1.01 1.66 1.81 
242.0788 11.79 negative 1.11 1.22 1.25 1.11 1.19 1.19 1.48 1.02 1.03 1.15 0.59 1.07 0.76 
220 
 
242.9404 4.94 negative 0.97 0.99 0.42 0.32 0.36 1.02 1.13 0.74 0.72 1.09 0.06 0.60 0.05 
243.0542 3.23 negative 0.82 0.92 0.48 0.95 0.55 0.76 0.09 0.25 0.82 0.96 0.05 0.66 0.49 
243.0628 5.51 negative 0.84 0.66 0.85 1.56 1.05 1.16 1.15 0.67 1.11 0.70 9.14 1.04 0.86 
243.0824 11.79 negative 1.12 1.23 1.32 1.13 1.24 1.21 1.50 0.97 1.01 1.13 0.51 1.07 0.72 
244.0620 5.05 negative 1.19 1.03 0.66 0.99 1.01 0.84 0.02 0.16 1.18 1.13 2.73 1.16 1.09 
244.0924 11.80 positive 1.10 1.26 1.30 1.08 1.24 1.16 1.54 1.06 1.04 1.18 0.60 1.08 0.76 
244.1283 7.68 positive 0.81 0.73 1.31 0.88 1.31 1.04 2.15 1.34 0.84 1.09 65.52 1.28 10.75 
244.9412 10.73 negative 0.94 1.03 0.93 0.86 1.01 0.93 0.95 1.00 0.95 1.05 0.80 1.03 0.71 
245.0657 5.05 negative 1.20 1.03 0.70 0.99 1.07 0.84 1.44 0.24 1.20 1.14 3.32 1.15 1.14 
245.0963 11.80 positive 1.10 1.25 1.30 1.07 1.23 1.17 1.54 1.05 1.03 1.18 0.58 1.08 0.76 
247.1286 7.98 positive 1.10 0.75 0.73 1.12 0.85 1.05 1.06 0.47 0.97 0.83 4.33 1.05 1.00 
248.0804 16.06 negative 1.00 1.08 1.02 1.13 0.83 0.97 0.99 0.89 0.98 1.05 0.97 0.88 1.10 
248.1660 4.76 negative 1.17 1.07 1.00 1.23 1.21 1.13 0.78 1.12 1.02 0.74 0.98 1.18 0.77 
248.9608 1.12 negative 0.97 1.15 1.28 1.17 1.13 1.20 1.44 1.33 0.97 0.89 1.60 1.00 1.67 
248.9608 5.41 negative 1.22 0.85 1.12 1.05 1.32 0.95 0.29 1.52 1.22 0.30 1.22 1.18 9.96 
249.0984 6.37 negative 1.09 0.98 0.88 1.04 0.85 0.97 0.51 1.00 0.67 0.71 0.69 1.16 0.04 
249.1079 11.31 positive 1.06 4.73 2.71 1.28 3.08 1.80 22.13 5.84 1.13 6.50 1.13 2.37 1.63 
249.1095 1.10 positive 1.13 1.14 1.25 1.18 1.22 1.03 1.09 1.27 1.08 1.02 1.32 1.01 1.34 
250.0143 8.71 positive 0.77 0.76 0.53 0.36 0.56 0.85 0.62 0.70 0.68 0.95 0.28 0.65 0.18 
250.9959 11.20 negative 0.97 1.24 0.82 0.53 0.80 0.92 1.03 0.88 0.88 1.39 0.79 0.93 0.76 
251.0777 8.28 negative 1.09 0.94 0.94 1.03 0.75 1.02 1.17 1.07 1.07 1.18 0.10 0.83 0.21 
251.0781 12.27 positive 0.88 0.88 0.82 1.00 0.83 0.82 0.78 0.74 0.89 0.79 0.38 0.78 0.31 
251.9988 11.19 negative 1.01 1.24 0.52 0.12 0.55 0.73 0.96 0.51 0.59 1.44 0.39 0.88 0.47 
252.1084 13.36 positive 4.29 17.28 45.95 11.94 3.75 35.66 100.96 49.72 5.71 14.98 15.95 2.75 4.45 
253.0933 4.42 negative 1.03 0.78 0.67 0.59 0.64 0.80 0.58 0.95 0.61 0.37 0.36 0.86 0.32 
253.1044 5.57 positive 1.29 0.78 0.95 0.74 0.90 0.75 0.84 0.90 1.16 0.77 0.83 0.75 1.22 
253.1045 1.11 positive 1.08 1.05 1.12 1.03 1.13 1.06 1.06 1.17 1.06 1.01 1.18 1.04 1.15 
254.0003 5.74 negative 2.04 3.45 6.91 0.60 3.30 0.85 1.99 0.83 1.39 5.45 1.32 1.25 5.77 
254.0843 11.66 positive 4.82 31.90 114.05 13.84 4.84 62.23 287.25 188.28 3.42 17.73 38.43 1.44 11.48 
254.1616 5.81 positive 0.99 0.86 0.87 0.80 0.78 0.91 1.16 0.70 0.84 0.82 0.20 0.68 0.51 
254.9171 1.12 negative 0.90 1.11 1.27 1.09 1.06 1.23 1.51 1.32 0.91 0.83 1.64 0.95 1.68 
254.9172 5.49 negative 1.23 0.70 0.80 0.74 0.98 0.82 0.24 2.07 1.17 0.56 0.42 0.89 4.41 
255.0973 5.79 positive 0.92 0.75 0.90 1.06 0.86 1.25 1.04 0.36 1.22 1.08 1.49 0.76 0.40 
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255.1080 9.64 positive 1.01 0.95 0.44 1.18 1.35 0.91 0.88 0.77 1.62 1.77 0.59 1.42 1.58 
256.0813 9.95 positive 0.91 0.92 0.77 0.93 0.77 0.93 0.93 0.67 1.00 1.11 1.99 0.73 0.48 
258.1098 12.64 positive 1.67 5.58 3.93 1.08 9.64 1.51 5.08 6.23 1.50 8.72 0.38 1.49 9.32 
258.9565 9.85 negative 1.00 0.96 1.02 0.99 1.10 0.97 0.92 1.06 1.05 0.87 0.98 1.05 0.94 
259.0131 12.03 negative 1.36 2.11 1.48 0.46 1.86 1.23 1.62 2.08 1.52 2.54 2.10 1.58 3.48 
259.0226 19.06 negative 1.82 0.85 0.38 0.66 0.58 1.27 0.48 0.35 1.42 0.88 0.14 1.35 0.32 
259.1135 12.63 positive 1.75 5.36 3.76 1.07 9.19 1.48 4.87 6.07 1.43 8.34 1.57 1.41 4.33 
260.1966 11.22 positive 0.46 0.61 0.61 0.85 0.60 0.83 0.18 0.03 0.71 0.93 4.30 0.65 0.89 
261.1305 0.97 positive 2.07 1.32 0.75 1.22 0.80 1.29 1.32 0.89 1.47 2.13 0.86 1.08 1.25 
261.1441 7.39 positive 0.76 0.72 0.84 1.15 0.77 1.14 1.05 0.50 1.00 0.69 3.77 0.94 0.73 
262.0503 13.84 positive 0.85 1.41 0.90 0.65 0.62 0.83 1.04 1.19 0.97 1.53 0.64 0.83 0.31 
264.9885 9.36 negative 1.06 1.56 1.09 0.96 1.08 1.03 0.99 0.96 1.03 1.70 0.00 1.09 0.95 
265.0113 10.91 negative 1.10 2.67 0.95 0.77 2.10 0.99 1.76 1.39 0.83 2.51 0.75 2.28 4.03 
265.0718 5.60 negative 0.65 0.50 0.69 0.66 0.68 0.57 0.52 0.47 0.47 0.89 0.91 0.66 0.19 
265.1045 1.11 positive 1.01 1.01 1.12 1.06 1.05 1.03 1.05 1.11 0.99 0.96 1.35 1.00 1.20 
265.1141 11.14 positive 0.86 1.29 0.60 0.19 0.68 0.75 0.99 0.87 0.73 1.48 0.31 0.69 0.35 
265.9953 11.05 negative 1.10 0.88 0.91 0.71 1.11 1.12 0.95 1.12 0.87 0.75 0.27 0.95 0.82 
266.0745 11.77 positive 1.08 1.15 1.01 1.17 1.15 1.01 0.95 0.81 1.03 1.06 0.63 1.05 0.90 
266.1596 5.80 positive 0.63 0.54 1.25 0.86 0.56 1.15 3.60 0.94 0.85 0.85 0.26 0.64 0.33 
267.0781 11.77 positive 1.09 1.14 1.00 1.15 1.19 0.99 1.00 0.80 1.06 1.13 0.59 1.04 0.88 
267.0923 5.47 negative 0.77 0.26 0.64 0.56 0.55 0.74 0.73 0.26 0.94 0.60 2.94 0.57 0.81 
267.1630 5.88 positive 0.53 0.68 1.25 0.87 0.41 1.19 3.76 0.92 0.87 0.88 0.62 0.65 0.94 
268.1038 5.50 positive 1.02 0.58 0.80 1.71 1.25 1.02 0.85 0.49 1.20 0.58 24.08 1.33 1.20 
269.1077 5.48 positive 1.04 0.50 0.76 1.75 1.27 1.04 0.82 0.43 1.23 0.51 26.89 1.39 1.21 
270.0970 8.83 positive 1.01 1.09 0.81 0.86 0.75 1.03 1.16 0.80 1.01 1.30 0.47 0.75 0.53 
270.8909 5.40 negative 1.28 1.05 0.52 1.16 1.06 1.25 0.46 1.27 1.16 0.38 0.29 1.28 1.19 
271.0716 13.99 negative 0.70 0.89 0.71 0.44 0.55 0.61 0.71 0.70 0.84 1.60 0.53 0.49 1.40 
271.2279 1.04 negative 3.06 1.16 1.00 1.20 0.81 0.92 1.13 0.78 0.74 1.16 1.94 0.72 0.80 
273.0616 5.05 negative 0.85 0.85 1.09 0.71 0.61 1.12 1.22 0.92 0.92 0.97 0.02 0.70 0.45 
274.0721 3.24 negative 0.84 0.93 0.49 0.96 0.60 0.78 0.14 0.30 0.84 0.99 0.10 0.71 0.49 
274.8731 5.27 positive 1.23 1.02 1.00 0.72 0.84 1.17 0.81 1.09 1.25 0.65 0.51 0.78 1.52 
275.0215 7.34 negative 2.01 2.92 0.71 1.42 3.31 0.82 2.14 0.95 1.57 3.74 1.08 3.21 2.74 
275.0756 3.23 negative 0.85 0.92 0.50 0.92 0.59 0.75 0.11 0.28 0.82 0.99 0.07 0.71 0.48 
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275.1348 11.15 positive 0.69 1.02 1.92 0.33 0.67 1.15 3.41 3.60 0.61 1.92 0.40 0.67 1.36 
276.1185 13.05 positive 0.76 2.94 1.09 0.75 0.93 0.94 1.67 1.15 0.71 3.32 1.47 0.86 0.94 
276.8708 5.29 positive 1.40 1.11 0.62 0.63 0.59 1.44 0.69 1.04 1.48 0.73 0.59 0.91 1.87 
277.0240 7.87 negative 1.27 1.29 1.02 0.86 1.17 1.37 0.83 0.67 1.33 1.40 1.53 1.54 0.92 
277.0889 9.62 positive 0.91 0.73 0.61 1.29 0.92 0.95 0.79 0.79 1.41 1.20 0.90 0.95 1.27 
277.1671 5.82 positive 0.85 0.43 0.34 0.20 1.16 0.60 0.61 0.67 0.94 0.66 0.18 1.25 0.54 
279.0274 10.85 negative 1.15 1.97 0.50 0.01 1.91 0.98 1.59 1.25 0.64 1.86 0.04 1.88 2.49 
279.1182 11.50 positive 0.77 0.75 1.03 0.86 0.86 1.09 12.13 2.08 0.72 0.84 0.61 0.95 0.37 
280.0267 13.84 negative 1.02 1.75 0.92 0.74 0.70 0.96 1.00 1.22 0.98 1.77 0.78 0.99 0.40 
280.9089 5.27 negative 1.37 1.22 1.21 0.63 0.86 1.57 1.17 1.03 1.67 0.95 0.73 0.84 2.08 
280.9854 10.93 negative 1.36 5.81 0.85 0.07 3.90 0.79 3.61 1.25 0.60 6.49 0.20 3.67 7.16 
281.0884 12.72 negative 197.85 3.41 0.77 1.01 0.66 135.38 16.74 3.55 206.92 4.32 3.06 13.01 1.11 
281.1255 3.55 negative 0.84 0.66 0.92 1.58 0.81 0.52 0.77 0.72 1.63 1.20 0.57 0.99 1.12 
283.0829 4.71 negative 0.94 0.84 1.16 1.43 0.70 1.17 1.17 0.88 1.60 1.45 0.05 0.88 0.58 
283.2240 1.11 positive 0.99 1.05 1.05 1.04 1.09 1.04 1.01 1.05 0.98 1.00 1.06 1.01 1.10 
283.2240 5.64 positive 1.31 0.79 0.68 0.75 0.91 0.74 0.83 0.93 1.19 0.79 0.59 0.76 1.29 
283.2647 1.84 negative 0.48 0.65 0.88 0.55 0.85 0.55 0.59 1.10 1.00 0.49 0.39 0.88 0.51 
284.0985 9.05 positive 0.92 0.77 0.70 1.24 1.42 0.94 1.08 0.30 1.13 0.84 23.23 1.13 1.38 
285.0620 7.43 negative 1.22 1.03 1.30 2.45 1.14 1.25 1.43 0.99 2.10 2.03 0.39 1.23 1.12 
285.1022 9.04 positive 0.82 0.48 0.46 1.36 1.43 0.92 1.03 0.08 1.09 0.46 30.59 1.00 8.61 
286.0917 11.77 positive 0.90 0.92 0.92 0.89 0.79 1.01 1.16 0.80 1.01 1.11 0.10 0.71 0.54 
287.0777 4.89 negative 0.94 1.01 0.86 0.63 0.75 0.94 1.00 0.85 0.86 1.02 0.47 0.78 0.56 
287.9775 11.04 negative 1.07 1.01 0.87 0.56 1.19 1.13 0.95 1.17 0.85 0.83 0.12 1.01 1.02 
288.9875 7.28 negative 1.04 1.00 1.03 1.12 1.03 1.12 0.40 0.86 0.95 0.87 0.10 1.08 0.41 
289.0686 4.63 positive 1.13 0.97 0.88 0.89 0.71 0.94 0.95 0.80 0.92 1.10 0.32 0.82 0.47 
289.0847 6.57 negative 1.05 1.08 1.05 1.00 0.95 1.09 1.15 0.91 1.02 1.10 0.85 0.97 0.21 
289.0914 12.03 positive 1.26 2.33 1.48 0.47 2.17 1.12 1.56 2.26 1.43 2.84 2.82 1.60 6.17 
289.1392 6.83 positive 1.07 1.18 0.73 0.49 0.96 1.06 1.05 1.05 0.70 1.12 0.01 0.96 0.38 
291.0973 6.57 positive 1.02 0.97 0.97 0.88 0.84 0.95 0.97 0.74 0.99 1.07 0.54 0.86 1.43 
291.1297 15.85 positive 1.13 0.78 1.15 0.89 1.29 1.22 2.17 1.78 1.20 1.12 1.30 1.72 1.19 
293.0541 14.01 negative 0.77 0.95 0.84 0.68 0.79 0.78 0.81 0.85 0.95 1.28 0.79 0.73 0.05 
293.1452 10.64 positive 0.98 1.53 0.74 0.57 1.27 0.91 1.03 0.88 0.83 1.59 0.40 1.33 1.05 
293.1762 1.01 negative 1.44 0.77 0.69 0.79 0.84 0.80 4.50 1.13 1.26 1.19 2.43 0.47 1.32 
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293.1794 6.64 negative 1.42 0.63 1.43 1.98 1.11 0.53 0.07 0.79 1.10 0.74 0.89 0.77 1.11 
293.2107 0.90 positive 4.46 5.17 16.72 8.64 5.67 3.43 157.88 61.23 5.05 6.46 136.76 1.95 6.71 
294.9975 9.82 negative 0.76 0.83 0.90 0.89 0.64 0.90 0.59 0.53 0.86 0.91 0.08 0.56 0.44 
295.0348 4.41 negative 14.07 6.72 0.86 0.83 0.98 1.33 16.11 3.20 1.00 7.81 9.82 0.59 2.83 
295.0675 14.04 positive 0.90 0.80 0.88 0.85 0.99 0.87 0.72 0.89 1.03 0.79 0.82 0.93 0.61 
295.1045 6.38 negative 1.02 0.83 0.76 0.81 0.73 0.84 0.67 0.94 0.67 0.74 0.54 1.00 0.20 
296.0970 12.02 positive 1.53 0.93 1.02 0.49 0.76 1.01 0.83 1.22 1.46 1.19 0.38 1.32 0.94 
297.0585 5.99 positive 1.32 0.75 1.44 0.35 0.56 0.57 1.31 1.30 1.01 1.04 0.21 0.49 1.22 
297.1201 5.57 negative 1.08 0.76 0.75 0.69 0.49 0.83 0.76 0.85 0.74 1.81 0.44 0.68 0.48 
297.1539 8.23 negative 1.17 1.12 1.00 1.18 1.10 1.10 0.87 1.14 1.06 0.95 1.42 1.12 0.85 
297.2447 0.96 negative 1.17 0.89 0.87 1.15 0.76 0.81 1.27 0.80 1.05 1.55 1.06 0.62 1.00 
298.0955 14.04 positive 0.85 6.18 1.16 0.67 0.72 0.91 2.54 1.41 0.70 7.46 3.57 0.68 0.62 
298.1571 8.25 negative 1.16 1.13 1.00 1.19 1.12 1.09 0.90 1.14 1.05 0.93 1.08 1.12 0.83 
299.0522 4.40 positive 0.93 0.90 0.92 0.72 0.77 1.06 1.20 1.05 0.84 1.06 0.17 0.90 0.64 
299.0783 7.26 negative 0.94 1.09 1.27 1.31 0.91 1.22 1.61 1.23 1.32 1.50 0.16 1.17 1.19 
299.0993 9.63 negative 0.94 0.76 0.67 1.36 0.92 1.04 0.95 0.95 1.43 1.09 0.89 0.92 1.11 
301.0938 4.71 negative 0.87 0.74 0.83 0.98 0.70 0.91 0.99 0.93 1.09 1.24 0.31 0.81 0.62 
301.1057 8.67 positive 2.68 14.06 1.40 0.97 4.94 3.16 6.91 5.36 2.71 15.53 9.59 3.34 1.36 
302.1019 12.65 negative 0.69 5.53 3.75 1.13 9.72 0.61 3.73 5.13 0.54 8.08 0.19 1.37 8.33 
303.0037 10.78 negative 3.58 0.50 4.81 1.37 1.23 3.66 82.12 11.26 1.24 1.13 66.47 0.37 1.99 
303.0489 9.66 positive 1.17 1.25 0.90 0.82 1.19 1.13 1.19 0.95 0.89 0.97 0.03 1.26 0.74 
303.0730 8.24 negative 0.97 1.04 0.81 0.86 1.20 1.08 1.15 0.90 1.67 2.08 0.26 0.86 0.70 
305.0134 7.30 negative 1.21 1.05 0.26 0.09 0.17 1.70 0.73 1.07 1.17 1.04 0.00 0.23 0.51 
305.0886 4.40 negative 0.96 1.03 1.03 0.87 0.86 1.16 1.30 1.08 0.97 1.18 0.19 1.01 0.79 
305.0992 3.55 positive 1.01 0.95 0.88 0.82 0.84 0.99 1.11 0.90 0.88 1.03 0.46 0.81 0.65 
305.1566 0.94 positive 1.38 1.39 0.76 1.33 0.97 1.51 0.93 0.77 1.59 2.16 0.81 1.19 1.41 
306.0167 7.27 negative 1.33 0.98 0.22 0.00 0.00 2.09 0.78 1.03 1.42 0.67 0.00 0.10 0.67 
307.1405 6.47 negative 1.13 1.19 1.25 1.01 1.08 1.22 1.43 0.98 0.86 0.82 0.21 1.07 0.38 
308.0123 8.74 negative 0.84 0.65 0.56 0.41 0.63 0.90 0.45 0.82 0.69 0.66 0.35 0.73 0.20 
308.0905 11.42 positive 0.46 2.12 0.17 0.12 1.08 0.28 0.12 1.00 0.32 1.09 0.00 1.26 0.34 
309.1199 4.13 negative 0.95 0.92 0.87 0.89 0.70 0.94 0.95 0.85 0.97 1.11 0.18 0.78 0.53 
309.1301 5.60 positive 1.19 0.90 0.78 0.82 0.83 0.87 0.64 1.01 1.11 0.96 0.47 0.85 1.48 
309.1302 1.11 positive 1.02 1.04 1.13 1.06 1.08 1.01 0.96 1.12 0.94 0.93 1.18 1.07 1.22 
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309.2079 0.99 negative 1.63 1.11 2.50 1.75 1.45 0.84 10.71 4.39 1.79 1.49 3.08 1.11 2.38 
311.1144 6.02 negative 0.88 2.28 1.82 2.70 1.52 1.77 1.78 1.39 1.21 98.16 0.85 1.55 211.51 
311.1265 7.41 positive 0.76 1.42 0.86 0.48 0.85 0.78 0.87 1.15 0.67 1.81 0.83 0.84 0.23 
311.1459 5.70 positive 1.24 0.76 0.74 0.77 0.78 0.76 0.91 1.04 1.34 0.86 0.54 0.79 1.52 
311.1461 1.11 positive 1.04 1.03 1.04 1.03 1.05 0.96 0.98 1.10 0.97 0.91 1.14 1.02 1.19 
311.1693 8.15 negative 1.17 1.13 0.99 1.15 1.07 1.13 0.93 1.12 1.04 0.99 1.47 1.10 0.88 
311.2237 0.99 negative 1.66 1.22 1.65 1.74 1.37 0.87 19.30 4.55 1.51 1.61 5.98 1.04 1.58 
312.0956 5.48 negative 0.88 0.47 0.62 0.70 0.66 0.83 0.95 0.40 1.12 0.60 2.93 0.71 1.07 
312.1298 7.41 positive 0.75 1.40 0.85 0.47 0.84 0.77 0.86 1.15 0.66 1.79 0.81 0.84 0.22 
312.1726 8.16 negative 1.18 1.13 0.99 1.17 1.06 1.13 0.91 1.11 1.04 0.99 1.46 1.11 0.88 
313.0991 5.48 negative 0.89 0.49 0.62 0.69 0.64 0.82 0.95 0.39 1.10 0.93 2.93 0.72 1.09 
313.1205 7.39 positive 0.77 1.43 0.87 0.46 0.85 0.77 0.87 1.17 0.67 1.80 0.82 0.84 0.27 
313.1635 8.17 negative 1.12 1.10 0.94 1.13 1.01 1.10 0.84 1.06 1.01 0.95 1.38 1.07 0.82 
313.2731 9.04 positive 0.98 0.98 0.85 0.84 0.79 0.98 1.18 0.93 0.94 1.25 0.80 0.81 0.61 
314.1079 11.99 positive 1.16 0.87 0.88 0.58 0.71 0.86 0.81 0.96 1.21 1.16 0.21 1.00 0.70 
315.1091 4.09 negative 0.83 0.85 1.27 1.21 0.73 1.00 1.49 1.04 1.10 1.27 0.42 0.89 0.87 
315.1268 10.68 positive 1.08 1.02 0.70 0.57 1.13 1.09 0.98 1.07 0.92 0.98 0.51 1.16 0.60 
316.9491 1.12 negative 0.97 1.16 1.31 1.17 1.14 1.21 1.49 1.35 0.96 0.85 1.65 0.96 1.67 
316.9492 5.43 negative 1.10 0.87 1.06 1.11 1.49 0.97 0.21 2.07 1.40 0.54 1.33 1.29 3.32 
319.0684 5.06 negative 0.84 0.84 1.07 0.68 0.60 1.12 1.18 0.91 0.91 0.95 0.02 0.68 0.44 
319.1143 3.52 positive 0.81 0.78 0.88 0.53 0.79 0.91 0.98 0.98 0.51 0.66 0.21 0.83 0.35 
321.1203 6.77 negative 0.96 1.23 0.87 0.47 0.94 1.04 0.89 1.03 0.57 0.73 0.09 0.92 3.33 
322.1124 8.19 positive 0.94 1.02 0.83 0.88 1.43 1.09 1.07 0.94 1.92 2.28 0.27 0.94 0.68 
322.9055 1.12 negative 0.93 1.14 1.34 1.18 1.12 1.29 1.69 1.37 0.93 0.84 1.78 0.96 1.84 
323.1359 7.52 negative 1.07 0.92 0.99 0.96 0.85 1.08 1.23 0.96 1.03 1.21 0.77 0.85 0.52 
323.1359 5.85 negative 0.87 0.88 1.05 1.96 1.10 0.95 1.08 1.23 1.75 1.83 0.70 1.40 1.33 
323.1457 5.72 positive 1.41 0.75 0.72 0.48 0.73 0.76 1.11 1.04 1.27 1.02 0.41 0.61 1.65 
323.1458 1.11 positive 1.04 1.04 1.07 0.99 1.05 0.99 1.00 1.16 0.92 0.93 1.24 0.94 1.23 
324.0926 12.66 positive 3.38 38.86 206.32 6.40 3.00 177.43 603.92 489.35 2.20 12.06 17.52 1.17 7.31 
325.1121 12.05 positive 1.85 2.45 1.53 0.49 2.26 1.61 1.61 2.34 2.09 2.92 3.09 1.70 6.87 
325.1853 8.07 negative 1.16 1.14 1.00 1.12 1.05 1.12 0.95 1.11 1.05 1.02 1.46 1.08 0.88 
326.1887 8.08 negative 1.16 1.13 0.98 1.13 1.06 1.13 0.95 1.11 1.05 1.02 1.46 1.07 0.88 
326.9023 4.94 negative 0.98 0.99 0.38 0.26 0.31 1.02 1.13 0.70 0.71 1.07 0.02 0.56 0.02 
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327.0678 8.19 positive 0.92 0.95 0.73 0.87 1.24 1.00 0.87 0.77 1.75 2.07 0.27 0.82 0.66 
327.1128 3.65 negative 0.99 1.02 0.73 0.70 0.77 0.97 0.60 0.67 0.77 0.94 0.19 1.03 0.60 
327.1801 8.08 negative 1.14 1.10 0.69 0.77 1.01 1.13 0.90 1.07 1.03 1.00 1.17 1.12 0.88 
329.0889 4.68 negative 0.95 0.84 1.17 1.42 0.71 1.19 1.18 0.89 1.62 1.46 0.04 0.89 0.56 
329.1097 11.09 negative 1.15 0.90 0.94 1.24 0.73 1.15 1.08 0.95 1.11 1.20 0.75 1.18 0.65 
330.0922 4.70 negative 0.94 0.84 1.16 1.41 0.70 1.18 1.18 0.87 1.61 1.46 0.02 0.88 0.55 
330.1386 9.73 positive 1.05 1.00 0.40 1.16 1.49 0.89 0.91 0.75 1.68 1.92 0.49 1.59 1.06 
332.1697 8.57 positive 1.73 3.27 1.04 1.04 1.76 1.73 2.52 1.94 1.63 3.16 2.83 1.49 1.04 
332.8570 4.08 positive 1.49 1.56 0.39 0.98 1.22 0.53 0.72 0.36 1.52 2.32 2.30 1.48 1.03 
333.0836 4.92 negative 1.35 1.17 1.06 1.08 0.75 0.91 0.98 0.84 0.91 1.06 1.46 1.31 0.52 
335.1302 6.09 positive 1.63 0.85 4.14 5.07 4.06 2.68 0.92 5.27 8.80 7.95 6.84 0.65 8.04 
335.1355 6.52 negative 0.92 1.41 1.02 0.34 1.03 1.24 1.19 1.11 0.97 1.78 0.11 0.91 0.06 
337.0784 11.66 negative 0.95 0.91 0.92 0.70 0.80 1.01 1.07 0.87 0.81 1.12 0.32 0.87 0.57 
337.1098 11.88 positive 1.08 0.98 0.85 1.03 0.86 1.00 1.02 0.83 0.98 1.06 2.10 0.94 0.81 
338.1227 8.18 positive 1.21 1.09 0.90 0.82 1.35 1.21 1.21 0.83 0.78 0.81 0.27 1.16 0.69 
338.3410 0.99 positive 4.88 0.67 0.70 0.69 0.35 2.10 0.70 0.18 1.68 1.01 0.13 0.54 0.25 
338.8945 4.09 negative 1.56 1.73 0.45 1.06 1.37 0.58 0.75 0.56 1.63 2.46 2.49 1.62 1.10 
339.0736 5.91 negative 0.85 2.07 1.36 2.08 2.33 1.99 0.93 1.33 0.99 1.53 0.01 2.25 0.60 
339.1402 1.10 positive 1.03 1.09 1.18 1.05 1.09 1.01 1.03 1.24 1.01 0.95 1.31 0.99 1.33 
339.1404 5.79 positive 1.46 0.73 0.72 0.32 0.48 0.66 1.10 1.02 1.32 1.02 0.50 0.39 1.79 
339.2015 8.01 negative 1.11 1.09 0.98 1.08 1.01 1.09 0.97 1.07 1.04 1.00 1.42 1.05 0.86 
340.0472 11.79 negative 1.11 1.21 1.22 1.13 1.21 1.18 1.42 0.99 1.04 1.14 0.57 1.08 0.75 
340.0770 5.91 negative 0.86 2.08 1.36 2.09 2.31 2.00 0.92 1.34 0.99 1.52 0.01 2.25 0.15 
340.2048 8.01 negative 1.13 1.10 1.00 1.06 1.01 1.10 0.97 1.07 1.04 1.00 1.41 1.06 0.87 
341.0788 5.90 negative 1.09 2.75 1.77 2.70 3.03 2.60 1.18 1.69 1.29 1.99 1.51 2.95 0.77 
341.1103 12.66 negative 23.67 1.06 0.63 1.02 0.52 25.47 5.11 0.94 37.85 0.72 1.17 3.99 0.25 
341.1104 12.04 negative 1.30 1.98 1.41 0.63 1.79 1.21 1.49 1.92 1.42 2.40 2.12 1.49 3.97 
341.1972 8.01 negative 1.15 1.00 0.84 0.87 0.96 1.04 0.88 1.05 0.97 0.95 1.40 0.91 0.78 
342.1031 12.63 positive 3.66 49.90 290.16 5.85 38.49 214.59 854.78 741.06 0.53 130.46 172.75 0.63 635.95 
342.1139 12.04 negative 1.30 1.96 1.38 0.62 1.78 1.20 1.48 1.89 1.40 2.40 2.14 1.49 3.96 
342.1396 8.03 positive 0.98 1.05 0.90 0.76 0.87 1.03 1.06 0.77 0.99 1.18 0.45 0.82 0.45 
343.1153 12.04 negative 1.28 1.97 1.40 0.60 1.82 1.19 1.48 1.89 1.43 2.39 2.13 1.47 4.01 
345.1145 5.85 positive 1.34 0.60 0.78 0.80 0.48 0.59 1.45 0.87 2.35 2.11 0.17 0.45 2.08 
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348.8972 5.37 negative 1.28 1.07 0.73 0.79 0.76 1.23 0.77 1.09 1.15 0.62 1.35 1.15 1.38 
349.1519 6.32 negative 0.99 1.73 1.26 0.42 1.07 1.44 1.47 1.19 0.43 0.70 0.07 1.03 0.16 
349.1819 0.93 positive 1.47 1.05 0.70 1.04 0.77 1.10 0.88 0.63 1.28 2.11 0.70 0.87 1.06 
351.1035 6.16 positive 0.63 0.83 0.60 3.43 0.41 0.74 0.92 0.54 4.57 7.34 0.04 0.55 1.15 
351.1674 5.59 negative 1.08 1.05 1.72 1.45 0.88 1.12 1.53 1.09 1.05 1.20 2.27 1.10 0.94 
357.1204 6.02 negative 0.86 1.11 1.45 1.61 0.89 1.16 1.35 1.05 1.18 1.53 0.43 1.03 0.88 
358.1843 13.98 positive 0.89 1.30 0.83 0.66 0.65 0.83 3.35 1.00 0.93 1.87 0.66 0.77 0.50 
359.1480 0.95 positive 0.67 0.54 0.95 1.11 0.62 0.73 0.75 0.93 1.16 1.35 0.49 0.71 1.15 
360.1492 12.03 positive 1.19 2.05 1.32 0.53 1.95 1.16 1.35 1.96 1.50 2.28 2.31 1.50 3.95 
361.1515 6.27 negative 0.99 1.65 1.23 0.78 1.05 1.39 1.33 1.15 0.79 1.10 0.58 1.04 0.37 
363.1671 6.14 negative 0.92 1.93 1.52 0.41 1.08 1.80 1.96 1.46 0.48 0.63 0.32 1.17 0.43 
364.0647 18.38 positive 0.89 0.44 0.32 0.64 0.93 0.60 0.48 0.22 0.80 0.59 1.87 0.77 0.38 
364.8716 5.31 negative 1.41 1.23 1.45 0.41 0.33 1.79 1.48 1.06 1.98 1.18 0.05 0.72 2.29 
365.1042 12.03 positive 1.28 1.53 1.16 0.69 1.47 1.11 1.10 1.45 1.34 1.69 1.74 1.31 2.71 
365.1193 5.90 positive 1.71 0.48 0.95 0.38 0.43 0.59 1.78 0.77 0.98 0.48 0.02 0.38 0.74 
365.1835 5.51 negative 0.99 1.07 1.39 1.24 0.98 1.10 1.37 1.12 1.04 1.07 0.31 0.98 0.97 
366.1078 12.03 positive 1.28 1.54 1.14 0.70 1.46 1.10 1.10 1.45 1.34 1.69 1.75 1.31 2.74 
367.1093 12.03 positive 1.26 1.53 1.11 0.67 1.47 1.06 1.06 1.43 1.30 1.66 1.77 1.33 2.72 
367.1715 1.11 positive 1.01 1.04 1.11 0.99 1.05 0.97 0.99 1.09 0.96 0.94 1.31 1.02 1.26 
369.0410 14.01 negative 0.82 0.96 0.83 0.71 0.80 0.80 0.79 0.85 0.93 1.23 0.79 0.74 0.53 
369.0779 6.18 positive 1.56 1.03 1.09 0.98 1.15 1.04 1.18 1.68 1.60 1.43 0.36 1.08 2.12 
371.1360 5.87 negative 0.92 0.94 1.25 1.06 0.78 1.01 1.20 1.03 0.85 0.85 0.26 0.93 0.57 
375.2041 6.06 negative 0.87 1.29 1.33 1.27 1.05 1.31 1.37 1.16 0.89 1.12 1.06 1.05 0.73 
376.1956 8.61 positive 1.85 3.31 1.14 1.23 1.87 1.86 2.72 2.04 1.72 3.36 3.39 1.66 1.30 
377.9951 13.79 negative 1.02 1.52 0.77 0.68 0.66 0.85 0.79 1.00 0.90 1.68 0.65 0.93 0.54 
379.0991 6.02 positive 1.69 0.61 1.47 1.39 0.73 0.60 1.62 1.14 2.53 2.58 0.24 0.62 2.26 
379.1576 8.10 negative 1.07 1.12 0.73 1.00 0.57 0.96 0.66 1.39 1.18 0.60 1.30 0.99 1.56 
379.1989 5.45 negative 0.74 0.66 1.08 0.94 0.83 0.94 1.33 0.97 0.94 0.70 0.23 0.71 0.45 
381.0784 12.04 positive 1.19 1.48 1.01 0.59 1.23 1.04 1.11 1.24 1.19 1.81 1.11 1.15 1.89 
381.0936 5.90 positive 1.20 0.72 1.04 0.76 0.76 1.19 1.46 0.78 0.75 0.49 0.02 0.82 0.43 
381.1298 0.95 positive 0.70 0.60 1.06 1.13 0.65 0.76 0.74 1.11 1.05 1.34 0.62 0.78 1.33 
381.3389 1.00 negative 0.84 0.94 0.95 1.50 0.79 0.96 1.17 0.63 0.89 1.17 4.02 0.78 0.84 
382.1332 0.95 positive 0.74 0.60 1.08 1.08 0.64 0.78 0.67 1.10 1.04 1.32 0.62 0.77 1.35 
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383.1668 1.12 positive 1.08 1.13 1.12 1.15 1.18 1.91 1.55 1.21 1.01 0.98 1.33 1.06 1.31 
383.1669 5.80 positive 1.81 0.61 0.62 0.45 0.39 0.57 0.94 1.01 1.42 0.90 0.34 0.26 1.84 
384.9366 1.12 negative 1.01 1.20 1.40 1.19 1.19 1.26 1.69 1.42 0.98 0.91 1.86 0.95 1.86 
384.9367 3.42 negative 2.95 0.51 0.39 0.00 0.35 0.82 0.75 0.36 1.03 1.08 65.87 1.16 0.10 
385.1154 5.66 negative 0.88 0.77 0.74 0.74 0.49 0.82 0.90 0.85 0.91 1.06 0.05 0.57 0.50 
386.1187 5.62 negative 0.87 0.77 0.73 0.74 0.49 0.81 0.90 0.84 0.90 1.04 0.00 0.57 0.50 
387.1156 12.04 negative 1.28 1.94 1.39 0.61 1.75 1.19 1.44 1.90 1.41 2.33 2.03 1.47 3.76 
387.1310 5.91 negative 1.36 0.65 0.98 0.67 0.61 0.92 1.49 0.87 0.88 0.47 0.08 0.61 0.61 
388.1191 12.04 negative 1.28 1.95 1.37 0.62 1.74 1.16 1.43 1.87 1.40 2.36 2.02 1.46 3.77 
389.1206 12.04 negative 1.32 1.98 1.41 0.62 1.77 1.19 1.47 1.93 1.43 2.37 2.05 1.50 3.83 
389.1367 5.90 negative 1.54 0.51 1.15 0.66 0.50 1.02 1.75 0.97 1.03 0.28 0.06 0.59 0.67 
390.2113 8.57 positive 1.42 2.57 1.10 1.10 1.46 1.44 2.07 1.69 1.45 2.64 2.49 1.38 1.05 
390.8930 1.12 negative 0.99 1.28 1.50 1.34 1.19 1.40 2.01 1.54 0.97 0.90 2.11 0.98 2.15 
391.1194 7.38 positive 0.74 0.72 0.31 0.17 0.47 0.59 0.25 0.60 0.65 1.02 0.63 0.59 0.11 
391.1986 6.62 negative 0.93 1.02 1.40 1.03 0.89 1.12 1.26 1.06 0.73 0.70 0.80 0.96 0.42 
393.1328 4.70 positive 0.90 0.97 0.72 0.85 0.66 0.89 0.96 0.76 0.85 1.04 0.28 0.78 0.34 
393.1729 8.02 negative 1.31 1.00 0.76 0.60 0.47 1.20 0.78 1.29 0.92 0.81 1.10 0.87 1.23 
399.1708 4.71 negative 0.92 1.03 0.77 0.91 0.66 0.93 0.97 0.74 0.87 0.98 0.39 0.76 0.42 
401.1817 5.45 negative 1.17 1.30 0.78 1.17 1.17 1.18 0.54 1.55 1.27 0.52 0.25 1.13 1.37 
403.1635 6.42 negative 1.04 1.28 1.01 0.38 1.14 1.10 1.17 1.01 0.22 0.20 0.36 1.09 0.09 
405.2147 6.47 negative 1.08 1.07 1.57 1.13 0.88 1.15 1.31 1.06 0.74 0.76 0.84 1.08 0.28 
406.2062 8.58 positive 1.82 3.65 1.23 1.13 1.91 1.83 3.03 2.05 1.73 3.93 3.60 1.64 1.22 
409.1094 5.63 positive 1.16 0.89 0.56 0.33 0.48 1.03 0.82 1.26 1.23 0.83 0.06 0.33 0.88 
410.8641 4.94 negative 0.95 0.97 0.35 0.23 0.28 1.02 1.09 0.69 0.68 1.06 0.01 0.53 0.00 
413.1011 7.39 positive 0.77 0.75 0.40 0.24 0.55 0.65 0.33 0.67 0.70 1.06 0.62 0.64 0.34 
415.1470 13.39 negative 0.89 1.21 0.66 1.52 1.03 1.03 0.80 0.24 1.25 1.55 0.67 1.01 1.00 
415.1987 3.34 negative 1.21 1.31 0.84 0.99 1.04 1.10 1.27 0.98 1.08 1.67 1.15 1.00 0.95 
417.1510 5.41 positive 0.70 0.84 1.08 0.81 0.68 0.89 1.60 0.69 0.87 1.36 0.24 0.62 0.39 
417.2117 8.05 negative 1.15 1.13 1.00 1.18 1.09 1.17 0.99 1.07 1.09 0.97 1.17 1.06 0.87 
420.0473 12.65 negative 1.18 7.52 39.59 1.78 1.40 27.97 120.42 96.33 0.77 2.84 3.50 0.72 1.42 
421.1880 5.79 negative 0.84 1.07 1.19 1.19 0.87 1.13 1.31 1.10 0.96 1.10 0.91 0.86 0.75 
423.1527 8.02 negative 1.11 1.13 1.11 1.23 0.88 1.00 0.46 0.93 1.08 0.86 1.46 1.11 0.60 
425.0836 5.62 positive 0.70 0.76 0.72 0.77 0.48 0.67 0.96 0.69 0.74 1.26 0.00 0.56 0.28 
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431.1940 4.66 negative 1.14 1.10 0.90 0.94 0.89 1.07 1.14 0.95 0.98 1.23 0.77 0.97 0.71 
431.2220 8.51 negative 1.08 1.16 2.34 1.21 0.90 1.60 3.57 2.79 0.97 1.40 2.41 0.99 0.64 
431.3182 1.06 negative 1.15 0.66 0.88 1.14 0.81 0.99 1.10 1.02 0.96 0.63 0.28 0.96 0.68 
433.1114 7.71 positive 1.07 1.17 0.83 0.70 1.19 1.05 0.94 0.91 0.96 1.21 0.89 1.33 0.55 
433.2094 4.19 negative 1.00 1.02 0.78 0.86 0.86 1.00 1.02 0.90 1.00 1.36 0.71 0.91 0.74 
436.0427 15.70 negative 1.23 3.31 8.75 1.15 0.83 5.28 35.70 21.60 0.43 1.85 6.02 0.74 1.44 
437.2046 6.62 negative 0.93 1.00 1.44 0.98 0.85 1.13 1.24 1.04 0.69 0.74 0.70 0.96 0.28 
439.0775 12.05 negative 1.40 1.84 1.33 0.60 1.69 1.24 1.35 1.77 1.51 2.20 1.87 1.45 3.15 
439.1411 13.40 positive 0.90 1.25 0.64 1.35 1.08 1.00 0.81 0.28 1.27 1.58 0.62 1.01 1.18 
440.0809 12.05 negative 1.39 1.83 1.30 0.61 1.67 1.22 1.33 1.75 1.49 2.18 1.87 1.44 3.13 
441.0771 12.06 negative 1.39 1.83 1.34 0.59 1.68 1.25 1.34 1.76 1.48 2.20 1.84 1.44 3.11 
447.0548 13.82 negative 1.01 6.94 17.74 0.94 0.50 13.02 57.93 34.80 0.41 1.95 6.66 0.56 0.47 
450.2322 8.60 positive 1.81 3.39 1.12 1.13 1.94 1.81 2.89 2.11 1.70 3.59 3.42 1.67 1.27 
453.0928 12.08 negative 1.36 1.83 1.26 0.45 1.54 1.09 1.20 1.73 1.77 2.54 1.49 1.38 4.38 
455.1027 12.06 negative 1.40 1.79 1.32 0.65 1.68 1.25 1.38 1.74 1.50 2.14 1.85 1.47 3.05 
457.1099 3.47 positive 1.08 0.91 1.27 1.66 1.42 1.41 1.34 0.73 0.84 0.51 0.26 0.81 0.49 
457.2043 1.12 positive 1.03 1.13 1.13 1.15 1.12 1.09 1.06 1.26 1.00 1.01 1.42 1.06 1.39 
458.8798 1.12 negative 0.84 1.29 1.62 1.22 1.22 1.50 2.07 1.67 1.01 0.74 2.31 0.93 2.47 
461.1518 13.39 negative 0.89 1.20 0.63 1.44 1.02 0.96 0.73 0.22 1.21 1.50 0.65 0.98 0.98 
463.1463 3.47 negative 1.08 0.95 1.27 1.74 1.41 1.45 1.41 0.75 0.86 0.54 0.29 0.85 0.53 
464.2473 8.56 positive 1.49 2.93 1.17 1.12 1.57 1.55 2.41 1.87 1.51 3.05 2.17 1.48 1.21 
476.1600 12.06 positive 1.49 0.87 0.95 0.52 0.74 0.97 0.81 1.11 1.46 1.07 0.39 1.25 0.85 
476.2761 7.71 positive 2.29 2.09 6.64 2.61 2.82 3.09 22.83 15.61 1.57 2.42 15.95 3.53 1.26 
477.0651 11.95 negative 0.43 21.52 105.08 2.32 0.54 95.33 189.85 93.24 3.20 4.88 24.99 0.75 1.26 
478.2629 6.75 positive 0.96 1.19 0.97 1.03 1.22 1.16 1.21 1.24 1.05 1.07 2.25 1.08 0.44 
479.2503 7.08 negative 0.90 1.03 1.01 0.86 0.92 1.05 1.18 0.88 0.77 0.86 0.11 0.75 0.33 
480.2428 8.58 positive 1.80 3.71 1.21 1.13 1.96 1.86 3.01 2.05 1.71 3.91 3.51 1.66 1.27 
482.2224 6.04 positive 0.25 1.55 1.54 1.71 1.34 1.41 1.09 1.05 0.41 0.92 1.56 1.30 0.01 
487.1790 6.01 positive 1.41 0.65 1.04 0.64 0.51 0.67 1.39 1.17 1.34 1.11 0.55 0.51 1.44 
492.1039 13.34 negative 3.83 14.14 39.25 10.69 2.96 29.74 83.93 42.75 4.57 11.78 14.53 2.41 3.38 
494.2581 6.70 positive 0.85 1.07 1.23 1.14 1.18 1.26 1.63 1.26 1.03 1.03 2.64 1.16 0.00 
503.1611 14.65 negative 2.15 13.55 3.79 1.13 7.73 3.16 9.27 7.36 1.86 19.59 2.27 1.89 8.04 
505.2470 7.98 negative 1.42 2.23 1.10 0.91 1.97 1.66 0.70 0.88 1.60 3.02 4.33 2.79 1.53 
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505.2566 10.05 negative 1.66 0.23 1.07 1.56 1.02 0.79 17.16 5.86 1.02 0.91 62.75 1.19 1.23 
513.1133 13.39 negative 0.90 1.22 0.63 1.39 1.02 0.99 0.73 0.22 1.23 1.56 0.62 1.00 1.09 
525.2453 3.84 positive 1.09 0.76 1.10 0.75 0.83 1.86 2.66 2.71 0.94 1.32 1.83 0.94 0.76 
527.1577 12.02 positive 1.44 2.77 1.55 0.36 2.59 1.21 1.43 2.46 1.71 3.50 3.32 1.95 6.46 
539.2247 4.47 positive 1.98 0.80 1.70 2.35 1.49 0.71 0.91 3.53 3.00 1.55 0.03 1.19 0.73 
539.2880 9.03 positive 1.00 1.02 0.86 0.86 0.85 1.01 1.22 0.94 1.00 1.31 0.88 0.86 0.53 
571.4702 8.37 positive 1.12 1.05 0.84 0.83 0.89 1.06 0.88 1.12 0.87 1.16 0.69 0.99 0.68 
573.4853 8.36 positive 1.17 1.10 0.92 0.93 0.96 1.01 0.95 1.26 0.94 1.25 0.75 1.04 0.72 
573.4857 10.36 positive 1.00 1.14 0.96 0.80 1.02 1.02 1.34 1.22 0.94 1.22 0.94 1.02 0.95 
575.5012 10.34 positive 1.08 1.13 1.01 0.87 1.06 1.03 1.33 1.23 1.00 1.28 0.99 1.04 0.94 
576.5047 10.34 positive 1.07 1.13 1.01 0.84 1.06 0.99 1.35 1.27 0.97 1.28 0.99 1.04 0.95 
577.5167 8.34 positive 1.09 0.91 0.77 0.93 0.87 0.90 0.95 1.06 0.91 0.93 0.80 0.98 0.58 
585.4498 1.11 positive 0.98 0.91 0.58 0.56 0.75 1.24 0.76 0.58 0.67 0.92 0.80 0.88 0.56 
591.1749 3.15 negative 0.89 0.94 0.86 0.91 0.71 0.93 0.97 0.74 0.87 0.67 0.00 0.73 0.58 
593.2742 6.69 positive 0.87 1.07 0.84 1.02 1.08 1.06 1.83 0.39 0.84 1.38 0.43 1.18 0.28 
593.2759 12.14 negative 0.48 1.42 1.49 1.68 0.75 1.16 9.02 1.00 0.83 2.53 23.54 0.53 0.72 
595.1644 8.44 positive 1.25 1.20 1.00 0.87 1.12 1.31 1.34 1.18 0.98 1.02 0.32 1.19 0.65 
595.2917 12.05 negative 1.36 2.97 1.83 2.83 1.29 2.07 9.23 1.13 1.41 3.03 22.77 1.53 0.77 
596.1678 8.43 positive 2.11 0.00 1.09 0.00 2.78 3.28 2.33 1.01 0.00 1.17 0.73 2.94 0.00 
611.1573 9.66 positive 1.13 1.18 0.89 0.79 1.12 1.13 1.15 0.95 0.87 0.91 0.00 1.20 0.67 
613.1557 17.01 positive 1.22 1.22 1.28 0.81 0.94 1.31 1.84 1.56 1.15 1.26 0.23 1.16 0.70 
669.4559 6.87 negative 1.08 1.00 1.01 1.08 0.98 1.18 1.19 0.90 0.97 1.11 0.82 0.90 0.61 
671.4711 6.85 negative 1.12 0.83 1.00 1.15 0.99 1.18 1.06 0.83 1.01 0.93 0.67 0.92 0.60 
672.4748 6.85 negative 1.13 0.82 1.00 1.16 0.99 1.19 1.07 0.84 1.02 0.93 0.67 0.93 0.56 
693.4624 6.82 negative 1.19 0.82 0.94 1.05 0.89 1.20 0.89 0.72 1.00 0.91 0.54 0.93 0.49 
695.4777 6.80 negative 1.19 0.73 0.87 1.13 0.90 1.18 0.87 0.67 1.05 0.84 0.50 0.97 0.51 
696.4814 6.80 negative 1.20 0.72 0.86 1.13 0.89 1.17 0.86 0.66 1.05 0.84 0.50 0.96 0.46 
707.1257 9.65 negative 1.10 1.11 0.89 0.76 0.91 1.19 1.24 0.95 0.84 0.82 0.02 1.04 0.51 
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Supplemental Table 3-5. Average fold change of metabolites identified with reference standard in all treatments compared to 
control 
Metabolites Cold Heat Drought Salinity 
High 
light 
Cold x 
drought 
Heat x 
drought 
High light 
x drought 
Cold x 
salinity 
Heat x 
salinity 
High light 
x heat 
High light 
x cold 
High light 
x salinity 
Adenine 0.84 0.71 0.70 1.50 1.20 1.00 1.09 0.41 0.97 0.64 4.89 1.17 0.13 
Adenosine 1.02 0.58 0.80 1.71 1.25 1.02 0.85 0.49 1.20 0.58 24.08 1.33 1.20 
Alanine 2.22 5.69 1.26 1.15 2.15 2.29 4.47 2.66 2.10 6.15 5.31 1.82 1.25 
alpha-Ketoglutaric acid 0.83 0.80 0.67 1.12 0.92 0.66 0.47 0.52 0.96 0.79 0.31 0.88 0.48 
Arginine 0.74 0.96 0.78 0.53 0.65 0.67 0.77 0.82 0.87 1.68 0.64 0.58 0.35 
Asparagine 0.88 1.28 0.82 0.51 0.69 0.89 1.10 0.91 0.76 1.53 0.47 0.74 0.48 
Aspartic acid 1.26 0.59 0.75 0.74 0.50 0.86 0.67 0.75 1.13 0.63 0.23 0.94 0.41 
Citric acid 0.88 1.26 0.88 0.32 0.59 0.70 0.73 0.82 0.69 2.09 0.31 0.62 0.13 
Citrulline 1.04 0.32 0.57 0.68 0.53 0.79 0.61 0.73 0.98 0.55 0.25 1.11 0.40 
Dihydroxyacetone 
phosphate 
6.33 0.97 0.74 1.65 1.46 1.06 0.72 0.95 3.11 1.13 1.76 3.62 0.91 
Fructose 1.22 1.29 0.98 0.81 1.18 1.31 1.05 0.72 1.19 1.43 1.06 1.38 0.99 
Fructose 6-phosphate 1.36 2.11 1.48 0.46 1.86 1.23 1.62 2.08 1.52 2.54 2.10 1.58 3.48 
Fumaric acid 1.37 3.35 0.74 1.69 6.02 1.26 1.62 1.41 1.04 2.99 2.94 3.84 2.11 
gamma-Aminobutyric acid 0.85 1.30 2.29 1.38 1.36 1.80 3.86 2.00 0.87 1.14 3.42 1.14 0.41 
Glucose 1.14 1.40 0.68 1.02 1.29 0.98 0.65 0.37 1.13 1.52 1.10 1.34 1.02 
Glucose 6-phosphate 1.82 0.85 0.38 0.66 0.58 1.27 0.48 0.35 1.42 0.88 0.14 1.35 0.32 
Glutamic acid 1.04 0.84 0.87 0.61 1.04 1.16 1.02 1.19 0.81 0.79 0.15 0.78 0.60 
Glutamine 1.04 1.79 0.84 0.79 1.23 0.93 1.32 0.90 0.92 1.09 0.45 1.29 1.13 
Glycine 1.33 1.63 0.69 0.92 3.01 0.88 1.37 1.24 1.31 2.26 1.05 2.39 1.57 
GSH  0.46 2.12 0.17 0.12 1.08 0.28 0.12 1.00 0.32 1.09 0.00 1.26 0.34 
GSSG 1.22 1.22 1.28 0.81 0.94 1.31 1.84 1.56 1.15 1.26 0.23 1.16 0.70 
Guanine 0.94 0.79 0.68 1.26 1.40 0.93 1.08 0.30 1.11 0.85 24.16 1.12 0.96 
Guanosine monophosphate 0.89 0.44 0.32 0.64 0.93 0.60 0.48 0.22 0.80 0.59 1.87 0.77 0.38 
Histidine 1.26 2.19 1.13 0.72 1.32 1.06 1.29 1.27 1.02 2.63 0.86 1.18 1.51 
Leucine 1.27 11.42 2.70 1.20 2.40 1.63 4.30 3.47 1.01 11.45 11.37 1.46 1.19 
Lysine 0.87 4.43 1.67 0.94 0.97 1.01 2.19 1.88 0.87 4.78 4.32 0.76 1.01 
Malic acid 1.16 1.39 0.85 1.13 1.52 0.90 1.16 0.84 1.04 1.54 0.87 1.46 0.83 
Maltose 23.67 1.06 0.63 1.02 0.52 25.47 5.11 0.94 37.85 0.72 1.17 3.99 0.25 
Mannitol 1.69 13.22 2.58 1.26 1.76 1.67 4.47 3.94 1.15 13.15 15.69 1.40 4.07 
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Ornithine 0.82 0.45 0.53 0.54 0.61 0.66 0.57 0.70 1.04 1.14 0.18 0.48 0.30 
Phenylalanine 2.51 5.96 2.11 1.18 2.19 2.93 2.71 2.43 2.07 5.82 7.27 3.01 1.19 
Proline 0.93 2.48 1.80 0.98 1.23 0.98 2.23 1.90 0.74 2.64 1.42 1.06 0.38 
Pyruvic acid 1.49 1.56 0.52 1.03 1.23 0.63 0.78 0.50 1.48 2.25 3.14 1.47 1.04 
Raffinose 2.15 13.55 3.79 1.13 7.73 3.16 9.27 7.36 1.86 19.59 2.27 1.89 8.04 
Ribose 5-phosphate 1.39 0.74 0.72 0.62 0.73 1.06 0.23 0.37 1.19 0.86 0.12 1.21 0.17 
Serine 0.74 1.03 0.88 0.86 0.78 1.03 1.04 1.09 0.73 1.24 0.63 0.67 1.29 
Shikimic acid 1.16 1.20 0.94 0.86 1.06 1.21 1.52 0.95 0.79 1.08 0.42 1.05 0.23 
Succinic acid 0.98 2.00 1.51 1.26 1.45 0.92 2.58 1.58 0.69 1.71 5.35 1.10 0.98 
Sucrose 1.30 1.98 1.41 0.63 1.79 1.21 1.49 1.92 1.42 2.40 2.12 1.49 3.97 
Threonine 1.00 1.77 1.02 0.94 1.83 0.89 1.28 1.14 0.93 2.18 1.54 1.21 1.37 
Tryptophan 2.58 11.23 1.79 0.99 2.66 1.94 3.95 2.85 1.85 12.17 5.70 2.35 1.92 
Tyrosine 1.61 11.48 2.51 1.26 1.72 1.56 3.94 3.52 1.18 11.53 13.84 1.32 3.69 
Urea 5.70 0.95 1.25 1.42 1.20 0.97 1.31 0.92 1.81 1.27 0.79 1.00 2.68 
Valine 1.48 4.72 2.01 1.02 1.99 1.67 2.19 2.30 1.17 4.45 3.47 1.69 1.01 
Xylose 1.13 1.58 0.93 1.07 1.42 1.30 1.32 1.01 1.00 1.50 0.83 1.10 0.18 
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Supplemental Table 3-6. Standard compounds used for feature identification 
Adenine 
Adenosine 
Citric acid 
D-(−)-Fructose 
D-(+)-Glucose 
D-(+)-Maltose monohydrate 
D-(+)-Raffinose pentahydrate 
D-(+)-Xylose 
D-Fructose 6-phosphate disodium salt hydrate 
D-Glucose 6-phosphate sodium salt 
Dihydroxyacetone phosphate dilithium salt 
D-Mannitol 
D-Ribose 5-phosphate disodium salt hydrate 
Fumaric acid 
Glycine 
Guanine 
Guanosine 3′-monophosphate disodium salt 
L-Alanine 
L-Arginine 
L-Asparagine 
L-Aspartic acid 
L-Citrulline 
L-Cysteine 
L-Glutamic acid 
L-Glutamine 
L-Glutathione oxidized 
L-Glutathione reduced 
L-Histidine 
L-Leucine 
L-Lysine 
L-Ornithine monohydrochloride 
L-Phenylalanine 
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L-Proline 
L-Serine 
L-Threonine 
L-Tryptophan 
L-Tyrosine 
L-Valine 
Malic acid 
Pyruvic acid 
Shikimic acid 
Succinic acid 
Sucrose 
Urea 
α-Ketoglutaric acid 
γ-Aminobutyric acid 
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Chapter 4. Conclusion: the use of metabolomics for plant abiotic stress responses 
The goal of this thesis research has been to understand how plant respond to 
different abiotic stresses and to do this a  metabolomics approach was used, as 
metabolomics is one of the most frequently used and powerful tools of systems biology. In 
Chapter 1, I investigated Arabidopsis thaliana’s priming effect from temperature stresses 
and plant memory during the recovery phase between different stresses as elicited by heat, 
cold, drought, and high light in a standardized reference system. We found many 
metabolites in central metabolism, including amino acid metabolism, sugar metabolism, 
glycolysis, TCA cycle, GABA shunt, glutathione metabolism, purine metabolism, and the 
urea cycle, showed shared stress response patterns across different stresses. However, 
cysteine, GSH, and maltose showed unique and dramatic patterns, demonstrating unique 
and large changes in glutathione biosynthesis, GSH oxidation, and starch degradation. The 
similar response patterns between cold and high light, heat and drought may predict their 
potential cross stress tolerance. During recovery, plants subjected to basal heat and drought 
showed an overcompensation behavior. Priming treatment had a greater impact on cold 
stress as contrasted with heat stress. Entire metabolic pathways were monitored from 
precursors and intermediates to their products simultaneously. The subtle interplay of 
functionally related metabolites and the important transitions that regulate stress and 
recovery processes were revealed. 
In Chapter 2, the LC-MS based metabolomics approach developed in Chapter 1 
were employed to further study Arabidopsis thaliana in response to a combination of 
abiotic stresses that better mimics field conditions, a model approach which is surprisingly 
rarely studied. Both untargeted and targeted metabolomics approaches were employed to 
investigate the relationship between combined stress with metabolic responses to each 
single stress elicited by heat, cold, drought, salinity, and high light in Arabidopsis thaliana 
11-day-old seedlings. Interestingly, only two combined stresses, including high light x cold 
and cold x salinity, had metabolic effects from both of their individual stresses. Most of 
the combined stresses exhibited one dominant stress response. Among them, drought stress 
was the dominant stress for all its combined stresses and the dominant effect was not caused 
by the more severe experimental conditions tested in our study, indicating that water 
deficiency may either be a more important stress responded to by plant or, alternatively, 
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the one stress that metabolic intervention can partially alleviate. The metabolic response of 
plants to the combined stresses of high light and heat, and high light and salinity are unique 
in that they cannot be simply explained by linear combinations of the corresponding single 
stress responses. Most of metabolic features are specifically changed in these two 
combined stresses that should be considered as novel stress conditions. Many identified 
stress signatures contributed to the differences between stress and control showed shared 
patterns across different abiotic treatments. However, maltose and GSH showed unique 
stress response patterns, which was consistent with the results in Chapter 1.  
Altogether, the metabolomics methods used in this study provided results that are 
a direct indication of the biochemical adaptations of a stress-responding plant. Shared and 
unique stress signatures were identified in a single platform to eliminate other factors in 
addition to stress. To my knowledge, this is the first metabolomics study that 
comprehensively investigated combinations of abiotic stresses that plants are more often 
to encounter in field and natural environments. In addition to the combined responses and 
the dominant effects from two individual stresses, combined stresses including high light 
x heat and high light x salinity showed unique responses that should be considered as novel 
stress condition responses. This study highlights the importance of studying plants that are 
subjected to combined stresses and thus these results may potentially contribute to future 
research designed to enhance crop plant tolerance to field stress conditions. In conclusion, 
the efforts at characterizing plant abiotic stress responses in this thesis have provided 
significant insights to a number of important biological questions. The untargeted 
metabolomics approach developed in this study shall be a valuable tool for future plant 
metabolomics studies into plant environmental adaptation. The metabolic abundance 
changes for decreased precursors and increased products in this study may be related to 
their different metabolic flux. Therefore, this work may lay the foundation for future 
dynamic metabolic flux analyses, within the entire plant and in specific tissues, to better 
understand the kinetics of metabolic response networks that facilitate a plant’s adaptation 
to abiotic stress events. 
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Appendix 1. Metabolomics study of Arabidopsis thaliana abiotic stress related 
mutants in relation to cold and drought treatments 
Background 
Nine important stress related mutants, including abi1, dreb2a, fab1, fad5, fad7, lea, 
lpat1, p5cs1, sos1 described in (Table 1) and wild-type Col-0, were studied in control, 
cold, and drought treated plants. ABA INSENSITIVE 1 (ABI1) is a negative regulator of 
the ABA signal transduction cascade and of ABA promotion of stomatal closure (Leung et 
al., 1994). The transcription factor  DEHYDRATION-RESPONSIVE ELEMENT-
BINDING PROTEIN2A (DREB2A) specifically binds to the cis-acting dehydration-
responsive element/C-repeat (DRE/CRT) involved in gene expression responses to drought 
and low-temperature stress (Sakuma et al., 2006). ARABIDOPSIS BETA-KETOACYL-
ACP SYNTHETASE 2 (FAB1) encodes a β-ketoacyl-acyl carrier protein (ACP) synthase 
II (KASII) that is involved in 16:0-ACP to 18:0-ACP fatty acid elongation (Alonso et al., 
2003). FATTY ACID DESATURASE 5 (FAD5) encodes a chloroplastic enzyme involved 
in 16:1 fatty acids synthesis from galactolipids and sulpholipids (Heilmann, 2004). FATTY 
ACID DESATURASE 7 (FAD7) encodes a chloroplastic enzyme that participates in the 
synthesis of 16:3 and 18:3 fatty acids from galactolipids, sulpholipids and 
phosphatidylglycerol (Iba et al., 1993). LATE-EMBRYOGENESIS ABUNDANT (LEA) 
genes encode a large and diverse group of proteins that accumulate during plant seed 
dehydration, at the maturation phase of seed development (Tolleter et al., 2007). 
LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE 1 (LPAT1) encodes 
lysophosphatidic acid acyltransferase (LPAAT) that is involved in  chloroplastic 
phosphatidic acid biosynthesis (Yu et al., 2004). DELTA1-PYRROLINE-5-
CARBOXYLATE SYNTHASE 1 (P5CS1) encodes a delta-1-pyrroline-5-carboxylate 
synthase that is the key enzyme in proline biosynthesis (Yoshiba et al., 1999). SALT 
OVERLY SENSITIVE 1 (SOS1) encodes a plasma membrane-localized Na+/H+ 
antiporter that is essential for cell toxic Na+ extrusion which is a key determinant for plant 
salt tolerance (Shi et al., 2000). 
 
Results 
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Multivariate statistical comparisons using principle components analysis (PCA) and 
orthogonal projections to latent structures discriminant analysis (OPLS-DA)  
A comprehensive characterization of Arabidopsis thaliana metabolome variations 
between stress related mutants and wild-type under control conditions and abiotic stress 
treatments, including cold and drought, was addressed. The most statistically significant 
metabolic differences between stressed and control plants, with both mutants and wild-type 
plants were identified using an untargeted metabolomics approach. Multivariate statistics 
modeling PCA and OPLS-DA were performed.  
PCA was generated for all ten genotypes in control, cold, and drought conditions 
(Figure A-1). In control conditions, mutants including lea, dreb2a, fad7, and abi1 are 
separated from Col-0, indicting their different metabolic phenotype without stress 
treatment. In contrast, sos1 and dreb2a are clustered together with control, indicating these 
two mutants showed similar metabolic phenotype with wild-type during control conditions. 
With drought treatment, most mutants, including fad5, lpat1, fab1, p5cs1, fad7, clustered 
together with their corresponding control, indicating these mutants are not, at the metabolic 
level, drought stress related. However, sos1 and abi1 separated between drought stress and 
control in PC1 (25%), indicating these two mutants have a drought related metabolic 
phenotype. With cold stress treatment, most mutants, including lea, p5cs1, dreb2a, sos1, 
fad7, abi1, are well separated from their corresponding control, suggesting they may have 
a cold stress related metabolic phenotype. By comparison, lpat1 and fad5, with cold 
conditions, are clustered together with their corresponding control, indicating these two 
mutants are not, at the metabolic level, cold related. In summary, cold stress induced a 
stronger metabolic profile change for most of the mutants tested in our study when 
compared to drought stress. 
The OPLS-DA were then performed between both stress and control, mutant and 
wild-type, to identify important metabolic feature drivers of differentiation. The OPLS-DA 
score plot and s-plot, for comparison between stress and control in the same genotype, are 
shown in Figure A-2 and Figure A-3. For comparison, the OPLS-DA score plot and s-
plot, for comparison between mutant and wild-type in the same treatment, are shown in 
Figure A-4 and Figure A-5. The top ten metabolic features with the highest and lowest 
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OPLS-DA S-plot covariance value in the different treatments compared to control and 
different mutants compared to wild-type are reported in Table A-2 and Table A-3.   
 
Hierarchical clustering analysis (HCA) for all the metabolic features 
The measured metabolome is represented by the total of the metabolic features 
detected. The HCA results for the average abundance of all the features from the ten 
genotypes in the three treatments is reported in Figure A-6. Abi1 under cold conditions 
and sos1 under drought conditions formed two single clusters, 1 and 7, highlighting their 
specific response patterns across all the samples. The HCA results for the ratio changes for 
all the features in the different treatments compared to control in the same genotype is 
reported in Figure A-7. Lea under drought treatment and cold treatment, as well as sos1 
under cold treatment formed their own single clusters, 3 and 4. This result suggested that 
lea has a specific metabolic response in both drought and cold stress, whereas sos1 has a 
specific metabolic response in cold stress only. The HCA results for the ratio changes of 
all the features in different mutant compared to wild-type in the same treatment is reported 
in Figure A-8. Fad7 in control conditions, sos1 in drought treatment, and lea in cold 
treatment formed their own single clusters, 6, 7, and 4. This result indicated that fad7 has 
large  and specific metabolic changes when compared to wild-type without stress treatment. 
Sos1 showed a specific metabolic difference compared to wild-type during drought 
treatment, and showed specific metabolic changes compared to wild-type with cold 
conditions. 
 
Materials and Methods 
Plant materials, growth conditions, and treatments 
Arabidopsis thaliana wild-type (Col-0) was obtained from Lehle Seeds. Abi1, 
dreb2a, fab1, fad5, fad7, lea, lpat1, p5cs1, sos1 seeds were obtained from the Arabidopsis 
Biological Resource Center. Seeds were sterilized with 30% (v/v) bleach containing 0.1% 
(v/v) Triton X-100 and vernalized at 4 °C for 2 days. Seedlings were germinated on 1/2 x 
MS media made from MS Salts (PhytoTechnology Laboratories, M524 Murashige & 
Skoog (MS) Basal Salt Mixture, 4.33 g/L for 1 x MS) with 1.5% agar. Plants were grown 
prior to stress, during recovery, and as unstressed controls, vertically, at 22°C under a 16-
247 
 
h-light/8-h-dark photoperiod, with ∼80 μmol m-2 s-1 illumination from cool-white 
fluorescent tube lights (control conditions). Eleven-day-old seedlings were treated with 
cold (4°C for 2h) and drought (plants moved to desiccate in air for 2h) conditions. Whole 
seedlings were harvested, frozen in liquid nitrogen, and stored at -80°C. Experiments were 
performed using three biological replicates.  
 
Sample extraction and LC-HRMS analysis 
Seedlings were lyophilized, weighed, and extracted in 70% isopropanol alcohol 
with one 2.5 mm tungsten carbide ball in a Geno/Grinder™ (OPS Diagnostics) for 7 
minutes at an intensity of 10,956 x g on -20°C chilled blocks to make a final concentration 
of 10 mg/ml (dry weight). After centrifugation for 10 minutes at 100,956 x g, 1 μL of 
supernatant was injected onto a UHPLC (Ultimate 3000, Dionex) with a ZIC-cHILIC 
column (100 mm ×2.1 mm, 3 μm particle size, EMD Millipore Corporation, Billerica, 
MA). Solvents A (0.1% (v/v) formic acid in water) and B (0.1% (v/v) formic acid in 
acetonitrile) were used as mobile phases for gradient separation. An extract corresponding 
to 100 µg of plant material (fresh weight) was loaded onto the column with at a flow rate 
of 0.4 mL/min, followed by the following gradient separation: 1 min from 98% B, 17 min 
to 65% B and maintained for 2 min, then 95% B and maintained for 1.5 min. The column 
was equilibrated for 1 min with 98% B prior to the next run. The samples were analyzed 
using a hybrid quadrupole Orbitrap mass spectrometer (Q Exactive, Thermo Fisher 
Scientific, San Jose CA). Full scan MS (range 50−750 m/z) were acquired with 35 k 
resolution for both positive and negative mode in polarity switching. The target value based 
on predictive automatic gain control was 1.0 × 106 with 200 ms of maximum injection 
time. The flow rate for sheath gas, aux gas, and sweep gas was 50, 20, and 1 ml/min, 
respectively. The capillary temperature was 350 °C. The S-lens RF was set to 55. The Aux 
gas heater temperature was 300 °C. Targeted MS/MS acquisition was used during 
metabolite identification with an inclusion list of ions of interest. Briefly, the precursor 
ions were sequentially fragmented in the HCD collision cell with normalized collision 
energy of 10%, 20%, 40%. MS/MS scans were acquired with 17.5 k resolution and the 
target value was 2.0 × 105 with 100 ms of maximum injection time. An isolation width of 
2.0 m/z was used for precursor ion selection in MS/MS mode.  
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Data analysis 
Thermo RAW files were converted to mzXML format using MSConvert 
(Chambers et al., 2012).  Preprocessing including peak detection, grouping, and retention 
time correction and statistics analysis including multivariate modeling PCA, OPLS-DA 
and hierarchical clustering analysis were performed in Workflow4Metabolomics.org 
online resource for computational metabolomics (Giacomoni et al., 2015). Annotation was 
first performed from databases including BMRB (Markley et al., 2008), METLIN (Smith 
et al., 2005), and HMDB (Wishart et al., 2013) public databases, and identities were 
confirmed with authentic standards for accurate mass measurement, retention time, and 
fragmentation data. S-plots of OPLS-DA were generated to select variables with both high 
covariance and correlation values as metabolic signature candidates (Wiklund et al., 2008). 
To generate these S-plots the covariance was plotted on the x-axis whereas the correlation 
profile is plotted on the y-axis; the most positive and negative loadings in covariance and 
correlation represent variables with both high magnitude and high reliability. The S-plots 
for all the treatment compared to control and all the mutant compared to wild-type are 
performed. The top 10 most positive and negative loadings in the S-plot of the different 
groups were reported.  
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Tables 
Table A-1. Stress related mutants 
Mutant 
name 
Gene other names Stress phenotype 
Germp
lasm / 
Stock 
Locus Description Reference 
abi1 
ABA 
INSENSITIVE 1, 
ABI1, ATABI1 
osmotic 
susceptible 
CS22 
AT4G
26080 
Involved in abscisic acid (ABA) signal transduction. Negative regulator of ABA 
promotion of stomatal closure. 
Leung et 
al., 1994) salinity 
susceptible 
dreb2a 
DEHYDRATION-
RESPONSIVE 
ELEMENT 
BINDING 
PROTEIN 2, DRE-
BINDING 
PROTEIN 2A, 
DREB2, DREB2A 
cold susceptible 
SALK
_0975
69C 
AT5G
05410 
Encodes a transcription factor that specifically binds to DRE/CRT cis elements 
(responsive to drought and low-temperature stress). Belongs to the DREB subfamily A-2 
of ERF/AP2 transcription factor family (DREB2A). There are eight members in this 
subfamily including DREB2B. The protein contains one AP2 domain. Overexpression of 
transcriptional activation domain of DREB2A resulted in significant drought stress 
tolerance but only slight freezing tolerance in transgenic Arabidopsis plants. Microarray 
and RNA gel blot analyses revealed that DREB2A regulates expression of many water 
stress–inducible genes. 
Sakuma et 
al., 2006 
drought 
susceptible 
salinity 
susceptible 
fab1 
ARABIDOPSIS 
BETA-
KETOACYL-ACP 
SYNTHETASE 2, 
ATKAS2, BETA-
KETOACYL-ACP 
SYNTHETASE 2, 
FAB1, FATTY 
ACID 
BIOSYNTHESIS 
1, KAS2 
cold susceptible 
SALK
_0183
37C 
AT1G
74960 
Encodes a plastidic beta-ketoacyl-ACP synthase II, involved in fatty acid elongation from 
16:0-ACP to 18:0-ACP. Homozygous knock-out mutants are embryo lethal, indicating 
early embryo development is sensitive to elevated 16:0. 
Alonso et 
al., 2003 
heat resistant 
high light 
susceptible 
fad5 
ADS3, ATADS3, 
FAD5, FADB, 
FATTY ACID 
DESATURASE 5, 
FATTY ACID 
DESATURASE B, 
JB67 
high light 
susceptible 
CS238
79 
AT3G
15850 
Chloroplastic enzyme responsible for the synthesis of 16:1 fatty acids from galactolipids 
and sulpholipids. Uses ferredoxin as electron donor. 
Heilmann, 
2004 
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AT2G
37290 
Ypt/Rab-GAP domain of gyp1p superfamily protein; FUNCTIONS IN: RAB GTPase 
activator activity; INVOLVED IN: regulation of Rab GTPase activity; CONTAINS 
InterPro DOMAIN/s: RabGAP/TBC (InterPro:IPR000195); BEST Arabidopsis thaliana 
protein match is: Ypt/Rab-GAP domain of gyp1p superfamily protein 
(TAIR:AT3G55020.1). 
fad7 
ATFAD7, FAD7, 
FADD, FATTY 
ACID 
DESATURASE 7, 
FATTY ACID 
DESATURASE D 
heat resistant 
CS803
6 
AT3G
11170 
Chloroplastic enzyme responsible for the synthesis of 16:3 and 18:3 fatty acids from 
galactolipids, sulpholipids and phosphatidylglycerol. Uses ferredoxin as electron donor. 
Gene expression is induced by wounding in shoot and root. The wound-response in shoot 
is independent of jasmonic acid mediated pathway whereas the root response is mediated 
by jasmonic acid. 
Iba et al., 
1993 cold susceptible 
lea 
DEHYDRIN LEA, 
LEA 
salinity 
susceptible 
SALK
_1495
21C 
AT2G
21490 
Dehydrin LEA (LEA); FUNCTIONS IN: molecular_function unknown; INVOLVED IN: 
response to water, response to stress; LOCATED IN: cellular_component unknown; 
EXPRESSED IN: petal, leaf whorl, sepal, flower; EXPRESSED DURING: 4 anthesis, 
petal differentiation and expansion stage; CONTAINS InterPro DOMAIN/s: Dehydrin 
(InterPro:IPR000167); BEST Arabidopsis thaliana protein match is: Dehydrin family 
protein (TAIR:AT4G39130.1); Has 1372 Blast hits to 1173 proteins in 160 species: 
Archae - 0; Bacteria - 7; Metazoa - 17; Fungi - 21; Plants - 1314; Viruses - 2; Other 
Eukaryotes - 11 (source: NCBI BLink). 
Tolleter et 
al., 2007 drought 
susceptible 
lpat1 
ATS2, EMB1995, 
EMBRYO 
DEFECTIVE 
1995, LPAT1, 
LYSOPHOSPHAT
IDIC ACID 
ACYLTRANSFER
ASE 1 
cold resistant 
SALK
_1338
05C 
AT4G
30580 
Encodes a plastidic lysophosphatidic acid acyltransferase (LPAAT). Is critical for 
chloroplasts phosphatidic acid biosynthesis. The null allele is embryo lethal. 
Yu et al., 
2004 
heat susceptible 
high light 
resistant 
p5cs1 
ATP5CS, 
DELTA1-
PYRROLINE-5-
CARBOXYLATE 
SYNTHASE 1, 
P5CS1 
salinity 
susceptible 
SALK
_0635
17C 
AT2G
39800 
Encodes a delta1-pyrroline-5-carboxylate synthase that catalyzes the rate-limiting 
enzyme in the biosynthesis of proline. Gene is expressed in reproductive organs and 
tissues under non-stress conditions but in the whole plant under water-limiting condition. 
Expression is also induced by abscisic acid and salt stress in a light-dependent manner. 
encodes a delta1-pyrroline-5-carboxylate synthase that catalyzes the rate-limiting enzyme 
in the biosynthesis of proline. Gene is expressed in reproductive organs and tissues under 
non-stress conditions but in the whole plant under water-limiting condition. Expression is 
also induced by abscisic acid and salt stress in a light-dependent manner. P5CS1 appears 
to be involved in salt stress responses related to proline accumulation, including 
Yoshiba et 
al., 1999 
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protection from reactive oxidative species. P5CS1 appears to be present in different cells 
and/or different subcellular locations from P5CS2 in a tissue-dependent manner. 
sos1 
ATGL1, 
ATMYB0, GL1, 
GLABRA 1, MYB 
DOMAIN 
PROTEIN 0, 
MYB0 
salinity 
susceptible 
CS386
2 
AT3G
27920 
Encodes GL1, a Myb-like protein that is required for induction of trichome development. 
Interacts with JAZ and DELLA proteins to regulate trichome initiation. 
Shi et al., 
2000 
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Table A-2. Metabolic features with top 10 most positive and negative covariance loadings for the OPLS-DA S-plot for the  
treatment as compared to control 
M/z Retention time Polarity Covariance Correlation Vip_prediction Genotype Treatment Identified with reference standard 
147.0759 624.87 positive 2975 0.60 0.89 abi1 cold Glutamine 
130.0494 626.99 positive 2211 0.56 0.83 abi1 cold   
90.0546 507.61 positive 1809 0.98 1.44 abi1 cold Alanine 
148.0599 655.96 positive 1433 0.92 1.35 abi1 cold Glutamic acid 
145.0696 625.01 negative 1105 0.86 1.26 abi1 cold Glutamine 
116.0702 439.21 positive 1099 0.90 1.33 abi1 cold Proline 
439.0847 715.38 negative 1073 0.96 1.42 abi1 cold   
104.1066 56.07 positive 1027 0.88 1.29 abi1 cold   
133.0603 660.77 positive 939 0.76 1.12 abi1 cold Asparagine 
133.0185 449.98 negative 917 0.97 1.44 abi1 cold Malic acid 
110.0083 289.70 positive -228 -0.83 1.22 abi1 cold   
82.5369 289.37 positive -256 -0.80 1.19 abi1 cold   
112.9827 455.41 negative -263 -0.23 0.35 abi1 cold   
74.0963 213.33 positive -276 -0.78 1.15 abi1 cold   
132.0535 621.06 positive -315 -0.97 1.43 abi1 cold   
253.1289 348.78 positive -337 -0.92 1.36 abi1 cold   
381.1283 55.17 positive -425 -0.97 1.43 abi1 cold   
148.0790 623.73 positive -498 -0.88 1.30 abi1 cold Glutamine [M+1] 
106.0495 680.89 positive -524 -0.77 1.13 abi1 cold Serine 
118.0857 424.74 positive -652 -0.71 1.04 abi1 cold Valine 
90.0546 507.61 positive 1053 0.99 1.31 Col_0 cold Alanine 
118.0857 424.74 positive 932 1.00 1.32 Col_0 cold Valine 
166.0856 394.32 positive 718 0.98 1.29 Col_0 cold Phenylalanine 
439.0847 715.38 negative 687 0.96 1.26 Col_0 cold   
104.0702 381.14 positive 663 0.90 1.18 Col_0 cold gamma-Aminobutyric acid 
76.0391 577.83 positive 616 0.97 1.28 Col_0 cold Glycine 
81.0445 105.70 positive 594 1.00 1.32 Col_0 cold   
387.1207 715.25 negative 540 0.95 1.26 Col_0 cold   
120.0804 394.32 positive 513 0.97 1.28 Col_0 cold   
147.0759 624.87 positive 473 0.20 0.27 Col_0 cold Glutamine 
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114.1022 717.99 positive -455 -0.83 1.09 Col_0 cold   
196.0632 438.06 positive -460 -0.54 0.71 Col_0 cold   
194.0625 438.17 negative -471 -0.66 0.88 Col_0 cold   
116.0702 439.21 positive -493 -0.48 0.63 Col_0 cold Proline 
88.0754 286.44 positive -754 -0.84 1.11 Col_0 cold   
133.0603 660.77 positive -848 -0.97 1.28 Col_0 cold Asparagine 
106.0495 680.89 positive -906 -0.99 1.31 Col_0 cold Serine 
112.9827 455.41 negative -942 -1.00 1.32 Col_0 cold   
148.0599 655.96 positive -1044 -0.89 1.18 Col_0 cold Glutamic acid 
61.9896 629.65 negative -2146 -0.95 1.26 Col_0 cold   
96.9625 908.66 negative 1467 0.45 0.68 dreb2a cold   
148.0599 655.96 positive 1327 0.94 1.42 dreb2a cold Glutamic acid 
106.0495 680.89 positive 1062 0.91 1.37 dreb2a cold Serine 
74.0963 213.33 positive 939 0.99 1.50 dreb2a cold   
175.1182 828.03 positive 883 0.46 0.70 dreb2a cold Arginine 
133.0603 660.77 positive 733 0.70 1.06 dreb2a cold Asparagine 
114.1022 717.99 positive 680 0.68 1.03 dreb2a cold   
194.0625 438.17 negative 542 0.56 0.85 dreb2a cold   
234.0189 438.75 positive 533 0.58 0.88 dreb2a cold   
66.0681 718.06 positive 532 0.64 0.97 dreb2a cold   
112.9827 540.78 negative -623 -0.90 1.37 dreb2a cold   
387.1207 715.25 negative -666 -0.95 1.43 dreb2a cold   
133.0185 449.98 negative -734 -0.82 1.24 dreb2a cold Malic acid 
76.0391 577.83 positive -758 -0.95 1.45 dreb2a cold Glycine 
81.0445 105.70 positive -783 -0.96 1.46 dreb2a cold   
104.0702 381.14 positive -873 -0.59 0.89 dreb2a cold gamma-Aminobutyric acid 
166.0856 394.32 positive -887 -0.98 1.49 dreb2a cold Phenylalanine 
439.0847 715.38 negative -938 -0.99 1.50 dreb2a cold   
147.0759 624.87 positive -1353 -0.38 0.57 dreb2a cold Glutamine 
90.0546 507.61 positive -1440 -0.97 1.48 dreb2a cold Alanine 
106.0495 680.89 positive 836 0.98 1.40 fab1 cold Serine 
61.9896 629.65 negative 749 0.45 0.64 fab1 cold   
74.0963 213.33 positive 691 0.99 1.41 fab1 cold   
254 
 
114.1022 717.99 positive 313 0.73 1.03 fab1 cold   
457.1086 197.05 positive 274 0.92 1.32 fab1 cold   
447.0494 827.34 negative 261 0.89 1.27 fab1 cold   
194.0625 438.17 negative 256 0.38 0.54 fab1 cold   
104.0291 678.70 negative 233 0.99 1.41 fab1 cold Serine 
385.1228 329.16 negative 233 1.00 1.42 fab1 cold   
176.1024 691.43 positive 222 0.85 1.21 fab1 cold Citrulline 
133.0185 449.98 negative -707 -0.96 1.37 fab1 cold Malic acid 
387.1207 715.25 negative -721 -0.99 1.41 fab1 cold   
76.0391 577.83 positive -732 -0.98 1.40 fab1 cold Glycine 
81.0445 105.70 positive -772 -1.00 1.42 fab1 cold   
130.0494 626.99 positive -785 -0.48 0.68 fab1 cold   
104.1066 56.07 positive -838 -0.90 1.28 fab1 cold   
166.0856 394.32 positive -871 -1.00 1.42 fab1 cold Phenylalanine 
439.0847 715.38 negative -897 -0.99 1.41 fab1 cold   
147.0759 624.87 positive -1166 -0.80 1.15 fab1 cold Glutamine 
90.0546 507.61 positive -1330 -1.00 1.42 fab1 cold Alanine 
106.0495 680.89 positive 1156 1.00 1.44 fad5 cold Serine 
148.0599 655.96 positive 1018 0.90 1.29 fad5 cold Glutamic acid 
104.0702 381.14 positive 736 0.95 1.37 fad5 cold gamma-Aminobutyric acid 
194.0625 438.17 negative 545 0.82 1.18 fad5 cold   
116.0702 439.21 positive 526 0.81 1.17 fad5 cold Proline 
175.1182 828.03 positive 450 0.31 0.45 fad5 cold Arginine 
87.0438 381.14 positive 394 0.96 1.38 fad5 cold   
86.0598 381.14 positive 361 0.96 1.38 fad5 cold   
146.0532 648.68 negative 345 0.93 1.35 fad5 cold Glutamic acid 
98.9838 908.56 positive 327 0.54 0.78 fad5 cold   
76.0391 577.83 positive -639 -0.99 1.42 fad5 cold Glycine 
341.1180 715.28 negative -645 -0.99 1.43 fad5 cold Sucrose 
110.9735 638.84 negative -656 -1.00 1.44 fad5 cold   
166.0856 394.32 positive -771 -0.99 1.43 fad5 cold Phenylalanine 
387.1207 715.25 negative -818 -0.99 1.43 fad5 cold   
130.0494 626.99 positive -891 -0.83 1.20 fad5 cold   
255 
 
439.0847 715.38 negative -1001 -0.99 1.43 fad5 cold   
90.0546 507.61 positive -1176 -1.00 1.44 fad5 cold Alanine 
147.0759 624.87 positive -1285 -0.87 1.26 fad5 cold Glutamine 
61.9896 629.65 negative -2012 -0.67 0.96 fad5 cold   
175.1182 828.03 positive 1192 0.66 0.91 fad7 cold Arginine 
106.0495 680.89 positive 499 0.72 0.99 fad7 cold Serine 
94.0448 289.23 positive 468 0.80 1.11 fad7 cold   
65.0603 828.64 positive 404 0.64 0.88 fad7 cold   
82.5369 289.37 positive 379 0.81 1.12 fad7 cold   
176.1024 691.43 positive 327 0.69 0.96 fad7 cold Citrulline 
173.1183 827.89 negative 311 0.74 1.03 fad7 cold Arginine 
176.1217 828.09 positive 300 0.66 0.91 fad7 cold Arginine [M+1] 
70.0650 828.64 positive 283 0.70 0.97 fad7 cold   
129.0405 253.59 negative 277 0.28 0.39 fad7 cold   
439.0847 715.38 negative -906 -0.94 1.31 fad7 cold   
133.0185 449.98 negative -967 -0.89 1.23 fad7 cold Malic acid 
116.0702 439.21 positive -971 -0.88 1.22 fad7 cold Proline 
104.1066 56.07 positive -1000 -0.91 1.26 fad7 cold   
104.0702 381.14 positive -1111 -0.92 1.27 fad7 cold gamma-Aminobutyric acid 
136.0615 342.73 positive -1164 -0.92 1.27 fad7 cold Adenine 
90.0546 507.61 positive -1291 -0.91 1.26 fad7 cold Alanine 
148.0599 655.96 positive -1409 -0.82 1.14 fad7 cold Glutamic acid 
130.0494 626.99 positive -2234 -0.84 1.17 fad7 cold   
147.0759 624.87 positive -2496 -0.79 1.09 fad7 cold Glutamine 
106.0495 680.89 positive 1063 0.99 1.35 lea cold gamma-Aminobutyric acid [M+1] 
175.1182 828.03 positive 1012 0.63 0.86 lea cold   
194.0625 438.17 negative 547 0.75 1.02 lea cold   
339.1034 348.29 negative 540 0.95 1.30 lea cold   
133.0603 660.77 positive 431 0.52 0.72 lea cold Leucine 
148.0790 623.73 positive 375 0.92 1.26 lea cold Lysine 
223.0671 347.80 negative 366 0.93 1.27 lea cold   
88.0754 286.44 positive 339 0.30 0.41 lea cold   
176.1024 691.43 positive 332 0.86 1.18 lea cold Arginine 
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173.1183 827.89 negative 322 0.82 1.12 lea cold Arginine 
145.0696 625.01 negative -813 -0.91 1.25 lea cold Glutamine 
166.0856 394.32 positive -826 -1.00 1.36 lea cold   
116.0702 439.21 positive -834 -0.93 1.27 lea cold   
76.0391 577.83 positive -907 -1.00 1.36 lea cold   
387.1207 715.25 negative -932 -1.00 1.37 lea cold   
439.0847 715.38 negative -1130 -1.00 1.37 lea cold   
90.0546 507.61 positive -1166 -0.99 1.36 lea cold   
104.1066 56.07 positive -1259 -0.97 1.34 lea cold   
130.0494 626.99 positive -2430 -0.91 1.25 lea cold   
147.0759 624.87 positive -2836 -0.88 1.20 lea cold   
61.9896 629.65 negative 1305 0.94 1.31 lpat1 cold   
106.0495 680.89 positive 964 1.00 1.38 lpat1 cold Serine 
194.0625 438.17 negative 561 0.79 1.09 lpat1 cold   
98.9838 908.56 positive 482 0.86 1.19 lpat1 cold   
96.9625 908.66 negative 373 0.78 1.08 lpat1 cold   
196.0632 438.06 positive 365 0.47 0.65 lpat1 cold   
74.0963 213.33 positive 349 0.98 1.36 lpat1 cold   
234.0189 438.75 positive 280 0.79 1.09 lpat1 cold   
104.0291 678.70 negative 266 0.99 1.38 lpat1 cold Serine 
447.0494 827.34 negative 245 0.84 1.17 lpat1 cold   
110.9735 638.84 negative -604 -0.99 1.37 lpat1 cold   
341.1180 715.28 negative -611 -0.99 1.37 lpat1 cold Sucrose 
104.1066 56.07 positive -710 -0.91 1.25 lpat1 cold   
76.0391 577.83 positive -736 -1.00 1.38 lpat1 cold Glycine 
387.1207 715.25 negative -746 -0.99 1.37 lpat1 cold   
166.0856 394.32 positive -747 -0.99 1.37 lpat1 cold Phenylalanine 
439.0847 715.38 negative -962 -1.00 1.38 lpat1 cold   
130.0494 626.99 positive -1005 -0.97 1.34 lpat1 cold   
90.0546 507.61 positive -1332 -1.00 1.38 lpat1 cold Alanine 
147.0759 624.87 positive -1338 -0.97 1.34 lpat1 cold Glutamine 
61.9896 629.65 negative 968 0.40 0.57 p5cs1 cold   
106.0495 680.89 positive 868 0.98 1.40 p5cs1 cold Serine 
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74.0963 213.33 positive 491 0.94 1.34 p5cs1 cold   
104.0702 381.14 positive 474 0.55 0.78 p5cs1 cold gamma-Aminobutyric acid 
94.0448 289.23 positive 363 0.65 0.93 p5cs1 cold   
87.0438 381.14 positive 348 0.74 1.06 p5cs1 cold   
82.5369 289.37 positive 316 0.74 1.05 p5cs1 cold   
86.0598 381.14 positive 313 0.73 1.04 p5cs1 cold   
447.0494 827.34 negative 242 0.83 1.18 p5cs1 cold   
104.0291 678.70 negative 237 0.99 1.42 p5cs1 cold Serine 
133.0185 449.98 negative -803 -0.94 1.34 p5cs1 cold Malic acid 
166.0856 394.32 positive -853 -0.96 1.38 p5cs1 cold Phenylalanine 
145.0696 625.01 negative -868 -0.92 1.32 p5cs1 cold Glutamine 
76.0391 577.83 positive -893 -0.99 1.41 p5cs1 cold Glycine 
439.0847 715.38 negative -994 -0.98 1.40 p5cs1 cold   
175.1182 828.03 positive -994 -0.75 1.07 p5cs1 cold Arginine 
104.1066 56.07 positive -1045 -0.78 1.12 p5cs1 cold   
90.0546 507.61 positive -1462 -0.97 1.38 p5cs1 cold Alanine 
130.0494 626.99 positive -2116 -0.76 1.08 p5cs1 cold   
147.0759 624.87 positive -2756 -0.80 1.14 p5cs1 cold Glutamine 
61.9896 629.65 negative 2412 0.91 1.28 sos1 cold   
148.0599 655.96 positive 1181 0.87 1.23 sos1 cold Glutamic acid 
112.9827 455.41 negative 992 1.00 1.40 sos1 cold   
106.0495 680.89 positive 974 0.95 1.34 sos1 cold Serine 
133.0603 660.77 positive 881 0.89 1.24 sos1 cold Asparagine 
104.0702 381.14 positive 816 0.64 0.91 sos1 cold gamma-Aminobutyric acid 
98.9838 908.56 positive 755 0.98 1.37 sos1 cold   
96.9625 908.66 negative 585 0.98 1.38 sos1 cold   
175.1182 828.03 positive 474 0.35 0.49 sos1 cold Arginine 
194.0625 438.17 negative 418 0.75 1.05 sos1 cold   
387.1207 715.25 negative -507 -0.97 1.36 sos1 cold   
120.0804 394.32 positive -529 -0.99 1.39 sos1 cold   
76.0391 577.83 positive -533 -0.92 1.30 sos1 cold Glycine 
147.0759 624.87 positive -585 -0.32 0.44 sos1 cold Glutamine 
130.0494 626.99 positive -615 -0.35 0.49 sos1 cold   
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439.0847 715.38 negative -676 -0.98 1.38 sos1 cold   
166.0856 394.32 positive -703 -0.99 1.39 sos1 cold Phenylalanine 
110.9735 638.84 negative -722 -0.97 1.36 sos1 cold   
118.0857 424.74 positive -798 -0.83 1.17 sos1 cold Valine 
90.0546 507.61 positive -1236 -0.99 1.40 sos1 cold Alanine 
104.0702 381.14 positive 1146 0.77 1.16 abi1 drought gamma-Aminobutyric acid 
87.0438 381.14 positive 546 0.75 1.13 abi1 drought 
86.0598 381.14 positive 506 0.76 1.13 abi1 drought 
110.9735 638.84 negative 439 0.85 1.28 abi1 drought 
94.0448 289.23 positive 433 0.82 1.23 abi1 drought 
325.1991 476.30 negative 406 0.69 1.03 abi1 drought 
447.0494 827.34 negative 365 0.94 1.41 abi1 drought 
311.1682 479.61 negative 361 0.66 0.99 abi1 drought 
118.0857 424.74 positive 309 0.36 0.54 abi1 drought Valine 
148.0790 623.73 positive 297 0.87 1.31 abi1 drought Glutamine [M+1] 
192.1411 281.27 positive -613 -0.97 1.45 abi1 drought 
106.0495 680.89 positive -648 -0.73 1.09 abi1 drought Serine 
209.1391 62.38 positive -657 -0.99 1.49 abi1 drought 
145.0696 625.01 negative -726 -0.83 1.24 abi1 drought Glutamine 
175.1182 828.03 positive -899 -0.74 1.11 abi1 drought Arginine 
209.1390 270.29 positive -999 -0.97 1.46 abi1 drought 
88.0754 286.44 positive -1088 -0.97 1.46 abi1 drought 
148.0599 655.96 positive -1121 -0.83 1.25 abi1 drought Glutamic acid 
61.9896 629.65 negative -1462 -0.56 0.84 abi1 drought 
130.0494 626.99 positive -1661 -0.44 0.66 abi1 drought 
104.0702 381.14 positive 2717 0.97 1.49 Col-0 drought gamma-Aminobutyric acid 
147.0759 624.87 positive 2308 0.73 1.12 Col-0 drought Glutamine 
116.0702 439.21 positive 1685 0.91 1.40 Col-0 drought Proline 
130.0494 626.99 positive 1354 0.56 0.85 Col-0 drought 
87.0438 381.14 positive 1331 0.97 1.49 Col-0 drought 
86.0598 381.14 positive 1225 0.97 1.49 Col-0 drought 
61.9896 629.65 negative 1217 0.73 1.12 Col-0 drought 
132.1015 375.46 positive 1213 0.97 1.49 Col-0 drought Leucine 
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90.0546 507.61 positive 1015 0.99 1.52 Col-0 drought Alanine 
104.1066 56.07 positive 882 0.96 1.48 Col-0 drought 
112.9827 455.41 negative -266 -0.87 1.33 Col-0 drought 
115.0033 334.72 negative -267 -0.73 1.12 Col-0 drought Fumaric acid 
82.5369 289.37 positive -287 -0.61 0.94 Col-0 drought 
151.0347 289.20 positive -290 -0.64 0.98 Col-0 drought 
105.0161 348.07 negative -297 -0.91 1.39 Col-0 drought 
173.0231 429.81 negative -303 -0.97 1.48 Col-0 drought 
209.1390 270.29 positive -341 -0.86 1.32 Col-0 drought 
106.0495 680.89 positive -404 -0.71 1.08 Col-0 drought Serine 
94.0448 289.23 positive -454 -0.72 1.10 Col-0 drought 
148.0599 655.96 positive -753 -0.69 1.05 Col-0 drought Glutamic acid 
104.0702 381.14 positive 2134 0.95 1.49 dreb2a drought gamma-Aminobutyric acid 
116.0702 439.21 positive 1450 0.86 1.35 dreb2a drought Proline 
132.1015 375.46 positive 1064 0.95 1.48 dreb2a drought Leucine 
87.0438 381.14 positive 1049 0.95 1.48 dreb2a drought 
90.0546 507.61 positive 976 0.96 1.49 dreb2a drought Alanine 
86.0598 381.14 positive 967 0.95 1.48 dreb2a drought 
439.0847 715.38 negative 870 0.97 1.51 dreb2a drought 
387.1207 715.25 negative 740 0.93 1.45 dreb2a drought 
196.0632 438.06 positive 623 0.95 1.49 dreb2a drought 
311.1256 438.39 positive 602 0.87 1.36 dreb2a drought 
130.0494 626.99 positive -465 -0.14 0.22 dreb2a drought 
98.9838 908.56 positive -530 -0.71 1.10 dreb2a drought 
146.0532 648.68 negative -555 -0.77 1.20 dreb2a drought Glutamic acid 
104.1066 56.07 positive -604 -0.69 1.08 dreb2a drought 
339.1034 348.29 negative -618 -0.78 1.22 dreb2a drought 
88.0754 286.44 positive -697 -0.88 1.38 dreb2a drought 
133.0185 449.98 negative -800 -1.00 1.56 dreb2a drought Malic acid 
106.0495 680.89 positive -815 -0.80 1.26 dreb2a drought Serine 
96.9625 908.66 negative -1483 -0.44 0.69 dreb2a drought 
148.0599 655.96 positive -1658 -0.95 1.48 dreb2a drought Glutamic acid 
175.1182 828.03 positive 693 0.75 1.02 fab1 drought Arginine 
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148.0599 655.96 positive 525 0.67 0.91 fab1 drought Glutamic acid 
133.0185 449.98 negative 373 0.77 1.05 fab1 drought Malic acid 
74.0963 213.33 positive 359 0.85 1.15 fab1 drought 
112.9827 540.78 negative 329 0.65 0.88 fab1 drought 
209.1390 270.29 positive 321 1.00 1.35 fab1 drought 
105.0161 348.07 negative 296 0.90 1.22 fab1 drought 
98.9838 908.56 positive 287 0.56 0.76 fab1 drought 
118.0857 424.74 positive 283 0.42 0.57 fab1 drought Valine 
106.0495 680.89 positive 281 0.67 0.92 fab1 drought Serine 
387.1207 715.25 negative -691 -0.99 1.35 fab1 drought 
439.0847 715.38 negative -722 -0.99 1.34 fab1 drought 
104.1066 56.07 positive -885 -0.93 1.26 fab1 drought 
90.0546 507.61 positive -991 -1.00 1.36 fab1 drought Alanine 
132.1015 375.46 positive -1039 -1.00 1.36 fab1 drought Leucine 
86.0598 381.14 positive -1048 -1.00 1.36 fab1 drought 
87.0438 381.14 positive -1134 -1.00 1.36 fab1 drought 
61.9896 629.65 negative -1239 -0.66 0.90 fab1 drought 
116.0702 439.21 positive -1688 -0.99 1.34 fab1 drought Proline 
104.0702 381.14 positive -2301 -1.00 1.36 fab1 drought gamma-Aminobutyric acid 
148.0599 655.96 positive 1416 0.96 1.31 fad5 drought Glutamic acid 
175.1182 828.03 positive 747 0.48 0.66 fad5 drought Arginine 
106.0495 680.89 positive 681 0.97 1.33 fad5 drought Serine 
98.9838 908.56 positive 577 0.82 1.12 fad5 drought 
196.0632 438.06 positive 576 0.65 0.89 fad5 drought 
133.0185 449.98 negative 563 0.88 1.21 fad5 drought Malic acid 
194.0625 438.17 negative 496 0.67 0.92 fad5 drought 
114.1022 717.99 positive 480 0.82 1.12 fad5 drought 
133.0603 660.77 positive 431 0.61 0.84 fad5 drought Asparagine 
96.9625 908.66 negative 429 0.84 1.15 fad5 drought 
387.1207 715.25 negative -576 -0.99 1.36 fad5 drought 
72.0806 406.23 positive -588 -1.00 1.36 fad5 drought 
104.1066 56.07 positive -823 -0.95 1.30 fad5 drought 
86.0598 381.14 positive -925 -0.99 1.36 fad5 drought 
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90.0546 507.61 positive -969 -0.98 1.35 fad5 drought Alanine 
87.0438 381.14 positive -1002 -0.99 1.36 fad5 drought 
132.1015 375.46 positive -1166 -1.00 1.37 fad5 drought Leucine 
116.0702 439.21 positive -1534 -0.98 1.34 fad5 drought Proline 
104.0702 381.14 positive -2036 -0.99 1.36 fad5 drought gamma-Aminobutyric acid 
61.9896 629.65 negative -2336 -0.77 1.06 fad5 drought 
94.0448 289.23 positive 404 0.78 1.20 fad7 drought 
105.0161 348.07 negative 348 0.97 1.50 fad7 drought 
95.0435 289.05 positive 157 0.78 1.20 fad7 drought 
95.0600 828.77 positive 101 0.94 1.46 fad7 drought 
96.0441 210.07 positive 66 0.99 1.53 fad7 drought 
104.0291 678.70 negative 53 0.28 0.43 fad7 drought Serine 
101.0194 578.29 negative 42 0.72 1.12 fad7 drought 
101.0193 437.59 negative 34 0.30 0.47 fad7 drought 
98.0598 396.50 positive 24 0.66 1.03 fad7 drought 
105.0354 678.20 negative 6 0.17 0.26 fad7 drought Serine [M+1] 
98.0233 661.85 positive -3 -0.14 0.22 fad7 drought 
98.9838 908.56 positive -6 -0.01 0.02 fad7 drought 
102.9510 814.22 negative -21 -0.54 0.83 fad7 drought 
108.0022 309.96 negative -37 -0.36 0.56 fad7 drought 
106.0190 348.39 negative -49 -0.53 0.82 fad7 drought 
103.0343 116.36 negative -49 -0.83 1.28 fad7 drought 
98.0710 109.39 positive -57 -0.83 1.29 fad7 drought 
99.0913 59.13 positive -78 -0.74 1.14 fad7 drought 
97.0282 717.74 positive -96 -0.86 1.33 fad7 drought 
102.9979 410.69 negative -158 -0.78 1.20 fad7 drought 
175.1182 828.03 positive 1410 0.86 1.11 lea drought 
148.0599 655.96 positive 1402 0.99 1.28 lea drought Lysine 
147.0759 624.87 positive 1151 0.79 1.02 lea drought 
130.0494 626.99 positive 916 0.78 1.01 lea drought 
106.0495 680.89 positive 828 0.99 1.29 lea drought 
133.0603 660.77 positive 805 0.91 1.18 lea drought 
196.0632 438.06 positive 706 0.78 1.01 lea drought 
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98.9838 908.56 positive 643 0.86 1.11 lea drought 
114.1022 717.99 positive 607 0.92 1.20 lea drought 
194.0625 438.17 negative 593 0.80 1.03 lea drought 
387.1207 715.25 negative -594 -0.95 1.23 lea drought 
104.1066 56.07 positive -678 -0.88 1.14 lea drought gamma-Aminobutyric acid 
112.9827 455.41 negative -923 -1.00 1.29 lea drought 
132.1015 375.46 positive -1025 -0.97 1.26 lea drought 
90.0546 507.61 positive -1048 -0.99 1.29 lea drought 
86.0598 381.14 positive -1056 -0.99 1.28 lea drought 
87.0438 381.14 positive -1144 -0.99 1.28 lea drought 
61.9896 629.65 negative -1420 -0.55 0.71 lea drought 
116.0702 439.21 positive -1514 -0.86 1.11 lea drought 
104.0702 381.14 positive -2318 -0.99 1.28 lea drought 
61.9896 629.65 negative 1730 0.63 0.84 lpat1 drought 
148.0599 655.96 positive 713 0.91 1.22 lpat1 drought Glutamic acid 
106.0495 680.89 positive 429 0.95 1.29 lpat1 drought Serine 
136.0615 342.73 positive 334 0.90 1.21 lpat1 drought Adenine 
112.9827 455.41 negative 304 0.93 1.25 lpat1 drought 
115.0033 334.72 negative 303 0.97 1.30 lpat1 drought Fumaric acid 
133.0185 449.98 negative 264 0.82 1.10 lpat1 drought Malic acid 
105.0161 348.07 negative 242 0.91 1.23 lpat1 drought 
74.0963 213.33 positive 217 0.73 0.99 lpat1 drought 
146.0532 648.68 negative 213 0.92 1.24 lpat1 drought Glutamic acid 
387.1207 715.25 negative -731 -1.00 1.34 lpat1 drought 
104.1066 56.07 positive -773 -0.91 1.23 lpat1 drought 
439.0847 715.38 negative -780 -0.99 1.34 lpat1 drought 
147.0759 624.87 positive -885 -0.96 1.30 lpat1 drought Glutamine 
86.0598 381.14 positive -972 -0.99 1.33 lpat1 drought 
90.0546 507.61 positive -989 -0.99 1.33 lpat1 drought Alanine 
87.0438 381.14 positive -1053 -0.99 1.33 lpat1 drought 
132.1015 375.46 positive -1081 -0.99 1.34 lpat1 drought Leucine 
116.0702 439.21 positive -1850 -0.96 1.29 lpat1 drought Proline 
104.0702 381.14 positive -2156 -0.99 1.33 lpat1 drought gamma-Aminobutyric acid 
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61.9896 629.65 negative 1125 0.48 0.70 p5cs1 drought 
148.0599 655.96 positive 971 0.90 1.33 p5cs1 drought Glutamic acid 
106.0495 680.89 positive 490 0.77 1.14 p5cs1 drought Serine 
196.0632 438.06 positive 483 0.62 0.91 p5cs1 drought 
98.9838 908.56 positive 414 0.77 1.14 p5cs1 drought 
391.1180 437.14 positive 348 0.78 1.15 p5cs1 drought 
74.0963 213.33 positive 303 0.77 1.13 p5cs1 drought 
136.0615 342.73 positive 300 0.83 1.23 p5cs1 drought Adenine 
194.0625 438.17 negative 297 0.55 0.81 p5cs1 drought 
84.0441 649.02 positive 287 0.92 1.36 p5cs1 drought 
72.0806 406.23 positive -613 -0.97 1.43 p5cs1 drought 
387.1207 715.25 negative -705 -1.00 1.47 p5cs1 drought 
439.0847 715.38 negative -739 -1.00 1.47 p5cs1 drought 
147.0759 624.87 positive -844 -0.70 1.03 p5cs1 drought Glutamine 
90.0546 507.61 positive -948 -1.00 1.47 p5cs1 drought Alanine 
86.0598 381.14 positive -1072 -0.99 1.46 p5cs1 drought 
87.0438 381.14 positive -1162 -0.99 1.45 p5cs1 drought 
132.1015 375.46 positive -1185 -0.97 1.43 p5cs1 drought Leucine 
116.0702 439.21 positive -1400 -0.92 1.36 p5cs1 drought Proline 
104.0702 381.14 positive -2385 -0.99 1.46 p5cs1 drought gamma-Aminobutyric acid 
61.9896 629.65 negative 1678 0.84 1.02 sos1 drought 
112.9827 455.41 negative 848 1.00 1.21 sos1 drought 
339.1034 348.29 negative 653 0.99 1.19 sos1 drought 
112.9827 540.78 negative 635 0.96 1.16 sos1 drought 
94.0448 289.23 positive 520 0.86 1.04 sos1 drought 
223.0671 347.80 negative 440 0.98 1.18 sos1 drought 
82.5369 289.37 positive 366 0.82 1.00 sos1 drought 
68.9956 513.43 negative 328 0.97 1.17 sos1 drought 
110.9735 638.84 negative 303 0.86 1.04 sos1 drought 
105.0161 348.07 negative 286 0.87 1.05 sos1 drought 
114.1022 717.99 positive -1091 -0.97 1.18 sos1 drought 
87.0438 381.14 positive -1097 -0.99 1.19 sos1 drought 
132.1015 375.46 positive -1198 -0.99 1.20 sos1 drought Leucine 
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148.0599 655.96 positive -1360 -0.94 1.14 sos1 drought Glutamic acid 
104.1066 56.07 positive -1404 -0.96 1.17 sos1 drought 
133.0603 660.77 positive -1493 -0.99 1.19 sos1 drought Asparagine 
130.0494 626.99 positive -1724 -0.65 0.79 sos1 drought 
116.0702 439.21 positive -1939 -0.99 1.19 sos1 drought Proline 
147.0759 624.87 positive -2182 -0.68 0.82 sos1 drought Glutamine 
104.0702 381.14 positive -2255 -0.99 1.19 sos1 drought gamma-Aminobutyric acid 
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Table A-3. Metabolic features with the top 10 most positive and negative covariance loadings for the  OPLS-DA S-plot for the 
mutant as compared to wildtype 
M/z 
Retention 
time 
Polarity Covariance Correlation Vip_prediction Mutant Identified with reference standard 
61.9896 10.49 negative 1721 0.90 1.23 abi1   
98.9838 15.14 positive 769 0.93 1.27 abi1   
116.0702 7.32 positive 738 0.64 0.87 abi1 Proline 
339.1034 5.80 negative 618 0.83 1.13 abi1   
96.9625 15.14 negative 595 0.95 1.29 abi1   
148.0599 10.93 positive 472 0.54 0.74 abi1 Glutamic acid 
106.0495 11.35 positive 460 0.84 1.15 abi1 Serine 
223.0671 5.80 negative 453 0.84 1.14 abi1   
94.0448 4.82 positive 432 0.84 1.14 abi1   
104.0702 6.35 positive 416 0.58 0.79 abi1 gamma-Aminobutyric acid 
209.1391 1.04 positive -598 -0.99 1.35 abi1   
118.0857 7.08 positive -604 -0.71 0.96 abi1 Valine 
192.1411 4.69 positive -659 -0.98 1.33 abi1   
84.0441 10.82 positive -755 -0.77 1.04 abi1   
209.1390 4.50 positive -843 -0.97 1.33 abi1   
145.0696 10.42 negative -1033 -0.97 1.32 abi1 Glutamine 
133.0603 11.01 positive -1213 -0.98 1.33 abi1 Asparagine 
175.1182 13.80 positive -1392 -0.87 1.18 abi1 Arginine 
130.0494 10.45 positive -1501 -0.43 0.59 abi1   
147.0759 10.41 positive -2407 -0.55 0.75 abi1 Glutamine 
147.0759 10.41 positive 1547 0.41 0.64 dreb2a Glutamine 
96.9625 15.14 negative 1474 0.44 0.68 dreb2a 
148.0599 10.93 positive 1297 0.88 1.36 dreb2a Glutamic acid 
104.0702 6.35 positive 1127 0.88 1.36 dreb2a gamma-Aminobutyric acid 
104.1066 0.93 positive 1103 0.95 1.46 dreb2a 
175.1182 13.80 positive 1075 0.54 0.83 dreb2a Arginine 
130.0494 10.45 positive 910 0.29 0.45 dreb2a 
114.1022 11.97 positive 748 0.71 1.09 dreb2a 
196.0632 7.30 positive 724 0.69 1.06 dreb2a 
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194.0625 7.30 negative 712 0.70 1.08 dreb2a 
138.0624 6.39 negative -279 -0.88 1.35 dreb2a 
95.0435 4.82 positive -287 -0.96 1.48 dreb2a 
123.0401 4.92 positive -288 -0.96 1.48 dreb2a 
133.0185 7.50 negative -296 -0.89 1.37 dreb2a Malic acid 
85.0758 1.45 positive -328 -0.93 1.43 dreb2a 
151.0347 4.82 positive -462 -0.91 1.41 dreb2a 
112.9827 9.01 negative -481 -0.81 1.25 dreb2a 
82.5369 4.82 positive -543 -0.97 1.49 dreb2a 
94.0448 4.82 positive -748 -0.96 1.48 dreb2a 
88.0754 4.77 positive -974 -0.89 1.37 dreb2a 
61.9896 10.49 negative 1054 0.54 0.86 fab1   
175.1182 13.80 positive 684 0.52 0.82 fab1 Arginine 
192.1411 4.69 positive 471 0.97 1.53 fab1   
194.0625 7.30 negative 449 0.53 0.83 fab1   
244.0919 11.74 positive 423 0.91 1.44 fab1   
196.0632 7.30 positive 419 0.41 0.64 fab1   
118.0857 7.08 positive 381 0.48 0.76 fab1 Valine 
303.0805 8.13 negative 302 0.94 1.48 fab1   
74.0963 3.56 positive 286 0.91 1.44 fab1   
327.0666 8.11 positive 276 0.96 1.50 fab1   
84.0441 10.82 positive -608 -0.61 0.96 fab1   
116.0702 7.32 positive -648 -0.52 0.82 fab1 Proline 
133.0185 7.50 negative -677 -0.96 1.50 fab1 Malic acid 
148.0599 10.93 positive -686 -0.63 1.00 fab1 Glutamic acid 
104.0702 6.35 positive -723 -0.91 1.43 fab1 gamma-Aminobutyric acid 
145.0696 10.42 negative -923 -0.93 1.46 fab1 Glutamine 
133.0603 11.01 positive -967 -0.95 1.50 fab1 Asparagine 
88.0754 4.77 positive -1367 -0.96 1.52 fab1   
130.0494 10.45 positive -2417 -0.83 1.30 fab1   
147.0759 10.41 positive -2477 -0.77 1.21 fab1 Glutamine 
148.0599 10.93 positive 1044 0.89 1.18 fad5 Glutamic acid 
116.0702 7.32 positive 829 0.72 0.96 fad5 Proline 
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196.0632 7.30 positive 679 0.72 0.95 fad5   
106.0495 11.35 positive 676 0.98 1.30 fad5 Serine 
194.0625 7.30 negative 662 0.81 1.07 fad5   
175.1182 13.80 positive 647 0.44 0.59 fad5 Arginine 
115.0033 5.58 negative 503 0.95 1.26 fad5 Fumaric acid 
234.0189 7.31 positive 416 0.93 1.23 fad5   
244.0919 11.74 positive 393 1.00 1.32 fad5   
112.9827 7.59 negative 383 0.96 1.27 fad5   
148.0790 10.40 positive -518 -0.99 1.30 fad5 Glutamine [M+1] 
104.0702 6.35 positive -600 -0.90 1.19 fad5 gamma-Aminobutyric acid 
112.9827 9.01 negative -650 -0.99 1.31 fad5   
94.0448 4.82 positive -686 -0.97 1.28 fad5   
145.0696 10.42 negative -887 -0.95 1.26 fad5 Glutamine 
133.0603 11.01 positive -907 -0.96 1.28 fad5 Asparagine 
88.0754 4.77 positive -1109 -0.96 1.27 fad5   
61.9896 10.49 negative -1900 -0.96 1.28 fad5   
130.0494 10.45 positive -2437 -0.89 1.17 fad5   
147.0759 10.41 positive -2721 -0.87 1.15 fad5 Glutamine 
175.1182 13.80 positive 1338 0.84 1.02 fad7 Arginine 
129.0405 4.23 negative 595 0.70 0.85 fad7   
65.0603 13.81 positive 497 0.88 1.07 fad7   
118.0857 7.08 positive 414 0.70 0.84 fad7 Valine 
176.1217 13.80 positive 335 0.84 1.02 fad7 Arginine [M+1] 
381.1283 0.92 positive 327 0.84 1.02 fad7   
70.0650 13.81 positive 306 0.87 1.06 fad7   
173.1183 13.80 negative 304 0.86 1.04 fad7 Arginine 
112.9827 9.01 negative 269 0.91 1.11 fad7   
112.0866 13.81 positive 230 0.87 1.06 fad7   
145.0696 10.42 negative -730 -0.93 1.13 fad7 Glutamine 
133.0185 7.50 negative -816 -0.98 1.19 fad7 Malic acid 
112.9827 7.59 negative -869 -1.00 1.21 fad7   
88.0754 4.77 positive -942 -0.94 1.14 fad7   
133.0603 11.01 positive -1087 -1.00 1.21 fad7 Asparagine 
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116.0702 7.32 positive -1109 -0.88 1.07 fad7 Proline 
148.0599 10.93 positive -1369 -0.95 1.15 fad7 Glutamic acid 
61.9896 10.49 negative -2024 -0.95 1.16 fad7   
130.0494 10.45 positive -2073 -0.86 1.04 fad7   
147.0759 10.41 positive -2226 -0.83 1.01 fad7 Glutamine 
175.1182 13.80 positive 1510 0.91 1.14 lea Arginine 
148.0599 10.93 positive 1100 0.93 1.16 lea Glutamic acid 
196.0632 7.30 positive 861 0.80 1.00 lea   
106.0495 11.35 positive 763 0.98 1.23 lea Serine 
194.0625 7.30 negative 758 0.84 1.06 lea   
98.9838 15.14 positive 701 0.93 1.17 lea   
234.0189 7.31 positive 576 0.95 1.19 lea   
114.1022 11.97 positive 537 0.88 1.11 lea   
96.9625 15.14 negative 505 0.92 1.15 lea   
116.0702 7.32 positive 502 0.52 0.65 lea Proline 
209.1390 4.50 positive -429 -0.97 1.22 lea   
87.0438 6.35 positive -461 -0.98 1.22 lea   
94.0448 4.82 positive -617 -0.95 1.19 lea   
112.9827 9.01 negative -677 -1.00 1.25 lea   
145.0696 10.42 negative -697 -0.91 1.14 lea Glutamine 
104.0702 6.35 positive -892 -0.97 1.22 lea gamma-Aminobutyric acid 
112.9827 7.59 negative -893 -1.00 1.25 lea   
147.0759 10.41 positive -1713 -0.70 0.87 lea Glutamine 
130.0494 10.45 positive -1753 -0.78 0.98 lea   
61.9896 10.49 negative -1782 -0.97 1.21 lea   
61.9896 10.49 negative 2187 0.98 1.35 lpat1   
196.0632 7.30 positive 749 0.71 0.97 lpat1   
194.0625 7.30 negative 673 0.77 1.06 lpat1   
98.9838 15.14 positive 522 0.79 1.09 lpat1   
115.0033 5.58 negative 427 0.96 1.31 lpat1 Fumaric acid 
234.0189 7.31 positive 388 0.87 1.18 lpat1   
244.0919 11.74 positive 380 0.98 1.34 lpat1   
96.9625 15.14 negative 377 0.73 1.00 lpat1   
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391.1180 7.29 positive 348 0.73 1.00 lpat1   
106.0495 11.35 positive 329 0.78 1.07 lpat1 Serine 
148.0790 10.40 positive -501 -0.99 1.36 lpat1 Glutamine [M+1] 
209.1390 4.50 positive -501 -0.98 1.34 lpat1   
104.0702 6.35 positive -512 -0.54 0.74 lpat1 gamma-Aminobutyric acid 
112.9827 9.01 negative -563 -0.99 1.36 lpat1   
94.0448 4.82 positive -677 -0.96 1.31 lpat1   
145.0696 10.42 negative -877 -0.94 1.28 lpat1 Glutamine 
133.0603 11.01 positive -925 -0.99 1.35 lpat1 Asparagine 
88.0754 4.77 positive -1114 -0.95 1.30 lpat1   
130.0494 10.45 positive -2428 -0.87 1.19 lpat1   
147.0759 10.41 positive -2651 -0.85 1.16 lpat1 Glutamine 
61.9896 10.49 negative 1551 0.89 1.37 p5cs1   
104.0702 6.35 positive 709 0.81 1.26 p5cs1 gamma-Aminobutyric acid 
196.0632 7.30 positive 639 0.58 0.90 p5cs1   
194.0625 7.30 negative 519 0.61 0.94 p5cs1   
104.1066 0.93 positive 473 0.73 1.13 p5cs1   
192.1411 4.69 positive 421 0.96 1.49 p5cs1   
87.0438 6.35 positive 364 0.83 1.28 p5cs1   
391.1180 7.29 positive 356 0.67 1.05 p5cs1   
244.0919 11.74 positive 350 0.92 1.43 p5cs1   
62.0600 5.65 positive 342 0.87 1.35 p5cs1   
110.9735 10.65 negative -453 -0.93 1.44 p5cs1   
209.1390 4.50 positive -495 -0.97 1.50 p5cs1   
133.0185 7.50 negative -502 -0.85 1.32 p5cs1 Malic acid 
84.0441 10.82 positive -541 -0.56 0.87 p5cs1   
116.0702 7.32 positive -909 -0.70 1.08 p5cs1 Proline 
145.0696 10.42 negative -918 -0.92 1.43 p5cs1 Glutamine 
133.0603 11.01 positive -1006 -0.96 1.49 p5cs1 Asparagine 
88.0754 4.77 positive -1213 -0.93 1.45 p5cs1   
130.0494 10.45 positive -2391 -0.81 1.26 p5cs1   
147.0759 10.41 positive -2509 -0.77 1.20 p5cs1 Glutamine 
104.0702 6.35 positive 1376 0.79 1.36 sos1 gamma-Aminobutyric acid 
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61.9896 10.49 negative 700 0.33 0.57 sos1   
87.0438 6.35 positive 671 0.78 1.35 sos1   
86.0598 6.35 positive 614 0.78 1.34 sos1   
244.0919 11.74 positive 450 0.87 1.49 sos1   
118.0857 7.08 positive 397 0.44 0.75 sos1 Valine 
126.9077 8.49 negative 393 0.91 1.56 sos1   
175.1182 13.80 positive 391 0.29 0.50 sos1 Arginine 
192.1411 4.69 positive 371 0.89 1.52 sos1   
136.0615 5.71 positive 347 0.62 1.07 sos1 Adenine 
94.0448 4.82 positive -360 -0.53 0.92 sos1   
90.0546 8.46 positive -373 -0.79 1.36 sos1 Alanine 
209.1390 4.50 positive -392 -0.82 1.41 sos1   
131.0526 10.61 positive -420 -0.65 1.12 sos1   
84.0441 10.82 positive -605 -0.57 0.98 sos1   
116.0702 7.32 positive -797 -0.57 0.98 sos1 Proline 
145.0696 10.42 negative -906 -0.90 1.55 sos1 Glutamine 
88.0754 4.77 positive -1326 -0.93 1.60 sos1   
147.0759 10.41 positive -2227 -0.68 1.16 sos1 Glutamine 
130.0494 10.45 positive -2396 -0.79 1.35 sos1   
118.0857 7.08 positive 889 1.00 1.26 cold_abi1 Valine 
98.9838 15.14 positive 545 0.87 1.10 cold_abi1 
94.0448 4.82 positive 448 0.79 1.00 cold_abi1 
96.9625 15.14 negative 414 0.89 1.13 cold_abi1 
81.0445 1.76 positive 370 0.92 1.17 cold_abi1 
82.5369 4.82 positive 305 0.83 1.05 cold_abi1 
115.0033 5.58 negative 246 0.96 1.21 cold_abi1 Fumaric acid 
146.0630 0.86 positive 244 0.92 1.17 cold_abi1 
168.0448 0.85 positive 241 0.93 1.18 cold_abi1 
151.0347 4.82 positive 225 0.70 0.88 cold_abi1 
84.0441 10.82 positive -929 -0.96 1.21 cold_abi1 
196.0632 7.30 positive -970 -0.85 1.08 cold_abi1 
90.0546 8.46 positive -1247 -0.96 1.21 cold_abi1 Alanine 
145.0696 10.42 negative -1385 -0.96 1.21 cold_abi1 Glutamine 
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61.9896 10.49 negative -1506 -0.78 0.98 cold_abi1 
148.0599 10.93 positive -1521 -0.95 1.21 cold_abi1 Glutamic acid 
133.0603 11.01 positive -1659 -0.97 1.22 cold_abi1 Asparagine 
175.1182 13.80 positive -1668 -0.92 1.17 cold_abi1 Arginine 
130.0494 10.45 positive -3355 -0.96 1.22 cold_abi1 
147.0759 10.41 positive -4263 -0.96 1.21 cold_abi1 Glutamine 
147.0759 10.41 positive 2527 0.86 1.16 cold_dreb2a Glutamine 
61.9896 10.49 negative 2085 0.88 1.19 cold_dreb2a 
130.0494 10.45 positive 1575 0.86 1.16 cold_dreb2a 
104.0702 6.35 positive 1139 0.78 1.06 cold_dreb2a gamma-Aminobutyric acid 
148.0599 10.93 positive 1100 0.95 1.28 cold_dreb2a Glutamic acid 
104.1066 0.93 positive 1040 0.84 1.14 cold_dreb2a 
116.0702 7.32 positive 1039 0.83 1.12 cold_dreb2a Proline 
196.0632 7.30 positive 844 0.76 1.03 cold_dreb2a 
112.9827 7.59 negative 676 0.69 0.94 cold_dreb2a 
90.0546 8.46 positive 636 0.78 1.05 cold_dreb2a Alanine 
209.1391 1.04 positive -160 -0.66 0.89 cold_dreb2a 
138.0624 6.39 negative -173 -0.79 1.07 cold_dreb2a 
381.1283 0.92 positive -174 -0.77 1.04 cold_dreb2a 
139.0132 9.09 negative -196 -0.74 1.01 cold_dreb2a 
82.5369 4.82 positive -213 -0.65 0.88 cold_dreb2a 
94.0448 4.82 positive -315 -0.61 0.82 cold_dreb2a 
110.9735 10.65 negative -494 -0.96 1.30 cold_dreb2a 
88.0754 4.77 positive -524 -0.81 1.10 cold_dreb2a 
118.0857 7.08 positive -540 -0.56 0.76 cold_dreb2a Valine 
74.0963 3.56 positive -676 -0.98 1.33 cold_dreb2a 
61.9896 10.49 negative 2356 0.96 1.33 cold_fab1 
112.9827 7.59 negative 1003 1.00 1.37 cold_fab1 
196.0632 7.30 positive 901 0.87 1.20 cold_fab1 
175.1182 13.80 positive 871 0.78 1.08 cold_fab1 Arginine 
148.0599 10.93 positive 759 0.86 1.18 cold_fab1 Glutamic acid 
194.0625 7.30 negative 670 0.86 1.18 cold_fab1 
104.1066 0.93 positive 657 0.74 1.01 cold_fab1 
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90.0546 8.46 positive 537 0.84 1.15 cold_fab1 Alanine 
439.0847 11.92 negative 486 0.84 1.16 cold_fab1 
311.1256 7.31 positive 475 0.91 1.26 cold_fab1 
87.0438 6.35 positive -352 -0.76 1.04 cold_fab1 
94.0448 4.82 positive -384 -0.69 0.96 cold_fab1 
110.9735 10.65 negative -400 -0.90 1.23 cold_fab1 
74.0963 3.56 positive -550 -0.96 1.32 cold_fab1 
84.0441 10.82 positive -574 -0.72 0.99 cold_fab1 
145.0696 10.42 negative -664 -0.87 1.20 cold_fab1 Glutamine 
88.0754 4.77 positive -664 -0.89 1.22 cold_fab1 
104.0702 6.35 positive -689 -0.73 1.01 cold_fab1 gamma-Aminobutyric acid 
130.0494 10.45 positive -1544 -0.76 1.05 cold_fab1 
147.0759 10.41 positive -2262 -0.91 1.25 cold_fab1 Glutamine 
61.9896 10.49 negative 1981 0.73 0.89 cold_fad5 
148.0599 10.93 positive 1090 0.95 1.16 cold_fad5 Glutamic acid 
116.0702 7.32 positive 997 0.97 1.18 cold_fad5 Proline 
112.9827 7.59 negative 951 1.00 1.22 cold_fad5 
196.0632 7.30 positive 904 0.97 1.19 cold_fad5 
175.1182 13.80 positive 737 0.88 1.08 cold_fad5 Arginine 
194.0625 7.30 negative 691 0.96 1.18 cold_fad5 
439.0847 11.92 negative 629 0.93 1.14 cold_fad5 
311.1256 7.31 positive 575 0.99 1.21 cold_fad5 
387.1207 11.92 negative 556 0.95 1.16 cold_fad5 
87.0438 6.35 positive -521 -0.99 1.21 cold_fad5 
112.9827 9.01 negative -589 -0.96 1.18 cold_fad5 
94.0448 4.82 positive -636 -0.93 1.13 cold_fad5 
88.0754 4.77 positive -680 -0.91 1.12 cold_fad5 
84.0441 10.82 positive -698 -0.99 1.21 cold_fad5 
145.0696 10.42 negative -803 -0.99 1.21 cold_fad5 Glutamine 
118.0857 7.08 positive -864 -1.00 1.22 cold_fad5 Valine 
104.0702 6.35 positive -1077 -0.99 1.21 cold_fad5 gamma-Aminobutyric acid 
130.0494 10.45 positive -2043 -0.97 1.19 cold_fad5 
147.0759 10.41 positive -2578 -0.97 1.18 cold_fad5 Glutamine 
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136.0615 5.71 positive 1440 1.00 1.68 cold_fad7 Adenine 
148.0599 10.93 positive 1047 0.61 1.04 cold_fad7 Glutamic acid 
175.1182 13.80 positive 836 0.44 0.74 cold_fad7 Arginine 
112.9827 7.59 negative 788 0.70 1.18 cold_fad7 
381.1283 0.92 positive 727 0.95 1.60 cold_fad7 
104.0702 6.35 positive 695 0.80 1.35 cold_fad7 gamma-Aminobutyric acid 
325.1991 7.94 negative 623 0.72 1.22 cold_fad7 
110.9735 10.65 negative 596 0.96 1.62 cold_fad7 
89.0180 2.40 negative 509 0.90 1.53 cold_fad7 
129.0405 4.23 negative 477 0.47 0.79 cold_fad7 
268.1034 5.33 positive -404 -0.98 1.66 cold_fad7 Adenosine 
96.9625 15.14 negative -417 -0.68 1.15 cold_fad7 
118.0857 7.08 positive -420 -0.40 0.68 cold_fad7 Valine 
147.0759 10.41 positive -492 -0.16 0.26 cold_fad7 Glutamine 
133.0603 11.01 positive -556 -0.61 1.04 cold_fad7 Asparagine 
82.5369 4.82 positive -557 -0.87 1.47 cold_fad7 
98.9838 15.14 positive -565 -0.72 1.22 cold_fad7 
151.0347 4.82 positive -574 -0.90 1.52 cold_fad7 
81.0445 1.76 positive -645 -0.99 1.67 cold_fad7 
94.0448 4.82 positive -824 -0.89 1.51 cold_fad7 
148.0599 10.93 positive 1542 0.98 1.18 cold_lea Glutamic acid 
116.0702 7.32 positive 1187 0.97 1.17 cold_lea Proline 
104.1066 0.93 positive 1107 0.94 1.13 cold_lea 
130.0494 10.45 positive 1079 0.60 0.72 cold_lea 
196.0632 7.30 positive 994 0.97 1.17 cold_lea 
175.1182 13.80 positive 943 0.69 0.84 cold_lea Arginine 
147.0759 10.41 positive 930 0.42 0.50 cold_lea Glutamine 
439.0847 11.92 negative 849 0.99 1.19 cold_lea 
98.9838 15.14 positive 835 0.91 1.09 cold_lea 
61.9896 10.49 negative 790 0.61 0.74 cold_lea 
136.0615 5.71 positive -323 -0.83 1.01 cold_lea Adenine 
87.0438 6.35 positive -344 -0.75 0.90 cold_lea 
209.1390 4.50 positive -346 -0.89 1.07 cold_lea 
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110.9735 10.65 negative -414 -0.97 1.17 cold_lea 
82.5369 4.82 positive -417 -0.94 1.13 cold_lea 
339.1034 5.80 negative -504 -0.99 1.19 cold_lea 
94.0448 4.82 positive -622 -0.93 1.12 cold_lea 
104.0702 6.35 positive -717 -0.76 0.91 cold_lea gamma-Aminobutyric acid 
112.9827 9.01 negative -721 -1.00 1.20 cold_lea 
118.0857 7.08 positive -846 -1.00 1.20 cold_lea Valine 
61.9896 10.49 negative 2569 0.98 1.21 cold_lpat1 
148.0599 10.93 positive 999 0.95 1.17 cold_lpat1 Glutamic acid 
112.9827 7.59 negative 912 1.00 1.23 cold_lpat1 
196.0632 7.30 positive 848 0.94 1.16 cold_lpat1 
116.0702 7.32 positive 747 0.90 1.11 cold_lpat1 Proline 
194.0625 7.30 negative 657 0.95 1.17 cold_lpat1 
90.0546 8.46 positive 582 0.91 1.13 cold_lpat1 Alanine 
175.1182 13.80 positive 582 0.82 1.01 cold_lpat1 Arginine 
439.0847 11.92 negative 575 0.92 1.14 cold_lpat1 
311.1256 7.31 positive 505 0.96 1.19 cold_lpat1 
81.0445 1.76 positive -492 -0.99 1.22 cold_lpat1 
112.9827 9.01 negative -531 -0.98 1.21 cold_lpat1 
88.0754 4.77 positive -602 -0.90 1.11 cold_lpat1 
94.0448 4.82 positive -621 -0.92 1.14 cold_lpat1 
104.0702 6.35 positive -669 -0.86 1.06 cold_lpat1 gamma-Aminobutyric acid 
84.0441 10.82 positive -689 -0.98 1.21 cold_lpat1 
145.0696 10.42 negative -716 -0.95 1.17 cold_lpat1 Glutamine 
118.0857 7.08 positive -869 -1.00 1.23 cold_lpat1 Valine 
130.0494 10.45 positive -1949 -0.96 1.19 cold_lpat1 
147.0759 10.41 positive -2468 -0.96 1.18 cold_lpat1 Glutamine 
61.9896 10.49 negative 1831 0.72 0.93 cold_p5cs1 
148.0599 10.93 positive 1290 0.92 1.20 cold_p5cs1 Glutamic acid 
196.0632 7.30 positive 1043 0.96 1.25 cold_p5cs1 
104.1066 0.93 positive 995 0.78 1.02 cold_p5cs1 
112.9827 7.59 negative 983 1.00 1.30 cold_p5cs1 
175.1182 13.80 positive 863 0.72 0.94 cold_p5cs1 Arginine 
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194.0625 7.30 negative 781 0.96 1.25 cold_p5cs1 
90.0546 8.46 positive 706 0.77 1.01 cold_p5cs1 Alanine 
114.1022 11.97 positive 599 0.88 1.14 cold_p5cs1 
439.0847 11.92 negative 598 0.87 1.13 cold_p5cs1 
209.1391 1.04 positive -275 -0.92 1.19 cold_p5cs1 
116.0702 7.32 positive -374 -0.56 0.72 cold_p5cs1 Proline 
82.5369 4.82 positive -380 -0.88 1.14 cold_p5cs1 
74.0963 3.56 positive -380 -0.88 1.15 cold_p5cs1 
110.9735 10.65 negative -446 -0.94 1.22 cold_p5cs1 
112.9827 9.01 negative -450 -0.74 0.96 cold_p5cs1 
104.0702 6.35 positive -490 -0.63 0.82 cold_p5cs1 gamma-Aminobutyric acid 
94.0448 4.82 positive -556 -0.85 1.10 cold_p5cs1 
88.0754 4.77 positive -621 -0.82 1.06 cold_p5cs1 
118.0857 7.08 positive -918 -1.00 1.30 cold_p5cs1 Valine 
110.9735 10.65 negative 847 0.97 1.64 cold_sos1 
196.0632 7.30 positive 451 0.58 0.99 cold_sos1 
244.0919 11.74 positive 448 0.98 1.67 cold_sos1 
129.0405 4.23 negative 430 0.40 0.68 cold_sos1 
148.0790 10.40 positive 398 0.85 1.44 cold_sos1 Glutamine [M+1] 
114.1022 11.97 positive 350 0.68 1.15 cold_sos1 
90.0546 8.46 positive 348 0.55 0.93 cold_sos1 Alanine 
457.1086 3.28 positive 338 0.71 1.20 cold_sos1 
194.0625 7.30 negative 334 0.66 1.12 cold_sos1 
126.9077 8.49 negative 327 0.96 1.63 cold_sos1 
96.9625 15.14 negative -464 -0.89 1.50 cold_sos1 
94.0448 4.82 positive -466 -0.65 1.10 cold_sos1 
98.9838 15.14 positive -588 -0.87 1.47 cold_sos1 
81.0445 1.76 positive -629 -0.98 1.67 cold_sos1 
84.0441 10.82 positive -655 -0.64 1.08 cold_sos1 
145.0696 10.42 negative -708 -0.79 1.34 cold_sos1 Glutamine 
116.0702 7.32 positive -713 -0.79 1.34 cold_sos1 Proline 
88.0754 4.77 positive -911 -0.89 1.51 cold_sos1 
130.0494 10.45 positive -1537 -0.63 1.07 cold_sos1 
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147.0759 10.41 positive -2332 -0.77 1.30 cold_sos1 Glutamine 
61.9896 10.49 negative 2678 0.86 1.20 drought_abi1 
104.0702 6.35 positive 2195 0.94 1.31 drought_abi1 gamma-Aminobutyric acid 
116.0702 7.32 positive 1936 0.97 1.35 drought_abi1 Proline 
130.0494 10.45 positive 1137 0.52 0.72 drought_abi1 
132.1015 6.26 positive 1121 0.97 1.36 drought_abi1 Leucine 
87.0438 6.35 positive 1086 0.94 1.31 drought_abi1 
86.0598 6.35 positive 998 0.94 1.31 drought_abi1 
98.9838 15.14 positive 930 0.95 1.33 drought_abi1 
148.0599 10.93 positive 887 0.76 1.06 drought_abi1 Glutamic acid 
104.1066 0.93 positive 876 0.77 1.07 drought_abi1 
94.0448 4.82 positive -356 -0.65 0.91 drought_abi1 
145.0696 10.42 negative -369 -0.54 0.75 drought_abi1 Glutamine 
325.1991 7.94 negative -378 -0.69 0.96 drought_abi1 
381.1283 0.92 positive -409 -0.96 1.35 drought_abi1 
112.9827 9.01 negative -449 -0.89 1.24 drought_abi1 
133.0603 11.01 positive -535 -0.39 0.55 drought_abi1 Asparagine 
110.9735 10.65 negative -574 -0.95 1.33 drought_abi1 
175.1182 13.80 positive -802 -0.64 0.89 drought_abi1 Arginine 
118.0857 7.08 positive -854 -0.95 1.33 drought_abi1 Valine 
147.0759 10.41 positive -1602 -0.45 0.63 drought_abi1 Glutamine 
175.1182 13.80 positive 1274 0.73 1.22 drought_dreb2a Arginine 
196.0632 7.30 positive 864 0.68 1.14 drought_dreb2a 
114.1022 11.97 positive 818 0.84 1.42 drought_dreb2a 
194.0625 7.30 negative 780 0.71 1.20 drought_dreb2a 
66.0681 11.97 positive 663 0.84 1.41 drought_dreb2a 
244.0919 11.74 positive 623 0.97 1.63 drought_dreb2a 
131.1287 11.96 positive 605 0.85 1.43 drought_dreb2a 
118.0857 7.08 positive 532 0.45 0.76 drought_dreb2a Valine 
439.0847 11.92 negative 484 0.79 1.33 drought_dreb2a 
311.1256 7.31 positive 447 0.71 1.20 drought_dreb2a 
76.0391 9.63 positive -430 -0.99 1.67 drought_dreb2a Glycine 
87.0438 6.35 positive -435 -0.49 0.83 drought_dreb2a 
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223.0671 5.80 negative -463 -0.89 1.51 drought_dreb2a 
61.9896 10.49 negative -516 -0.22 0.37 drought_dreb2a 
339.1034 5.80 negative -657 -0.90 1.51 drought_dreb2a 
133.0185 7.50 negative -881 -0.81 1.36 drought_dreb2a Malic acid 
130.0494 10.45 positive -885 -0.31 0.53 drought_dreb2a 
104.0702 6.35 positive -951 -0.52 0.88 drought_dreb2a gamma-Aminobutyric acid 
147.0759 10.41 positive -1021 -0.29 0.50 drought_dreb2a Glutamine 
88.0754 4.77 positive -1289 -0.95 1.60 drought_dreb2a 
175.1182 13.80 positive 1274 0.73 1.22 drought_fab1 Arginine 
196.0632 7.30 positive 864 0.68 1.14 drought_fab1 
114.1022 11.97 positive 818 0.84 1.42 drought_fab1 
194.0625 7.30 negative 780 0.71 1.20 drought_fab1 
66.0681 11.97 positive 663 0.84 1.41 drought_fab1 
244.0919 11.74 positive 623 0.97 1.63 drought_fab1 
131.1287 11.96 positive 605 0.85 1.43 drought_fab1 
118.0857 7.08 positive 532 0.45 0.76 drought_fab1 Valine 
439.0847 11.92 negative 484 0.79 1.33 drought_fab1 
311.1256 7.31 positive 447 0.71 1.20 drought_fab1 
76.0391 9.63 positive -430 -0.99 1.67 drought_fab1 Glycine 
87.0438 6.35 positive -435 -0.49 0.83 drought_fab1 
223.0671 5.80 negative -463 -0.89 1.51 drought_fab1 
61.9896 10.49 negative -516 -0.22 0.37 drought_fab1 
339.1034 5.80 negative -657 -0.90 1.51 drought_fab1 
133.0185 7.50 negative -881 -0.81 1.36 drought_fab1 Malic acid 
130.0494 10.45 positive -885 -0.31 0.53 drought_fab1 
104.0702 6.35 positive -951 -0.52 0.88 drought_fab1 gamma-Aminobutyric acid 
147.0759 10.41 positive -1021 -0.29 0.50 drought_fab1 Glutamine 
88.0754 4.77 positive -1289 -0.95 1.60 drought_fab1 
116.0702 7.32 positive 859 0.74 1.01 drought_fad5 Proline 
61.9896 10.49 negative 579 0.24 0.32 drought_fad5 
115.0033 5.58 negative 523 0.88 1.20 drought_fad5 Fumaric acid 
106.0495 11.35 positive 395 0.74 1.01 drought_fad5 Serine 
62.0600 5.65 positive 302 0.82 1.11 drought_fad5 
278 
 
173.0231 7.16 negative 298 1.00 1.36 drought_fad5 
143.0072 7.16 negative 255 1.00 1.36 drought_fad5 
70.0650 7.32 positive 245 0.73 1.00 drought_fad5 
335.1084 3.71 positive 243 0.85 1.15 drought_fad5 
126.9077 8.49 negative 243 0.96 1.31 drought_fad5 
741.6599 8.32 negative 236 0.99 1.34 drought_fad5 
86.0598 6.35 positive -611 -0.81 1.11 drought_fad5 
87.0438 6.35 positive -671 -0.82 1.11 drought_fad5 
131.0526 10.61 positive -690 -0.99 1.35 drought_fad5 
84.0441 10.82 positive -982 -0.99 1.35 drought_fad5 
88.0754 4.77 positive -1068 -0.96 1.31 drought_fad5 
145.0696 10.42 negative -1074 -0.99 1.34 drought_fad5 Glutamine 
133.0603 11.01 positive -1230 -0.94 1.29 drought_fad5 Asparagine 
104.0702 6.35 positive -1357 -0.81 1.11 drought_fad5 gamma-Aminobutyric acid 
130.0494 10.45 positive -3072 -0.99 1.35 drought_fad5 
147.0759 10.41 positive -3773 -0.99 1.35 drought_fad5 Glutamine 
118.0857 7.08 positive 843 0.98 1.23 drought_fad7 Valine 
381.1283 0.92 positive 639 0.99 1.25 drought_fad7 
112.9827 9.01 negative 396 0.90 1.13 drought_fad7 
397.1016 0.95 positive 359 0.98 1.24 drought_fad7 
139.0132 9.09 negative 342 0.97 1.22 drought_fad7 
110.9735 10.65 negative 329 0.96 1.21 drought_fad7 
359.1467 0.92 positive 315 0.99 1.25 drought_fad7 
129.0405 4.23 negative 304 0.36 0.45 drought_fad7 
382.1317 0.99 positive 300 0.99 1.25 drought_fad7 
89.0180 2.40 negative 196 0.69 0.87 drought_fad7 
104.1066 0.93 positive -967 -0.96 1.21 drought_fad7 
145.0696 10.42 negative -1007 -0.98 1.24 drought_fad7 Glutamine 
148.0599 10.93 positive -1138 -0.89 1.12 drought_fad7 Glutamic acid 
88.0754 4.77 positive -1147 -0.97 1.22 drought_fad7 
133.0603 11.01 positive -1316 -0.97 1.22 drought_fad7 Asparagine 
116.0702 7.32 positive -1520 -0.93 1.17 drought_fad7 Proline 
104.0702 6.35 positive -1646 -0.90 1.14 drought_fad7 gamma-Aminobutyric acid 
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61.9896 10.49 negative -2343 -0.97 1.23 drought_fad7 
130.0494 10.45 positive -2945 -0.99 1.24 drought_fad7 
147.0759 10.41 positive -3621 -0.98 1.24 drought_fad7 Glutamine 
116.0702 7.32 positive 866 0.51 0.79 drought_lea Proline 
90.0546 8.46 positive 556 0.83 1.29 drought_lea Alanine 
115.0033 5.58 negative 499 0.92 1.42 drought_lea Fumaric acid 
194.0625 7.30 negative 433 0.47 0.73 drought_lea 
311.1256 7.31 positive 365 0.62 0.97 drought_lea 
62.0600 5.65 positive 353 0.83 1.29 drought_lea 
106.0495 11.35 positive 331 0.66 1.03 drought_lea Serine 
196.0632 7.30 positive 327 0.31 0.48 drought_lea 
234.0189 7.31 positive 267 0.59 0.91 drought_lea 
112.9827 7.59 negative 266 0.84 1.30 drought_lea 
88.0754 4.77 positive -668 -0.65 1.01 drought_lea 
112.9827 9.01 negative -680 -0.96 1.49 drought_lea 
61.9896 10.49 negative -713 -0.24 0.38 drought_lea 
104.0702 6.35 positive -767 -0.46 0.72 drought_lea gamma-Aminobutyric acid 
131.0526 10.61 positive -771 -0.92 1.43 drought_lea 
133.0603 11.01 positive -1052 -0.88 1.36 drought_lea Asparagine 
84.0441 10.82 positive -1103 -0.99 1.54 drought_lea 
145.0696 10.42 negative -1160 -0.98 1.53 drought_lea Glutamine 
130.0494 10.45 positive -3259 -0.98 1.52 drought_lea 
147.0759 10.41 positive -3987 -0.98 1.52 drought_lea Glutamine 
116.0702 7.32 positive 1106 0.79 1.06 drought_lpat1 Proline 
196.0632 7.30 positive 888 0.78 1.05 drought_lpat1 
194.0625 7.30 negative 773 0.81 1.09 drought_lpat1 
98.9838 15.14 positive 653 0.98 1.32 drought_lpat1 
311.1256 7.31 positive 615 0.91 1.23 drought_lpat1 
96.9625 15.14 negative 471 0.95 1.27 drought_lpat1 
115.0033 5.58 negative 403 0.97 1.30 drought_lpat1 Fumaric acid 
244.0919 11.74 positive 398 0.98 1.32 drought_lpat1 
234.0189 7.31 positive 389 0.84 1.13 drought_lpat1 
439.0847 11.92 negative 389 0.91 1.22 drought_lpat1 
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129.0405 4.23 negative -535 -0.72 0.97 drought_lpat1 
131.0526 10.61 positive -653 -0.99 1.33 drought_lpat1 
61.9896 10.49 negative -726 -0.29 0.39 drought_lpat1 
133.0603 11.01 positive -904 -0.89 1.21 drought_lpat1 Asparagine 
84.0441 10.82 positive -955 -0.99 1.34 drought_lpat1 
104.0702 6.35 positive -1027 -0.68 0.92 drought_lpat1 gamma-Aminobutyric acid 
145.0696 10.42 negative -1027 -0.98 1.32 drought_lpat1 Glutamine 
88.0754 4.77 positive -1045 -0.95 1.28 drought_lpat1 
130.0494 10.45 positive -2914 -0.99 1.33 drought_lpat1 
147.0759 10.41 positive -3556 -0.98 1.33 drought_lpat1 Glutamine 
192.1411 4.69 positive 432 0.99 1.64 drought_p5cs1 
244.0919 11.74 positive 305 0.87 1.44 drought_p5cs1 
303.0805 8.13 negative 276 0.94 1.56 drought_p5cs1 
212.0582 8.63 positive 274 0.83 1.37 drought_p5cs1 
178.1254 4.76 positive 256 0.99 1.64 drought_p5cs1 
166.0856 6.57 positive 250 0.65 1.08 drought_p5cs1 Phenylalanine 
327.0666 8.11 positive 245 0.98 1.62 drought_p5cs1 
194.0625 7.30 negative 245 0.27 0.44 drought_p5cs1 
131.0514 11.12 negative 244 0.46 0.77 drought_p5cs1 Asparagine 
322.1111 8.09 positive 206 0.97 1.60 drought_p5cs1 
129.0405 4.23 negative -646 -0.71 1.18 drought_p5cs1 
131.0526 10.61 positive -741 -0.99 1.63 drought_p5cs1 
61.9896 10.49 negative -998 -0.38 0.63 drought_p5cs1 
133.0603 11.01 positive -1153 -0.90 1.49 drought_p5cs1 Asparagine 
145.0696 10.42 negative -1183 -0.98 1.63 drought_p5cs1 Glutamine 
84.0441 10.82 positive -1192 -1.00 1.65 drought_p5cs1 
88.0754 4.77 positive -1256 -0.93 1.54 drought_p5cs1 
116.0702 7.32 positive -1325 -0.80 1.32 drought_p5cs1 Proline 
130.0494 10.45 positive -3311 -0.99 1.63 drought_p5cs1 
147.0759 10.41 positive -4031 -0.98 1.63 drought_p5cs1 Glutamine 
148.0599 10.93 positive 1676 0.99 1.24 drought_sos1 Glutamic acid 
133.0603 11.01 positive 1386 0.97 1.23 drought_sos1 Asparagine 
104.1066 0.93 positive 1235 0.93 1.17 drought_sos1 
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104.0702 6.35 positive 1170 0.77 0.97 drought_sos1 gamma-Aminobutyric acid 
114.1022 11.97 positive 1159 0.98 1.23 drought_sos1 
116.0702 7.32 positive 1134 0.86 1.08 drought_sos1 Proline 
66.0681 11.97 positive 1048 0.99 1.24 drought_sos1 
196.0632 7.30 positive 942 0.83 1.04 drought_sos1 
244.0919 11.74 positive 926 0.97 1.22 drought_sos1 
106.0495 11.35 positive 813 0.96 1.21 drought_sos1 Serine 
147.0759 10.41 positive -368 -0.13 0.16 drought_sos1 Glutamine 
130.0494 10.45 positive -406 -0.17 0.21 drought_sos1 
223.0671 5.80 negative -432 -0.95 1.20 drought_sos1 
94.0448 4.82 positive -474 -0.83 1.05 drought_sos1 
129.0405 4.23 negative -480 -0.70 0.88 drought_sos1 
112.9827 9.01 negative -622 -0.97 1.23 drought_sos1 
339.1034 5.80 negative -625 -0.96 1.20 drought_sos1 
112.9827 7.59 negative -857 -1.00 1.26 drought_sos1 
88.0754 4.77 positive -896 -0.92 1.15 drought_sos1 
61.9896 10.49 negative -2027 -0.96 1.21 drought_sos1  
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Figure A-1. PCA score plots of stress resistant or susceptible mutants and wild-type 
in control, cold, and drought treatments. 
In the score plot, the names and colors corresponded to different genotypes (Col-0, abi1, 
dreb2a, fab1, fad5, fad7, lea, lpat1, p5cs1, sos1) and treatments (control, cold, drought).  
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Figure A-2. OPLS-DA score plots of treatment compared to corresponding control. 
Figure A-J show different genotypes in cold treatment compared to control. (A) abi1, (B) Col-0, (C) dreb2a, (D) fab1,  (E) fad5, (F) 
fad7, (G) lea, (H) lpat1, (I) p5cs1, (J) sos1. Figure K-T show different genotypes in drought treatment compared to control. (K) abi1, 
(L) Col-0, (M) dreb2a, (N) fab1,  (O) fad5, (P) fad7, (Q) lea, (R) lpat1, (S) p5cs1, (T) sos1. 
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Figure A-3. OPLS-DA S-plots of treatment compared to corresponding control. 
Figure A-J show different genotypes in cold treatment compared to control. (A) abi1, (B) Col-0, (C) dreb2a, (D) fab1,  (E) fad5, (F) 
fad7, (G) lea, (H) lpat1, (I) p5cs1, (J) sos1. Figure K-T show different genotypes in drought 
treatment compared to control. (K) abi1, (L) Col-0, (M) dreb2a, (N) fab1,  (O) fad5, (P) fad7, (Q) lea, (R) lpat1, (S) p5cs1, (T) sos1.
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Figure A-4. OPLS-DA score plots for mutant compared to corresponding wild-type. 
Figure A-I show different mutants compared to wild-type in control conditions. (A) abi1 
and Col-0, (B) dreb2a and Col-0, (C) fab1 and Col-0,  (D) fad5 and Col-0, (E) fad7 and 
Col-0, (F) lea and Col-0, (G) lpat1 and Col-0, (H) p5cs1 and Col-0, (I) sos1 and Col-0. 
Figure J-R show different mutants compared to wild-type in cold treatment. (J) abi1 and 
Col-0, (K) dreb2a and Col-0, (L) fab1 and Col-0,  (M) fad5 and Col-0, (N) fad7 and Col-
0, (O) lea and Col-0, (P) lpat1 and Col-0, (Q) p5cs1 and Col-0, (R) sos1 and Col-0. 
Figure S-AA show different mutants compared to wild-type in control conditions. (S) 
abi1 and Col-0, (T), dreb2a and Col-0, (U) fab1 and Col-0,  (V) fad5 and Col-0, (W) fad7 
and Col-0, (X) lea and Col-0, (Y) lpat1 and Col-0, (Z) p5cs1 and Col-0, (AA) sos1 and 
Col-0. 
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Figure A-5. OPLS-DA S-plots for mutants compared to corresponding wild-type. 
Figure A-I show different mutants compared to wild-type in control conditions. (A) abi1 
and Col-0, (B) dreb2a and Col-0, (C) fab1 and Col-0,  (D) fad5 and Col-0, (E) fad7 and 
Col-0, (F) lea and Col-0, (G) lpat1 and Col-0, (H) p5cs1 and Col-0, (I) sos1 and Col-0. 
Figure J-R show different mutants compared to wild-type in cold treatment. (J) abi1 and 
Col-0, (K) dreb2a and Col-0, (L) fab1 and Col-0,  (M) fad5 and Col-0, (N) fad7 and Col-
0, (O) lea and Col-0, (P) lpat1 and Col-0, (Q) p5cs1 and Col-0, (R) sos1 and Col-0. 
Figure S-AA show different mutants compared to wild-type in control conditions. (S) 
abi1 and Col-0, (T), dreb2a and Col-0, (U) fab1 and Col-0,  (V) fad5 and Col-0, (W) fad7 
and Col-0, (X) lea and Col-0, (Y) lpat1 and Col-0, (Z) p5cs1 and Col-0, (AA) sos1 and 
Col-0. 
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Figure A-6. HCA for average abundance of all the metabolic features for all ten 
genotypes with all three treatments. 
The top horizontal side bar reflects the log2-transformed average abundance of all 
metabolic features for all genotypes in all treatments. Clusters were generated using the 
Mcquitty method and Euclidean distance function. Seven clusters of treatments are 
labeled 1-7.  
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Figure A-7. HCA for ratios of all the metabolic features in treatment compared to 
the corresponding control. 
The top horizontal side bar reflects the log2-transformed average abundance of all 
metabolic features for all genotypes in all treatments. Clusters were generated using the 
Mcquitty method and Euclidean distance function. Five clusters of treatments are labeled 
1-5.  
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Figure A-8. HCA for ratios of all the metabolic features in mutants compared to the 
corresponding wildtype. 
The top horizontal side bar reflects the log2-transformed average abundance of all 
metabolic features for all genotypes in all treatments. Clusters were generated using the 
Mcquitty method and Euclidean distance function. Seven clusters of treatments are 
labeled 1-7.  
 
 
 
 
